Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGRP,Agouti-related protein,42754,0.279849578563313,0.00486974325204837,0.270304881789298,0.289394275337328,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCN1,CCN family member 1,42569,0.363547063946085,0.0070558630976254,0.34971757227474,0.377376555617431,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CES1,Liver carboxylesterase 1,42661,0.329726462892561,0.00801386330793275,0.314019290809012,0.345433634976109,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HHEX,Hematopoietically-expressed homeobox protein HHEX,40483,0.296326875579909,0.00741024779832824,0.281802789895186,0.310850961264633,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LDLR,Low-density lipoprotein receptor,42644,0.41205348861208,0.00402186512129284,0.404170632974346,0.419936344249814,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LPL,Lipoprotein lipase,42636,-0.197814134993829,0.00458442676941699,-0.206799611461886,-0.188828658525772,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MFGE8,Lactadherin,42611,0.231055812923083,0.00412229049714468,0.22297612354868,0.239135502297487,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPY,Pro-neuropeptide Y,42721,0.348529176730845,0.00606298084281113,0.336645734278935,0.360412619182755,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GHR,Growth hormone receptor,40283,0.110143095274751,0.00279361193299134,0.104667615886088,0.115618574663414,1.11253692939212e-308
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLA2G7,Platelet-activating factor acetylhydrolase,42611,0.128810618510298,0.00330027546679444,0.12234207859538,0.135279158425215,1.11253698024436e-308
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FURIN,Furin,42679,0.125392995121192,0.00324857678217533,0.119025784628128,0.131760205614255,1.25821672994438e-308
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADIPOQ,Adiponectin,40539,-0.2649932819546,0.00683477880540068,-0.278389448413186,-0.251597115496015,1.43397039117401e-308
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGSF9,Protein turtle homolog A,40511,0.317513990837508,0.00819542122194451,0.301450965242497,0.33357701643252,2.05766232718459e-308
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GCG,Pro-glucagon,42346,0.484949482004341,0.0125859280757053,0.460281062975959,0.509617901032724,7.68497063172618e-308
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LCAT,Phosphatidylcholine-sterol acyltransferase,40532,0.083688928750786,0.00219389978852731,0.0793888851652725,0.0879889723362995,1.15233545671019e-299
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMOC1,SPARC-related modular calcium-binding protein 1,42721,0.122805277566018,0.00327642886108478,0.116383476998292,0.129227078133744,1.29245314894884e-292
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42689,0.152217913241536,0.00423618005607197,0.143915000331635,0.160520826151437,4.04237643004787e-270
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRAP1,Proline-rich acidic protein 1,40527,0.14673056224238,0.00414322482826843,0.138609841578974,0.154851282905786,1.1845767027838e-260
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RARRES2,Retinoic acid receptor responder protein 2,42705,0.165329840244877,0.00472591112459324,0.156067054440675,0.17459262604908,9.43205084356999e-257
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INHBC,Inhibin beta C chain,42611,0.143864879904094,0.0041230183207773,0.135783763995371,0.151945995812818,2.04592632699955e-255
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLTP,Phospholipid transfer protein,42752,-0.124457651797121,0.00360915992842833,-0.13153160525684,-0.117383698337401,7.36709757477268e-250
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTH,Parathyroid hormone,40182,0.283526209834748,0.00819408931725039,0.267465794772937,0.299586624896559,4.14441033336913e-249
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F7,Coagulation factor VII,42671,0.107089483195995,0.00312153741766061,0.10097126985738,0.113207696534609,2.30856769491868e-247
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJB1,DnaJ homolog subfamily B member 1,42587,0.296317013770456,0.00870471814933539,0.279255766197759,0.313378261343154,1.13750629753885e-243
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMAD1,Mothers against decapentaplegic homolog 1,42346,0.276996653534011,0.00818572519188016,0.260952632157926,0.293040674910096,9.42689176913356e-241
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL23,C-C motif chemokine 23,42676,0.142810043508281,0.00423083555102678,0.134517605828269,0.151102481188294,7.5846808308082e-240
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL27,C-C motif chemokine 27,42636,0.199754795330502,0.00594078158122391,0.188110863431303,0.2113987272297,4.64160768042991e-238
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NRP1,Neuropilin-1,42705,-0.0923383773696006,0.0028063437568181,-0.0978388111329641,-0.0868379436062371,1.79335114056431e-228
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42721,0.11440767599642,0.0034819885249941,0.107582978487431,0.121232373505408,7.21738329462831e-228
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC39A5,Zinc transporter ZIP5,42594,0.177904760848491,0.00544211837727125,0.167238208829039,0.188571312867943,1.36905713370452e-225
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VPS37A,Vacuolar protein sorting-associated protein 37A,42587,0.261834446452039,0.00801734545575973,0.24612044935875,0.277548443545329,3.62947833595905e-225
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DSG2,Desmoglein-2,42611,-0.0892229829193603,0.00275415126018997,-0.0946211193893326,-0.083824846449388,9.71920482558784e-222
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD4,T-cell surface glycoprotein CD4,42570,0.101623297024409,0.00313712038052222,0.0954745410785852,0.107772052970232,1.09278044394568e-221
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DEFB4A_DEFB4B,Beta-defensin 4A,42477,0.487440827197738,0.0151828447972537,0.457682451395121,0.517199203000356,7.14314192505982e-218
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPR37,Prosaposin receptor GPR37,42357,0.220873363444429,0.00690699882339411,0.207335645750577,0.234411081138282,3.63360183179375e-216
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDKN1A,Cyclin-dependent kinase inhibitor 1,42587,0.33684487911305,0.01056720214576,0.31613316290736,0.357556595318739,5.47328899312843e-215
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C9,Complement component C9,40532,-0.167835443118073,0.00535294833238975,-0.178327221849557,-0.157343664386589,5.08072587257161e-207
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTN3,Contactin-3,42611,0.0983884032859244,0.00316458589258141,0.0921858149364648,0.104590991635384,5.52458062127157e-205
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA5,Plasma serine protease inhibitor,40387,0.0984359990492788,0.00318342835750047,0.0921964794685778,0.10467551862998,1.58737025362436e-201
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPM,Carboxypeptidase M,42655,0.105236299751789,0.00342372780079685,0.098525793262227,0.111946806241351,1.41515842428601e-200
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,42357,0.252513939588441,0.00824110278829179,0.236361378123389,0.268666501053493,3.17692557878456e-199
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMPRSS15,Enteropeptidase,42587,0.281291978560182,0.00927085912581669,0.263121094673582,0.299462862446783,1.25180599345835e-195
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GUSB,Beta-glucuronidase,42711,0.185344924504251,0.00616571380993086,0.173260125436786,0.197429723571715,3.12936499336488e-192
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFBP2,Insulin-like growth factor-binding protein 2,42771,-0.188827056386967,0.00630846720796512,-0.201191652114579,-0.176462460659355,1.09034033859929e-190
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APCS,Serum amyloid P-component,40419,0.103584178795816,0.00345948620269642,0.0968035858385313,0.110364771753101,1.40310998718019e-189
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PROC,Vitamin K-dependent protein C,42663,0.0760181144991065,0.00255450177948039,0.071011291011325,0.0810249379868881,1.58724827708071e-188
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRIP2,Cysteine-rich protein 2,42495,0.110267019627977,0.00372683337457402,0.102962426213812,0.117571613042142,2.21460052054177e-186
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TTR,Transthyretin,40424,0.0759169269398138,0.00255909507354592,0.0709011005956638,0.0809327532839638,2.91522326314155e-186
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFBP1,Insulin-like growth factor-binding protein 1,42770,-0.360982240826694,0.0122357499533778,-0.384964310735315,-0.337000170918074,1.80001885968615e-185
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL6,C-X-C motif chemokine 6,42754,0.2293260192731,0.00778580805262527,0.214065835489955,0.244586203056246,6.89850435049524e-185
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MXRA8,Matrix remodeling-associated protein 8,40283,-0.0931550242914957,0.0031593242961921,-0.0993472999120322,-0.0869627486709592,4.94128092976275e-184
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VMO1,Vitelline membrane outer layer protein 1 homolog,42587,0.20834144138443,0.00708978291915916,0.194445466862878,0.222237415905982,5.34099708894425e-184
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCHE,Cholinesterase,40346,0.083021989693723,0.00282561843088195,0.0774837775691944,0.0885602018182516,7.74995667931597e-183
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42711,0.153160884020557,0.00527608324790754,0.142819760854658,0.163502007186456,8.70100671594015e-180
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSRC1,Proline/serine-rich coiled-coil protein 1,42346,0.173484109778096,0.00601902854247557,0.161686813834844,0.185281405721348,3.38556100373965e-177
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA4,Kallistatin,40342,0.0701055977018353,0.00244797288128476,0.0653075708545172,0.0749036245491534,4.10693017191192e-174
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42613,0.329867562436861,0.0115790468398974,0.307172630630662,0.35256249424306,2.23841203096152e-173
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF21,Fibroblast growth factor 21,42689,0.340101567252475,0.0119485050936777,0.316682497268867,0.363520637236083,4.04408854504038e-173
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNCA,Alpha-synuclein,40283,0.332284542528072,0.0116841120072157,0.309383682993929,0.355185402062214,8.87767114324565e-172
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASGR1,Asialoglycoprotein receptor 1,42495,0.0879118822048937,0.00311396981067804,0.0818085013759648,0.0940152630338227,2.40307942123033e-170
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PON3,Serum paraoxonase/lactonase 3,42676,-0.0818523825492899,0.00290460912417039,-0.0875454164326638,-0.0761593486659159,8.12925712744921e-170
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHMP6,Charged multivesicular body protein 6,40511,0.159514784011185,0.00568842545784192,0.148365470113815,0.170664097908555,2.42569872758742e-167
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AFM,Afamin,40539,0.0564260377778513,0.00202886972971685,0.0524494531076062,0.0604026224480963,9.76668537842475e-165
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42495,0.206166673207946,0.00743442868140497,0.191595192992392,0.2207381534235,1.34155708315387e-164
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERP44,Endoplasmic reticulum resident protein 44,42569,0.0721649767436538,0.00260504243472072,0.0670590935716012,0.0772708599157064,2.73395109991523e-164
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFP,Properdin,40539,0.0627702118963733,0.00227145671502282,0.0583181567349286,0.067222267057818,9.78780419501932e-163
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD300LG,CMRF35-like molecule 9,42611,-0.108336732196563,0.00393174927752657,-0.116042960780515,-0.100630503612611,1.26440693098353e-162
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLA2G10,Group 10 secretory phospholipase A2,42495,-0.165766095142622,0.00602522137564886,-0.177575529038894,-0.15395666124635,4.15844237611524e-162
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAMP2,Lysosome-associated membrane glycoprotein 2,42238,0.0554904802242058,0.00201960544689555,0.0515320535482905,0.0594489069001211,1.29722804955262e-161
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLAT,Tissue-type plasminogen activator,42760,0.141609563014834,0.00515864495369684,0.131498618905588,0.15172050712408,1.68120009913217e-161
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAMR1,Inactive serine protease PAMR1,42611,0.0748279565030529,0.002734341351402,0.069468647454305,0.0801872655518008,1.70346966204438e-160
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFH,Complement factor H,39956,0.0632911527283336,0.00232872957840587,0.0587268427546581,0.0678554627020092,2.22516786820518e-157
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSTA3,Glutathione S-transferase A3,42346,0.21141788037267,0.00780379634783893,0.196122439530905,0.226713321214434,2.46307328942112e-157
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGR3,Anterior gradient protein 3,42326,0.165617450189135,0.00612204160281607,0.153618248647616,0.177616651730655,6.80624750199361e-157
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,42357,0.151842426478803,0.00566465236656858,0.140739707840329,0.162945145117278,3.70879830302298e-154
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SHBG,Sex hormone-binding globulin,40532,-0.137277470541199,0.00515140305933092,-0.147374220537488,-0.127180720544911,8.30443345911871e-152
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUMB,Protein numb homolog,40199,0.223103003340969,0.00837603050110677,0.206685983558799,0.239520023123138,1.55668974570824e-151
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FLI1,Friend leukemia integration 1 transcription factor,42346,0.297236573996837,0.0112350715946027,0.275215833671416,0.319257314322259,2.56488826116757e-150
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFI,Complement factor I,40539,0.0527227218162725,0.00199723437771969,0.0488081424359419,0.0566373011966031,4.36041173074493e-149
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINF1,Pigment epithelium-derived factor,40351,0.0719142904343809,0.0027235898865237,0.0665760542567945,0.0772525266119674,4.39763903049905e-149
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SKAP1,Src kinase-associated phosphoprotein 1,42476,0.198397608444529,0.00754114404519455,0.183616966115948,0.213178250773111,9.54109109187042e-149
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERBB3,Receptor tyrosine-protein kinase erbB-3,42586,0.0510138942218028,0.00194206328235349,0.0472074501883899,0.0548203382552156,2.4721533913781e-148
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANGPTL2,Angiopoietin-related protein 2,42640,0.107553485700062,0.00410925797344708,0.0994993400721056,0.115607631328018,2.52934529284191e-147
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACY1,Aminoacylase-1,42636,0.16174873107178,0.00618835682158875,0.149619551701466,0.173877910442094,6.1990032689331e-147
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPHA1,Ephrin type-A receptor 1,42658,0.088271331140319,0.0033816275698106,0.0816433411034902,0.0948993211771478,1.43973855796979e-146
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLA,Alpha-galactosidase A,40267,0.0992866234850597,0.00380238045495532,0.0918339577933473,0.106739289176772,6.62647032014509e-146
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOS3,"Nitric oxide synthase, endothelial",42311,0.14601033016605,0.00560804712621388,0.135018557798671,0.157002102533429,9.48894380383406e-146
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAT2,Linker for activation of T-cells family member 2,42587,0.327995085830227,0.0126171826840886,0.303265407769413,0.352724763891041,2.15783955237366e-145
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL16,C-C motif chemokine 16,42794,0.139077073935228,0.0053522412827745,0.12858668102099,0.149567466849466,2.51394129206069e-145
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TFPI,Tissue factor pathway inhibitor,42618,0.0822041019459107,0.00317056712372794,0.0759897903834039,0.0884184135084174,1.15905765434383e-144
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LATS1,Serine/threonine-protein kinase LATS1,40199,0.223744846317544,0.00861235369098396,0.206864633083216,0.240625059551873,1.81025632826579e-144
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENO3,Beta-enolase,40223,0.156124363110405,0.00602231461404681,0.144320626466873,0.167928099753937,6.85508065599789e-144
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMAD2,Mothers against decapentaplegic homolog 2,40451,0.182914648795487,0.0070671661715986,0.169063003099154,0.19676629449182,1.5811686687093e-143
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BPIFB1,BPI fold-containing family B member 1,42573,-0.165084298141425,0.0064075395632118,-0.17764307568532,-0.152525520597529,6.65030448514464e-143
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,P4HB,Protein disulfide-isomerase,42563,0.100801795703704,0.00392209590390337,0.093114487732053,0.108489103675354,3.14716309228419e-142
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UPB1,Beta-ureidopropionase,40511,0.235596566365578,0.00918747636214778,0.217589112695768,0.253604020035387,5.10910665902766e-141
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOMO1,Nodal modulator 1,42611,0.0606793122391707,0.0023716314721342,0.0560309145537877,0.0653277099245537,5.18039445254761e-141
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CKB,Creatine kinase B-type,40527,-0.157160769930993,0.00617591863796314,-0.1692655704614,-0.145055969400585,5.76539874800425e-139
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DTYMK,Thymidylate kinase,40511,0.176459063692884,0.00694248810310002,0.162851787010808,0.19006634037496,1.20485977768581e-138
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNAPIN,SNARE-associated protein Snapin,40482,0.148534540482729,0.00588402343007167,0.137001854559789,0.16006722640567,7.94274004060125e-137
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSTA1,Glutathione S-transferase A1,42611,0.212628120860417,0.00844386488877514,0.196078145678418,0.229178096042416,9.36561739137955e-137
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",40223,0.147498783075296,0.0058462255122415,0.136040181071303,0.15895738507929,1.34975303116551e-136
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F9,Coagulation factor IX,42663,0.0465913224360012,0.00185218369256517,0.0429610423985735,0.050221602473429,1.72771995405579e-136
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,40449,0.355893854236933,0.0141349347748151,0.328189382078296,0.383598326395571,3.88474512642794e-136
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBP5,Retinol-binding protein 5,42587,0.143360856790826,0.00572648308234343,0.132136949949433,0.154584763632219,3.21217023067892e-135
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOTCH3,Neurogenic locus notch homolog protein 3,42794,-0.0875848741821276,0.00350522418526902,-0.0944551135852549,-0.0807146347790003,9.07345200875542e-135
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGFR2,Fibroblast growth factor receptor 2,42679,0.0572028566132295,0.00229772320008967,0.0526993191410537,0.0617063940854053,8.54652457536201e-134
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42689,-0.0957287104876361,0.0038530148297978,-0.10328061955404,-0.0881768014212324,2.81848249922557e-133
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,42443,0.122940015309572,0.00497173501120355,0.113195414687613,0.132684615931531,5.16467333152514e-132
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,42346,0.171727898903168,0.00697038065591342,0.158065952817578,0.185389844988758,4.65631226859071e-131
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTSS1,Protein MTSS 1,40449,0.282062018627175,0.011427324539154,0.259664462530433,0.304459574723916,4.77001229057834e-131
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,40116,0.171191018403139,0.00694577858652656,0.157577292373547,0.184804744432731,1.41226602511391e-130
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRCP,Lysosomal Pro-X carboxypeptidase,42733,0.0794488541004063,0.00323420549944325,0.0731098113214975,0.0857878968793151,2.08689051280437e-130
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPIND1,Heparin cofactor 2,40516,0.0707658998600858,0.00287833112955407,0.0651243708461598,0.0764074288740118,4.45812813763658e-130
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KYNU,Kynureninase,42754,0.111410120868613,0.0045674749350486,0.102457869995918,0.120362371741308,1.20431024663875e-128
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL16,Pro-interleukin-16,42754,0.103405531800097,0.00424426973309752,0.095086763123226,0.111724300476968,2.34561539480813e-128
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNAP29,Synaptosomal-associated protein 29,42679,0.227828086373145,0.00935837141089772,0.209485678407786,0.246170494338505,3.75917232196737e-128
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL13,C-X-C motif chemokine 13,42711,0.15640990395796,0.00643980866477012,0.143787878975011,0.169031928940909,1.39674982566515e-127
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPY30,Protein dpy-30 homolog,42651,0.149594169837994,0.00619153899155057,0.137458753414555,0.161729586261433,2.74457206222999e-126
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLUL1,Clusterin-like protein 1,42621,-0.111255468814433,0.00461618686952564,-0.120303195078703,-0.102207742550163,1.11430751932934e-125
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EEF1D,Elongation factor 1-delta,40511,0.225527854516816,0.00936314571169185,0.2071760889219,0.243879620111732,4.68269941623178e-125
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SYAP1,Synapse-associated protein 1,40283,0.141121457590184,0.0058670783485816,0.129621984026965,0.152620931153404,1.16868495889782e-124
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1RN,Interleukin-1 receptor antagonist protein,42585,0.134164968990039,0.00559447484921592,0.123199798285576,0.145130139694502,1.78571048761613e-124
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRP,Gastrin-releasing peptide,40223,0.138169373101829,0.0057543806181856,0.126890787090185,0.149447959113473,3.17031309348056e-124
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FYB1,FYN-binding protein 1,42590,0.225865879437795,0.00943112069539189,0.207380882874827,0.244350876000763,3.7820133648527e-124
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YES1,Tyrosine-protein kinase Yes,42587,0.277301434518885,0.0116354991245216,0.254495856234823,0.300107012802947,5.50807323107922e-123
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42587,0.0822301259867298,0.00345136677834038,0.0754654471011827,0.088994804872277,6.46310178580948e-123
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ABL1,Tyrosine-protein kinase ABL1,42587,0.163509258622804,0.00686309154399653,0.150057599196571,0.176960918049037,6.60494614954002e-123
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HJV,Hemojuvelin,40482,0.108028146620755,0.00452557460968882,0.0991580203857649,0.116898272855745,6.66844829695729e-123
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RTN4R,Reticulon-4 receptor,42721,0.0840494025897432,0.00354429716239148,0.0771025801514559,0.0909962250280305,7.7922942587428e-122
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SORT1,Sortilin,42613,0.0900521685552494,0.00379730470696607,0.0826094513295959,0.0974948857809028,8.00547299880262e-122
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYH9,Myosin-9,40527,0.278547318046395,0.0117454656038063,0.255526205462935,0.301568430629856,2.20450749223649e-121
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDHR5,Cadherin-related family member 5,42636,0.0942494297057787,0.0039853428474867,0.0864381577247048,0.102060701686853,3.54392079956707e-121
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42587,0.0967298443750044,0.00409627422517225,0.0887011468936667,0.104758541856342,7.99519430444066e-121
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAA80,N-alpha-acetyltransferase 80,40182,0.292210275000108,0.0123652337493133,0.267974416851454,0.316446133148762,1.79067220680049e-120
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42587,0.105650396555259,0.00448437254440051,0.0968610263682341,0.114439766742284,2.74801465605731e-120
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IPCEF1,Interactor protein for cytohesin exchange factors 1,42475,0.214169846665228,0.0091460727523402,0.196243544070641,0.232096149259815,7.29459706611718e-119
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MEGF9,Multiple epidermal growth factor-like domains protein 9,42760,0.046462203199134,0.0019875115604242,0.0425666805407026,0.0503577258575655,1.58688304651965e-118
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SARG,Specifically androgen-regulated gene protein,40456,0.259744011832628,0.0111428728009456,0.237903981142775,0.281584042522482,2.04315866160387e-117
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F11R,Junctional adhesion molecule A,42611,0.132690954742471,0.0057092697832517,0.121500785967298,0.143881123517645,3.54001282988224e-117
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATRN,"Attractin, Isoform 2",40539,0.0398735205219845,0.00172250941345042,0.0364974020716216,0.0432496389723473,7.1111109460892e-116
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AP1G2,AP-1 complex subunit gamma-like 2,40451,0.187601670547378,0.00811179178508328,0.171702558648615,0.203500782446141,1.19834067095308e-115
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGSF8,Immunoglobulin superfamily member 8,42636,0.0728433436007908,0.00315643362585037,0.0666567336941241,0.0790299535074575,1.34877796223297e-115
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TJAP1,Tight junction-associated protein 1,42679,0.195063920344176,0.00846501852206912,0.17847248404092,0.211655356647431,2.83900150818234e-115
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42594,0.228462867190113,0.00992131288842774,0.209017093928794,0.247908640451431,4.18422447224706e-115
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MASP1,Mannan-binding lectin serine protease 1,42476,0.0556264316062081,0.00241642018205208,0.050890248049386,0.0603626151630302,5.143304946947e-115
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OXT,Oxytocin-neurophysin 1,42711,0.32772233936645,0.0142471959154395,0.299797835372189,0.355646843360712,6.96216715298746e-115
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CREG1,Protein CREG1,42445,0.0912279237902614,0.00397065088761835,0.0834454480505294,0.0990103995299934,1.3987616585371e-114
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FTCD,Formimidoyltransferase-cyclodeaminase,40462,0.201920788725511,0.00878891851524274,0.184694508435635,0.219147069015386,3.44526608940322e-114
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GH1,Somatotropin,42613,-0.404966857824722,0.0176772971832914,-0.439614360303973,-0.370319355345471,5.74278559706222e-114
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD2AP,CD2-associated protein,42636,0.149795152925181,0.00654478753749142,0.136967369351697,0.162622936498664,9.08743734607531e-114
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM20A,Pseudokinase FAM20A,40511,0.0663507811885268,0.00290606008136686,0.0606549034290478,0.0720466589480059,7.66395221283097e-113
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STC1,Stanniocalcin-1,42711,0.105991936721556,0.00465728385356297,0.0968636603685723,0.115120213074539,1.52740831375831e-112
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KDR,Vascular endothelial growth factor receptor 2,42679,0.0579162730259361,0.00254522945019705,0.0529276233035498,0.0629049227483223,1.66740467171648e-112
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BECN1,Beclin-1,40223,0.140283539927072,0.00615374006426248,0.128222209401118,0.152344870453027,1.92459047946513e-112
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CES3,Carboxylesterase 3,42587,0.164950993351735,0.00725929906729463,0.150722767179837,0.179179219523632,3.48467955106951e-112
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERBB2,Receptor tyrosine-protein kinase erbB-2,42679,0.0552232358364166,0.00243066333222079,0.0504591357052638,0.0599873359675693,3.62722549265398e-112
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SELPLG,P-selectin glycoprotein ligand 1,42594,0.0643133027039338,0.00283573744331845,0.0587552573150296,0.0698713480928379,8.94360653455632e-112
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJC6,Putative tyrosine-protein phosphatase auxilin,40223,0.196274698708051,0.00863819439388209,0.179343837696042,0.21320555972006,9.80178723028119e-112
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HEG1,Protein HEG homolog 1,40283,0.0628940768024769,0.0027737072906255,0.057457610512851,0.0683305430921029,2.61833644672341e-111
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJA2,DnaJ homolog subfamily A member 2,42721,0.188798269893591,0.00834363748339387,0.172444740426139,0.205151799361043,2.65354737456517e-111
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42587,0.225553143087198,0.00997611904352692,0.205999949761885,0.24510633641251,4.16265932903785e-111
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIMP4,Metalloproteinase inhibitor 4,42611,-0.0958007685776286,0.00426060713415551,-0.104151558560573,-0.0874499785946838,6.14600349642904e-110
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXLNA,Alpha-taxilin,42495,0.202943684229322,0.0090285537594275,0.185247718860844,0.2206396495978,7.4852303321882e-110
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MLN,Promotilin,42594,0.205545938409817,0.00915497596344106,0.187602185521473,0.223489691298162,1.27617947753372e-109
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAPK9,Mitogen-activated protein kinase 9,42594,0.0973954230055086,0.00434554126902652,0.0888781621182166,0.105912683892801,2.97707241227661e-109
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STAB2,Stabilin-2,40527,0.0647552650289494,0.00288745189330245,0.0590958593180766,0.0704146707398222,5.01837629146614e-109
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIT1,Signaling threshold-regulating transmembrane adapter 1,42370,0.128477519036976,0.00574607860958701,0.117215204962185,0.139739833111766,1.0224413497394e-108
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLKB1,Plasma kallikrein,40293,0.0565434392064979,0.00253704534628714,0.0515708303277751,0.0615160480852207,1.11152940760057e-107
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAXX,Protein PAXX,40283,0.103917861357245,0.00467439538906742,0.0947560463946726,0.113079676319817,3.6781007625875e-107
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPPC,C-type natriuretic peptide,42594,0.114824330984348,0.00517752547427357,0.104676381054771,0.124972280913924,4.72886725080169e-107
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F10,Coagulation factor X,40532,0.0646184854063463,0.00292099106058687,0.058893342927596,0.0703436278850966,3.35538361389006e-106
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100A4,Protein S100-A4,42679,0.129567964184949,0.0058681590722705,0.118066372403299,0.141069555966599,3.7160435644191e-106
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42495,0.121378771955375,0.00550534461899169,0.110588296502151,0.132169247408599,7.86012214270235e-106
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL18R1,Interleukin-18 receptor 1,42754,0.0749068063030099,0.0034049066497065,0.0682331892695852,0.0815804233364347,2.00566041212986e-105
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,40302,0.253520981359844,0.0115039971340534,0.230973146977099,0.276068815742588,2.22988811790091e-105
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HGF,Hepatocyte growth factor,42754,0.0789267393732519,0.00359319303382022,0.0718840810269643,0.0859693977195396,4.13693571276808e-105
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCTN1,Dynactin subunit 1,42721,0.146286045974245,0.00666146850029482,0.133229567713667,0.159342524234823,4.70649464711811e-105
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,40465,0.181941262566381,0.00828402361662128,0.165704576277804,0.198177948854959,1.00624645096566e-104
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YTHDF3,YTH domain-containing family protein 3,42370,0.191638243068463,0.00874279766683697,0.174502359641463,0.208774126495463,1.23920870676594e-104
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DAAM1,Disheveled-associated activator of morphogenesis 1,40283,0.187837462079027,0.00856428832206802,0.171051456967773,0.20462346719028,2.06392564600533e-104
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,40283,0.0488564644605091,0.00222757355178681,0.0444904202990069,0.0532225086220112,2.06601076934678e-104
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL17,C-X-C motif chemokine 17,42754,0.0916752739263735,0.00419072812746528,0.0834614467965416,0.0998891010562055,2.78513991967122e-104
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YOD1,Ubiquitin thioesterase OTU1,40116,0.143203032978559,0.00653683035153501,0.13039084548955,0.156015220467568,3.80959662993261e-104
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BANK1,B-cell scaffold protein with ankyrin repeats,42594,0.238126341325031,0.0108954905806523,0.216771179786952,0.259481502863109,4.48573226019662e-104
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,40449,0.0683984710837451,0.00312645605560715,0.0622706172147551,0.0745263249527351,6.14906119117112e-104
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,40483,0.0899384052933837,0.00411204202723594,0.0818788029200012,0.0979980076667661,6.78332379491988e-104
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AXIN1,Axin-1,42594,0.212855008472467,0.00975170435019575,0.193741667946083,0.23196834899885,8.11130658723362e-104
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDHR2,Cadherin-related family member 2,42587,0.158070362159775,0.00728609033146867,0.143789625110097,0.172351099209454,1.32871793649695e-102
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSD,Cathepsin D,41747,0.0944187946647273,0.0043498465627315,0.0858930954017735,0.102944493927681,1.36307862274634e-102
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCN2,Ficolin-2,42597,0.0915022463368826,0.00423997980715873,0.0831918859148515,0.0998126067589137,1.44340234305035e-101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTSS2,Protein MTSS 2,40451,0.218621221717825,0.0101475503034128,0.198732023123136,0.238510420312515,6.44399446442756e-101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LDLRAP1,Low density lipoprotein receptor adapter protein 1,40482,0.214796656981583,0.0100125987532688,0.195171963425176,0.23442135053799,4.23716926677503e-100
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AP3S2,AP-3 complex subunit sigma-2,40483,0.105139857744607,0.00490141775508378,0.0955330789446431,0.114746636544572,4.38965686188967e-100
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PROS1,Vitamin K-dependent protein S,40539,0.057792773711795,0.00269581909147533,0.0525089682925034,0.0630765791310867,5.61416717796396e-100
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNF41,E3 ubiquitin-protein ligase NRDP1,42346,0.145549756089783,0.00680872190033212,0.132204661165132,0.158894851014434,1.07831628060055e-99
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SORD,Sorbitol dehydrogenase,42658,0.147222312474292,0.00689939532239077,0.133699497642406,0.160745127306178,2.19144550172878e-99
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,42346,0.141632485892848,0.00665690698423876,0.12858494820374,0.154680023581956,8.6766549970657e-99
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KHK,Ketohexokinase,40223,0.137720575389002,0.00646479836466111,0.125049570594266,0.150391580183738,1.01897799212421e-98
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARF6,ADP-ribosylation factor 6,40449,0.234563713153629,0.0110332838470334,0.212938476813444,0.256188949493815,2.27392514680227e-98
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP6V1G1,V-type proton ATPase subunit G 1,40223,0.158342412421194,0.00745432375319674,0.143731937864928,0.17295288697746,3.58772056729794e-98
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD63,CD63 antigen,42475,0.111727282050574,0.00527172640772306,0.101394698291437,0.122059865809711,4.55632671122069e-98
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTS,6-pyruvoyl tetrahydrobiopterin synthase,42250,0.120670537688121,0.00569900984925504,0.109500478383581,0.131840596992661,7.27458535013146e-98
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CANT1,Soluble calcium-activated nucleotidase 1,42580,0.0448071706859261,0.00211719235461367,0.0406574736708833,0.0489568677009689,8.23170669544055e-98
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42679,0.080634661054636,0.0038135457889429,0.0731601113083079,0.0881092108009641,1.18906865742546e-97
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL22,C-C motif chemokine 22,42509,0.115782127559821,0.00547874872428595,0.105043780060221,0.126520475059422,1.56953456732914e-97
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCLY,Selenocysteine lyase,42674,0.101792832201147,0.00482798738582438,0.092329976924931,0.111255687477363,4.10038069218219e-97
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZBTB16,Zinc finger and BTB domain-containing protein 16,42346,0.156757237178156,0.00743484398538539,0.1421849429668,0.171329531389511,4.45630592328399e-97
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,40283,0.108065169157068,0.00512128274167638,0.0980274549833818,0.118102883330753,6.14985852057165e-97
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRSS8,Prostasin,42568,0.0913863176519345,0.00433828392676056,0.0828832811554838,0.0998893541483852,6.19523950263845e-97
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEMA3F,Semaphorin-3F,42636,0.0590413567652655,0.00280331199688247,0.0535468652513759,0.0645358482791552,6.57642473467177e-97
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDGFC,Platelet-derived growth factor C,42346,0.0620873459161234,0.00295077074500103,0.0563038352559214,0.0678708565763254,1.07391690071373e-96
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EHBP1,EH domain-binding protein 1,40511,0.16061917572153,0.00764764276470678,0.145629795902705,0.175608555540356,4.19117707137632e-96
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ISM1,Isthmin-1,42594,0.0834166358443467,0.00397794679757792,0.075619860121094,0.0912134115675994,4.29735742485368e-96
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP85,Centrosomal protein of 85 kDa,42346,0.138424435806471,0.00660543774660083,0.125477777823134,0.151371093789809,6.0539118769325e-96
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADH1B,All-trans-retinol dehydrogenase,40283,0.160340347259097,0.00767166127317763,0.145303891163669,0.175376803354526,3.58608250565279e-95
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,40511,0.159876649618952,0.00765586073036513,0.144871162587436,0.174882136650467,4.6917011181121e-95
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TARBP2,RISC-loading complex subunit TARBP2,42311,0.167776606394087,0.00805176178134197,0.151995153302656,0.183558059485517,6.80158596015289e-95
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GCC1,GRIP and coiled-coil domain-containing protein 1,40483,0.230597882793509,0.0110522450356862,0.208935482523564,0.252260283063454,6.88718208642468e-95
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFBP3,Insulin-like growth factor-binding protein 3,42689,0.0681560304213654,0.00328066616326208,0.0617259247413717,0.0745861361013591,2.16934046472527e-94
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPY,Pancreatic prohormone,42600,0.222218559663356,0.0107134043863084,0.201220287066192,0.243216832260521,4.30930551195982e-94
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAMDC4,Apical endosomal glycoprotein,40451,0.117849690441112,0.00567613251416021,0.106724470713358,0.128974910168866,5.40852008612949e-94
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGRN,Agrin,42676,0.0779218776899917,0.00376101684602179,0.070550284671789,0.0852934707081944,6.83029083357391e-94
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP1R9B,Neurabin-2,42754,0.200120936706439,0.00966214083616682,0.181183140667552,0.219058732745326,7.62928984910593e-94
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MVK,Mevalonate kinase,42370,0.171034912817546,0.00825933896798342,0.154846608440299,0.187223217194794,9.05779697237378e-94
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KAZN,Kazrin,40449,0.22262286365684,0.0107404408266061,0.201571599636692,0.243674127676988,1.08629436031814e-93
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LECT2,Leukocyte cell-derived chemotaxin-2,40511,0.143304775220106,0.00691424494652908,0.129752855124909,0.156856695315303,1.09596770753515e-93
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCS1,Neuronal calcium sensor 1,42721,0.0617757735513553,0.00299133597021394,0.055912755049736,0.0676387920529746,2.58315213974758e-93
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERBIN,Erbin,42587,0.217089671797992,0.01051743382122,0.196475501508401,0.237703842087583,3.30237881856365e-93
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",40408,0.231429252807815,0.0112233153693065,0.209431554683975,0.253426950931656,9.35255662940459e-93
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGEF12,Rho guanine nucleotide exchange factor 12,42594,0.220158884537901,0.0106932358786104,0.199200142215824,0.241117626859977,9.40144918025873e-93
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PYY,Peptide YY,40116,0.218387484539334,0.0106008276814903,0.197609862283613,0.239165106795055,1.5251786141837e-92
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IKBKG,NF-kappa-B essential modulator,42594,0.192909399915545,0.0093899705549743,0.174505057627795,0.211313742203295,2.28388569376702e-92
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFX1,Transcriptional repressor NF-X1,40116,0.14448184339408,0.00702179799739231,0.130719119319191,0.158244567468969,2.49600310752552e-92
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFKBIE,NF-kappa-B inhibitor epsilon,42346,0.104983533956453,0.00512294542178695,0.0949425609297501,0.115024506983155,6.75582300595644e-92
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EZR,Ezrin,42711,0.0505201728762282,0.0024678092203128,0.0456832668044151,0.0553570789480412,9.43158953915236e-92
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EFCAB14,EF-hand calcium-binding domain-containing protein 14,40449,0.0621106794649659,0.00303074781584821,0.0561704137459034,0.0680509451840284,1.1460433512641e-91
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFKB1,Nuclear factor NF-kappa-B p105 subunit,40116,0.155282473485719,0.00760323254089635,0.140380137705563,0.170184809265876,5.14969073130152e-91
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF4B,Eukaryotic translation initiation factor 4B,42495,0.120854930778256,0.00594139202329187,0.109209802412604,0.132500059143908,1.3203396628461e-90
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL10,C-X-C motif chemokine 10,42676,0.1417261695624,0.00699651671028766,0.128012996810236,0.155439342314564,6.71755052382505e-90
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP20,Centrosomal protein 20,42346,0.156538703392972,0.00773168911105925,0.141384592735296,0.171692814050649,8.8732514514615e-90
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDLIM7,PDZ and LIM domain protein 7,42676,0.257727853591265,0.0127586811649762,0.232720838507912,0.282734868674619,2.04150127656186e-89
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATG16L1,Autophagy-related protein 16-1,40449,0.176156520555482,0.00870884022395401,0.159087193716532,0.193225847394432,2.16185457649987e-89
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LSP1,Lymphocyte-specific protein 1,42594,0.0829493986749549,0.00411360588234297,0.0748867311455627,0.0910120662043471,4.17859682276849e-89
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NHLRC3,NHL repeat-containing protein 3,40013,0.0671812348160779,0.00333082676301918,0.0606528143605603,0.0737096552715955,7.70528805715752e-89
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLXNA4,Plexin-A4,42594,0.170418485410437,0.00846769676504236,0.153821799750954,0.18701517106992,8.96156805351897e-89
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCR,Breakpoint cluster region protein,42594,0.189317989959064,0.00941036694730212,0.170873670742352,0.207762309175776,1.04187448187179e-88
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRB,Receptor-type tyrosine-protein phosphatase beta,40511,0.0613809369621561,0.00305102371539377,0.0554009304799843,0.0673609434443279,1.78608487154677e-88
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNIP1,TNFAIP3-interacting protein 1,40483,0.183947094018835,0.00915379020045938,0.166005665225934,0.201888522811735,2.81635283998736e-88
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42570,0.2178728302335,0.0108598057949119,0.196587610875473,0.239158049591528,3.11256298910506e-88
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DAB2,Disabled homolog 2,42721,0.225500368897969,0.0112717497921586,0.203407739305338,0.2475929984906,9.07108376704905e-88
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SOST,Sclerostin,42613,0.0805477862586714,0.00403065319496049,0.0726477059965489,0.088447866520794,1.42427264015503e-87
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLA2,Src-like-adapter 2,40482,0.213587798313536,0.0107093939885687,0.192597386095941,0.234578210531131,5.27994214294888e-87
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42754,0.201455906740777,0.0101278939674105,0.181605234564653,0.221306578916902,8.34881862579047e-87
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUCB2,Nucleobindin-2,42683,0.0759739432334503,0.00382226237217043,0.0684823089839963,0.0834655774829043,1.12190308827182e-86
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TOP2B,DNA topoisomerase 2-beta,40199,0.163563366487512,0.00821929888527197,0.147453540672379,0.179673192302645,1.34566132817746e-86
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC1B,C-type lectin domain family 1 member B,42711,0.19538350741142,0.00984177000362203,0.176093638204321,0.214673376618519,1.78220868198839e-86
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RLN2,Prorelaxin H2,40257,0.102652913234819,0.00516348807914628,0.0925324765996919,0.112773349869945,1.9195441507008e-86
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DKK1,Dickkopf-related protein 1,42711,0.120326314751446,0.00606797105216217,0.108433091489208,0.132219538013684,2.76551577540185e-86
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,40277,0.0952300239962438,0.00480324832082407,0.0858156572874286,0.104644390705059,5.42421381208086e-86
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STAT5B,Signal transducer and activator of transcription 5B,42587,0.27961980177846,0.0141449009955417,0.251895795827198,0.307343807729722,9.28991333131465e-86
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC4A,C-type lectin domain family 4 member A,42594,-0.0720873620008624,0.00364716135561937,-0.0792357982578764,-0.0649389257438484,9.81049889318312e-86
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IRAK1,Interleukin-1 receptor-associated kinase 1,42370,0.139055154443179,0.00704036096626496,0.125256046949299,0.152854261937058,1.35087393299659e-85
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLEKHO1,Pleckstrin homology domain-containing family O member 1,40483,0.141137197699012,0.00714023286407778,0.12714234128542,0.155132054112605,1.60377410895929e-85
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINF2,Alpha-2-antiplasmin,40317,0.0276561773943936,0.00139958135484178,0.0249129979389037,0.0303993568498835,1.89363102788777e-85
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BTD,Biotinidase,40539,0.0420570591509397,0.00212976014510081,0.0378827292665421,0.0462313890353373,2.27728217956355e-85
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAK4,Serine/threonine-protein kinase PAK 4,42311,0.123807341546549,0.00627699375917686,0.111504433778562,0.136110249314536,2.30508093861676e-85
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTBS,Di-N-acetylchitobiase,40383,0.0546969275511354,0.00277104985023596,0.0492656698446729,0.0601281852575979,2.80872291325057e-85
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BACH1,Transcription regulator protein BACH1,42594,0.148690190747633,0.00754960341038377,0.133892968063281,0.163487413431986,3.78455268084188e-85
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD6,T-cell differentiation antigen CD6,42746,0.107413888115755,0.00546445962793613,0.0967035472450007,0.11812422898651,7.64952866983405e-85
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SDCCAG8,Serologically defined colon cancer antigen 8,40451,0.230621086605442,0.0117286197456491,0.20763299190397,0.253609181306914,1.16630650420728e-84
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HBEGF,Proheparin-binding EGF-like growth factor,42674,0.147160829569253,0.00752204480279239,0.13241762175578,0.161904037382726,4.58019452408388e-84
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SRPK2,SRSF protein kinase 2,42594,0.168323417192206,0.00861818896470886,0.151431766821376,0.185215067563035,8.6854091905146e-84
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TANK,TRAF family member-associated NF-kappa-B activator,42370,0.139716258462378,0.00717466349986655,0.125653918002639,0.153778598922116,2.71497318613595e-83
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSIP1,PC4 and SFRS1-interacting protein,42594,0.129571230147463,0.00665968690329783,0.116518243817,0.142624216477927,3.62158411934464e-83
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL4A1,Collagen alpha-1(IV) chain,42636,-0.0804663647906309,0.00413706816605598,-0.0885750183961007,-0.0723577111851612,4.02243727795563e-83
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCK2,Cytoplasmic protein NCK2,42676,0.210099192356439,0.0108080004071372,0.18891551155845,0.231282873154428,4.90515004742191e-83
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRELD2,Protein disulfide isomerase CRELD2,42654,0.104251540454722,0.00536348781617682,0.0937391043350158,0.114763976574429,5.11247513095292e-83
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGFB1,Transforming growth factor beta-1 proprotein,42746,0.0765727260538487,0.00394038545856808,0.0688495705550553,0.0842958815526422,5.46791069112369e-83
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FETUB,Fetuin-B,42663,0.0646871335075696,0.00332978484469476,0.0581607552119679,0.0712135118031713,6.22098002530444e-83
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB11FIP3,Rab11 family-interacting protein 3,40511,0.214342050502874,0.011021614730146,0.192739685631788,0.23594441537396,6.85333615047034e-83
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSME1,Proteasome activator complex subunit 1,42480,0.0746147553809339,0.00384571691005186,0.0670771502372323,0.0821523605246356,1.03011819417332e-82
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNAP23,Synaptosomal-associated protein 23,42636,0.173546446171164,0.0089528069946924,0.155998944461566,0.191093947880761,1.39079690862493e-82
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42582,0.0543380361260035,0.00280450536316531,0.0488412056141995,0.0598348666378075,1.67578735603949e-82
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFE2,Transcription factor NF-E2 45 kDa subunit,40223,0.149231894204184,0.0076923240919978,0.134154938983868,0.164308849424499,1.80870914704536e-82
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MCAM,Cell surface glycoprotein MUC18,42689,-0.067375340831074,0.00348385720577912,-0.0742037009544011,-0.060546980707747,3.23927568982357e-82
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ELN,Elastin,40511,0.0734775702270434,0.00379721517250728,0.0660350284889291,0.0809201119651576,4.25851800498465e-82
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDCD5,Programmed cell death protein 5,42711,0.114796750479203,0.00595550468014152,0.103123961306126,0.12646953965228,1.06826924861987e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBPMS2,RNA-binding protein with multiple splicing 2,40223,0.204216291201983,0.0105815088381856,0.183476533879139,0.224956048524826,1.1978388618659e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMBP,Protein AMBP,42706,0.0417898611509448,0.00217125664470236,0.0375341981273282,0.0460455241745614,1.84020814436618e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OTUD7B,OTU domain-containing protein 7B,40482,0.123281700451956,0.0063987491364769,0.110740152144461,0.135823248759451,2.06570354247327e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FN1,Fibronectin,40539,0.0531113539922858,0.00275850476330828,0.0477046846562015,0.05851802332837,2.58861521900786e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLIP2,CAP-Gly domain-containing linker protein 2,42594,0.220502611979868,0.0114911921713892,0.197979875323946,0.243025348635791,5.57587374522586e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOXO1,Forkhead box protein O1,42594,0.168351807672633,0.00877548816615721,0.151151850866965,0.185551764478302,6.06751585116537e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42679,0.189478162669057,0.00988483023266116,0.170103895413041,0.208852429925072,8.02198951676053e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,40482,0.165842056440263,0.00864334021529838,0.148901109618278,0.182783003262248,9.07172856079207e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGEF1,Rho guanine nucleotide exchange factor 1,40483,0.177959600717635,0.00929309017826487,0.159745143968236,0.196174057467034,1.82603388041222e-80
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPD1,Glycerol-3-phosphate dehydrogenase,40451,0.102844250148106,0.00537126024374793,0.0923165800703601,0.113371920225852,1.92977442609523e-80
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRELD1,Protein disulfide isomerase CRELD1,40283,0.0748966155145714,0.00391435912551859,0.067224471628555,0.0825687594005879,2.58177707588177e-80
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPD52L2,Tumor protein D54,40283,0.21177228812412,0.0110726042947395,0.190069983706431,0.233474592541809,2.99661808758875e-80
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LEFTY2,Left-right determination factor 2,42689,0.0987614949561675,0.00518019990453128,0.0886083031432862,0.108914686769049,5.51475789728623e-80
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LEP,Leptin,42636,0.130944156619437,0.00687286512824608,0.117473340968075,0.1444149722708,7.07044219866053e-80
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IDUA,Alpha-L-iduronidase,42721,0.0914211289846871,0.00480287757244751,0.08200748894269,0.100834769026684,9.67752859305096e-80
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUGP1,SURP and G-patch domain-containing protein 1,40449,0.0786806402978115,0.00413228496306879,0.0705813617701967,0.0867799188254263,1.39584556236994e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HCLS1,Hematopoietic lineage cell-specific protein,42754,0.108153787843491,0.00569515172890551,0.0969912904548359,0.119316285232145,2.18465197410426e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCAMP3,Secretory carrier-associated membrane protein 3,42587,0.165870366015588,0.00874439360645148,0.148731354546943,0.183009377484232,3.36456174323548e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MINK1,Misshapen-like kinase 1,40483,0.181989835404482,0.00958274790953895,0.163207649501785,0.200772021307178,3.42655892006281e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPL,N-acetylneuraminate lyase,40511,0.0893420812845975,0.00471644493188602,0.0800978492181009,0.0985863133510941,8.35562340184679e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LBR,Delta(14)-sterol reductase LBR,42711,0.130281190839062,0.00688681154853589,0.116783040203932,0.143779341474193,8.50471558883455e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SELP,P-selectin,42689,0.109418352338429,0.00579408290050423,0.0980619498534409,0.120774754823417,1.56982630218962e-78
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DOK2,Docking protein 2,42636,0.23474874817462,0.0124355628766115,0.210375044936461,0.259122451412778,1.81194786068808e-78
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL18A1,Collagen alpha-1(XVIII) chain,42692,0.0474072192276271,0.00251708276664785,0.0424737370049973,0.0523407014502569,3.96475755229395e-78
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GGT1,Glutathione hydrolase 1 proenzyme,42590,0.0981796715255589,0.00521387664763758,0.0879604732961892,0.108398869754929,4.32071721936973e-78
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KRT18,"Keratin, type I cytoskeletal 18",42587,0.1573203895051,0.00835979525153827,0.140935190812085,0.173705588198115,5.36726843060576e-78
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAT,Linker for activation of T-cells family member 1,42754,0.146648362381463,0.00779498412227376,0.131370193501806,0.16192653126112,5.77651297428256e-78
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLSCR3,Phospholipid scramblase 3,40457,0.112852789607496,0.00599709093961681,0.101098491365848,0.124607087849145,8.35596666740148e-78
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,40511,0.151303014316751,0.00804977913292909,0.13552544721621,0.167080581417292,1.23359025841322e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINH1,Serpin H1,40302,0.250719433316316,0.0133447928385169,0.224563639352823,0.276875227279809,1.5039996821967e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCBP2,Poly(rC)-binding protein 2,40482,0.139690091442625,0.00744688870338989,0.125094189583981,0.154285993301269,2.47409965987164e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKT1S1,Proline-rich AKT1 substrate 1,42311,0.129133021924516,0.00689186935240873,0.115624957993795,0.142641085855237,2.51781444990953e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP43,Centrosomal protein 43,42255,0.133639011672018,0.00714671564419811,0.11963144900939,0.147646574334646,5.06031932444967e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42495,0.183408543710248,0.00981180829909801,0.164177399444016,0.20263968797648,5.49203348372491e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CMIP,C-Maf-inducing protein,40451,0.160095082562863,0.00856587533104944,0.143305966914006,0.17688419821172,8.64646464736732e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RABEP1,Rab GTPase-binding effector protein 1,40283,0.150965692517253,0.00807859446866635,0.135131647358667,0.166799737675839,9.45602760034642e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42587,0.148074053322513,0.00793473833437243,0.132521966187143,0.163626140457883,9.54945589747816e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,40449,0.210153875300387,0.0112481367823217,0.188107527207036,0.232200223393737,9.72285302078757e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,USP25,Ubiquitin carboxyl-terminal hydrolase 25,40451,0.137971389745518,0.00738943086450305,0.123488105251092,0.152454674239944,1.20832652763766e-76
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",40223,0.132491570707093,0.00709843951805427,0.118578629251707,0.14640451216248,1.43649498229996e-76
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,METAP2,Methionine aminopeptidase 2,42689,0.109708376440765,0.00590122123660463,0.09814198281702,0.12127477006451,3.40349311070605e-76
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLIN1,Perilipin-1,42311,0.0672085905176816,0.00361905303256994,0.0601152465738445,0.0743019344615187,5.20889274589409e-76
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HDGFL2,Hepatoma-derived growth factor-related protein 2,40483,0.12217139329951,0.0065808184096258,0.109272989216644,0.135069797382377,8.2841997728811e-76
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH2,Cadherin-2,42636,0.0682141357405221,0.00368322857292796,0.0609950077375833,0.0754332637434609,1.23554912454418e-75
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL13RA1,Interleukin-13 receptor subunit alpha-1,42448,0.0420539407579187,0.00227095825144681,0.0376028625850829,0.0465050189307544,1.32164311578375e-75
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AAMDC,Mth938 domain-containing protein,40223,0.101928275726421,0.00550363577414848,0.09114114960909,0.112715401843752,1.96597242937359e-75
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42657,0.196358879920399,0.0106576206168642,0.175469943511346,0.217247816329453,6.96918456717515e-75
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STK11,Serine/threonine-protein kinase STK11,42357,0.137913132125283,0.00749482063213482,0.123223283686299,0.152602980564268,1.1085198049438e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SRP14,Signal recognition particle 14 kDa protein,42587,0.112849951070251,0.0061413215433248,0.100812960845335,0.124886941295168,1.69438160755567e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AP3B1,AP-3 complex subunit beta-1,40449,0.145498619073728,0.00791208408038518,0.129990934276173,0.161006303871283,1.95553113563914e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSO,Cathepsin O,42754,0.0585668805651634,0.00318923799958019,0.0523159740859862,0.0648177870443406,2.03487326297376e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HEXIM1,Protein HEXIM1,42594,0.153312772302154,0.00835085826075598,0.136945090111073,0.169680454493236,2.28045057757398e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,USP8,Ubiquitin carboxyl-terminal hydrolase 8,42357,0.179077157311454,0.00976703430619922,0.159933770071303,0.198220544551604,3.6449839835853e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,USO1,General vesicular transport factor p115,42587,0.170717082993684,0.00931218908261871,0.152465192391751,0.188968973595617,3.65859776209904e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASAH2,Neutral ceramidase,42495,0.101877441995388,0.00555767708995529,0.0909843948990753,0.1127704890917,3.82634108766789e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GFER,FAD-linked sulfhydryl oxidase ALR,42346,0.119376440513694,0.00651311076531382,0.106610743413679,0.132142137613709,4.08196913386243e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJB6,DnaJ homolog subfamily B member 6,40183,0.158789474911767,0.00865484096616634,0.141825986618081,0.175752963205453,4.43748452539665e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NIT2,Omega-amidase NIT2,40462,0.138688934253724,0.00756402764433406,0.123863440070829,0.153514428436618,5.12953024610614e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NSFL1C,NSFL1 cofactor p47,42711,0.122873138836273,0.00671728052656488,0.109707269004206,0.13603900866834,7.42629365022844e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNX15,Sorting nexin-15,40283,0.102790399670614,0.00561732203106159,0.0917804484897335,0.113800350851495,1.02273188719211e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCXR,L-xylulose reductase,42679,0.0995522197610745,0.00544852486804461,0.088873111019707,0.110231328502442,1.08046262838735e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OGFR,Opioid growth factor receptor,42587,0.0615266748687413,0.00337296330757474,0.0549156667858948,0.0681376829515878,1.88153404562081e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THOP1,Thimet oligopeptidase,42571,0.0583401730413471,0.00320030465367873,0.0520675759201368,0.0646127701625574,2.31842874171445e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EGLN1,Egl nine homolog 1,42594,0.104783138943333,0.00575030243970318,0.0935125461615146,0.116053731725151,2.63517835774798e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNMBP,Dynamin-binding protein,42495,0.113236482278001,0.00621697332099911,0.101051214568843,0.125421749987159,3.09088172083026e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STAMBP,STAM-binding protein,42476,0.119192089648866,0.00654967761288603,0.106354721527609,0.132029457770123,4.11665330033131e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,42476,0.209486810954448,0.0115144289111482,0.186918530288597,0.232055091620298,4.47950914424516e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FABP5,Fatty acid-binding protein 5,42678,0.127480135673384,0.00701200161789668,0.113736612502306,0.141223658844461,5.49248248500515e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TCTN3,Tectonic-3,40511,0.0565765603336347,0.00310957585063966,0.050481791666381,0.0626713290008885,6.24301331588136e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RGCC,Regulator of cell cycle RGCC,40482,0.141924614997551,0.00780369305503304,0.126629376609686,0.157219853385416,7.16722934452309e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGF,Placenta growth factor,42754,0.0501459213140103,0.00276270027594179,0.0447310287731644,0.0555608138548562,9.13523912148491e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMNDC1,Survival of motor neuron-related-splicing factor 30,40449,0.111938777363362,0.00615994950915296,0.0998652763254224,0.124012278401302,9.38385562160156e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VEGFC,Vascular endothelial growth factor C,42679,0.104204966774641,0.00575660831293071,0.092922014481297,0.115487919067985,2.21357998153661e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PON2,Serum paraoxonase/arylesterase 2,42357,0.0657353559496233,0.00363154388773842,0.058617529929656,0.0728531819695906,2.3452476481996e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGSF3,Immunoglobulin superfamily member 3,42587,0.067966661480069,0.003757693025268,0.0606015831505437,0.0753317398095942,2.89835075854649e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDC42BPB,Serine/threonine-protein kinase MRCK beta,40449,0.192442297834691,0.0106316762234876,0.171604212436656,0.213280383232727,3.30221051348091e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PHACTR2,Phosphatase and actin regulator 2,40482,0.212048107974063,0.0117328824365476,0.189051658398429,0.235044557549696,5.36097915274451e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,40511,0.11812370291245,0.00654665687299558,0.105292255441379,0.130955150383521,8.97696844352966e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTDH,Protein LYRIC,40199,0.175407271999107,0.00972188640180562,0.156352374651568,0.194462169346646,9.71675984235797e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINE1,Plasminogen activator inhibitor 1,42794,0.123278426804243,0.00684601342978172,0.109860240481871,0.136696613126615,1.15761845219045e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SYTL4,Synaptotagmin-like protein 4,40511,0.137513686147191,0.00763936437687686,0.122540531968512,0.152486840325869,1.90081689082663e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LZTFL1,Leucine zipper transcription factor-like protein 1,40283,0.132025030437724,0.00734800980985976,0.117622931210399,0.146427129665049,3.56336102144029e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIT1,ARF GTPase-activating protein GIT1,40199,0.180071664335973,0.0100308481159786,0.160411202028655,0.199732126643291,4.76954723310493e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAS6,Growth arrest-specific protein 6,42718,-0.0471284865555129,0.00263322884625577,-0.0522896150941742,-0.0419673580168516,8.05990649163116e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SELE,E-selectin,42794,0.0942931747769217,0.00526869987171183,0.0839665230283665,0.104619826525477,8.08199939455307e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZFYVE19,Abscission/NoCut checkpoint regulator,40449,0.167505721254038,0.00935363502303033,0.149172596608899,0.185838845899178,9.73404332618771e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PXN,Paxillin,42311,0.0948687118185464,0.00530448165854215,0.0844719277678038,0.105265495869289,1.0713447675983e-70
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42636,-0.214311297270772,0.0119887449492753,-0.237809237371351,-0.190813357170192,1.18945217603442e-70
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIM5,Tripartite motif-containing protein 5,42594,0.157895264288024,0.00883962887025491,0.140569591702325,0.175220936873724,1.5242936460756e-70
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MEP1A,Meprin A subunit alpha,40449,0.134437943954219,0.00751900218141395,0.119700699678647,0.14917518822979,1.59596636732172e-70
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPB2,Carboxypeptidase B2,40516,0.0411727442144798,0.00230310872247669,0.0366586511184255,0.0456868373105341,1.65209343460221e-70
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PBLD,Phenazine biosynthesis-like domain-containing protein,42311,0.0947835900075175,0.00530757636886911,0.084380740324534,0.105186439690501,1.70248727376074e-70
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WASF1,Wiskott-Aldrich syndrome protein family member 1,42357,0.171185315475052,0.00958712523802609,0.152394550008521,0.189976080941583,1.76432382742507e-70
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SH2D1A,SH2 domain-containing protein 1A,42594,0.106793357293253,0.00599195854176255,0.0950491185513979,0.118537596035107,3.03678314591854e-70
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BTN3A2,Butyrophilin subfamily 3 member A2,42594,0.0721951457166737,0.00405262885731518,0.0642519931563359,0.0801382982770114,3.51535090775848e-70
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAGK,N-acetyl-D-glucosamine kinase,40209,0.102957322827714,0.00577333762975094,0.091641581073402,0.114273064582026,3.76290561029432e-70
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GMPR,GMP reductase 1,42754,0.0912148940527576,0.00512214097405231,0.0811754977436151,0.1012542903619,3.84923989750308e-70
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1R2,Interleukin-1 receptor type 2,42600,0.0367000779122302,0.00206664187253749,0.0326494598420567,0.0407506959824037,9.33621408109386e-70
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SH2B3,SH2B adapter protein 3,42346,0.17922566226107,0.010094366714735,0.159440703500189,0.199010621021951,1.02388916396631e-69
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MME,Neprilysin,42587,0.149657686631717,0.00843013068306886,0.133134630492902,0.166180742770532,1.03104197657265e-69
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL5,C-X-C motif chemokine 5,42605,0.208379984795931,0.0117423943042562,0.185364891959589,0.231395077632273,1.15687725267256e-69
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALDH1A1,Retinal dehydrogenase 1,42611,0.0983128159481445,0.00556302370741381,0.0874092894816134,0.109216342414676,4.13368715243721e-69
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BID,BH3-interacting domain death agonist,42594,0.123006322621338,0.00696787653355485,0.109349284615571,0.136663360627106,5.77762823061632e-69
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AZI2,5-azacytidine-induced protein 2,40482,0.100664315237166,0.00570517248016915,0.0894821771760348,0.111846453298298,9.37595976625449e-69
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYN,Tyrosine-protein kinase Lyn,42587,0.153213423325166,0.00869725694490291,0.136166799713157,0.170260046937176,1.09739849104592e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ST13,Hsc70-interacting protein,40283,0.103039722992777,0.00584532622479783,0.0915828835921737,0.114496562393381,1.29700462221631e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOA2,Apolipoprotein A-II,40532,-0.0899506191781591,0.00510751754395374,-0.0999613535643084,-0.0799398847920098,1.63887849570748e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGF2R,Cation-independent mannose-6-phosphate receptor,42611,0.0424504748216196,0.00242070435451619,0.0377058942867678,0.0471950553564713,4.33440532536225e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42587,0.0806728259545255,0.00460644210719158,0.07164419942443,0.089701452484621,6.49695105971031e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLB1,Beta-galactosidase,42495,0.0752621259352444,0.00429771039534384,0.0668386135603704,0.0836856383101183,6.67686368649012e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARSB,Arylsulfatase B,42587,0.0997884528361449,0.0057038987956771,0.0886088111966178,0.110968094475672,8.88978643967425e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42636,0.0501850633129293,0.00287154082320635,0.0445568432994448,0.0558132833264137,1.20462418422609e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SKAP2,Src kinase-associated phosphoprotein 2,42676,0.188572114809963,0.0107970221161322,0.167409951462343,0.209734278157582,1.45985580222539e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OPHN1,Oligophrenin-1,40483,0.193606511400532,0.0110737432521583,0.171901974626302,0.215311048174763,1.48349366515822e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUDT5,ADP-sugar pyrophosphatase,42611,0.0912876323444555,0.00524113256730739,0.081015012512533,0.101560252176378,3.32656339025739e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYDGF,Myeloid-derived growth factor,40511,0.177192819623702,0.0101761374043293,0.157247590311217,0.197138048936188,4.93505972286607e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACE2,Angiotensin-converting enzyme 2,42357,0.0969528846845967,0.00557486640124744,0.0860261465381517,0.107879622831042,5.3982612871493e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMN,Protein amnionless,42370,0.0850638410145463,0.00489319650066595,0.075473175873241,0.0946545061558516,6.06879861832202e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NIT1,Deaminated glutathione amidase,40223,0.0857034703506992,0.00492502080051405,0.0760504295816916,0.0953565111197067,6.2572133693653e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",40482,0.139482602781464,0.00802404741452933,0.123755469848986,0.155209735713941,8.19108715139793e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMOT,Angiomotin,40283,0.0697973554868687,0.00402257280854002,0.0619131127821302,0.0776815981916071,1.4515442948365e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42587,0.0791142802932312,0.0045688990537018,0.0701592381479756,0.0880693224384867,1.88795505822146e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SFRP4,Secreted frizzled-related protein 4,40283,0.0725003515777097,0.00418399468373149,0.064299721997596,0.0807009811578235,2.1575233775393e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,QDPR,Dihydropteridine reductase,42581,0.0762669683294995,0.00440730938775062,0.0676286419295083,0.0849052947294908,2.28431818264648e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRHBP,Corticotropin-releasing factor-binding protein,42618,0.0492502175945573,0.0028462845008043,0.0436714999729809,0.0548289352161337,2.32554050713147e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42651,0.104641519177912,0.00605657694306266,0.0927706283695087,0.116512409986314,3.60089131986046e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",40482,0.142549524802181,0.00824442802746356,0.126390445868352,0.158708603736009,3.93722369741863e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BIRC2,Baculoviral IAP repeat-containing protein 2,42346,0.112340822400128,0.00650338415083515,0.0995941894644909,0.125087455335765,3.94203807080291e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM13A,Protein FAM13A,40449,0.120615296204368,0.00697842608652143,0.106937581074786,0.13429301133395,4.41034873726615e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DAG1,Dystroglycan,42676,0.0820031547284425,0.00475764786441299,0.0726781649141931,0.091328144542692,7.22271360449366e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPKOW,G-patch domain and KOW motifs-containing protein,42311,0.0514885228380421,0.00299026361233074,0.0456276061578739,0.0573494395182104,1.01244834439743e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DLK1,Protein delta homolog 1,42794,0.098388205423981,0.00572059293271135,0.0871758432758668,0.109600567572095,1.33416357218984e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,40449,0.158567164311221,0.00921239522065318,0.14051086967874,0.176623458943701,1.47620789321332e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOF,Apolipoprotein F,40532,-0.0426003704214843,0.00247534375370519,-0.0474520441787465,-0.0377486966642221,1.51817135915272e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRAP,BRCA1-associated protein,40342,0.194410582577489,0.0113009362547874,0.172260747518106,0.216560417636872,1.75843132704269e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNST,Consortin,42636,0.193066162985922,0.0112448438591237,0.171026269022039,0.215106056949804,2.24111472057558e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDC27,Cell division cycle protein 27 homolog,42346,0.107343703891874,0.0062520424988181,0.0950897005941904,0.119597707189557,2.31761763875846e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,40030,0.0595246988217044,0.00346639837549881,0.0527305580057268,0.0663188396376821,3.13325114334203e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MITD1,MIT domain-containing protein 1,42495,0.170090049804694,0.0099327424718496,0.150621874559869,0.189558225049519,4.87122967723599e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGALS9,Galectin-9,42620,0.0573613357659737,0.00334993743519966,0.0507954583929823,0.063927213138965,4.88731538373045e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CMC1,COX assembly mitochondrial protein homolog,40511,0.16074235215324,0.0093811806110273,0.142355238155626,0.179129466150853,5.39734706243531e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VWA1,von Willebrand factor A domain-containing protein 1,42689,0.0732958062923793,0.00428336473916024,0.0649004114036252,0.0816912011811333,5.8695730895872e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IST1,IST1 homolog,40375,0.175248979659646,0.0102359171988852,0.155186581949831,0.195311377369461,6.92882657331858e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRKL,Crk-like protein,42636,0.1854444739612,0.0108456945790087,0.164186912586343,0.206702035336057,7.38331780346094e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EVI5,Ecotropic viral integration site 5 protein homolog,40199,0.157969608851784,0.00923126305479098,0.139876333264394,0.176062884439174,8.23338787750608e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TAX1BP1,Tax1-binding protein 1,40483,0.112022891639129,0.00655661578945536,0.0991719246917968,0.124873858586462,1.23272955980523e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEC31A,Protein transport protein Sec31A,40223,0.135679059427733,0.00795351030865304,0.120090179222773,0.151267939632693,2.00187053107913e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FKBPL,FK506-binding protein-like,40449,0.103586559243768,0.00607466640412016,0.0916802130916922,0.115492905395843,2.15960664333616e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EREG,Proepiregulin,42476,0.14220756019213,0.00835865758603392,0.125824591323503,0.158590529060756,3.13565010851909e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STIP1,Stress-induced-phosphoprotein 1,42586,0.114074935722041,0.00670726236916146,0.100928701478484,0.127221169965597,3.3959159765129e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGBP1,Immunoglobulin-binding protein 1,40482,0.107678356613535,0.00632668136902166,0.0952780611302528,0.120078652096818,3.69219605991286e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASPSCR1,Tether containing UBX domain for GLUT4,40482,0.118340992215697,0.00695931493855918,0.104700734936121,0.131981249495273,4.7417677827816e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SH3GLB2,Endophilin-B2,40483,0.11754877246193,0.00692013315146535,0.103985311485058,0.131112233438803,6.41659696660352e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GOLM2,Protein GOLM2,42711,0.0406723244850826,0.00239756962729925,0.0359730880155761,0.0453715609545891,6.94210948681666e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GOLGA3,Golgin subfamily A member 3,40482,0.13795618775665,0.00812587065836448,0.122029481266256,0.153882894247045,7.46347754195091e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MUC13,Mucin-13,42311,0.0919920123494578,0.00542708868521013,0.081354918526446,0.10262910617247,9.09143038829108e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42569,0.134516833894171,0.00794372714848812,0.118947128683134,0.150086539105208,1.16743500020201e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FUOM,Fucose mutarotase,40283,0.11125161406274,0.00657040257117518,0.0983736250232368,0.124129603102243,1.63003050722691e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GMPR2,GMP reductase 2,40283,0.118179297495194,0.00698313830362007,0.104492346420098,0.131866248570289,1.88306744423597e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL17,C-C motif chemokine 17,42604,0.160794111858936,0.00951447815831177,0.142145734668645,0.179442489049227,2.03866259881271e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCN2,CCN family member 2,42624,0.096713968505553,0.00572371764326816,0.0854954819247474,0.107932455086359,2.1339881028179e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBCC,Tubulin-specific chaperone C,42495,0.14023428217992,0.00832202658323176,0.123923110076786,0.156545454283054,4.64719604632541e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COMMD1,COMM domain-containing protein 1,40223,0.105654380604397,0.00626802943047489,0.0933690429206659,0.117939718288127,5.79498477822109e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DBNL,Drebrin-like protein,42676,0.159821177426575,0.00950313235920343,0.141195038002536,0.178447316850613,7.89576542087221e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAPGEF2,Rap guanine nucleotide exchange factor 2,40302,0.0922124457915109,0.00547845099463127,0.0814746818420337,0.102950209740988,8.53071196605125e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ELOA,Elongin-A,42587,0.0934991523212815,0.00556550169942317,0.0825907689904121,0.104407535652151,1.07270425999163e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGAP45,Rho GTPase-activating protein 45,40283,0.143605520967496,0.00853974257372993,0.126867625522986,0.160343416412007,1.10809904722812e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42594,0.174909822351837,0.0104205686226996,0.154485507851346,0.195334136852328,1.36654464210856e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMAD5,Mothers against decapentaplegic homolog 5,42587,0.0349877097600835,0.0020851390071559,0.0309008373060579,0.0390745822141091,1.49740139842065e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42711,-0.0822668077716839,0.00490634216757306,-0.0918832384201271,-0.0726503771232407,1.80436657006035e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRAF2,TNF receptor-associated factor 2,42594,0.12084438835331,0.00720962378796655,0.106713525728895,0.134975250977724,2.01373357891384e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BAG4,BAG family molecular chaperone regulator 4,40199,0.0852983846435341,0.0050864285643105,0.0753289846574855,0.0952677846295827,2.40488856741358e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GORASP2,Golgi reassembly-stacking protein 2,40449,0.0817427086774892,0.00487792517120338,0.0721819753419306,0.0913034420130478,2.82226382196632e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL32,Interleukin-32,42594,-0.0770242724488675,0.00460861934565144,-0.0860571663663443,-0.0679913785313907,4.46867833289279e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GASK1A,Golgi-associated kinase 1A,40116,0.0753097875088015,0.00450395964730853,0.0664820266000768,0.0841375484175262,5.43941256273584e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AHSG,Alpha-2-HS-glycoprotein,40532,0.047112089255073,0.0028209724502285,0.0415829832526252,0.0526411952575209,7.09459264041071e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,40302,0.182435219939226,0.0109234103069704,0.161025335737564,0.203845104140888,7.26679415252301e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIM21,E3 ubiquitin-protein ligase TRIM21,42594,0.136433745331865,0.00817851822264696,0.120403849615477,0.152463641048253,7.44878651726405e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL5,C-C motif chemokine 5,42689,0.172409453680939,0.0103385220819546,0.152145950400308,0.19267295696157,8.07793646743266e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PACS2,Phosphofurin acidic cluster sorting protein 2,40116,0.107265076378281,0.0064343721413792,0.0946537069811781,0.119876445775385,1.23441614892461e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CES2,Cocaine esterase,42587,0.0949445581798512,0.00570476601925256,0.0837632167821162,0.106125899577586,1.41076993315656e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL13,C-C motif chemokine 13,42734,0.119457053515187,0.00717853289970055,0.105387129031774,0.1335269779986,1.43922108719296e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB27B,Ras-related protein Rab-27B,40511,0.142341579145218,0.00854654178832246,0.125590357240106,0.15909280105033,1.50339303577316e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GZMA,Granzyme A,42754,0.0614714342945548,0.00369680377926138,0.0542256988872025,0.0687171697019071,1.76529614091398e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL3,C-C motif chemokine 3,42594,0.099389654397198,0.00598068533865162,0.0876675111334409,0.111111797660955,2.10736773446953e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,42346,0.133466822477392,0.00803047529405574,0.117727090901042,0.149206554053741,2.10765671423259e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIAE,Sialate O-acetylesterase,42646,0.0791222084330582,0.00476347995869805,0.06978578771401,0.0884586291521063,2.39927017730679e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCPEP1,Retinoid-inducible serine carboxypeptidase,40169,0.0849473830769109,0.0051110803458348,0.0749296655990747,0.0949651005547472,2.7826919081108e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,42346,0.0752735724857605,0.00453478553448329,0.0663853928381733,0.0841617521333478,2.96446146246132e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SSNA1,Sjoegren syndrome nuclear autoantigen 1,40449,0.0892865762667396,0.00538256436683378,0.0787367501077454,0.0998364024257338,4.49903066019703e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42754,0.0439629906638798,0.00265643404288469,0.0387563799398258,0.0491696013879338,6.36950625173364e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,42370,0.0793405834860938,0.00480233048765508,0.0699280157302899,0.0887531512418978,1.05077276156747e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,40283,0.0990581765963779,0.00599438894886151,0.0873091742566093,0.110807178936146,1.27990889011254e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UBXN1,UBX domain-containing protein 1,40283,0.117265185678921,0.00709630396853059,0.103356429900601,0.131173941457241,1.28664685173298e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RRM2,Ribonucleoside-diphosphate reductase subunit M2,42346,0.0876004901861058,0.00531318956998657,0.0771866386289321,0.0980143417432794,1.82620930308097e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIGYF2,GRB10-interacting GYF protein 2,40482,0.128686416590441,0.00780700894962827,0.11338467904917,0.143988154131713,2.44095866288324e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STAT2,Signal transducer and activator of transcription 2,40199,0.130055882072544,0.00789362692504849,0.114584373299448,0.145527390845639,2.86514471376902e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42594,0.121635896935289,0.00740059878390348,0.107130723318838,0.13614107055174,4.09316730044269e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,40482,0.183666473203735,0.0111647039647772,0.161783653432772,0.205549292974698,4.14521775715185e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GP1BA,Platelet glycoprotein Ib alpha chain,42583,0.0563065647110413,0.00342926567179471,0.0495852039943237,0.063027925427759,5.35259597903041e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIMP3,Metalloproteinase inhibitor 3,42676,0.221729180702712,0.0135236830187002,0.195222761986059,0.248235599419364,7.78890938756812e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNASE4,Ribonuclease 4,40169,0.0499048009219223,0.00304253642460003,0.0439414295297062,0.0558681723141384,9.42888147456384e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADD1,Alpha-adducin,40283,0.121131994991323,0.00738558217038423,0.106656253937369,0.135607736045276,9.45847408073444e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,40451,0.0816708446738723,0.00498076018912371,0.0719085547031898,0.0914331346445547,9.83063343225067e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DGKA,Diacylglycerol kinase alpha,40199,0.0929073796734185,0.00568094669087175,0.0817727241593098,0.104042035187527,2.03332367123028e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,40482,0.111791511002517,0.00684223077335131,0.0983807386867486,0.125202283318286,2.51507068081912e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MARS1,"Methionine--tRNA ligase, cytoplasmic",40267,0.143907622063232,0.00880745767533308,0.126645005019579,0.161170239106885,2.55714069300937e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TACC3,Transforming acidic coiled-coil-containing protein 3,42587,0.195569760286467,0.0119826189989005,0.172083827048622,0.219055693524312,2.60681300462178e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDHD2,Phospholipase DDHD2,40482,0.111082174753829,0.00680596160889219,0.0977424900004004,0.124421859507258,3.31013165639073e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CIRBP,Cold-inducible RNA-binding protein,40449,0.160749506408385,0.00985884552856987,0.141426169172388,0.180072843644381,4.30866359462552e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HS1BP3,HCLS1-binding protein 3,40223,0.149574520774412,0.00919143805800262,0.131559302180727,0.167589739368097,7.39430678253307e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1S,Complement C1s subcomponent,40539,0.0351858354968181,0.00216450451986912,0.0309434066378746,0.0394282643557615,9.34799994251257e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATXN2L,Ataxin-2-like protein,40482,0.0814513743521821,0.00501330342366087,0.0716252996418068,0.0912774490625574,1.08361766106588e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGALS8,Galectin-8,42711,0.10082412384334,0.00621424350883057,0.0886442065660324,0.113004041120648,1.20750617630088e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42587,0.14793921526696,0.00911840803392288,0.130067135520472,0.165811295013449,1.23036355836998e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FUS,RNA-binding protein FUS,42336,0.0671495503518585,0.00413949541693551,0.0590361393346649,0.0752629613690521,1.31318693633687e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COCH,Cochlin,40511,0.0790075065699745,0.00487665947109092,0.0694492540066363,0.0885657591333127,2.24081899420621e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",40449,0.244746641461668,0.0151225959913874,0.215106353318549,0.274386929604787,2.95889443375951e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TWF2,Twinfilin-2,40527,0.139410049279094,0.00861508530651618,0.122524482078322,0.156295616479866,3.02718708422732e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WASHC3,WASH complex subunit 3,40483,0.125772192229918,0.00777242631511335,0.110538236652296,0.14100614780754,3.05637549726297e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42611,0.102157683296613,0.00632662815760273,0.0897574921077119,0.114557874485515,4.18625357813595e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOD,Apolipoprotein D,40033,-0.0732953227710106,0.0045420666071008,-0.0821977733209282,-0.0643928722210931,6.61355644647632e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASC3,Protein CASC3,40182,0.0703428035826086,0.00436025197755138,0.0617967097066079,0.0788888974586093,6.92971430274764e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OGA,Protein O-GlcNAcase,40449,0.117313907274995,0.00727297928018013,0.103058867885842,0.131568946664148,6.97126762268139e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FLT4,Vascular endothelial growth factor receptor 3,42679,0.0552546890468981,0.00343381001113749,0.0485244214250687,0.0619849566687276,1.01027084976962e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42611,0.0755895908430086,0.00470479200219058,0.0663681985187151,0.0848109831673022,1.50679266432532e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSPA1A,Heat shock 70 kDa protein 1A,42658,0.11674429593158,0.00726898643054885,0.102497082527704,0.130991509335456,1.64743061832962e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDLIM5,PDZ and LIM domain protein 5,40482,0.194715254579178,0.0121204615491512,0.170959149942841,0.218471359215514,1.9411330262425e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RABGAP1L,Rab GTPase-activating protein 1-like,42370,0.100240633650063,0.00624549399790163,0.0879994654141762,0.112481801885951,1.99807067052148e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDGFB,Platelet-derived growth factor subunit B,42676,0.142374818667227,0.00887613058283732,0.124977602724866,0.159772034609588,2.27120806650952e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGA5,Integrin alpha-5,42611,0.0417799146171596,0.00260508878872029,0.0366739405912679,0.0468858886430514,2.37210359931292e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VAMP8,Vesicle-associated membrane protein 8,40199,0.146692809685797,0.00914536350612731,0.128767897213787,0.164617722157806,2.9802767723778e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNLR1,Interferon lambda receptor 1,42594,0.0607308816263197,0.00379019765074739,0.0533020942308549,0.0681596690217846,2.99475248136895e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBC1D23,TBC1 domain family member 23,42587,0.148769367290925,0.00929174573070074,0.130557545658752,0.166981188923099,3.63422226491057e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",42346,0.135750517082375,0.00848745576911039,0.119115103774918,0.152385930389831,4.83101845959474e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPART,Spartin,40283,0.127316490693816,0.00795326400299051,0.111728093247955,0.142904888139678,4.87805777796565e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TALDO1,Transaldolase,40499,0.0732647563405767,0.00458005563507557,0.0642878472958286,0.0822416653853248,5.69366464604658e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,40451,0.136253544577656,0.00852544497096579,0.119543672434563,0.152963416720749,7.19098926970217e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RWDD1,RWD domain-containing protein 1,42711,0.104052821618527,0.00653121087006925,0.0912516483131913,0.116853994923863,1.25166334483509e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD5,T-cell surface glycoprotein CD5,42706,0.0597899278210684,0.00375695073730448,0.0524263043759516,0.0671535512661852,1.63874459275059e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PARP1,Poly [ADP-ribose] polymerase 1,42594,0.0963374369131217,0.00605380256512709,0.0844719838854726,0.108202889940771,1.67941624547633e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1RL2,Interleukin-1 receptor-like 2,42370,0.0638227156642318,0.00402007737897193,0.0559433640014468,0.0717020673270168,3.08437293497453e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATXN3,Ataxin-3,40483,0.102789242473525,0.00647032846377069,0.0901073986845349,0.115471086262516,3.20273855524676e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIM58,E3 ubiquitin-protein ligase TRIM58,40451,0.144475440936911,0.00910330909045422,0.126632955119621,0.162317926754202,4.100523861372e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCDH9,Protocadherin-9,40449,0.0569164114242242,0.00358993845435855,0.0498801320536815,0.063952690794767,5.28093016678995e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",40209,0.131449022601895,0.00829175287932959,0.115197186958409,0.147700858245381,5.56477676554039e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FMNL1,Formin-like protein 1,42311,0.101929241367478,0.0064355620592021,0.0893155397314423,0.114542943003515,5.57505797700908e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLXNB3,Plexin-B3,42597,0.0769622462841719,0.00486552007585867,0.0674258269354889,0.0864986656328549,7.49099311799863e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP5IF1,"ATPase inhibitor, mitochondrial",42676,0.179997123090241,0.0113847035697632,0.157683104093505,0.202311142086977,8.35717218907159e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSNK2A1,Casein kinase II subunit alpha,40482,-0.0738001207056831,0.00466745889094066,-0.0829483401319268,-0.0646519012794394,1.02329246680071e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD36,Platelet glycoprotein 4,40199,0.0736723570878921,0.00466038149157364,0.0645380093644077,0.0828067048113764,1.11703187864953e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MFAP5,Microfibrillar-associated protein 5,42794,0.0676147892078593,0.00428434165354862,0.059217479566904,0.0760120988488146,1.29174072621897e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNCG,Gamma-synuclein,42495,0.113107049156162,0.00717322026980429,0.0990475374273454,0.127166560884978,1.64375127000051e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL17RB,Interleukin-17 receptor B,42416,-0.0875564108018135,0.00556804722833124,-0.0984697833693427,-0.0766430382342842,3.23370555279819e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42495,0.071295077726142,0.004537315336699,0.062401939666212,0.0801882157860721,3.85291530835978e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42654,0.138609342509186,0.00883329303510169,0.121296088160387,0.155922596857986,5.29190305026964e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TDRKH,Tudor and KH domain-containing protein,42311,0.137892547179714,0.00878701913710458,0.120669989670989,0.155115104688439,5.35880975375042e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIM24,Transcription intermediary factor 1-alpha,40287,0.105815216631979,0.00674626921436876,0.0925925289718161,0.119037904292142,7.42785953622545e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TP53,Cellular tumor antigen p53,42346,0.0700648523723034,0.00448162533172426,0.0612808667221239,0.078848838022483,1.32745993425024e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IMPACT,Protein IMPACT,40483,0.0911186928626871,0.00582642172302439,0.0796989062855593,0.102538479439815,1.47593873631292e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANGPTL7,Angiopoietin-related protein 7,42721,0.0592085324450203,0.0037900776460032,0.051779980258854,0.0666370846311865,1.5441470072895e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MPHOSPH8,M-phase phosphoprotein 8,42357,0.122261584686218,0.0078298112279043,0.106915154679526,0.13760801469291,1.77493269582699e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KRT5,"Keratin, type II cytoskeletal 5",42311,0.083506240451402,0.00535088715700697,0.0730185016236684,0.0939939792791357,2.0411186104275e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIA1,Nucleolysin TIA-1 isoform p40,42190,0.195386653202975,0.0125460773330404,0.170796341630216,0.219976964775735,3.39976959557843e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA5A,"Carbonic anhydrase 5A, mitochondrial",42357,0.149527639710507,0.00960242974792785,0.130706877404568,0.168348402016445,3.43918671600583e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GHRL,Appetite-regulating hormone,42636,0.13747537590811,0.00884417714684414,0.120140788700296,0.154809963115925,5.14118099741934e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GTPBP2,GTP-binding protein 2,40182,0.130571973539775,0.00839501005664885,0.114117753828743,0.147026193250807,5.65493001348387e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNPY4,Protein canopy homolog 4,42587,0.119431437489591,0.00768857591783066,0.104361828690643,0.134501046288539,6.06670930818138e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F13B,Coagulation factor XIII B chain,40479,0.0418651994804706,0.00269776022847702,0.0365775894326557,0.0471528095282856,9.32826238243005e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42679,0.11572521906489,0.00746506401598142,0.101093693593566,0.130356744536213,9.73693450748662e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AP2B1,AP-2 complex subunit beta,40182,0.0779668375339461,0.00502916253741851,0.0681096789606059,0.0878239961072864,1.22334385088226e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD40,Tumor necrosis factor receptor superfamily member 5,42620,0.0791609501346345,0.00512321450376969,0.0691194497072459,0.0892024505620231,2.12526713734254e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IRAK4,Interleukin-1 receptor-associated kinase 4,42594,0.166699998044114,0.0107906644609665,0.145550295700619,0.187849700387608,2.22526664608181e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HARS1,"Histidine--tRNA ligase, cytoplasmic",42611,0.122487563197456,0.00794103933429227,0.106923126102243,0.138052000292669,3.19870772593152e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLOD4,Glyoxalase domain-containing protein 4,42602,0.0559921993795405,0.00363070296795809,0.0488760215623427,0.0631083771967384,3.33846625871609e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DLG4,Disks large homolog 4,40483,0.112177637762206,0.00728220609642404,0.0979045138132152,0.126450761711197,5.28873561808959e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOXJ3,Forkhead box protein J3,40199,0.0700891462334886,0.00455010312052306,0.0611709441172634,0.0790073483497138,5.49885842764082e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DOK1,Docking protein 1,40483,0.217263521455522,0.0141175719517725,0.189593080430048,0.244933962480996,6.61406354241612e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUSD1,Sushi domain-containing protein 1,42357,0.0786980773326095,0.00512685954472179,0.0686494326249548,0.0887467220402642,1.01067913227034e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGFBP3,Fibroblast growth factor-binding protein 3,40483,0.0591545137928407,0.00385334867740926,0.0516019503851186,0.0667070772005629,1.17704983154486e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YWHAQ,14-3-3 protein theta,40283,0.117159957438926,0.00763683689494052,0.102191757124842,0.132128157753009,1.39955346218349e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP1R2,Protein phosphatase inhibitor 2,42636,0.125142532862401,0.00817487162636445,0.109119784474727,0.141165281250075,1.86609602122056e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBM17,Splicing factor 45,40482,0.121487986192902,0.00793957141732732,0.10592642621494,0.137049546170863,2.4970928117764e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUDC,Nuclear migration protein nudC,42754,0.0983433677846794,0.00644604181311249,0.0857091258309789,0.11097760973838,4.0414372299054e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ICA1,Islet cell autoantigen 1,42370,0.124671821546092,0.00818072261053677,0.10863760522944,0.140706037862744,5.34634339323134e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJB2,DnaJ homolog subfamily B member 2,40283,0.0853680704345938,0.0055991168231724,0.0743938014611759,0.0963423394080117,5.8177888284187e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TP53I3,Quinone oxidoreductase PIG3,40058,0.0842514660535901,0.00552842857329166,0.0734157460499385,0.0950871860572418,6.62578231211897e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UROD,Uroporphyrinogen decarboxylase,40283,0.109175010963393,0.00716480289509306,0.0951319972890109,0.123218024637776,6.66002425093031e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DFFA,DNA fragmentation factor subunit alpha,42754,0.105690896227968,0.00694536320790092,0.0920779843404826,0.119303808115454,7.25822952499648e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXNDC5,Thioredoxin domain-containing protein 5,42711,0.10575351747984,0.00695245687917217,0.0921267019966625,0.119380332963017,8.02991606802136e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL3,C-X-C motif chemokine 3,42620,0.147248995858802,0.0096870996970352,0.128262280452613,0.166235711264991,9.4536181479294e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VEGFA,Vascular endothelial growth factor A,42716,0.092590809881187,0.00609318185143969,0.0806481734523652,0.104533446310009,1.00769138621841e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42587,0.0599910025977945,0.00394820291801914,0.052252524878477,0.067729480317112,1.03716564971307e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL18,Interleukin-18,42566,0.0734642922090693,0.0048350583622415,0.063987577819076,0.0829410065990627,1.04536940300056e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CST3,Cystatin-C,42659,0.0477653800916675,0.00314854867012065,0.041594224698231,0.053936535485104,1.47642867708987e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,40451,0.0603191710563713,0.00397329951063511,0.0525315040155265,0.0681068380972161,1.52534471862421e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FARSA,Phenylalanine--tRNA ligase alpha subunit,40182,0.109432197489454,0.00723132592580401,0.0952587986748782,0.12360559630403,3.21259757827675e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LPP,Lipoma-preferred partner,40116,0.103632319859111,0.00685447511879865,0.0901975486262656,0.117067091091956,3.99343424652992e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,40482,0.0761865771074232,0.00504373129077219,0.0663008637775097,0.0860722904373367,4.71522578034602e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FABP4,"Fatty acid-binding protein, adipocyte",42794,0.080613622304693,0.00534148724875365,0.0701443072971358,0.0910829373122502,4.73516244801475e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RTBDN,Retbindin,42587,0.0469997414303216,0.00311540167378307,0.0408935541497068,0.0531059287109365,5.23250717908059e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNM3,Dynamin-3,40482,0.0862004840577489,0.00571373663942865,0.0750015602444687,0.097399407871029,6.22278598798742e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HYOU1,Hypoxia up-regulated protein 1,42794,0.0363078686753652,0.00240892142842537,0.0315863826756514,0.0410293546750789,6.35320743023196e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SULT2A1,Bile salt sulfotransferase,42594,0.088030127977534,0.00584461207385841,0.0765746883127715,0.0994855676422965,7.5314396161847e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSZ,Cathepsin Z,42648,0.0505707684673026,0.00335800284684357,0.0439890828874892,0.057152454047116,7.72735039765992e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YJU2,Splicing factor YJU2,40451,0.0508865628044685,0.00337760573794631,0.0442664555580937,0.0575066700508433,8.48291364496998e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NT5E,5'-nucleotidase,42679,0.0887519303186334,0.00589800196743854,0.0771918464624538,0.100312014174813,9.21403789420887e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAVS,Mitochondrial antiviral-signaling protein,42346,0.141951943996057,0.00943922630475833,0.123451060438731,0.160452827553384,1.08300809527413e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AHNAK,Neuroblast differentiation-associated protein AHNAK,40223,0.0500345378814992,0.00332482973796195,0.0435178715950938,0.0565512041679046,1.11888828358708e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CETN3,Centrin-3,40449,0.118434508070685,0.00787751464243884,0.102994579371505,0.133874436769865,1.35046687187295e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP6AP2,Renin receptor,42346,0.063242588803115,0.00420956337773187,0.0549918445827605,0.0714933330234694,1.35234364109909e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCGB3A2,Secretoglobin family 3A member 2,42654,-0.136100103689455,0.00906791629281082,-0.153873219623364,-0.118326987755546,1.64252278136321e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VPS28,Vacuolar protein sorting-associated protein 28 homolog,40302,0.102798240126236,0.00684852411454928,0.0893751328617194,0.116221347390753,1.96098382234254e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERMAP,Erythroid membrane-associated protein,40199,0.0699446894707259,0.00466549699995551,0.0608003153508131,0.0790890635906387,2.59919445591559e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBL1X,F-box-like/WD repeat-containing protein TBL1X,42346,0.131593341894558,0.0087884595533726,0.114367961169948,0.148818722619168,2.84129347127187e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHMP1A,Charged multivesicular body protein 1a,42495,0.122855045147645,0.00821049469210199,0.106762475551125,0.138947614744164,3.27165619484494e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APPL2,DCC-interacting protein 13-beta,40283,0.172508266019657,0.0115364859034912,0.149896753648814,0.1951197783905,4.55433689716038e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,A1BG,Alpha-1B-glycoprotein,40539,0.0264676842247705,0.0017715957261011,0.0229953566016123,0.0299400118479286,5.39887750972924e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD207,C-type lectin domain family 4 member K,42365,0.0619420096081565,0.00414888925402271,0.053810186670272,0.070073832546041,5.40540137556648e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MENT,Protein MENT,40283,-0.0360387139714448,0.00241628731596823,-0.0407746371107426,-0.0313027908321471,8.0061822205769e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DRG2,Developmentally-regulated GTP-binding protein 2,42587,0.0871003158398414,0.00584601587274836,0.0756421247292546,0.0985585069504281,8.36659655214344e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL7,C-C motif chemokine 7,42594,0.0918215888935407,0.00616402196011416,0.0797401058517169,0.103903071935364,8.70347086083116e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAX,Protein max,42311,0.162167863040179,0.0108963525727292,0.14081101199763,0.183524714082728,1.0842317057381e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NEXN,Nexilin,40532,0.106785084086106,0.00717248749207295,0.0927270086016433,0.120843159570569,1.15766396965268e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VNN1,Pantetheinase,40532,0.112814561490185,0.00758170763935751,0.0979544145170445,0.127674708463326,1.30781768235224e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD244,Natural killer cell receptor 2B4,42754,0.0424299934356732,0.00285604524698821,0.0368321447515763,0.0480278421197701,1.55436713570247e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL11,Eotaxin,42754,0.0567575020522156,0.00382469459731897,0.0492611006414705,0.0642539034629608,1.97901539318339e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GYS1,"Glycogen [starch] synthase, muscle",42357,0.142412586033661,0.00960505746864119,0.123586673395125,0.161238498672198,2.45587525113777e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,40283,0.13014771287321,0.00877252925630765,0.112953555530847,0.147341870215573,2.55034216989486e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,XIAP,E3 ubiquitin-protein ligase XIAP,40199,0.087894578309245,0.00592449669499922,0.0762825647870465,0.0995065918314434,2.57272466602608e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRSS2,Trypsin-2,42689,0.0861340098764068,0.0058225999064303,0.0747217140598034,0.0975463056930101,3.93827840456801e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPPED1,Serine/threonine-protein phosphatase CPPED1,42711,0.0999879472856619,0.00677270971339234,0.0867134362474129,0.113262458323911,6.068250062819e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKG1,cGMP-dependent protein kinase 1,40283,0.191042549481586,0.0129373063755227,0.165685428985561,0.21639966997761,6.97761696609252e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KYAT1,Kynurenine--oxoglutarate transaminase 1,42620,0.086917298300017,0.00589208890643072,0.0753688040434128,0.0984657925566212,7.25425541650004e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBKS,Ribokinase,42317,0.0763515203994063,0.00517773596652464,0.066203157905018,0.0864998828937946,8.00814718816119e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP10,Stromelysin-2,42608,-0.0903380563907243,0.00612849690212577,-0.102349910318891,-0.0783262024625578,8.50647778183376e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ESYT2,Extended synaptotagmin-2,40483,0.126196360680967,0.00856141083538386,0.109415995443615,0.142976725918319,1.00911048414975e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RILPL2,RILP-like protein 2,40511,0.148373946670784,0.0100769923942219,0.128623041578108,0.168124851763459,1.27174033712064e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,40482,0.123244978667779,0.00838336373577254,0.106813585745665,0.139676371589893,1.77715521596663e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUB1,NEDD8 ultimate buster 1,42594,0.12689135888948,0.00864226129116867,0.10995252675879,0.143830191020171,1.97916132730696e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGAP25,Rho GTPase-activating protein 25,42346,0.0907728506498776,0.00619023075032476,0.0786399983792411,0.102905702920514,2.64068544774798e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCSK9,Proprotein convertase subtilisin/kexin type 9,42794,0.0603640141108336,0.0041180371224553,0.0522926613508213,0.068435366870846,2.77701407602544e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42636,0.126480523499767,0.00862903642055833,0.109567612115472,0.143393434884061,2.84112510026314e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANXA11,Annexin A11,42570,0.101645254214376,0.00693945796890087,0.0880439165953302,0.115246591833422,3.30330374310963e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIFBP,KIF-binding protein,42587,0.124361623954819,0.00849211239841333,0.107717083653929,0.141006164255709,3.44953575464061e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RRAS,Ras-related protein R-Ras,40182,0.197640067941869,0.0134935826144253,0.171192646017595,0.224087489866142,3.99878976743e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",40483,0.148039860083385,0.0101091741101273,0.128225878827536,0.167853841339235,4.05429177671061e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANKRD54,Ankyrin repeat domain-containing protein 54,42346,0.088612355755774,0.00605542911201553,0.0767437146962236,0.100480996815324,4.09800777017215e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSMG3,Proteasome assembly chaperone 3,42594,0.0780439039577785,0.00533455895494309,0.06758816840609,0.0884996395094669,4.25306675880324e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PENK,Proenkephalin-A,40283,0.0499759579096358,0.00341783620682693,0.043276998944255,0.0566749168750166,5.67021794007607e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,42295,0.0873861153265957,0.00598422415564268,0.0756570359815361,0.0991151946716554,6.41596069479857e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OTUD6B,Deubiquitinase OTUD6B,40449,0.0890048859900244,0.00609148699144728,0.0770655714867878,0.100944200493261,6.52186555663215e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MED18,Mediator of RNA polymerase II transcription subunit 18,42346,0.114854647719305,0.00786901734197697,0.0994313737290302,0.13027792170958,7.06858587906598e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIM40,E3 ubiquitin ligase TRIM40,40182,0.109244025178001,0.00747944566293087,0.0945843116786565,0.123903738677345,7.22784935923448e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42794,0.0445077037928726,0.00305079991672565,0.0385281359560904,0.0504872716296549,7.59717426062537e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRADD,Death domain-containing protein CRADD,42476,0.113624719572425,0.00779054861255772,0.0983552442918114,0.128894194853038,8.19898495257124e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MOCS2,Molybdopterin synthase catalytic subunit,40283,0.100332602093029,0.00688399499169887,0.0868399719092991,0.113825232276759,1.12059478716782e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEMA4D,Semaphorin-4D,42711,0.0452914654846217,0.00311328391773717,0.0391894290058568,0.0513935019633865,1.37963611627943e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42495,0.11820424640048,0.0081249543081778,0.102279335956452,0.134129156844509,1.38836710920749e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPRY2,Protein sprouty homolog 2,42370,0.139296148853844,0.00957616886402488,0.120526857880356,0.158065439827333,1.44377739247776e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TADA3,Transcriptional adapter 3,40451,0.0599249257101001,0.0041186978588184,0.051852277906816,0.0679975735133841,1.58714283714591e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CACYBP,Calcyclin-binding protein,40267,0.154250706577621,0.0106058032976475,0.133463332114232,0.17503808104101,1.74539619982162e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PEBP1,Phosphatidylethanolamine-binding protein 1,42611,0.0857987767010381,0.00590631931648013,0.074222390840737,0.0973751625613391,1.88290976152391e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF19,Fibroblast growth factor 19,42676,0.11740872229493,0.00808359935806603,0.10156486755312,0.133252577036739,1.93833018224566e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,42307,0.11782143064322,0.00811495350121905,0.101916121780831,0.133726739505609,2.13895628143193e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RFC4,Replication factor C subunit 4,40451,0.0319831260256515,0.00220253109015328,0.0276661650889511,0.0363000869623519,2.38477927556232e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRRC59,Leucine-rich repeat-containing protein 59,40511,0.0734963984194196,0.00506177078026623,0.0635753276900978,0.0834174691487414,2.41293431488893e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRAP2,GRB2-related adapter protein 2,42636,0.191560402468343,0.0132050148040677,0.16567857345237,0.217442231484315,2.50427569681616e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD99L2,CD99 antigen-like protein 2,42611,0.0366501883206944,0.00252905361553836,0.0316932432342392,0.0416071334071495,3.10918372235088e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATG4A,Cysteine protease ATG4A,42346,0.0888754050071735,0.00613480554765018,0.0768511861337791,0.100899623880568,3.37504066714316e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,42346,0.148022715032529,0.0102218179699431,0.12798795181144,0.168057478253617,3.6790982086148e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",40449,0.157647502555023,0.0108878498249932,0.136307316898036,0.17898768821201,4.34053319910843e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMED8,Protein TMED8,40449,0.153735544865359,0.0106215482025701,0.132917310388321,0.174553779342396,4.68067254339366e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD226,CD226 antigen,40199,0.0639421659815714,0.00442001945446435,0.0552789278508213,0.0726054041123215,5.3196201950629e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42638,0.0479368249401947,0.00331998439718457,0.0414296555217129,0.0544439943586765,6.60757204808567e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HTRA2,"Serine protease HTRA2, mitochondrial",42679,0.0910851920008756,0.00630896728605004,0.0787196161202175,0.103450767881534,6.72982959802837e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PARK7,Parkinson disease protein 7,42611,0.0778692768541503,0.00539362139999367,0.0672977789101627,0.0884407747981378,6.76932448769998e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK10,Kallikrein-10,42636,0.061061011643744,0.00423880652819299,0.0527529508484858,0.0693690724390023,1.06790807766272e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGEF10,Rho guanine nucleotide exchange factor 10,40482,0.139715879076604,0.00969513382602342,0.120713416777598,0.15871834137561,1.14531457538449e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPB1,Carboxypeptidase B,42794,0.0911227107838282,0.00632891427602606,0.0787180388028171,0.103527382764839,1.17572743824255e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42587,0.0798967260587136,0.0055529948031114,0.0690128562446153,0.090780595872812,1.36824658734075e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERP29,Endoplasmic reticulum resident protein 29,40283,0.177195036556453,0.012312833173407,0.153061883536575,0.201328189576331,1.5440608976948e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RASSF2,Ras association domain-containing protein 2,42346,0.0851548421674827,0.00592419224361708,0.0735434253699932,0.0967662589649722,1.69315654269865e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP10,Caspase-10,42311,0.106995630582648,0.00744480119237177,0.0924038202455988,0.121587440919696,1.7513517158192e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPI,Glucose-6-phosphate isomerase,40532,0.0702461250336227,0.00488656027604973,0.0606684668925653,0.0798237831746802,1.88986735963887e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42495,0.0878931082623472,0.00611885584809625,0.0759001508000785,0.0998860657246158,1.92833438322977e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42594,0.142692022942331,0.00993887613810175,0.123211825711652,0.16217222017301,2.12806672311798e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCT5,T-complex protein 1 subunit epsilon,42346,0.068746837324184,0.004789405868455,0.0593596018220122,0.0781340728263558,2.25438070506901e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",40283,0.154822261089654,0.0107812069080049,0.133691095549965,0.175953426629344,2.38640750351209e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42587,0.0415137043689831,0.00289513155059395,0.0358392465298189,0.0471881622081472,2.74168919178617e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HAO1,Hydroxyacid oxidase 1,42721,0.186404811713335,0.0130291515635387,0.160867674648799,0.211941948777871,4.30628255842786e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MGLL,Monoglyceride lipase,42654,0.127354518347882,0.00892684840565734,0.109857895472794,0.14485114122297,7.6419956903e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMAD3,Mothers against decapentaplegic homolog 3,40451,0.0767865809935753,0.00538292318526566,0.0662360515504546,0.087337110436696,9.07115872834728e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPC5,Glypican-5,42495,0.0837137721258341,0.00587479692762075,0.0721991701476974,0.0952283741039707,9.77704076427134e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,42346,0.12513811852673,0.00880206222683198,0.107886076562139,0.14239016049132,1.56401605702039e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOXO3,Forkhead box protein O3,42346,0.140449597791814,0.00989690477961411,0.121051664423771,0.159847531159858,2.24289195568065e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MIF,Macrophage migration inhibitory factor,42586,0.0999851127598864,0.00704712759906487,0.0861727426657193,0.113797482854054,2.31411306819426e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBCB,Tubulin-folding cofactor B,42495,0.146972304130729,0.0103626327158815,0.126661544007601,0.167283064253857,2.50060954208838e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ELAC1,Zinc phosphodiesterase ELAC protein 1,40482,0.12554725497729,0.008847853237623,0.108205462631549,0.142889047323031,2.6045652177414e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THPO,Thrombopoietin,42357,0.0575533992686027,0.00406330717233159,0.0495893172108327,0.0655174813263726,3.27811961044391e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GGCT,Gamma-glutamylcyclotransferase,40500,0.0703451524654705,0.00496497566556227,0.0606138001609685,0.0800765047699726,3.50427354284491e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPCDC,Phosphopantothenoylcysteine decarboxylase,42711,0.0679119702650805,0.0048053728457216,0.0584934394874662,0.0773305010426948,5.00855619007491e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSC22D1,TSC22 domain family protein 1,40482,0.0960296190936716,0.00679032863897751,0.0827205749612756,0.109338663226067,5.05832778007866e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RILP,Rab-interacting lysosomal protein,42674,0.0874268415278137,0.00620291842762485,0.075269121409669,0.0995845616459584,8.54057688404697e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MDH1,"Malate dehydrogenase, cytoplasmic",40481,0.0583150511838851,0.0041383801651717,0.0502038260601486,0.0664262763076217,1.02767694649575e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATOX1,Copper transport protein ATOX1,42679,0.102012166699582,0.00724758154162516,0.0878069068779965,0.116217426521167,1.11498222459937e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF4E,Eukaryotic translation initiation factor 4E,40199,0.132110004867371,0.00939511521908768,0.113695579037959,0.150524430696783,1.5876678011706e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINE2,Glia-derived nexin,40511,0.0940746625030546,0.00669253374239733,0.0809572963679559,0.107192028638153,1.65899475028232e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTSL2,ADAMTS-like protein 2,40527,0.0501107226337627,0.00356673266164571,0.0431199266169371,0.0571015186505883,1.83075047077082e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LEPR,Leptin receptor,42636,-0.04561303248705,0.00325153065962601,-0.051986032579917,-0.039240032394183,2.15458469628245e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,42346,0.0950521402480992,0.00677862192657031,0.0817660412720214,0.108338239224177,2.37342098234973e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",42459,0.0608773001893226,0.0043455027205207,0.0523601148571021,0.0693944855215432,2.82813750605226e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJB14,DnaJ homolog subfamily B member 14,40449,0.0923067438949601,0.00659833982393529,0.0793739978400469,0.105239489949873,4.23206972800176e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTF1,Cardiotrophin-1,42357,0.122272589757871,0.0087479240654696,0.10512665858955,0.139418520926191,4.42732459543887e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLPBP,Pyridoxal phosphate homeostasis protein,42636,0.0971348429462871,0.00695678801854888,0.0834995384299313,0.110770147462643,5.34793231580391e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FHIT,Bis(5'-adenosyl)-triphosphatase,42311,0.106326202884011,0.00761520586684715,0.0914003993849906,0.121252006383031,5.46000274921865e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,42192,0.124797516720821,0.00893804113365357,0.10727895609886,0.142316077342782,5.48393380792795e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANG,Angiogenin,42618,0.0488481570082682,0.00349909236631331,0.0419899359702941,0.0557063780462423,5.5307812298546e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAP2,Microtubule-associated protein 2,40483,0.0676314345275059,0.00484485146959953,0.0581355256470908,0.077127343407921,6.38270792036939e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,40283,0.0904883447417763,0.006507982291076,0.0777326994512674,0.103243990032285,1.3855986106161e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,40223,0.110418831236882,0.00794675721262362,0.0948431871001394,0.125994475373624,1.5831984678589e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NACC1,Nucleus accumbens-associated protein 1,40451,0.0799318932598755,0.00575591916413581,0.0686502916981693,0.0912134948215817,1.73557610812762e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CIAPIN1,Anamorsin,42679,0.089568619657443,0.00645747618627809,0.0769119663323379,0.102225272982548,1.89930305518868e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GET3,ATPase GET3,40511,0.0782073683869417,0.00563769219108313,0.0671574916924187,0.0892572450814646,2.11336252764575e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,40283,0.0433449192522161,0.00312726282705541,0.0372154841111875,0.0494743543932448,2.52902020960047e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THTPA,Thiamine-triphosphatase,40436,0.126852826702554,0.0091599437619999,0.108899336929035,0.144806316476074,2.93504096288413e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL10RB,Interleukin-10 receptor subunit beta,42676,0.0434556739694839,0.00314259107891061,0.0372961954548191,0.0496151524841486,3.40660663518794e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PF4,Platelet factor 4,40463,0.141405698922217,0.0102294334540107,0.121356009352356,0.161455388492078,4.13647574002918e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPRC5C,G-protein coupled receptor family C group 5 member C,40451,0.0819433928776783,0.00592973433447404,0.0703211135821091,0.0935656721732474,4.39336849223277e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ORM1,Alpha-1-acid glycoprotein 1,40483,0.0289587462266823,0.00209680153117517,0.0248490152255789,0.0330684772277856,4.89959183510066e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EHD3,EH domain-containing protein 3,40223,0.168684921485243,0.0122259776512521,0.144722005288789,0.192647837681697,6.01490952852923e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MPRIP,Myosin phosphatase Rho-interacting protein,40417,0.062487469010802,0.00453424635660122,0.0536003461518636,0.0713745918697404,7.3794085466809e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX4,Syntaxin-4,42587,0.085287054790848,0.00619404166872102,0.0731467331201548,0.0974273764615412,7.64363943475603e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CALCA,Calcitonin,42476,0.0908434633758368,0.00660546690698773,0.0778967482381408,0.103790178513533,9.61809404651961e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,40511,0.0872301227170335,0.00634263890936761,0.074798550454673,0.099661694979394,1.07690513580521e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD22,B-cell receptor CD22,42754,0.0625243533324488,0.00455102066784703,0.0536043528234686,0.0714443538414289,1.15184132671355e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CETN2,Centrin-2,42311,0.0961393815252317,0.00700439550214535,0.0824107663410268,0.109867996709437,1.40448290984402e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM172A,Cotranscriptional regulator FAM172A,40223,0.0872361715584503,0.00635216411226761,0.0747859298984058,0.0996864132184948,1.43571380454647e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DUSP13,Dual specificity protein phosphatase 13 isoform A,40451,0.0602787587797083,0.00438985043401838,0.0516746519290323,0.0688828656303843,1.44978375328348e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",40302,0.0703255420937769,0.00512369432800412,0.0602831012108888,0.0803679829766649,1.58583810326673e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WDR46,WD repeat-containing protein 46,40451,0.0514390813784677,0.00375128361139682,0.04408656550013,0.0587915972568055,1.87602981261054e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C19orf12,Protein C19orf12,42311,0.090817931446735,0.00663402441379054,0.0778152435957056,0.103820619297764,2.28605620012888e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD74,HLA class II histocompatibility antigen gamma chain,42711,0.0507378304678244,0.00370854965037391,0.0434690731530915,0.0580065877825573,2.51240537913507e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,40283,0.0855802600601605,0.00625123456247934,0.073327840317701,0.0978326798026199,2.56606153253083e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGL1,Fibrinogen-like protein 1,40532,-0.0939145083196709,0.00686230826298596,-0.107364632515123,-0.0804643841242184,2.68367281283523e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD72,B-cell differentiation antigen CD72,40283,0.0633387199635584,0.00462858961624181,0.0542666843157244,0.0724107556113923,2.77930805131612e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMOC2,SPARC-related modular calcium-binding protein 2,42676,0.0561655260595956,0.00411034071030125,0.0481092582674051,0.0642217938517861,3.16323664528412e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINB1,Leukocyte elastase inhibitor,42569,0.126187307414505,0.00923547422058541,0.108085777942158,0.144288836886852,3.22803549805356e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",40511,0.103747641048115,0.00759119741866666,0.0888688941075279,0.118626387988701,3.46190317672882e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACYP1,Acylphosphatase-1,40250,0.0932335580530405,0.00682911755870101,0.0798484876379865,0.106618628468094,4.28577618564888e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,40199,0.0712396897072201,0.00522005414352162,0.0610083835859177,0.0814709958285225,4.60451209026221e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRYZL1,Quinone oxidoreductase-like protein 1,40223,0.130019624090201,0.00954502477169094,0.111311375537687,0.148727872642715,6.4903456449632e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFASC,Neurofascin,42754,0.0412528261381541,0.00303118328569204,0.0353117068981977,0.0471939453781105,6.62777212813606e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPA1,Carboxypeptidase A1,42794,0.0887338601295169,0.00652023301704467,0.0759542034161093,0.101513516842924,6.65835767847573e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DYNLT1,Dynein light chain Tctex-type 1,40182,0.114351045958178,0.00840481744567928,0.0978776037646461,0.130824488151709,8.10577800710884e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42495,0.132216498930572,0.0097264334158877,0.113152689435433,0.151280308425712,8.32019461130742e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KCTD5,BTB/POZ domain-containing protein KCTD5,40290,0.0628543710921522,0.00462804711836609,0.0537833987401546,0.0719253434441497,1.11427238101388e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,JAM3,Junctional adhesion molecule C,40283,0.0718332065960587,0.00529098946858118,0.0614628672376396,0.0822035459544778,1.18695238293628e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOA1,Apolipoprotein A-I,40539,-0.0391504021408828,0.00288503920853987,-0.0448050789896209,-0.0334957252921446,1.27105137360735e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VAV3,Guanine nucleotide exchange factor VAV3,40136,0.140149809972053,0.0103264841881392,0.119909900963301,0.160389718980806,1.27606945946774e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP2,Caspase-2,42594,0.095079748436826,0.00701423643334746,0.081331845027465,0.108827651846187,1.38624226288101e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VASP,Vasodilator-stimulated phosphoprotein,40532,0.101776017569589,0.00751168160294387,0.0870531216278189,0.116498913511359,1.68798289271546e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LTBP2,Latent-transforming growth factor beta-binding protein 2,42794,-0.0465601676847006,0.00344199579706825,-0.0533064794469544,-0.0398138559224469,2.00529210512224e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EGF,Pro-epidermal growth factor,42597,0.14460576187719,0.0106931804286168,0.123647128237102,0.165564395517279,2.13230457884584e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGALS1,Galectin-1,42636,0.0494569154925979,0.00365960135002894,0.0422840968465412,0.0566297341386547,2.39781867133137e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FEN1,Flap endonuclease 1,42346,0.0898386803461716,0.00665107799264322,0.0768025674805908,0.102874793211752,2.66616225106578e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDNF,Cerebral dopamine neurotrophic factor,42587,0.0473628333734801,0.00351535871146759,0.0404727302990036,0.0542529364479566,4.17011277758669e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ABRAXAS2,BRISC complex subunit Abraxas 2,40116,0.0937530696247784,0.00695364342389003,0.0801239285139539,0.107382210735603,4.21927785581566e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,42370,0.0745958127439133,0.00554765893337703,0.0637224012344943,0.0854692242533323,6.02062796986867e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,XCL1,Lymphotactin,42721,0.0788387464627521,0.00586393280099948,0.0673454381727931,0.0903320547527111,6.05872585553974e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HPSE,Heparanase,40408,0.131540479441426,0.00978072065416855,0.112370266959256,0.150710691923597,6.47670794414679e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LACTB2,Endoribonuclease LACTB2,42636,0.0909783076041593,0.00677764903884004,0.0776941154880329,0.104262499720286,8.08959351708342e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP7,Caspase-7,40483,0.116851048366277,0.00871088157928004,0.0997777204708886,0.133924376261666,1.02069509973994e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINB9,Serpin B9,42495,0.0459460071780524,0.00342869656271159,0.0392257619151377,0.0526662524409671,1.10345063979372e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42636,0.0880538440721831,0.00658117120947554,0.075154748501611,0.100952939642755,1.44493650466702e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BPIFB2,BPI fold-containing family B member 2,40473,0.0962876594194686,0.00719206102218168,0.0821912198159925,0.110384099022945,1.44821570521273e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PQBP1,Polyglutamine-binding protein 1,42346,0.079501200517587,0.00594789800771138,0.0678433204224727,0.0911590806127013,1.74857806356942e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD69,Early activation antigen CD69,42585,0.121761405399593,0.0091104066079769,0.103905008447959,0.139617802351228,1.7571130079753e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPARC,SPARC,42679,0.0975182921818893,0.00729731608053268,0.0832155526640453,0.111821031699733,1.78519831209676e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COMT,Catechol O-methyltransferase,42214,0.115721262940732,0.00866090904776168,0.0987458812071187,0.132696644674345,1.87831431844651e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,JPT2,Jupiter microtubule associated homolog 2,40449,0.121125216136893,0.00906067177067221,0.103366299466376,0.138884132807411,1.88542436290891e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXNDC9,Thioredoxin domain-containing protein 9,40483,0.0733726814068613,0.00549243905254945,0.0626075008638644,0.0841378619498582,2.13015509772969e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,40449,0.0891014536179957,0.00667207788812272,0.0760241809572751,0.102178726278716,2.2647203861511e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSPB1,Heat shock protein beta-1,42448,0.0940815710017675,0.0070531915784626,0.0802573155079808,0.107905826495554,2.50230931110223e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL12A_IL12B,Interleukin-12,42587,0.114135043595458,0.00856138349505198,0.0973547319451564,0.13091535524576,2.74596271714454e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUOX,"Sulfite oxidase, mitochondrial",40482,0.0863667088663196,0.00649093152780852,0.0736444830718149,0.0990889346608243,4.29366076937494e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42495,0.0798770359735474,0.00601103118077999,0.0680954148592186,0.0916586570878761,4.86344395000922e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NARS1,"Asparagine--tRNA ligase, cytoplasmic",40482,0.0658210213425818,0.00495174914026752,0.0561155930276575,0.0755264496575062,5.11345159728555e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PMVK,Phosphomevalonate kinase,42303,0.149401628703845,0.0112552029826864,0.127341430857779,0.17146182654991,5.93030814768952e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,40511,0.124917577385203,0.00940723171381404,0.106479403226128,0.143355751544279,6.10376840331796e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEBPB,CCAAT/enhancer-binding protein beta,42357,0.0526630888345324,0.00397198261769715,0.044878002903846,0.0604481747652188,7.24235175659379e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,40223,0.0678410711663592,0.00511781850590404,0.0578101468947873,0.0778719954379311,8.40746480262308e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,42311,0.152804025738481,0.0115403144983681,0.13018500932168,0.175423042155282,9.16498170408612e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDT,D-dopachrome decarboxylase,40527,0.0574893525111167,0.0043404258579099,0.0489821178296133,0.0659965871926201,9.50428427627986e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BOLA2_BOLA2B,BolA-like protein 2,40223,0.0749046193406385,0.00565587783622497,0.0638190987816376,0.0859901398996395,9.8637877206516e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MESD,LRP chaperone MESD,42611,0.165804971892387,0.0125319147727957,0.141242418937708,0.190367524847067,1.03535471666448e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STK24,Serine/threonine-protein kinase 24,42311,0.0847095156685219,0.00640626475161293,0.0721532367553605,0.0972657945816832,1.16042540122527e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LARP1,La-related protein 1,40451,0.084517454523412,0.00638967979493882,0.0719936821253319,0.0970412269214921,1.2074220249813e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BIN2,Bridging integrator 2,42611,0.124409013804947,0.00941156557070925,0.105962345286357,0.142855682323538,1.2101094288402e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB33A,Ras-related protein Rab-33A,40116,0.09032028109729,0.00685542749705352,0.0768836432030651,0.103756918991515,2.43751071803176e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJC9,DnaJ homolog subfamily C member 9,40449,0.105442006974585,0.00800484236655883,0.0897525159361297,0.12113149801304,2.47520668861498e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRP11,Low-density lipoprotein receptor-related protein 11,42636,0.0514864537479888,0.00391195053627859,0.0438190306968828,0.0591538767990949,2.56381949555022e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42587,0.0467408176361544,0.00355352032955401,0.0397759177902285,0.0537057174820802,2.84986196780409e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ESM1,Endothelial cell-specific molecule 1,42618,-0.0471857174212591,0.00358947613215374,-0.0542210906402804,-0.0401503442022377,3.15183132366508e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIP,Gastric inhibitory polypeptide,40223,0.0805785657814332,0.00612899334352576,0.0685657388281227,0.0925913927347437,3.48270455493784e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,40451,0.0471665617411986,0.00358989508030619,0.0401303673837985,0.0542027560985987,3.83323146084173e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PHLDB1,Pleckstrin homology-like domain family B member 1,40449,0.0721998931252963,0.00549599250726845,0.0614277478110501,0.0829720384395425,3.92846207426403e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C3,Complement C3,39989,0.0644782432818458,0.00491310581317703,0.0548485558880188,0.0741079306756728,4.78972734643947e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINB6,Serpin B6,42679,0.0790149323002096,0.00603105032878057,0.0671940736557997,0.0908357909446195,5.59421401357772e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DTD1,D-aminoacyl-tRNA deacylase 1,40283,0.117529701862331,0.0089786321248553,0.0999315828976142,0.135127820827047,7.2940361956397e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",40511,0.121933635290451,0.00931854117242736,0.103669294592493,0.140197975988409,7.66822410888839e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MPI,Mannose-6-phosphate isomerase,42587,0.115009567795748,0.00880106235988237,0.0977594855703788,0.132259650021118,8.69622729813828e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBCA,Tubulin-specific chaperone A,40283,0.115438962084785,0.00883317718163663,0.0981259348087776,0.132751989360793,9.59213307199826e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MCEMP1,Mast cell-expressed membrane protein 1,40199,0.124160057168269,0.00950363722802349,0.105532928201343,0.142787186135195,1.01936172661286e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REEP4,Receptor expression-enhancing protein 4,40482,0.0844024230107205,0.00646181979915548,0.0717372562043758,0.0970675898170653,1.03928926738319e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CERT,Ceramide transfer protein,42311,0.0831296319035745,0.00637155475381408,0.0706413845860989,0.0956178792210501,1.15031828988792e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STXBP1,Syntaxin-binding protein 1,40482,0.104529063877455,0.00800828331291147,0.0888328285841486,0.120225299170762,1.16903240215621e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MICALL2,MICAL-like protein 2,40182,0.0937984755420789,0.0071859008042872,0.079714109965676,0.107882841118482,1.18175422957377e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCL2L1,Bcl-2-like protein 1,40483,0.134810626949682,0.0103328743567305,0.114558193210491,0.155063060688874,1.26080276165031e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DXO,Decapping and exoribonuclease protein,40483,0.0621022758090137,0.0047657513667984,0.0527614031300889,0.0714431484879386,1.54668257492087e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANXA3,Annexin A3,42681,0.0941595539301575,0.00724209056638533,0.0799650564200423,0.108354051440273,2.03568768789594e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL7,Interleukin-7,42594,0.086037404512308,0.00662153433574891,0.0730591972142402,0.0990156118103759,2.26884317995828e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DBI,Acyl-CoA-binding protein,42562,0.103399131830531,0.00796017477270668,0.0877971892760263,0.119001074385037,2.39267151767748e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDIA4,Protein disulfide-isomerase A4,40527,0.0811160789163367,0.00624633775768402,0.068873256911276,0.0933589009213974,2.74786997675978e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GNPDA2,Glucosamine-6-phosphate isomerase 2,40283,0.0495875301046687,0.00382031807503622,0.0420997066775977,0.0570753535317397,3.01835037844707e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F12,Coagulation factor XII,40539,0.056263294372428,0.00433500359391279,0.0477666873283589,0.064759901416497,3.01835153357649e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42594,0.133647394039729,0.0103224368517474,0.113415417810304,0.153879370269154,4.12013099217262e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD274,Programmed cell death 1 ligand 1,42495,0.0473810707443023,0.00366119054911143,0.0402051372680439,0.0545570042205607,4.45835969352246e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GMFG,Glia maturation factor gamma,40511,0.0964416581494817,0.00745352449585238,0.081832750137611,0.111050566161352,5.038130610422e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANGPTL3,Angiopoietin-related protein 3,42652,0.0482144254504811,0.00373131459101074,0.0409010488521,0.0555278020488621,5.7201161938998e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPBP,Platelet basic protein,40471,0.113262056143937,0.00877696428370764,0.0960592061478697,0.130464906140004,7.86471317983459e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUGT1,Protein SGT1 homolog,42346,0.107705175040096,0.00835776899130207,0.0913239478171437,0.124086402263048,9.03580534706138e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACP5,Tartrate-resistant acid phosphatase type 5,42711,0.0425205022030917,0.00330263048024457,0.0360473464618123,0.048993657944371,1.04012501441348e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX8,Syntaxin-8,42594,0.0641563833532128,0.00499005661141038,0.0543758723948485,0.0739368943115772,1.31326677486469e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL4,C-C motif chemokine 4,42642,0.0917996718417677,0.00714093094720015,0.0778034471852554,0.10579589649828,1.33495767179767e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TTF2,Transcription termination factor 2,40182,0.0657664298377256,0.00511540123971269,0.0557402434078887,0.0757926162675625,1.47321889024026e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLMAP,Sarcolemmal membrane-associated protein,40449,0.110725039276458,0.00861491706706619,0.0938398018250082,0.127610276727908,1.52468257396017e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPIB,Peptidyl-prolyl cis-trans isomerase B,42656,0.124752478702816,0.00971923729072999,0.105702773612986,0.143802183792647,1.71788539897326e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCTD,Deoxycytidylate deaminase,40283,0.125901619496494,0.00980290243222496,0.106687930729333,0.145115308263655,1.73436370286338e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAPKAPK2,MAP kinase-activated protein kinase 2,40302,0.0988779222889894,0.00771185139528531,0.0837626935542302,0.113993151023749,2.28467773441219e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42654,0.101058322060551,0.00789725646795866,0.0855796993833524,0.11653694473775,2.82295609160019e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FIS1,Mitochondrial fission 1 protein,42624,0.100395709472923,0.00784931963545618,0.0850110429874292,0.115780375958417,3.06046626401307e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZNRD2,Protein ZNRD2,40449,0.092993539481451,0.00727934937995379,0.0787260146967416,0.10726106426616,4.09354013407441e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42667,0.147680580351443,0.0115695687123847,0.125004225675169,0.170356935027717,4.24043620414011e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42673,-0.0433294295270775,0.00339514409931555,-0.049983911961736,-0.0366749470924191,4.37025760977871e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGALS3BP,Galectin-3-binding protein,40539,0.0408433581694639,0.00320172597401536,0.0345679752603938,0.047118741078534,5.13760288835219e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42754,0.0533724949154188,0.00418716405340467,0.0451656533707456,0.0615793364600919,5.30274972546785e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL2,C-C motif chemokine 2,42475,0.070714708083973,0.00555985110297602,0.05981739992214,0.081612016245806,7.6236337862028e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC8,Sialic acid-binding Ig-like lectin 8,40223,0.060739896432394,0.00477472032283977,0.051381444599628,0.0700983482651599,8.18180327944203e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRG1,Leucine-rich alpha-2-glycoprotein,40539,-0.0354886664201536,0.00279459451892202,-0.0409660716772408,-0.0300112611630664,1.0635182379882e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL8,C-C motif chemokine 8,42706,0.0800128625041399,0.00631518069662837,0.0676351083387483,0.0923906166695315,1.40120901224039e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",40223,0.0340382342835931,0.00268611483269997,0.0287734492115011,0.039303019355685,1.52050324387443e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,40451,0.142303201955651,0.0112310019044282,0.120290438222972,0.16431596568833,1.52844977858114e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SOD1,Superoxide dismutase [Cu-Zn],42365,0.0634242897743628,0.00501339904524981,0.0535980276456731,0.0732505519030524,1.80103560546322e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BMPER,BMP-binding endothelial regulator protein,40283,0.0306982951251689,0.00242567527753546,0.0259439715811994,0.0354526186691384,1.86136394676641e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNF5,E3 ubiquitin-protein ligase RNF5,40223,0.0967507783248163,0.00764715756457249,0.0817623494982542,0.111739207151378,1.95606073507469e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBC1D5,TBC1 domain family member 5,42594,0.103383727406611,0.00817917216525303,0.0873525499627147,0.119414904850507,2.0531715454952e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NBN,Nibrin,42370,0.0706966832341922,0.00559466024539808,0.0597311491532119,0.0816622173151724,2.16067158959103e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDGFA,Platelet-derived growth factor subunit A,42794,0.0944456086331387,0.00748086953935695,0.0797831043359991,0.109108112930278,2.45941552480581e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,40199,0.105289942279363,0.00833467588694573,0.0889539775409498,0.121625907017777,2.48859555665939e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC4G,C-type lectin domain family 4 member G,42594,0.0437001900991645,0.00346158958067327,0.0369154745210449,0.0504849056772841,2.49646884870368e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRYBB1,Beta-crystallin B1,40511,0.0841171933159386,0.00665993955386835,0.0710637117903567,0.0971706748415206,2.52534267519154e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PKD2,Polycystin-2,40116,0.0770050050521672,0.00609809150524235,0.0650527457018922,0.0889572644024422,2.66221976005685e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF23,Fibroblast growth factor 23,42711,0.0718309383161947,0.00569248793514301,0.0606736619633143,0.082988214669075,2.6728232896261e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39940,0.140153800851962,0.011099332966113,0.11839910823838,0.161908493465543,2.70423937772093e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTP4A3,Protein tyrosine phosphatase type IVA 3,40199,0.0701991995215298,0.00556295299665069,0.0592958116480945,0.0811025873949652,2.95452793969539e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VPS4B,Vacuolar protein sorting-associated protein 4B,40451,0.123812540887643,0.00981914646327042,0.104567013819633,0.143058067955653,3.29570914519359e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GFRA1,GDNF family receptor alpha-1,42689,0.0391240729410433,0.00310653645758452,0.0330352614841776,0.0452128843979089,3.63368100478935e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BAG6,Large proline-rich protein BAG6,42357,0.0467550711495158,0.00371358746646172,0.0394764397152508,0.0540337025837808,3.85771915273398e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNASEH2A,Ribonuclease H2 subunit A,40482,0.0630296784295628,0.00500878382112205,0.0532124621401635,0.072846894718962,4.52415467346308e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDAP1,28 kDa heat- and acid-stable phosphoprotein,40511,0.127670061910256,0.0101471444473816,0.107781658793388,0.147558465027124,4.62956990626163e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK13,Kallikrein-13,42381,0.0605977939054291,0.00482449022080824,0.051141793072645,0.0700537947382133,5.59581662341225e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SWAP70,Switch-associated protein 70,40449,0.0468173963695422,0.00372858169189742,0.0395093762534233,0.0541254164856612,6.38366466772483e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NRGN,Neurogranin,40532,0.118913950217108,0.00947139906408516,0.100350008051502,0.137477892382715,6.46180260172485e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,POSTN,Periostin,40527,-0.0506585134561418,0.00403598193077536,-0.0585690380404615,-0.0427479888718221,6.73772533447756e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42721,0.0802846025281646,0.0064039114153226,0.0677329361541323,0.0928362689021969,7.42885860465764e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMEM106A,Transmembrane protein 106A,40451,0.091707232820754,0.00731589153401766,0.0773680854140793,0.106046380227429,8.29139535065505e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HNMT,Histamine N-methyltransferase,42439,0.0628557005366755,0.00501867648253573,0.0530190946309055,0.0726923064424456,8.76005880621567e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDC37,Hsp90 co-chaperone Cdc37,42679,0.10897577235458,0.00870191712712622,0.091920014785413,0.126031529923748,8.81535458417234e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42587,0.121570662378664,0.00971081463224468,0.102537465699464,0.140603859057863,9.30515046855061e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP3,Caspase-3,42794,0.113229980716491,0.00904543159100859,0.0955009347981139,0.130959026634868,9.37755284490841e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42594,0.0800268092388681,0.00639866747579614,0.0674854209863077,0.0925681974914286,1.08429149929664e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NTRK3,NT-3 growth factor receptor,42711,-0.0284787674932565,0.00227725406404803,-0.0329421854587907,-0.0240153495277224,1.09414756315347e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYO9B,Unconventional myosin-IXb,42370,0.0860606033922186,0.00689220054732711,0.0725518903194575,0.0995693164649797,1.40328556066626e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSNAX,Translin-associated protein X,40116,0.051597956101513,0.00413187490646253,0.0434994812848465,0.0596964309181796,1.5215581923397e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F2,Prothrombin,40539,0.0194128331618331,0.00155528989199665,0.0163644649735197,0.0224612013501465,1.60499740817143e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,40511,0.0523820824599485,0.00419773032774838,0.0441545310175616,0.0606096339023353,1.67090911247513e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OCLN,Occludin,40482,0.0586867203082009,0.00470626815695325,0.0494624347205725,0.0679110058958292,1.86495203870919e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLRD1,Natural killer cells antigen CD94,42754,0.0611808247102379,0.00492091293464752,0.0515358353583288,0.0708258140621471,2.70017476804992e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DIABLO,"Diablo homolog, mitochondrial",42603,0.140788825988102,0.0113413294705273,0.118559820225868,0.163017831750335,3.43338718864358e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F2R,Proteinase-activated receptor 1,42654,0.072443434093446,0.00583697621271001,0.0610029607165344,0.0838839074703576,3.54217889383773e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCN1,Ficolin-1,40515,0.07226715180486,0.00582247178038052,0.0608551071153142,0.0836791964944058,3.81827125425328e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARL13B,ADP-ribosylation factor-like protein 13B,40116,0.0894668011636414,0.00721638917690859,0.0753226783769006,0.103610923950382,4.62602132874854e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMSB10,Thymosin beta-10,42611,0.0956918498761156,0.0077305811448038,0.0805399108323002,0.110843788919931,5.31396456326786e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEMIP2,Cell surface hyaluronidase,40199,0.0445299789314861,0.00360259238056954,0.0374688978655698,0.0515910599974024,7.27597741949512e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFBP4,Insulin-like growth factor-binding protein 4,42408,0.0619901955504297,0.00502531154143392,0.0521405849292192,0.0718398061716401,9.04990486518077e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DTNB,Dystrobrevin beta,40430,0.0550678752416609,0.00447078594339299,0.0463051347926107,0.0638306156907112,1.2230010204734e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LTBP3,Latent-transforming growth factor beta-binding protein 3,42346,0.067200689442695,0.0054587618701981,0.0565015161771068,0.0778998627082833,1.23189539307826e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUDT16,U8 snoRNA-decapping enzyme,40429,0.111189816876369,0.00903292195703712,0.0934852898405761,0.128894343912162,1.34666200033236e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINC1,Antithrombin-III,40516,0.0189141873106853,0.00153881108976523,0.0158981175747455,0.0219302570466252,1.67068832054282e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GP1BB,Platelet glycoprotein Ib beta chain,40116,0.0886776401236467,0.00722493482575133,0.074516767865174,0.102838512382119,2.10894112794225e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TREH,Trehalase,40527,0.0952497134124129,0.00776735301339602,0.0800257015061567,0.110473725318669,2.36682304997206e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCG2,Secretogranin-2,42636,0.043785392709608,0.00357974227409539,0.0367690978523811,0.050801687566835,3.20984491131044e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BLNK,B-cell linker protein,40199,0.0522078151480662,0.00427060625218279,0.0438374268937879,0.0605782034023444,3.80866042639185e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DMP1,Dentin matrix acidic phosphoprotein 1,40223,-0.0775157123783933,0.00634262993919749,-0.0899472670592204,-0.0650841576975662,3.97131587072525e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKT2,RAC-beta serine/threonine-protein kinase,40482,0.160234782960353,0.0131185326795815,0.134522458908374,0.185947107012333,4.27386013562309e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRD1,Adhesion G-protein coupled receptor D1,40283,0.0488940096951976,0.00400498126025268,0.0410442464251023,0.0567437729652928,4.64186465615219e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCYT2,Ethanolamine-phosphate cytidylyltransferase,40449,0.0966745252908051,0.00792451984043914,0.0811424664035443,0.112206584178066,5.13175468273728e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,42346,0.0847084315622334,0.00694766962886751,0.0710909990896531,0.0983258640348137,5.20940627627702e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42676,0.149798898596357,0.0122948498859706,0.125700992819855,0.173896804372859,5.71493134984117e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHRDL2,Chordin-like protein 2,42636,0.0600643901227232,0.00493802881235539,0.0503858536505066,0.0697429265949397,7.31253066295052e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTRB1,Chymotrypsinogen B,42611,0.0737900868858556,0.00606650795968089,0.0618997312848811,0.0856804424868302,7.32851206350584e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL12B,Interleukin-12 subunit beta,42754,0.0721297468817831,0.0059341116143095,0.0604988881177365,0.0837606056458297,8.07979446237027e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLB,Beta-klotho,42311,-0.0948571378888662,0.00780390977874481,-0.110152801055206,-0.0795614747225264,8.19278051673145e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLF4,Krueppel-like factor 4,40136,0.0510726835139603,0.00420030731313296,0.0428400811802197,0.0593052858477009,8.45755817770625e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LONP1,"Lon protease homolog, mitochondrial",40223,0.110074251616935,0.0090626884685164,0.0923113822186428,0.127837121015227,9.90381871404418e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BMP6,Bone morphogenetic protein 6,42342,0.0514221317007043,0.00423912465098983,0.0431134473847642,0.0597308160166444,1.10343941411948e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GNAS,Neuroendocrine secretory protein 55,40482,0.109046324656547,0.00898729584938697,0.0914312247917481,0.126661424521345,1.13847460542903e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42754,0.0357216755278541,0.00294612266468232,0.0299472751050768,0.0414960759506314,1.16299200003928e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AIF1,Allograft inflammatory factor 1,42346,0.0659496002186133,0.00544543885345408,0.0552765400658433,0.0766226603713833,1.39408733449273e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLO1,Lactoylglutathione lyase,42357,0.0732360923000913,0.00605387531983876,0.0613704966732073,0.0851016879269753,1.6416049666233e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42594,0.0762077524269264,0.00630203936787883,0.0638557552658839,0.0885597495879689,1.72760900560748e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NECAP2,Adaptin ear-binding coat-associated protein 2,40116,0.0868022075811396,0.00717867134293234,0.0727320117489923,0.100872403413287,1.91076957552233e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLA2G4A,Cytosolic phospholipase A2,42676,0.109146710315,0.00903586355513954,0.0914364177469267,0.126857002883074,2.02206191493001e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRI1,Methylthioribose-1-phosphate isomerase,40182,0.0868540560149637,0.0071906625979197,0.0727603573230411,0.100947754706886,2.22580290428356e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANGPT1,Angiopoietin-1,42554,0.105582157610069,0.00874869824640664,0.0884347090471118,0.122729606173026,2.3149605044747e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BAP18,Chromatin complexes subunit BAP18,40483,0.0854248737250078,0.0070806568943412,0.0715467862120991,0.0993029612379166,2.60511188962183e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL11,C-X-C motif chemokine 11,42711,0.10034647235923,0.00833995329766959,0.0840001638957976,0.116692780822662,3.56302112080911e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PNMA1,Paraneoplastic antigen Ma1,40223,0.0702133517361846,0.00583252431438866,0.0587816040799828,0.0816450993923864,3.6089329179143e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCARB2,Lysosome membrane protein 2,42302,0.0440967867415705,0.00366534071868996,0.0369127189329382,0.0512808545502028,3.66170691835738e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ECHS1,"Enoyl-CoA hydratase, mitochondrial",40223,0.121938920623694,0.0101367787602027,0.102070834253697,0.141807006993692,4.01365837999743e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGB1BP2,Integrin beta-1-binding protein 2,42357,0.137306377557053,0.0114218999597168,0.114919453636008,0.159693301478098,4.09225876721164e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,40223,0.0661800971025849,0.00551474902108759,0.0553711890212533,0.0769890051839166,5.66045982013436e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLG,Plasminogen,40285,0.0268376419244514,0.00224096884092247,0.0224453429962433,0.0312299408526594,7.57352443621011e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42658,0.0640101626129261,0.0053546707274057,0.0535150079872109,0.0745053172386412,9.05498977622114e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCN4,CCN family member 4,42721,0.050052331360429,0.00418949610067899,0.0418409190030982,0.0582637437177598,9.82232370200059e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,40482,0.0835156324900486,0.00699015503867301,0.0698149286142495,0.0972163363658477,1.0519221637829e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,40482,0.123751026845366,0.0103639308592034,0.103437722361327,0.144064331329405,1.14391105429243e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42689,0.0533101929194778,0.00446881934312805,0.0445513070069469,0.0620690788320088,1.2139652361826e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEPTIN9,Septin-9,42587,0.0355089702673317,0.00297657093340751,0.0296748912378529,0.0413430492968104,1.21569657199667e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SH3BP1,SH3 domain-binding protein 1,40449,0.0596845058335796,0.00500177751261482,0.0498810219088546,0.0694879897583047,1.25786736836067e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GDNF,Glial cell line-derived neurotrophic factor,42311,0.0475342996759621,0.00399570930139994,0.0397027094452182,0.055365889906706,1.8161315717021e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GGACT,Gamma-glutamylaminecyclotransferase,40511,0.087292584735716,0.00733587784749795,0.07291426415462,0.101670905316812,1.86081918253941e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKR1B1,Aldo-keto reductase family 1 member B1,42346,0.0918454828903082,0.00772270714481344,0.0767089768864739,0.106981988894143,1.88939319833298e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCS,Copper chaperone for superoxide dismutase,42495,0.0590052302906272,0.00497012702338978,0.0492637813247833,0.0687466792564712,2.41060968503143e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NT5C1A,Cytosolic 5'-nucleotidase 1A,40483,0.0400971228998258,0.00337713189827972,0.0334779443791976,0.0467163014204541,2.54144560555875e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PKN3,Serine/threonine-protein kinase N3,40302,0.0927717076239686,0.00782611940308671,0.0774325135939186,0.108110901654019,3.20341461412138e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAGR1,PAXIP1-associated glutamate-rich protein 1,40223,0.0540987151732645,0.00456519227254125,0.0451509383190837,0.0630464920274454,3.36291129210724e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HMOX2,Heme oxygenase 2,42311,0.0565268850339301,0.00477298729005651,0.0471718299454193,0.0658819401224409,3.40915074936973e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42794,0.0292005198315646,0.00246913956988206,0.0243610062745958,0.0340400333885334,4.10577179494127e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIMP1,Metalloproteinase inhibitor 1,42501,0.0361765202260031,0.00306277020930122,0.0301734906157727,0.0421795498362335,4.90878938937336e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EFNA4,Ephrin-A4,42475,0.0420101766301684,0.00355737180824802,0.0350377278860023,0.0489826253743346,5.05123276118625e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C2,Complement C2,42663,0.028285408174918,0.00239589810826284,0.0235894478827228,0.0329813684671132,5.24084781549293e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APP,Amyloid-beta precursor protein,42592,0.0818220513668425,0.00693975600383323,0.0682201295993293,0.0954239731343556,6.29545921077309e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAS,Tumor necrosis factor receptor superfamily member 6,42760,0.0411207728518445,0.0034909846493765,0.0342784429390666,0.0479631027646224,7.14896316644668e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AK2,"Adenylate kinase 2, mitochondrial",40483,0.129767336812885,0.0110178205134728,0.108172408606478,0.151362265019291,7.78614531471844e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BPIFA2,BPI fold-containing family A member 2,39838,-0.139467788576583,0.0118475258577943,-0.16268893925786,-0.116246637895306,8.57649999138544e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42594,0.111172833800597,0.00945343706347285,0.09264409715619,0.129701570445004,8.98289657995959e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,40421,0.037187519785435,0.00316192771003528,0.0309901414737659,0.0433848980971042,9.51462672894688e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGR,Tyrosine-protein kinase Fgr,42311,0.0703246692548702,0.00598313995946804,0.0585977149343128,0.0820516235754276,9.73871830523919e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASRGL1,Isoaspartyl peptidase/L-asparaginase,40223,0.125054496250824,0.0106417326088664,0.104196700337446,0.145912292164202,1.07389924424953e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITPA,Inosine triphosphate pyrophosphatase,40116,0.0824558772000217,0.00703116214082768,0.0686747994039994,0.096236954996044,1.42930780253982e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42594,0.0995788667217811,0.00850226907295561,0.0829144193387881,0.116243314104774,1.57528809267524e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP170,Centrosomal protein of 170 kDa,40223,0.0945514329077013,0.00806871612595457,0.0787367493008303,0.110366116514572,1.57954141563329e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,40199,0.0664785332244486,0.00567406731790491,0.055357361281355,0.0775997051675423,1.61962691282019e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINT2,Kunitz-type protease inhibitor 2,42676,0.0494057196954404,0.00422018177380049,0.0411341634187914,0.0576772759720894,1.66684570358079e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RP2,Protein XRP2,42587,0.0513395387857516,0.00438644048090117,0.0427421154431853,0.0599369621283179,1.72754752741793e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLAMF6,SLAM family member 6,42346,0.0474274019696802,0.00406482505858039,0.0394603448548626,0.0553944590844978,2.65647620545377e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,42346,0.0735949928988633,0.00630989867987701,0.0612275914863043,0.0859623943114222,2.79401680579618e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARSA,Arylsulfatase A,42611,0.0542771245379387,0.00465489896981772,0.045153522557096,0.0634007265187815,2.87997098888435e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMTN,Smoothelin,40460,0.11244128827208,0.00964013754040252,0.0935466186928911,0.131335957851269,2.94805465728672e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSTB,Cystatin-B,42437,0.0519366905892013,0.00445505703296466,0.0432047788045905,0.060668602373812,2.97134086874551e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP3R1,Calcineurin subunit B type 1,42495,0.0487940767234857,0.00418749116716828,0.0405865940358358,0.0570015594111355,3.16546379341816e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHM,Rab proteins geranylgeranyltransferase component A 1,40182,0.0741121105982413,0.00637216137858464,0.0616226742962154,0.0866015469002672,4.3796098199626e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,42311,0.0773244622390164,0.00665193967342565,0.0642866604791021,0.0903622639989307,4.40164070426078e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKT3,RAC-gamma serine/threonine-protein kinase,42297,0.0686912000841657,0.00592693131182508,0.0570744147129885,0.0803079854553428,6.57736047533204e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,40483,0.103668563163489,0.00895288871481573,0.0861209012824498,0.121216225044527,7.83107142646464e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ABHD14B,Protein ABHD14B,42460,0.0689208138573818,0.00595887603635043,0.057241416826135,0.0806002108886286,8.60087556889493e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DBN1,Drebrin,40199,0.0604664424884204,0.00522907021194471,0.0502174648730088,0.0707154201038321,9.49355523759706e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB10,Ras-related protein Rab-10,40511,0.0645346429427735,0.00558986013917735,0.0535785170699859,0.0754907688155612,1.16236890229296e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFT20,Intraflagellar transport protein 20 homolog,40182,0.0518837556878246,0.00449578566166863,0.0430720157909541,0.0606954955846951,1.23730674951117e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42638,0.031250894304313,0.00270949598746893,0.0259402821688739,0.0365615064397521,1.24134209248206e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SDC4,Syndecan-4,42636,0.0566026277161068,0.00492678349491818,0.0469461320660671,0.0662591233661464,2.08328130674621e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNRPB2,U2 small nuclear ribonucleoprotein B'',40483,0.0518955116637973,0.00452286878887594,0.0430306888376004,0.0607603344899941,2.62280588163888e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDC26,Anaphase-promoting complex subunit CDC26,40428,0.0828609384835753,0.00723081144880014,0.0686885480439271,0.0970333289232236,3.10449301105704e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FNDC1,Fibronectin type III domain-containing protein 1,40483,0.0564974619014814,0.00493788592551762,0.0468192054874669,0.066175718315496,3.79588291959673e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42579,0.0293315941481466,0.00256668907888186,0.0243008835535382,0.0343623047427551,4.18825547039419e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRF5,Adhesion G protein-coupled receptor F5,40511,0.0339815623188552,0.00297494365092895,0.0281506727630344,0.0398124518746759,4.71041255549949e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TCOF1,Treacle protein,40511,0.0385017153184352,0.00337290219911379,0.0318908270081722,0.0451126036286982,5.13450404435065e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJC21,DnaJ homolog subfamily C member 21,40483,0.0456646257463129,0.00400818931798586,0.0378085746830606,0.0535206768095652,6.61181460559614e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCTN6,Dynactin subunit 6,42311,0.0853744117053449,0.00749710034179445,0.0706800950354278,0.100068728375262,6.65657818376319e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ABCA2,ATP-binding cassette sub-family A member 2,40116,0.0430563361417934,0.00378764491406974,0.0356325521102167,0.0504801201733701,8.91391245984733e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KITLG,Kit ligand,42636,-0.0446124805334698,0.00392690723044536,-0.0523092187051427,-0.0369157423617969,8.96796430055529e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,40283,0.0496734422573401,0.00438659079638937,0.0410757242964169,0.0582711602182633,1.45140105858855e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAD23B,UV excision repair protein RAD23 homolog B,42346,0.0552825651332979,0.00488560699750154,0.0457067754181949,0.0648583548484009,1.50791019134801e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIPC3,PDZ domain-containing protein GIPC3,40449,0.114902447214157,0.0101604085866027,0.0949880463844156,0.134816848043898,1.71116747748233e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCARF1,Scavenger receptor class F member 1,42794,0.0493326796293986,0.00437384241600789,0.0407599484940231,0.057905410764774,2.24927715660528e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAP3,Cytosol aminopeptidase,42370,0.0571412857079827,0.00506857688284022,0.0472068750176158,0.0670756963983495,2.41302203918836e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42594,0.140301763820645,0.0124885788351268,0.115824149303796,0.164779378337493,3.73031625161009e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLA2G15,Phospholipase A2 group XV,42679,0.031234491663311,0.00278291414776974,0.0257799799336823,0.0366890033929397,4.19988584567203e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SRC,Proto-oncogene tyrosine-protein kinase Src,42664,0.139151424041266,0.0124005081381186,0.114846428090554,0.163456419991979,4.30777462952305e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ING1,Inhibitor of growth protein 1,42292,0.0552308139745661,0.00492849508303846,0.0455709636118107,0.0648906643373215,5.13848738958353e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TREM2,Triggering receptor expressed on myeloid cells 2,42618,0.0613304224716936,0.00547421796134293,0.0506009552674615,0.0720598896759258,5.27044148500286e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OPLAH,5-oxoprolinase,40223,0.0791673052982975,0.0070777502282671,0.065294914850894,0.093039695745701,6.87695669502731e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNX9,Sorting nexin-9,42636,0.0780679659809836,0.00699410911700729,0.0643595121116493,0.0917764198503179,8.3782271964171e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TREML2,Trem-like transcript 2 protein,42611,0.0406292573793128,0.00364109663241203,0.0334927079797853,0.0477658067788404,8.71016546249954e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL1,Growth-regulated alpha protein,42607,0.111415558712545,0.00998600180838423,0.0918429951681119,0.130988122256978,8.84277040060167e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,40199,0.0519751955601244,0.0046612670088461,0.042839112222786,0.0611112788974627,1.01528652555154e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MSR1,Macrophage scavenger receptor types I and II,42711,0.05374252313803,0.00482345246239842,0.0442885563117291,0.0631964899643309,1.04565090561115e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRLF1,Cytokine receptor-like factor 1,42676,0.029301424590134,0.00263169922205991,0.0241432941148966,0.0344595550653714,1.14239513310456e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42495,0.0836173981256415,0.00751226940895603,0.0688933500840877,0.0983414461671954,1.18911260359508e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGFBP1,Fibroblast growth factor-binding protein 1,42679,0.0383719076820744,0.00345536587956567,0.0315993905581257,0.0451444248060231,1.57661564615291e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPP1,Tripeptidyl-peptidase 1,42545,0.0523222579910907,0.00471383382321595,0.0430831436975875,0.061561372284594,1.67672079021115e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPPB,Natriuretic peptides B,42357,-0.164532217354939,0.0148274994457844,-0.193594116268676,-0.135470318441201,1.74630088337285e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSS,Cathepsin S,39872,0.0283829702834882,0.00255854499382832,0.0233682220955847,0.0333977184713917,1.93104799492602e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAMB1,Laminin subunit beta-1,40223,0.0353320826533338,0.00318537939838641,0.0290887390324964,0.0415754262741712,1.94018709962118e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,40189,0.0408219379534873,0.00368182535670757,0.0336055602543405,0.0480383156526342,2.04212461685428e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42711,0.066543879803986,0.00601761442546622,0.0547493555300722,0.0783384040778998,2.64611764748959e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSME2,Proteasome activator complex subunit 2,42441,0.0417252584323103,0.00378783183411573,0.0343011080374435,0.0491494088271771,4.25528405188294e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAN2B2,Epididymis-specific alpha-mannosidase,40511,0.0693281992772042,0.00630131075775199,0.0569776301920103,0.0816787683623981,5.17084708183204e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFAT5,Nuclear factor of activated T-cells 5,40199,0.0995008667414389,0.00905595565419418,0.0817511936592183,0.11725053982366,6.14112416196413e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1RL,Complement C1r subcomponent-like protein,40519,0.0228143160673625,0.00207683688212126,0.0187437157784048,0.0268849163563202,6.23322511049971e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL18,C-C motif chemokine 18,42477,0.0799742088688148,0.00728811834554329,0.06568949691155,0.0942589208260797,6.77224686237246e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCRN1,Secernin-1,42594,0.0633868630758173,0.00578060116212063,0.0520568847980609,0.0747168413535738,7.35797617531398e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F11,Coagulation factor XI,40383,0.0345457315362988,0.0031540520757437,0.0283637894678411,0.0407276736047564,8.91193554123727e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EGFL7,Epidermal growth factor-like protein 7,42346,0.045658517307885,0.00417043732023233,0.0374844601602296,0.0538325744555403,8.93844449284538e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42495,-0.137271997494131,0.0125432903236997,-0.161856846528583,-0.11268714845968,9.33785504980951e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GP5,Platelet glycoprotein V,40283,0.0413428430607252,0.00378269807842177,0.0339287548270185,0.0487569312944319,1.15320335797529e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTIF3,"Translation initiation factor IF-3, mitochondrial",40449,0.100323573880125,0.0091837326918968,0.0823234578040076,0.118323689956243,1.21741296015384e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MIA,Melanoma-derived growth regulatory protein,42679,0.043101193790374,0.00394821878387808,0.035362684973973,0.0508397026067751,1.25278069889682e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNF,Tumor necrosis factor,42339,0.0439427339262635,0.00402651428716348,0.036050765923423,0.0518347019291039,1.30723324262939e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP7,Matrilysin,42333,0.0576384681063658,0.0052815446067354,0.0472866406771644,0.0679902955355672,1.30967234849401e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FADD,FAS-associated death domain protein,42636,0.0860432070990776,0.00788495151347113,0.0705887021326742,0.101497712065481,1.31384623706674e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PECAM1,Platelet endothelial cell adhesion molecule,42611,0.034195879411375,0.00314521181195542,0.0280312642599424,0.0403604945628076,2.03111775636633e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INPP1,Inositol polyphosphate 1-phosphatase,42587,0.0600353167581778,0.00553200858686243,0.0491925799279274,0.0708780535884281,2.52509306362101e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADM,Pro-adrenomedullin,42721,0.030493802915489,0.0028104878543474,0.0249852467209681,0.0360023591100099,2.58364058779743e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",40511,0.0838487157142868,0.00772528122562175,0.0687071645120682,0.0989902669165054,2.60706969804707e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRIM1,Cysteine-rich motor neuron 1 protein,42676,-0.0235540085980025,0.00217159968220967,-0.0278103439751335,-0.0192976732208716,2.68931416985402e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UMOD,Uromodulin,42764,-0.0627271798616252,0.00578402293065044,-0.0740638648057001,-0.0513904949175504,2.72827735502105e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLRX,Glutaredoxin-1,42546,0.0635783284013503,0.00586305986705101,0.0520867310619304,0.0750699257407703,2.77027047903497e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GP6,Platelet glycoprotein VI,42590,0.0984860052208539,0.00908955175028681,0.0806704837902917,0.116301526651416,3.04492949108964e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCRG1,Scrapie-responsive protein 1,40511,0.0324381493221522,0.00299262635948159,0.0265726016575682,0.0383036969867361,3.04845911410652e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100P,Protein S100-P,42357,0.0617603974983717,0.00570227779278004,0.0505839330245229,0.0729368619722206,3.20290791904955e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZHX2,Zinc fingers and homeoboxes protein 2,40483,0.0369631096731218,0.00341170430064545,0.0302761692438567,0.0436500501023869,3.22556855964936e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RPL14,60S ribosomal protein L14,40223,0.0454738647283854,0.0041973444660351,0.0372470695749566,0.0537006598818142,3.25757631066723e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD164,Sialomucin core protein 24,42611,0.0309889066491436,0.00286338256900763,0.0253766768138887,0.0366011364843986,3.48834350174696e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSNL1,Visinin-like protein 1,40483,0.0434674093963277,0.00402086353965333,0.0355865168586072,0.0513483019340482,4.1684075840233e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SF3B4,Splicing factor 3B subunit 4,42587,0.0820326666898506,0.00761034106290423,0.0671163982065584,0.0969489351731429,5.57483487683682e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA9,Serpin A9,42538,0.0808914269925959,0.00751245740224833,0.0661670104841892,0.0956158435010026,6.31355004271953e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42495,0.0410589787755552,0.00382436729265194,0.0335632188819574,0.048554738669153,8.86422495270556e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPON2,Spondin-2,42562,-0.0402966605694452,0.00375523771812936,-0.0476569264969787,-0.0329363946419116,9.37742102374421e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDX58,Antiviral innate immune response receptor RIG-I,42346,0.0635489787720582,0.0059268600996432,0.0519323329767575,0.0751656245673588,1.03243392810653e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINK2,Serine protease inhibitor Kazal-type 2,40283,0.0423783149901407,0.00395324921521234,0.0346299465283245,0.0501266834519569,1.10939374103536e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TACSTD2,Tumor-associated calcium signal transducer 2,40980,-0.0356719252564199,0.00332844339919804,-0.0421956743188481,-0.0291481761939917,1.12035925808369e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CARHSP1,Calcium-regulated heat-stable protein 1,42311,0.0584359260680614,0.00545532828195693,0.0477434826354258,0.069128369500697,1.15595772228583e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,42346,0.064907036210707,0.00607765977196282,0.0529948230576599,0.0768192493637541,1.62842699770734e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASAH1,Acid ceramidase,40418,0.0511476710726946,0.00478794683615937,0.0417632952738223,0.060532046871567,1.64628268994816e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HAVCR1,Hepatitis A virus cellular receptor 1,42706,0.0741033209699659,0.0069424290876469,0.0604961599581779,0.0877104819817538,1.71798502951718e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANXA2,Annexin A2,40054,0.0811139743258668,0.00760635896592219,0.0662055107526593,0.0960224378990742,2.02720326217947e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,POMC,Pro-opiomelanocortin,40223,0.0781573558577287,0.00733309172477314,0.0637844960771733,0.092530215638284,2.14635843633746e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IDO1,"Indoleamine 2,3-dioxygenase 1",40223,0.0719314312060721,0.00674898837772305,0.058703413985735,0.0851594484264093,2.14788341354788e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,40449,0.051415751491615,0.00482739845865756,0.0419540505126462,0.0608774524705838,2.30735734769763e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRDX5,"Peroxiredoxin-5, mitochondrial",42754,0.073498403093225,0.00690563577756971,0.0599633569691883,0.0870334492172616,2.38187774911313e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MET,Hepatocyte growth factor receptor,42654,-0.02210696239697,0.00207966803635509,-0.026183111748226,-0.018030813045714,2.74603763596641e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RELT,Tumor necrosis factor receptor superfamily member 19L,42611,0.0342852940897813,0.00322910638712919,0.0279562455710081,0.0406143426085545,3.13735657880683e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MCFD2,Multiple coagulation factor deficiency protein 2,42565,0.0480526697285524,0.00452839272194434,0.0391770199935415,0.0569283194635633,3.35220402279069e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPM1F,Protein phosphatase 1F,40511,0.0577218845949764,0.00544740193973683,0.0470449767930922,0.0683987923968605,4.11162328305318e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX16,Syntaxin-16,42346,0.0640937761656391,0.00605992446029622,0.0522163242234586,0.0759712281078197,4.86407412188935e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42638,0.0398577957842478,0.00377032103687963,0.0324679665519637,0.0472476250165319,5.11266271405425e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSPN,Persephin,42594,0.103033457629741,0.00975646559232162,0.0839107850687907,0.122156130190691,5.74316892239229e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,40116,0.0315626584048095,0.00298740168889485,0.0257073510945756,0.0374179657150434,5.76108014055192e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FRMD4B,FERM domain-containing protein 4B,40116,0.0775780231190381,0.00735396184046256,0.0631642579117314,0.0919917883263447,6.82737869575848e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NADK,NAD kinase,42636,0.0603032815895576,0.00572313151697343,0.0490859438162897,0.0715206193628256,7.37530348285794e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCF2,Neutrophil cytosol factor 2,42578,0.0912670564431511,0.00867958326825108,0.074255073237379,0.108279039648923,9.27059138874688e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HPCAL1,Hippocalcin-like protein 1,42754,0.0794468910165539,0.00757155056103326,0.0646066519169287,0.094287130116179,1.16879025067586e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BDNF,Brain-derived neurotrophic factor,40527,0.0921282232257037,0.00878032211363576,0.0749187918829776,0.10933765456843,1.22463953396673e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42587,-0.0215842011893243,0.00206244223467082,-0.0256265879692791,-0.0175418144093695,1.56315311968265e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGA11,Integrin alpha-11,42594,-0.0372249795452996,0.00355828844172049,-0.0441992248910717,-0.0302507341995274,1.62770924626414e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPDC1,Neural proliferation differentiation and control protein 1,42636,0.0379772864124045,0.00363051027031646,0.0308614862825842,0.0450930865422248,1.64183719717901e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDCP1,CUB domain-containing protein 1,42495,0.0595213010649253,0.00569331422591044,0.0483624051821408,0.0706801969477097,1.75232266884574e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA6,Carbonic anhydrase 6,42581,-0.0684842536731803,0.00655238406869287,-0.0813269264478183,-0.0556415808985423,1.80158867709591e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPK1,Thiamin pyrophosphokinase 1,40511,0.0299886317756744,0.00286857539775879,0.0243662239960672,0.0356110395552816,1.83088100125172e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCAM2,Neural cell adhesion molecule 2,42611,-0.0297511356695524,0.00284929140738751,-0.035335746828032,-0.0241665245110729,2.00367227991614e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SORCS2,VPS10 domain-containing receptor SorCS2,42346,0.0410975778382753,0.00393640778404023,0.0333822185815564,0.0488129370949941,2.03841191448063e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FXYD5,FXYD domain-containing ion transport regulator 5,42370,0.0719534538212616,0.00689369976279106,0.0584418022861911,0.0854651053563321,2.09824581218052e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LTA,Lymphotoxin-alpha,42594,0.0446207475148495,0.00427843779791579,0.0362350094309345,0.0530064855987644,2.28080542298778e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAMP1,Lysosome-associated membrane glycoprotein 1,40185,0.0304660387208314,0.00292050279146034,0.0247418532495691,0.0361902241920936,2.33145129856869e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APRT,Adenine phosphoribosyltransferase,42480,0.0516356928608436,0.00495450741513889,0.0419248583271714,0.0613465273945159,2.46479080369961e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GBP1,Guanylate-binding protein 1,40466,0.0716626185208255,0.00687407189512185,0.0581894376063867,0.0851357994352643,2.48370971838265e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42594,0.1304654457906,0.0125196943338903,0.105926844896175,0.155004046685025,2.4896851168897e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DARS1,"Aspartate--tRNA ligase, cytoplasmic",42476,0.0792962672387619,0.0076232675693934,0.0643546628027508,0.0942378716747729,3.03899689191778e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMOTL2,Angiomotin-like protein 2,40404,0.0526073445901428,0.00505656682768695,0.0426964736078764,0.0625182155724092,3.10444495349896e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB2B,Ras-related protein Rab-2B,40451,0.0659142529425527,0.00633759723070512,0.0534925623703707,0.0783359435147348,3.20780607324104e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP3,Stromelysin-1,42611,-0.0549767915673103,0.00529143754098108,-0.0653480091476332,-0.0446055739869874,3.4394290175021e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DYNLT3,Dynein light chain Tctex-type 3,40451,0.0472891925735245,0.00455034519700732,0.0383705159873901,0.0562078691596588,3.4884325691491e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PNLIPRP1,Inactive pancreatic lipase-related protein 1,40483,0.0893395583546729,0.00860144468793064,0.0724807267663288,0.106198389943017,3.70475852033013e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NID1,Nidogen-1,42652,0.0416702505363668,0.00401358024192179,0.0338036332622001,0.0495368678105335,3.71398884839772e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA13,Carbonic anhydrase 13,42483,0.111404637931364,0.0107312720298923,0.0903713447527753,0.132437931109953,3.76342565197217e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,40449,0.127075779381275,0.0122528099823581,0.103060271815853,0.151091286946697,4.35093645917017e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAGED1,Melanoma-associated antigen D1,42346,0.0524558572994412,0.0050625687376566,0.0425332225736343,0.0623784920252482,4.6327293114128e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TST,Thiosulfate sulfurtransferase,42277,0.0806597916044883,0.00779448045985299,0.0653826099031764,0.0959369733058001,5.31751258958945e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1R,Complement C1r subcomponent,40539,0.0210809169286587,0.00203733567529329,0.0170877390050838,0.0250740948522335,5.55893943229339e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MZT1,Mitotic-spindle organizing protein 1,42346,0.0557686713380104,0.00540504897544523,0.0451747753461378,0.0663625673298831,7.27682132287918e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCRIB,Protein scribble homolog,40223,0.09808891194171,0.0095148581681023,0.0794397899322295,0.11673803395119,8.31266412597269e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STXBP3,Syntaxin-binding protein 3,42346,0.0467359857972342,0.00453803076646855,0.0378414454949558,0.0556305260995125,8.86667023751145e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINB8,Serpin B8,42754,0.0621970528533462,0.00604192830435484,0.0503548733768107,0.0740392323298816,9.22757051935672e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPC2,NPC intracellular cholesterol transporter 2,40367,0.0369569274082948,0.00359136598231181,0.0299178500829637,0.043996004733626,1.00270801559826e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PALM2,Paralemmin-2,40483,0.0406656861169582,0.00395610052427728,0.0329117290893747,0.0484196431445416,1.12287441442212e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MSTN,Growth/differentiation factor 8,42357,0.0573637265859462,0.00558302277273633,0.046421001951383,0.0683064512205094,1.1358612344253e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",42476,0.102491906277585,0.00998671765891777,0.0829179396661061,0.122065872889064,1.28059736232809e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOL1,Apolipoprotein L1,40532,0.0625481117064588,0.00609517916331316,0.050601560546365,0.0744946628665526,1.34026520498481e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRC,Receptor-type tyrosine-protein phosphatase C,40527,0.0250556058863026,0.00244252660407358,0.0202682537423183,0.0298429580302868,1.39413405872395e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COX6B1,Cytochrome c oxidase subunit 6B1,40511,0.0351506880648985,0.00342774541714937,0.0284323070472857,0.0418690690825112,1.4428407038649e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BAG3,BAG family molecular chaperone regulator 3,42475,0.0435897557046048,0.00425327771513882,0.0352533313829327,0.0519261800262768,1.4833996977009e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MNDA,Myeloid cell nuclear differentiation antigen,42611,0.104072318223188,0.0101656203310456,0.0841477023743387,0.123996934072037,1.65426607584712e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPME1,Protein phosphatase methylesterase 1,42587,0.063737383731232,0.00624458215800138,0.0514980027015493,0.0759767647609147,2.2694546704249e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA4,Carbonic anhydrase 4,42794,-0.0257941306244788,0.0025278969457597,-0.0307488086381678,-0.0208394526107898,2.33379436269712e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD302,CD302 antigen,42587,0.0342628334311609,0.00336077901222419,0.0276757065672015,0.0408499602951203,2.56342783466479e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PARD3,Partitioning defective 3 homolog,40302,0.0794256362485543,0.00778995591586312,0.0641573226534626,0.094693949843646,2.64586966179943e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BLMH,Bleomycin hydrolase,42794,0.0333154587691101,0.00327693803327587,0.0268926602238894,0.0397382573143309,3.40940991728116e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NT5C3A,Cytosolic 5'-nucleotidase 3A,42570,0.0922400683783406,0.00907449750842791,0.0744540532618219,0.110026083494859,3.48704817681196e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC27A4,Long-chain fatty acid transport protein 4,42311,0.0708165294892866,0.00697403402498836,0.0571474228003094,0.0844856361782638,3.89349943618171e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",40511,0.0323027168335886,0.0031811440439737,0.0260676745074002,0.0385377591597771,4.0171510801779e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RPE,Ribulose-phosphate 3-epimerase,40302,0.0743614345049035,0.00732301743080559,0.0600083203405245,0.0887145486692824,4.03317500921304e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42587,0.026648526031674,0.0026270050456885,0.0214995961421245,0.0317974559212235,4.30268430961609e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,40223,-0.0376229573449284,0.00370800962073786,-0.0448906562015746,-0.0303552584882822,4.38542860658278e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD8A,T-cell surface glycoprotein CD8 alpha chain,42711,0.0552745129500866,0.00545079203804847,0.0445909605555116,0.0659580653446616,4.44726108860555e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGAL,Integrin alpha-L,40199,0.047461839172851,0.00468008742860488,0.0382888678127854,0.0566348105329166,4.62418340731553e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CORO1A,Coronin-1A,42353,0.0946096467637341,0.00933515430475636,0.0763127443264116,0.112906549201057,4.74575290101472e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RGS10,Regulator of G-protein signaling 10,40482,0.0629228116800339,0.00621406527319455,0.0507432437445726,0.0751023796154952,5.37068889335721e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARAF,Serine/threonine-protein kinase A-Raf,40302,0.0727340790047767,0.00718952441401679,0.0586426111533038,0.0868255468562496,5.91711698216318e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPPK1,Epiplakin,40223,0.0768985240289303,0.00760829096688953,0.0619862737338268,0.0918107743240338,6.52329675563166e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PVR,Poliovirus receptor,42711,0.0387851537900666,0.00384791910701214,0.0312432323403228,0.0463270752398104,8.26075387662481e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42587,0.0723359449587652,0.0071820152517419,0.0582591950653511,0.0864126948521793,8.9442303327796e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",40482,0.0966465948093823,0.00961324771266411,0.0778046292925606,0.115488560326204,1.1153857796339e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSE,Cathepsin E,40283,0.0540139800251109,0.00537245983664061,0.0434839587452953,0.0645440013049264,1.11564280546402e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LBP,Lipopolysaccharide-binding protein,42689,-0.0617938728642648,0.00615647930304854,-0.0738605722982399,-0.0497271734302897,1.26577615394079e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPMT,Thiopurine S-methyltransferase,42346,0.0765399668529994,0.0076273080413323,0.0615904430919881,0.0914894906140107,1.30076011531376e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,40199,0.0461241723852696,0.00459465502143567,0.0371186485432557,0.0551296962272835,1.30218433211588e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD84,SLAM family member 5,42594,0.0329483694337645,0.00328444996404677,0.0265108475042328,0.0393858913632961,1.3407054881519e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD40LG,CD40 ligand,42754,0.081352800650706,0.00811078000626051,0.0654556718384354,0.0972499294629766,1.35689748974305e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARFIP1,Arfaptin-1,40482,0.0717602709867201,0.00715674054698127,0.0577330595146368,0.0857874824588034,1.45614407943153e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENTR1,Endosome-associated-trafficking regulator 1,40223,0.0611833237904937,0.00612580127748045,0.049176753286632,0.0731898942943554,2.16640381952615e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IMMT,MICOS complex subunit MIC60,40451,0.0472915357052212,0.00473573002551816,0.0380095048552056,0.0565735665552368,2.19328694280205e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCTN2,Dynactin subunit 2,42587,0.0977903090956042,0.0098025173187421,0.0785773751508697,0.117003243040339,2.34113662617814e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM3C,Protein FAM3C,42613,0.0325066035642766,0.00325916286190405,0.0261186443549446,0.0388945627736085,2.39063082966886e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPXM1,Probable carboxypeptidase X1,42679,0.0725487387853921,0.00727779401057379,0.0582842625246675,0.0868132150461167,2.52105086655932e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DENR,Density-regulated protein,40199,0.0595923585734387,0.00597578451054171,0.0478798209327769,0.0713048962141005,2.53040784190156e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPXM2,Inactive carboxypeptidase-like protein X2,40511,0.0279571505492921,0.00280578981142812,0.022457802518893,0.0334564985796912,2.72946489507906e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TLR3,Toll-like receptor 3,42754,0.0636193299062189,0.00639542536531294,0.0510842961902055,0.0761543636222323,3.10206985102204e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF2,Fibroblast growth factor 2,42594,0.0712505004608347,0.00716354975937976,0.0572099429324503,0.085291057989219,3.15174119437374e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA12,Serpin A12,42249,0.107644788256822,0.0108309615462003,0.0864161036262691,0.128873472887374,3.41763290608122e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD83,CD83 antigen,42594,0.0367769488070511,0.00370358244206987,0.0295179272205942,0.044035970393508,3.70214329614138e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HDGF,Hepatoma-derived growth factor,42700,0.0964467883029898,0.00974003680370482,0.0773563161677284,0.115537260438251,4.88373183392134e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NGRN,Neugrin,40483,0.0240495478795027,0.00242973672324871,0.0192872639019352,0.0288118318570702,5.26852549423346e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DHPS,Deoxyhypusine synthase,40451,0.0419568451810252,0.00424080824238092,0.0336448610259587,0.0502688293360918,5.50716534141537e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LPA,Apolipoprotein(a),40324,-0.188342192944405,0.0190698644318642,-0.225719127230859,-0.150965258657951,6.54298707684037e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSPYL1,Testis-specific Y-encoded-like protein 1,40199,0.0417141559042925,0.00422722652111121,0.0334287919229146,0.0499995198856705,7.13091794768825e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42594,0.0841427922932422,0.00853447535014109,0.0674152206069656,0.100870363979519,7.48347252916727e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UNC79,Protein unc-79 homolog,40080,0.0575006395017488,0.00583413588696649,0.0460657331632945,0.0689355458402031,8.05299841986495e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,40482,0.0599688927480165,0.00608725764039582,0.0480378677728406,0.0718999177231923,8.34115321320539e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERI1,3'-5' exoribonuclease 1,40302,0.0355684221243638,0.00361101883788736,0.0284908252021046,0.042646019046623,8.50081594412348e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCARA5,Scavenger receptor class A member 5,42711,0.0318198072138295,0.00323308357133162,0.0254829634140195,0.0381566510136395,8.85812891144204e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42754,0.0428361177590029,0.00435283295023833,0.0343045651765358,0.0513676703414701,8.93778367844668e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FST,Follistatin,42654,0.0506255191645025,0.00514692510637013,0.0405375459560171,0.060713492372988,9.39307307631911e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPR,Nucleoprotein TPR,40116,0.0501180813660154,0.00509658708356492,0.0401287706822282,0.0601073920498027,1.00196817718557e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BOLA1,BolA-like protein 1,40136,0.0559127686782234,0.00568622679493685,0.0447677641601472,0.0670577731962997,1.00788189205362e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACRBP,Acrosin-binding protein,40451,0.0402954187295752,0.00410802849199932,0.0322436828852566,0.0483471545738939,1.2695063081001e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",40283,0.0904718689861607,0.00923422483477188,0.0723727883100078,0.108570949662314,1.42561052513405e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SETMAR,Histone-lysine N-methyltransferase SETMAR,42459,0.0306115359555067,0.00312631495251062,0.0244839586485859,0.0367391132624275,1.45928037979206e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERBB4,Receptor tyrosine-protein kinase erbB-4,42679,-0.0246195906124292,0.00251764543562989,-0.0295541756662637,-0.0196850055585946,1.64920139053325e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRSK2,Serine/threonine-protein kinase BRSK2,40482,0.0390166697665549,0.00399024131511829,0.0311957967889231,0.0468375427441868,1.71840528410217e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CYB5R2,NADH-cytochrome b5 reductase 2,40329,0.0571671085246099,0.00585508909136536,0.0456911339055338,0.068643083143686,1.98329349807521e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM3B,Protein FAM3B,42587,0.036094820622143,0.00369935188371581,0.02884409093006,0.043345550314226,2.04333138878823e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MATN2,Matrilin-2,42638,0.0301989621741833,0.00310082262806114,0.0241213498231835,0.0362765745251831,2.43622204148365e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLIT2,Slit homolog 2 protein,42311,0.0536282145392344,0.0055071775047792,0.0428341466298671,0.0644222824486016,2.4739113712572e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL24,C-C motif chemokine 24,42654,0.0842801622260731,0.00866929108489933,0.0672883516996704,0.101271972752476,2.88461479164281e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",42357,0.0891704617171951,0.00917652966793735,0.0711844635680379,0.107156459866352,3.0242194638996e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AK1,Adenylate kinase isoenzyme 1,42636,0.0640444373262603,0.00659504491349275,0.0511181492958145,0.0769707253567061,3.20238730218298e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",40527,0.0643179636693541,0.00662825576176748,0.0513265823762899,0.0773093449624184,3.54981497672861e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAP1L4,Nucleosome assembly protein 1-like 4,40428,0.0421254909287285,0.00434548010350638,0.0336083499258559,0.050642631931601,3.90030444018778e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FABP2,"Fatty acid-binding protein, intestinal",42636,-0.0801194282633762,0.0082901297430481,-0.0963680825597505,-0.063870773967002,5.03532905954379e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APLP1,Amyloid-like protein 1,42636,-0.0521938757447008,0.00540675363818888,-0.062791112875551,-0.0415966386138506,5.60062177952578e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTGDS,Prostaglandin-H2 D-isomerase,42555,0.0330410058650547,0.00342533384710484,0.0263273515247292,0.0397546602053802,6.02209931147358e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DSCAM,Down syndrome cell adhesion molecule,40482,0.0366371921651657,0.00379746015444658,0.0291941702624504,0.044080214067881,6.10212215990516e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDA,Cytidine deaminase,40494,0.0473685119716103,0.00491897810702565,0.0377273148818401,0.0570097090613806,7.26441674069572e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FRZB,Secreted frizzled-related protein 3,42454,0.0251198766721362,0.00261274866874839,0.0199988892813893,0.030240864062883,8.19265260907399e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL16,C-X-C motif chemokine 16,42778,0.0240536389632451,0.00250257297836567,0.0191485959256483,0.0289586820008418,8.38314675936751e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTGES2,Prostaglandin E synthase 2,40102,0.0548142559857164,0.00570436972382815,0.0436336913270133,0.0659948206444196,8.91955091577552e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LETM1,Mitochondrial proton/calcium exchanger protein,40482,0.0533672656535207,0.0055551892900463,0.04247909464503,0.0642554366620115,9.07013723667174e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTN,Pleiotrophin,42357,0.0497732978023605,0.00518327960789638,0.0396140697708836,0.0599325258338374,9.18068793230616e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RANBP1,Ran-specific GTPase-activating protein,40223,0.0527446098439218,0.00549811872965144,0.041968297133805,0.0635209225540387,1.03776124868675e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DKK4,Dickkopf-related protein 4,42477,0.0466443115111654,0.00486482276644074,0.0371092588889416,0.0561793641333893,1.05495763573648e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C7orf50,Uncharacterized protein C7orf50,40483,0.0228915968954202,0.00238731033270695,0.0182124686433146,0.0275707251475259,1.07721187984797e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42683,0.0309989991220917,0.00323407539291758,0.0246602113519732,0.0373377868922101,1.0827822964138e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BTC,Probetacellulin,42346,0.0749486000263822,0.00783760709889265,0.0595868901125527,0.0903103099402118,1.34868555430067e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SFRP1,Secreted frizzled-related protein 1,42457,0.0442966795676836,0.00463524110445674,0.0352116070029484,0.0533817521324189,1.42929004094312e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRG2,Bone marrow proteoglycan,40527,-0.052992716119019,0.00554914547766205,-0.0638690412552366,-0.0421163909828014,1.56725150021562e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCDH7,Protocadherin-7,40449,0.0363349292299143,0.00380728521625653,0.0288726502060515,0.0437972082537771,1.66490234126028e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,42357,0.0578761744196812,0.00606699558891127,0.0459848630654151,0.0697674857739473,1.68405258429867e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMS,Spermine synthase,40136,0.0638951825506497,0.00669602448661297,0.0507709745568883,0.0770193905444112,1.69426429993885e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CALB2,Calretinin,42311,0.032016191744658,0.00335972565561917,0.0254311294596445,0.0386012540296716,1.85609408824739e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRK5,G protein-coupled receptor kinase 5,42357,0.0506769670746199,0.00532002104916673,0.0402497258182531,0.0611042083309867,1.92185828033137e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,40173,0.0274285922123147,0.00287899644862055,0.0217857591730185,0.033071425251611,1.95643239408954e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HEPH,Hephaestin,40511,0.026461522204618,0.0027793623818411,0.0210139719362095,0.0319090724730266,2.06838332762994e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGBL1,Integrin beta-like protein 1,40527,0.0388030287645101,0.00408598370832796,0.0307945006961873,0.0468115568328329,2.60204582530183e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CWC15,Spliceosome-associated protein CWC15 homolog,40383,0.0592334432391793,0.00624217344220937,0.0469987832924489,0.0714681031859096,2.79807441812726e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCDC134,Coiled-coil domain-containing protein 134,40451,0.04840782686105,0.00511149754127983,0.0383892916801416,0.0584263620419585,3.34365848962185e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGA2,Integrin alpha-2,40283,0.0346446209837674,0.00365996655527738,0.0274710865354237,0.041818155432111,3.5008633338832e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACOT13,Acyl-coenzyme A thioesterase 13,40449,0.112210227031003,0.0118576925186259,0.0889691496944965,0.13545130436751,3.58394978675244e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRSF1,G-rich sequence factor 1,40014,0.0801047135688412,0.00846769865687374,0.0635080242013687,0.0967014029363138,3.71565488148281e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GGH,Gamma-glutamyl hydrolase,42437,0.033852397702198,0.00358460311796421,0.0268265755909881,0.0408782198134078,4.18724048104878e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPAG1,Sperm-associated antigen 1,40482,0.0567540208189784,0.00601209640019625,0.0449703118745937,0.068537729763363,4.45912321856417e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",42370,0.0707297247781251,0.00749689210432022,0.0560358162536574,0.0854236333025927,4.57642526566199e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39983,0.0487348168631808,0.00516676424296376,0.0386079589469718,0.0588616747793897,4.83139288919936e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,40451,0.0544475373878031,0.00578802717775414,0.043103004119405,0.0657920706562012,6.09717146897603e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,40223,0.0411152055032258,0.0043705907954815,0.032548847544082,0.0496815634623695,6.10111017857591e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA2,Carbonic anhydrase 2,42573,0.0684489723072416,0.00727887866435319,0.0541823701251094,0.0827155744893738,6.10802211944497e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FXN,"Frataxin, mitochondrial",42721,0.0719139775460615,0.00765989342293817,0.0569005864371027,0.0869273686550203,7.05227912510987e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENO2,Gamma-enolase,42711,0.0632768480684825,0.00674360316558096,0.0500593858639438,0.0764943102730212,7.40314119096768e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL26,C-C motif chemokine 26,42594,0.0917402854215777,0.00978029717276417,0.0725709029629599,0.110909667880195,7.63429840157642e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ICAM1,Intercellular adhesion molecule 1,42595,0.028655344189522,0.00305654357865938,0.0226645187753496,0.0346461696036944,8.00473622102296e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLRF1,Killer cell lectin-like receptor subfamily F member 1,40199,0.0441594786813196,0.0047255466279231,0.0348974072905903,0.0534215500720489,1.09766038152778e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP8,Caspase-8,42674,0.0599557195918615,0.00641892721821653,0.0473746222441571,0.0725368169395659,1.10748692452591e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,42370,0.0424072776706675,0.0045412940169395,0.033506341397466,0.0513082139438689,1.13548887769469e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFB,Complement factor B,40344,0.0316788928999127,0.00339452957341239,0.0250256149360244,0.0383321708638009,1.23128729498404e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX7,Syntaxin-7,40199,0.0489318475695239,0.00524829190308093,0.0386451954394853,0.0592184996995625,1.3419209709866e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRSS27,Serine protease 27,42603,0.0393730601739173,0.00422502889407656,0.0310920035415272,0.0476541168063073,1.35521027457221e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNGR2,Interferon gamma receptor 2,42495,0.0508867372974169,0.00546282245591514,0.0401796052838232,0.0615938693110106,1.40727846463927e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLSTN3,Calsyntenin-3,40483,0.029967980704001,0.00322087968802527,0.0236550565154715,0.0362809048925305,1.59722309038129e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSL,Cathepsin L1,42636,0.0241742253429298,0.00259963299324603,0.0190789446761676,0.029269506009692,1.63208935375523e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DEFB103A_DEFB103B,Beta-defensin 103,40135,0.0416069047089874,0.00447899680891673,0.0328280709635106,0.0503857384544642,1.84606843602249e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSAP,Prosaposin,40440,0.0282215530814208,0.00304335946461505,0.0222565685307753,0.0341865376320662,2.13632001199409e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STK4,Serine/threonine-protein kinase 4,42636,0.0830177196706458,0.00896032707792638,0.0654554785979101,0.100579960743381,2.24241564699796e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBP2,Retinol-binding protein 2,42587,-0.0750507594062053,0.00810350583892482,-0.090933630850498,-0.0591678879619127,2.31818416453792e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL20,C-C motif chemokine 20,42754,0.0889557740696081,0.00961112040511567,0.0701179780755814,0.107793570063635,2.4473678507336e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXN,Thioredoxin,40384,0.0430564373198624,0.00466950794293359,0.0339042017517126,0.0522086728880122,3.47715206713892e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNAP25,Synaptosomal-associated protein 25,40136,0.0458842437330866,0.00497640865140877,0.0361304827763254,0.0556380046898478,3.50342076942305e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSR,"Glutathione reductase, mitochondrial",40490,0.0217236201502631,0.00235915665290811,0.0170996731105632,0.026347567189963,3.89926632966422e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CAT,Catalase,40361,0.0523073002885027,0.00568967324854764,0.0411555407213493,0.063459059855656,4.48044082416562e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AARSD1,Alanyl-tRNA editing protein Aarsd1,42587,0.0528125042943583,0.00575134340042158,0.041539871229532,0.0640851373591846,4.81595487398709e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGA6,Integrin alpha-6,42594,0.0489138752144053,0.00532993509191571,0.0384672024342505,0.0593605479945601,5.06349192261021e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42495,0.0327283295113765,0.00357478424567353,0.0257217523898564,0.0397349066328966,6.20014281921276e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TDP1,Tyrosyl-DNA phosphodiesterase 1,40451,0.0647601413619079,0.00707592217503332,0.0508913338988426,0.0786289488249732,6.53920866894334e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,40116,0.0388630354128801,0.00425080741197922,0.0305314528854009,0.0471946179403594,7.18168524956722e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SGSH,N-sulphoglucosamine sulphohydrolase,40332,0.0546193497362135,0.00597634684613126,0.0429057099177962,0.0663329895546307,7.37613985313026e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUSD2,Sushi domain-containing protein 2,42611,-0.0276428231694178,0.00302904766128785,-0.033579756585542,-0.0217058897532936,8.11546372689752e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTSL4,ADAMTS-like protein 4,40223,0.0227809982957454,0.00249549071462523,0.0178898364950799,0.0276721600964108,8.12624342276062e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADA,Adenosine deaminase,42754,0.0331494607335881,0.00363288038147322,0.0260290151859006,0.0402699062812756,8.18419491151598e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IMPA1,Inositol monophosphatase 1,42495,0.0577452564890249,0.00633554164875346,0.0453275948574681,0.0701629181205817,9.02159422391332e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BGLAP,Osteocalcin,40527,0.086616121006876,0.00950105046052941,0.0679940621042384,0.105238179909514,9.06401057756368e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTX3,Pentraxin-related protein PTX3,42594,-0.0467536126136691,0.0051319694871721,-0.0568122728085264,-0.0366949524188118,9.36874070579458e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DGKZ,Diacylglycerol kinase zeta,42370,0.0332886382666773,0.00365889485747051,0.0261172043460352,0.0404600721873195,1.05050547376119e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYOM3,Myomesin-3,40283,-0.0883982621787352,0.00972533838573626,-0.107459925414778,-0.0693365989426921,1.16410350305072e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,40199,0.0335490604973952,0.00369229655206698,0.0263121592553439,0.0407859617394465,1.20055818733608e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPA2,Carboxypeptidase A2,42670,0.0628021527649703,0.00692189000183885,0.0492352483613661,0.0763690571685744,1.31652473276783e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RARRES1,Retinoic acid receptor responder protein 1,42346,0.0314040534109649,0.0034616713143102,0.0246191776349169,0.0381889291870129,1.33330756482457e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCRL1,Fc receptor-like protein 1,42636,0.0445552257463231,0.00492790496094824,0.0348965320228646,0.0542139194697817,1.755671429983e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42495,0.0368673921981946,0.00407848561150461,0.0288735603996456,0.0448612239967437,1.78918910195097e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMIGO2,Amphoterin-induced protein 2,42587,0.02223040494953,0.00246277613879027,0.0174033637175011,0.0270574461815589,2.01023386843378e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAA10,N-alpha-acetyltransferase 10,40116,0.0487475511897067,0.0054009471061356,0.0381616948616809,0.0593334075177325,2.0837517119939e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HLA_E,,42594,0.0291058739038416,0.00323402869360648,0.0227671776643728,0.0354445701433103,2.56024452433003e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP1,Interstitial collagenase,42136,0.0861150278197855,0.00956957744651552,0.0673586560246151,0.104871399614956,2.5960558407503e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,40449,0.0748241914974151,0.00831343734941589,0.05852985429256,0.0911185287022703,2.60955217675261e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX6,Syntaxin-6,42346,0.062392083700403,0.00693722894065218,0.0487951149767248,0.0759890524240813,2.7113228650873e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAMP3,Lysosome-associated membrane glycoprotein 3,42746,0.0494969230195117,0.00550576113408069,0.0387056311967135,0.0602882148423099,2.79522448949868e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CBLN4,Cerebellin-4,42721,0.0306586946128141,0.00341334114156925,0.0239685459753384,0.0373488432502898,3.00569242745031e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ESAM,Endothelial cell-selective adhesion molecule,42794,0.0305742174878952,0.00340426537347613,0.023901857355882,0.0372465776199084,3.02740163371278e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOC1,Apolipoprotein C-I,40516,0.0347419547265729,0.00387030139668921,0.0271561639890621,0.0423277454640838,3.23378804696167e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOE,Apolipoprotein E,40539,0.0685015230670344,0.00763138604010075,0.0535440064284369,0.0834590397056318,3.24047367161609e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGAP1,Rho GTPase-activating protein 1,42346,0.0424073331360707,0.00473870221355641,0.0331194767975001,0.0516951894746413,4.05721216549066e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD1C,T-cell surface glycoprotein CD1c,42679,0.0236335161401686,0.00264303660591146,0.0184531643925821,0.0288138678877551,4.32109920701205e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC5A,C-type lectin domain family 5 member A,42603,-0.0282509537746414,0.00316189656332444,-0.0344482710387572,-0.0220536365105255,4.60468625035311e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL6A3,Collagen alpha-3(VI) chain,42794,0.035559772173429,0.00398343869930008,0.0277522323228008,0.0433673120240572,4.93554611659815e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SDHB,Succinate dehydrogenase,40449,0.0622086726559608,0.00696854995252513,0.0485503147490116,0.0758670305629101,5.05189108520413e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNM1,Dynamin-1,40449,0.106632742186226,0.0119451833218749,0.0832201828753513,0.130045301497101,5.06192560905547e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NRP2,Neuropilin-2,42611,-0.0268608614689696,0.00301342283566947,-0.0327671702268818,-0.0209545527110575,5.5636917417292e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLITRK2,SLIT and NTRK-like protein 2,42721,0.0371062753536249,0.00416411982926022,0.0289446004882749,0.0452679502189749,5.69887779751808e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP6V1F,V-type proton ATPase subunit F,42292,0.0619430927908355,0.00695812614486804,0.0483051655468942,0.0755810200347769,6.18419996945594e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NECTIN2,Nectin-2,42613,0.0293728055290521,0.00330627740097226,0.0228925018231465,0.0358531092349577,7.26456749031567e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLXNB2,Plexin-B2,42743,0.0223861628078386,0.00253144183546539,0.0174245368103264,0.0273477888053507,1.04337161546891e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CIT,Citron Rho-interacting kinase,40182,0.0421057523679343,0.00476406775484904,0.0327681795684302,0.0514433251674384,1.12086936222854e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLTA,Clathrin light chain A,42357,0.0440296628549764,0.0049940353434278,0.0342413535818579,0.0538179721280949,1.32840542951862e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MEP1B,Meprin A subunit beta,42636,0.108971827931268,0.0123788159747839,0.0847093486206911,0.133234307241844,1.49190147558709e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42611,0.0358909748812386,0.00407986370698416,0.0278944420155496,0.0438875077469275,1.57352539280793e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CR1,Complement receptor type 1,40509,0.0333904159554192,0.00379572815043207,0.0259507887805724,0.0408300431302661,1.61077033477294e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NEK7,Serine/threonine-protein kinase Nek7,40302,0.0703303422960782,0.00799722393001808,0.0546557833932428,0.0860049011989136,1.65086163948032e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRPEL1,"GrpE protein homolog 1, mitochondrial",42587,0.0546066078816079,0.00621338101696582,0.0424283810883549,0.066784834674861,1.69762090330897e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,40302,0.0838596814400244,0.00953975757649777,0.0651617565900888,0.10255760628996,1.70724300855172e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,40283,0.0649362530264831,0.00739475340484289,0.050442536352991,0.0794299696999752,1.8514476090736e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LY75,Lymphocyte antigen 75,42594,0.0358812180694154,0.00408748573126864,0.0278697460361288,0.0438926901027019,1.85841046738279e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42587,0.0500684936560929,0.00572283738715581,0.0388517323772675,0.0612852549349183,2.40936883220705e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42722,0.0260806032337807,0.0029849382547473,0.020230124254476,0.0319310822130854,2.66296527344267e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK7,Kallikrein-7,40009,0.0359137303237857,0.00411024154421417,0.0278576568971259,0.0439698037504454,2.73192092127976e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DMD,Dystrophin,40223,0.0472417428095109,0.00541045147695701,0.0366372579146752,0.0578462277043466,2.87338665233655e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL6R,Interleukin-6 receptor subunit alpha,42582,0.0311564186656505,0.00357202374938547,0.024155252116855,0.038157585214446,3.04337364954551e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",40223,0.0837161485290506,0.00959738869788599,0.0649052666811941,0.102527030376907,3.1032377776602e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGFA,Protransforming growth factor alpha,42594,0.0433551012195247,0.00497520683325961,0.0336036958263359,0.0531065066127135,3.26774626221965e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,40302,0.0348668644735411,0.00401040446256374,0.0270064717269162,0.042727257220166,3.98665854063767e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,40483,0.0428123364733707,0.00493107274730919,0.0331474338886447,0.0524772390580967,4.41627264898929e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EFCAB2,Dynein regulatory complex protein 8,40302,0.031766736401387,0.00366394831437629,0.0245853977052094,0.0389480750975645,4.9172960947605e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC3B,Tetranectin,40269,0.0191275031743221,0.00220645160393209,0.0148028580306152,0.023452148318029,4.97032171449212e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HPGDS,Hematopoietic prostaglandin D synthase,42346,0.0348969695268809,0.00402710932640886,0.0270038352471196,0.0427901038066423,5.01550552298213e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42689,-0.0403356263344875,0.00465561752874141,-0.0494606366908207,-0.0312106159781544,5.07423180881824e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFBP6,Insulin-like growth factor-binding protein 6,42595,0.0294348388723834,0.00339864528714739,0.0227734941095745,0.0360961836351923,5.21749805149324e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD300A,CMRF35-like molecule 8,40283,0.0282489696649598,0.00327349561088778,0.0218329182676198,0.0346650210622998,6.99577101152054e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,40171,0.03557836922103,0.0041276045450603,0.0274882643127118,0.0436684741293482,7.63908900301779e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTGR1,Prostaglandin reductase 1,40511,0.0758160919107844,0.0087974641552454,0.0585730621665035,0.0930591216550654,7.72071620767605e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COLEC12,Collectin-12,42618,0.0252967208542244,0.00293625578274772,0.0195416595200388,0.0310517821884099,7.7479577955592e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HRG,Histidine-rich glycoprotein,40479,0.0279189906935593,0.0032424425196064,0.0215638033551308,0.0342741780319879,8.24000400683006e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSDE1,Cold shock domain-containing protein E1,40116,0.105318452372173,0.012252242882732,0.0813040563220184,0.129332848422328,9.39133138062309e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MDK,Midkine,42638,0.0459942733227342,0.00535357087599208,0.0355012744057897,0.0564872722396787,9.53614397780756e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIT,Mast/stem cell growth factor receptor Kit,42663,-0.0271143719755314,0.00315901312207736,-0.033306037694803,-0.0209227062562598,1.02308322591796e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD28,T-cell-specific surface glycoprotein CD28,42346,0.0341949459396979,0.00398792985175176,0.0263786034302645,0.0420112884491314,1.10445618064363e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPQ,Carboxypeptidase Q,40516,0.0321727996788599,0.00375224022807768,0.0248184088318277,0.0395271905258922,1.12640882728809e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PMM2,Phosphomannomutase 2,40116,0.0541061591594438,0.00631219536643825,0.0417342562412248,0.0664780620776628,1.15714839921339e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TF,Serotransferrin,40539,0.0191362202147717,0.00223789513174431,0.0147499457565529,0.0235224946729906,1.37665180951999e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRH,Receptor-type tyrosine-protein phosphatase H,40449,0.0441119392985443,0.00516226342853624,0.0339939029786132,0.0542299756184753,1.44991591620624e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPT,Dermatopontin,42794,0.0226613694632756,0.00265392718082743,0.0174596721888539,0.0278630667376974,1.49883174740397e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNX5,Sorting nexin-5,40223,0.0260542529774896,0.0030526839283836,0.0200709924778578,0.0320375134771215,1.58684996369939e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANXA4,Annexin A4,42584,0.0637533216517031,0.00747338307592293,0.0491054908228942,0.0784011524805121,1.60934219563485e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMARCA2,Probable global transcription activator SNF2L2,42311,0.0648589776890738,0.00762104502242307,0.0499217294451245,0.079796225933023,1.91833733513702e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PNLIP,Pancreatic triacylglycerol lipase,40532,0.0581910952443911,0.00684889029596123,0.0447672702643071,0.0716149202244751,2.19910011818067e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TOR1AIP1,Torsin-1A-interacting protein 1,40223,0.0465299642491161,0.00547941320232418,0.0357903143725607,0.0572696141256715,2.29580326097811e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WAS,Wiskott-Aldrich syndrome protein,42370,0.0589756660275389,0.00695901749496613,0.0453359917374053,0.0726153403176726,2.60504401741044e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UBAC1,Ubiquitin-associated domain-containing protein 1,42587,0.0305176358298448,0.00360464460663682,0.0234525324008367,0.037582739258853,2.79695811524688e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD46,Membrane cofactor protein,42580,0.0256470786368748,0.00303299594718879,0.0197024065803848,0.0315917506933648,3.05078164310181e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,40482,0.0585209884011605,0.00695010476401528,0.0448987830636905,0.0721431937386304,4.21362037105231e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHCHD6,MICOS complex subunit MIC25,40451,0.0255366094998341,0.00303402750048553,0.0195899155988825,0.0314833034007858,4.33908215942382e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL15,C-C motif chemokine 15,42794,0.039443952770252,0.00469375485733748,0.0302441932498706,0.0486437122906335,4.76057736685317e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42594,0.0337465560923519,0.00401774985191921,0.0258717663825902,0.0416213458021135,4.93697659068143e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NID2,Nidogen-2,42611,0.0650975782537909,0.00775162222717301,0.0499043986885318,0.08029075781905,4.99685359445985e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",42370,0.0523827429583458,0.00624964520158741,0.0401334383632345,0.0646320475534572,5.74154384215621e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDIA3,Protein disulfide-isomerase A3,40283,0.0217339436077628,0.00259755731071395,0.0166427312787635,0.0268251559367622,6.61456216189771e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZBTB17,Zinc finger and BTB domain-containing protein 17,42357,0.0369850351768374,0.0044236032541067,0.0283147727987882,0.0456552975548865,6.84874982991904e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HIP1R,Huntingtin-interacting protein 1-related protein,40449,0.0391020558961256,0.00469002291292997,0.0299096109867829,0.0482945008054684,8.48499830237072e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDZD2,PDZ domain-containing protein 2,40116,0.0529228871954357,0.00634866529626273,0.0404795032147607,0.0653662711761106,8.60102640137297e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BGN,Biglycan,42328,-0.105107085934123,0.012620855774877,-0.129843963252882,-0.0803702086153645,9.02739747006724e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",40223,0.0385937344166301,0.0046430101982932,0.0294934344279755,0.0476940344052848,1.04938136030234e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIMAP8,GTPase IMAP family member 8,40080,0.0460387984939504,0.00553973854729964,0.0351809109412431,0.0568966860466577,1.06488534544555e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNASET2,Ribonuclease T2,42749,0.0240934804166511,0.00290307738046913,0.0184034487509315,0.0297835120823706,1.14567135191759e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DAPK2,Death-associated protein kinase 2,40199,0.0471532276915852,0.00568667437974295,0.0360073459072891,0.0582991094758814,1.24437771676786e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CBLIF,Cobalamin binding intrinsic factor,42613,0.0704018258202436,0.00849288996619129,0.0537557614865087,0.0870478901539786,1.24459615663352e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SBSN,Suprabasin,40511,-0.0304843816225838,0.00368036269318987,-0.037697892501236,-0.0232708707439317,1.33635994268276e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCN5,CCN family member 5,42611,0.0335232142912352,0.00405358490609384,0.0255781878752912,0.0414682407071791,1.46464651383704e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42587,-0.0359930394308995,0.00435300430178155,-0.0445249278623914,-0.0274611509994077,1.48290055571074e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD300C,CMRF35-like molecule 6,42711,0.0311830416032822,0.00377182384580007,0.023790266865514,0.0385758163410503,1.49643556133193e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZBP1,Z-DNA-binding protein 1,40199,0.0347831939957992,0.00420621188575872,0.0265390186997121,0.0430273692918863,1.50017267194333e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGMN,Legumain,42676,0.0309093521790816,0.00373982213661255,0.023579300791321,0.0382394035668422,1.52753642421536e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKR7L,Aflatoxin B1 aldehyde reductase member 4,40199,0.0592749767170126,0.00719053136349842,0.0451815352445557,0.0733684181894696,1.86268103774734e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNDP1,Beta-Ala-His dipeptidase,42689,0.039853033713349,0.00483846158362687,0.0303696490094403,0.0493364184172576,1.9318240845152e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPCAM,Epithelial cell adhesion molecule,42616,-0.0853250470289903,0.0103749681223675,-0.105659984548831,-0.06499010950915,2.1458106856907e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSNK1D,Casein kinase I isoform delta,40199,0.0543046634735613,0.00660538081352243,0.0413581170790573,0.0672512098680652,2.23952013568746e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42636,0.0300572712111442,0.00366260286575945,0.0228785695942556,0.0372359728280327,2.4825129039833e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFC1,Cryptic protein,42346,0.0408443824745031,0.0049773634358623,0.031088750140213,0.0506000148087932,2.49766911007223e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD276,CD276 antigen,42618,-0.0315417416010181,0.00385311717425628,-0.0390938512625604,-0.0239896319394758,2.94173360620961e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRSS22,Brain-specific serine protease 4,40199,0.0314647206283939,0.00384522441674418,0.0239280807715754,0.0390013604852125,3.07844613824595e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP9,Caspase-9,40199,0.0536511049552852,0.00657041745050965,0.0407730867522863,0.0665291231582841,3.54882084683851e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCARF2,Scavenger receptor class F member 2,42711,-0.0259157842792694,0.00318019824115833,-0.0321489728319397,-0.0196825957265991,3.98632444294198e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL19,C-C motif chemokine 19,42711,0.111952053826246,0.0137484722437936,0.0850050482284107,0.138899059424082,4.19616703907784e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHI3L1,Chitinase-3-like protein 1,42416,0.0704365910187545,0.0086508580917747,0.0534809091588761,0.087392272878633,4.22897312120162e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",40483,0.0357924271099853,0.00439815804593565,0.0271720373399514,0.0444128168800192,4.4379294017702e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INSL5,Insulin-like peptide INSL5,40449,0.0842636173602811,0.0103590652648061,0.0639598494412611,0.104567385279301,4.57845002786505e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIF22,Kinesin-like protein KIF22,40116,0.106626920510118,0.0131320274796893,0.0808881466499268,0.132365694370309,5.17953868616464e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD200R1,Cell surface glycoprotein CD200 receptor 1,42558,0.0299684675985635,0.00369477570689835,0.0227267072130427,0.0372102279840843,5.45401419199115e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL12RB1,Interleukin-12 receptor subunit beta-1,42370,0.0331051067710438,0.00408495614075592,0.0250985927351622,0.0411116208069254,5.7771337787311e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WFDC1,WAP four-disulfide core domain protein 1,40229,0.0480322060791763,0.00593037181090135,0.0364086773298097,0.059655734828543,6.10636314522929e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100A12,Protein S100-A12,42434,0.0638787366491356,0.0078936993098454,0.0484070860018387,0.0793503872964326,6.35889080911784e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FUT8,"Alpha-(1,6)-fucosyltransferase",42495,0.0499161441294046,0.00617488465482407,0.0378133702059494,0.0620189180528598,6.82087985338353e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42562,0.057294495805105,0.00708929030805326,0.0433994868013206,0.0711895048088894,6.9245916570996e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGALS7_LGALS7B,Galectin-7,42524,0.0367071300138159,0.00454827542459232,0.0277925101816149,0.0456217498460168,7.59356397283554e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL7R,Interleukin-7 receptor subunit alpha,42611,-0.044543359132553,0.00552564037158724,-0.055373614260864,-0.033713104004242,8.19012056786658e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDF1,Endothelial differentiation-related factor 1,40482,0.0566633784855456,0.007032195375747,0.0428802755490815,0.0704464814220098,8.5558368705302e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAS2,Growth arrest-specific protein 2,40302,0.0445207590541118,0.00553853404307326,0.0336652323296882,0.0553762857785354,1.00267117970022e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TCL1A,T-cell leukemia/lymphoma protein 1A,42490,0.0851142194994084,0.0106116122721657,0.0643154594459637,0.105912979552853,1.13752755326679e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA14,Carbonic anhydrase 14,42721,-0.0302229094803979,0.00377823763122818,-0.0376282552376052,-0.0228175637231907,1.35349805324826e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGF1R,Insulin-like growth factor 1 receptor,42587,0.0182359599773643,0.00228139025529823,0.0137644350769798,0.0227074848777488,1.42015319413629e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL14,C-C motif chemokine 14,42618,0.0337891683684214,0.00423047315571022,0.0254974409832294,0.0420808957536135,1.49355426808062e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEL1L,Protein sel-1 homolog 1,40223,0.0273922346200542,0.00343226101587668,0.0206650030289359,0.0341194662111725,1.59774275713615e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AFP,Alpha-fetoprotein,42459,0.0560711825884129,0.00703275178391378,0.042286989091942,0.0698553760848839,1.6766190271713e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSPG4,Chondroitin sulfate proteoglycan 4,40527,-0.0277780437939256,0.00348501518031269,-0.0346086735473385,-0.0209474140405127,1.72879711787254e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGXT,Serine--pyruvate aminotransferase,42636,0.0628356876747329,0.00789597479966435,0.0473595770673908,0.078311798282075,1.88871236469693e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C5,Complement C5,40539,0.0125809414792957,0.00158169531304376,0.00948081866572989,0.0156810642928614,1.97578828094855e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEMA7A,Semaphorin-7A,42760,0.0237035074055593,0.00298790366850855,0.0178472162152825,0.0295597985958361,2.30299314982836e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CGREF1,Cell growth regulator with EF hand domain protein 1,42636,0.0359603508442613,0.00454934096809309,0.0270436425467988,0.0448770591417238,2.89827985114598e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,40182,0.0458104613398644,0.00579643694425132,0.0344494449291318,0.057171477750597,2.97777339471884e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SFTPA2,Pulmonary surfactant-associated protein A2,42346,0.0432773688073569,0.00548604379561419,0.0325247229679531,0.0540300146467607,3.29556432029202e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH5,Cadherin-5,42794,-0.0249410378247103,0.00316357067293135,-0.0311416363436558,-0.0187404393057648,3.41575215330971e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD80,T-lymphocyte activation antigen CD80,40511,0.0288998087033899,0.00366548471510649,0.0217154586617812,0.0360841587449986,3.45299402107937e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTUS1,Microtubule-associated tumor suppressor 1,40302,0.0467945883771047,0.00593735213906968,0.0351573781845281,0.0584317985696812,3.53995364599956e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAMA4,Laminin subunit alpha-4,42676,0.0273054514246072,0.003473412361177,0.0204975631967003,0.0341133396525142,4.08986224525703e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",40511,0.0433505709518139,0.00551592596408123,0.0325393560622147,0.0541617858414131,4.2171609544972e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRDX6,Peroxiredoxin-6,42721,-0.0499964695646765,0.0063665144456714,-0.0624748378781925,-0.0375181012511606,4.3654606100233e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL17D,Interleukin-17D,42370,0.0283681957297221,0.00362016842828646,0.0212726656102806,0.0354637258491635,5.00053649591917e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD248,Endosialin,40527,-0.0335366510177603,0.00428743596386673,-0.0419400255069391,-0.0251332765285816,5.65664165532872e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL2A1,Collagen alpha-1(II) chain,40223,0.0660262226769981,0.00849408952813559,0.0493778072018523,0.0826746381521438,8.33336622686937e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC4D,C-type lectin domain family 4 member D,42594,0.0506364608756422,0.00653532695279588,0.0378272200481623,0.0634457017031222,9.99554444387392e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42679,0.0229115253277162,0.00295887975090153,0.0171121210159492,0.0287109296394832,1.03744442264694e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GCLM,Glutamate--cysteine ligase regulatory subunit,40116,0.0372769046621446,0.00481350487763211,0.0278424351019856,0.0467113742223035,1.04664840366636e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HMOX1,Heme oxygenase 1,42500,-0.039190224184061,0.00507306261832227,-0.0491334269159727,-0.0292470214521494,1.19684973862758e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VEGFB,Vascular endothelial growth factor B,40199,0.0240452981446821,0.00311251479783155,0.0179447691409323,0.030145827148432,1.21227307216734e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAMPT,Nicotinamide phosphoribosyltransferase,42346,0.0424244716275142,0.00549855116271066,0.0316473113486013,0.0532016319064271,1.29095742541091e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MARCO,Macrophage receptor MARCO,42636,0.0211826476259442,0.00275163442838342,0.0157894441463127,0.0265758511055757,1.47598041376966e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C7,Complement component C7,40251,-0.0266556524747876,0.00346532193191165,-0.0334476834613344,-0.0198636214882408,1.57015832531219e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42649,0.0172912106622398,0.00225220854457778,0.0128768819148674,0.0217055394096123,1.73456377903503e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42636,0.0395701764409327,0.00515411402748466,0.0294681129470628,0.0496722399348027,1.7353508596353e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AZU1,Azurocidin,42216,0.0615395384735328,0.00802514465456776,0.04581025495058,0.0772688219964856,1.86575204674802e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VWC2,Brorin,42456,0.0331207550452685,0.00432704753662949,0.0246397418734747,0.0416017682170623,2.07688093533069e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA1,Carbonic anhydrase 1,42362,0.0483158347386466,0.00631268889087969,0.0359429645125225,0.0606887049647708,2.08738094970391e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL8,Interleukin-8,42494,0.0558936889217764,0.00731495776358024,0.0415563717051592,0.0702310061383937,2.3023741673893e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FABP6,Gastrotropin,42334,0.0469754150700376,0.0061658264153817,0.0348903952958895,0.0590604348441857,2.73810420975242e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UXS1,UDP-glucuronic acid decarboxylase 1,42346,0.0424075431356606,0.00556634767538397,0.0314975016919081,0.0533175845794132,2.74036620515128e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LIPF,Gastric triacylglycerol lipase,40223,0.0498125318906856,0.00655138833304608,0.0369718107579153,0.0626532530234559,3.11985662704878e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC16A1,Monocarboxylate transporter 1,42311,0.045777368993819,0.0060342630920608,0.0339502133333799,0.0576045246542582,3.51479031829114e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINI2,Serpin I2,40449,0.0446040421453286,0.00588746314231535,0.0330646143863905,0.0561434699042667,3.83989508347982e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNAR1,Interferon alpha/beta receptor 1,40449,0.0204347371072426,0.00269999099761311,0.0151427547519209,0.0257267194625643,4.07195052051028e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACP6,Lysophosphatidic acid phosphatase type 6,42689,0.0544187757050377,0.00719184280848632,0.0403227638004045,0.0685147876096709,4.07466717267935e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AHCY,Adenosylhomocysteinase,42636,0.0531453877869519,0.00703227887614593,0.0393621211897059,0.0669286543841979,4.37940657539856e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",40451,0.0299353184591267,0.00396105107448035,0.0221716583531452,0.0376989785651082,4.43043761778304e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TREML1,Trem-like transcript 1 protein,40532,0.0415623496790071,0.00550378014241874,0.0307749405998664,0.0523497587581478,4.62943300968011e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRYGD,Gamma-crystallin D,40483,0.0771407092269041,0.0102288862537328,0.0570920921695878,0.0971893262842203,5.00386584150456e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42721,0.0210678607103304,0.00279754589836615,0.0155846707495327,0.026551050671128,5.36064264171303e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42587,0.0360294991458664,0.00478812649619833,0.0266447712133177,0.0454142270784151,5.61829972331222e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAP,Prolyl endopeptidase FAP,42794,0.0214537923104643,0.00286797274260967,0.0158325657349493,0.0270750188859792,7.85909042718717e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD93,Complement component C1q receptor,42141,-0.0253488596021924,0.00338866887482685,-0.031990650596853,-0.0187070686075317,7.88237250318787e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SDK2,Protein sidekick-2,40283,0.0317958106112807,0.00425068805473292,0.0234644620240042,0.0401271591985572,7.98434902390645e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGHMBP2,DNA-binding protein SMUBP-2,40116,0.0431707924494035,0.00577763430577843,0.0318466292100778,0.0544949556887292,8.49862452022408e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,XRCC4,DNA repair protein XRCC4,42311,0.0288772276724597,0.00386675378935626,0.0212983902453214,0.036456065099598,8.65106772661726e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDC,Aromatic-L-amino-acid decarboxylase,42613,-0.0372374770604412,0.00498656183577458,-0.0470111382585594,-0.027463815862323,8.67290202735597e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ELOB,Elongin-B,40116,0.0315157652185913,0.00422117027205731,0.023242271485359,0.0397892589518237,8.88849992122483e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINK6,Serine protease inhibitor Kazal-type 6,42721,0.0418588865521426,0.00561198511845441,0.030859395719972,0.0528583773843133,9.26017237291336e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSC,Dipeptidyl peptidase 1,42616,0.0343335985459397,0.00462187351774907,0.0252747264511516,0.0433924706407279,1.16462581409564e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CENPF,Centromere protein F,40302,0.0425444980114602,0.00573565602911679,0.0313026121943913,0.0537863838285291,1.28006078759442e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SV2A,Synaptic vesicle glycoprotein 2A,40182,0.048723006319331,0.0065812529349259,0.0358237505668762,0.0616222620717857,1.42554524660043e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GNLY,Granulysin,42611,0.0416056554628152,0.00562408456012781,0.0305824497249647,0.0526288612006657,1.4671825637056e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,42346,0.0370583295828303,0.00501588430849972,0.0272271963381708,0.0468894628274898,1.57807933681979e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42611,0.0418783985159618,0.00567407821942244,0.0307572052058939,0.0529995918260298,1.66780541230458e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C2orf69,UPF0565 protein C2orf69,40182,0.0472920165230492,0.00641455190139467,0.0347194947963156,0.0598645382497828,1.79346757344411e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42619,0.0452263621757443,0.0061413822902795,0.0331892528867965,0.0572634714646921,1.88595178048497e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANGPTL4,Angiopoietin-related protein 4,42654,-0.0345802408913295,0.00470353550812925,-0.0437991704872628,-0.0253613112953962,2.0658149687747e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,40302,0.0565168699950649,0.00769231316825185,0.0414399361852913,0.0715938038048385,2.16614948429451e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCRL2,Fc receptor-like protein 2,42681,0.0405173563764595,0.00553192599171278,0.0296747814327025,0.0513599313202166,2.5381476968203e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHL1,Neural cell adhesion molecule L1-like protein,42668,-0.0233851234536393,0.00320332903801211,-0.029663648368143,-0.0171065985391355,3.03312902346561e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TAFA5,Chemokine-like protein TAFA-5,42587,0.0295461039844636,0.00405344840539877,0.021601345109882,0.0374908628590452,3.29448016624577e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ICAM4,Intercellular adhesion molecule 4,42594,-0.040366182134268,0.00554302005247749,-0.0512305014371238,-0.0295018628314121,3.46371515649717e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RCOR1,REST corepressor 1,42357,0.0337787236361694,0.00465104595450574,0.0246626735653382,0.0428947737070007,4.01037615062779e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ROBO1,Roundabout homolog 1,42638,0.0186190403877707,0.00257459044721604,0.0135728431112273,0.0236652376643142,5.022362370578e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENAH,Protein enabled homolog,42370,0.0357681930215955,0.00495852094075137,0.0260494919777228,0.0454868940654682,5.75192702687407e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SART1,U4/U6.U5 tri-snRNP-associated protein 1,40116,0.0283982047655982,0.00393758479594156,0.0206805385655527,0.0361158709656436,5.87475301547183e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OMD,Osteomodulin,42676,-0.0319615846645573,0.00443617993614675,-0.040656497339405,-0.0232666719897097,6.12367154175214e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL15A1,Collagen alpha-1(XV) chain,40527,0.0212248114645769,0.00294654400973301,0.0154495852055002,0.0270000377236536,6.25033811155782e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCDC80,Coiled-coil domain-containing protein 80,42636,0.0284226627683433,0.00394745166095903,0.0206856575128636,0.036159668023823,6.32928036993973e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42721,0.0262985661664647,0.00366032667938086,0.0191243258748782,0.0334728064580511,7.08491694643623e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REPS1,RalBP1-associated Eps domain-containing protein 1,40199,0.0292899881369392,0.00408448257412899,0.0212844022916464,0.037295573982232,7.92065050564253e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STAM,Signal transducing adapter molecule 1,40451,0.028187899811812,0.00393259598904648,0.0204800116732809,0.0358957879503431,8.10062806603168e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MCTS1,Malignant T-cell-amplified sequence 1,40449,0.0205979890467575,0.00287595901186528,0.0149611093835016,0.0262348687100135,8.43898589393877e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRYM,Ketimine reductase mu-crystallin,40136,0.0569649376515917,0.00797738252565156,0.0413292679013147,0.0726006074018688,9.86736316088886e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCRL3,Fc receptor-like protein 3,42370,0.0423718994234565,0.00593549665273084,0.030738325984104,0.0540054728628089,9.9133165344593e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MPO,Myeloperoxidase,42611,0.0347816627741693,0.00488203462018223,0.0252128749186122,0.0443504506297265,1.0985226394255e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PER3,Period circadian protein homolog 3,40199,0.0922628394173249,0.0129477259513247,0.0668852965527284,0.117640382281921,1.09954716202391e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH3,Cadherin-3,42711,0.0280150188867328,0.00393894387135884,0.0202946888988694,0.0357353488745961,1.19848402459382e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RALY,RNA-binding protein Raly,40451,0.0354514042369781,0.0049836860175538,0.0256833796425726,0.0452194288313836,1.20010731640937e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP12,Macrophage metalloelastase,42592,0.0418633432823169,0.00588966670403871,0.0303195965424011,0.0534070900222328,1.23757809203279e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CST5,Cystatin-D,42357,0.042642512079777,0.00600102454267084,0.0308805039761422,0.0544045201834119,1.25720321964372e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD209,CD209 antigen,42668,-0.0289971017831002,0.00408140854606954,-0.0369966625333965,-0.0209975410328039,1.266595152894e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOBR,Apolipoprotein B receptor,40223,-0.0318266142074228,0.00448630752672135,-0.0406197769597966,-0.0230334514550489,1.38110348073463e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ECI2,Enoyl-CoA delta isomerase 2,40116,0.0459555255367482,0.0064801863478037,0.033254360295053,0.0586566907784435,1.40667374755172e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MEPE,Matrix extracellular phosphoglycoprotein,42618,0.0191590093181745,0.00270259604848925,0.0138619210631355,0.0244560975732134,1.41720042254094e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GALNT7,N-acetylgalactosaminyltransferase 7,42587,0.0158002294530406,0.0022304872056015,0.0114284745300617,0.0201719843760195,1.47305105094953e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GDF2,Growth/differentiation factor 2,42636,0.0266508011125309,0.00376250325653192,0.0192762947297283,0.0340253074953334,1.47803002010353e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THBD,Thrombomodulin,42636,0.0224313159227987,0.00317009107565381,0.0162179374145172,0.0286446944310802,1.55813323103679e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRG1,Adhesion G-protein coupled receptor G1,42587,0.0603083514923324,0.00852881611044278,0.0435918719158645,0.0770248310688003,1.61300017848429e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42594,0.0315482233507459,0.00446548384959078,0.0227958750055479,0.0403005716959438,1.68662722754071e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RABEPK,Rab9 effector protein with kelch motifs,42346,0.0426423021692617,0.00604081140373651,0.0308023118179381,0.0544822925205852,1.76074231113746e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRN,Progranulin,42552,0.0181875612672887,0.00257906905731383,0.0131325859149536,0.0232425366196238,1.85055906482742e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLITRK6,SLIT and NTRK-like protein 6,42357,-0.0262068569736924,0.00373296902318293,-0.0335234762591309,-0.0188902376882538,2.3211754506572e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FSTL3,Follistatin-related protein 3,42574,0.0249575721676554,0.00355603000501989,0.0179877533578164,0.0319273909774943,2.35266176050435e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BSG,Basigin,42746,0.0160183121676363,0.00228296593011608,0.0115436989446087,0.0204929253906638,2.38387577145691e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH15,Cadherin-15,42692,0.04591024046576,0.00654985529620484,0.0330725240851985,0.0587479568463215,2.50795747114841e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMFR,E3 ubiquitin-protein ligase AMFR,42311,0.0461077906737057,0.00659186366504512,0.0331877378902172,0.0590278434571941,2.7881372099916e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CABP2,Calcium-binding protein 2,40182,0.0474981243887796,0.00680024890265641,0.034169636539573,0.0608266122379861,3.01829998464338e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FES,Tyrosine-protein kinase Fes/Fps,42346,0.0348724942678559,0.00499499482457681,0.0250823044116854,0.0446626841240265,3.06089224831218e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,40116,0.0492021474602386,0.0070497912568949,0.0353845565967246,0.0630197383237526,3.13997782371098e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJB8,DnaJ homolog subfamily B member 8,42357,0.0426069405157915,0.00610892722153262,0.0306334431615876,0.0545804378699954,3.21537209693735e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNASE3,Eosinophil cationic protein,42578,0.0804105090563911,0.0115293486884969,0.0578129856269373,0.103008032485845,3.21559444945694e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRDT,Bromodomain testis-specific protein,40116,0.0273165378218758,0.00391682974133762,0.0196395515288541,0.0349935241148975,3.25524478252093e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNF149,E3 ubiquitin-protein ligase RNF149,40223,0.0237292647987868,0.00341092558810103,0.0170438506461088,0.0304146789514648,3.67704794494173e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSPAN1,Tetraspanin-1,42357,0.0495938613819846,0.00713049682939287,0.0356180875963746,0.0635696351675947,3.687544307207e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAST,Gastrin,40483,0.106409589257013,0.0153017536270242,0.0764181521480454,0.13640102636598,3.74475475642533e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPR15L,Protein GPR15L,40449,0.0443971963614424,0.00639759746126973,0.0318579053373538,0.0569364873855311,4.14618848185576e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCGB1A1,Uteroglobin,42646,0.0406261400268103,0.0058556518454149,0.0291490624097971,0.0521032176438235,4.16068476969871e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASGR2,Asialoglycoprotein receptor 2,40532,0.0196417945481118,0.00283212008140456,0.0140908391885588,0.0251927499076647,4.27204435567741e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD300LF,CMRF35-like molecule 1,42721,0.0443798265261718,0.0064023523595965,0.0318312159013627,0.056928437150981,4.34351677124119e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA7,Thyroxine-binding globulin,40539,0.0134583247608413,0.00194234694701919,0.00965132474468364,0.0172653247769989,4.47099691347631e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSHB,Thyrotropin subunit beta,42636,0.0576563504487263,0.0083252931876964,0.0413387758008413,0.0739739250966112,4.54363116228309e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",42346,0.0362062902810399,0.00523062381065291,0.0259542676121602,0.0464583129499196,4.66019146770076e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGFBP2,Fibroblast growth factor-binding protein 2,40527,0.0372287138867453,0.00540588399804418,0.0266331812505787,0.0478242465229119,6.01212118514749e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,42292,0.0350036122406114,0.00508410970099355,0.025038757226664,0.0449684672545587,6.04619574213053e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100A11,Protein S100-A11,42531,0.0328698260331693,0.0047800228663743,0.0235009812150756,0.0422386708512629,6.40726270036509e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNX2,Sorting nexin-2,40451,0.0593043494423749,0.0086320032125882,0.0423856231457021,0.0762230757390478,6.74527066552944e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGAM,Integrin alpha-M,42611,-0.0228036518436533,0.00332417219957787,-0.029319029354826,-0.0162882743324807,7.19047571474648e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PI3,Elafin,42446,0.0409545575424408,0.00597260918398515,0.0292482435418299,0.0526608715430517,7.34057395177355e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TEK,Angiopoietin-1 receptor,42679,0.0158089451665696,0.00230573769537024,0.0112896992836439,0.0203281910494953,7.37163475847769e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRELP,Prolargin,42618,0.0175364741991455,0.00255811590055379,0.0125225670340601,0.0225503813642309,7.43083871784591e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LTB,Lymphotoxin-beta,40451,0.0258103539921406,0.00376925136437533,0.0184226213179649,0.0331980866663162,7.90049062214048e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BTN2A1,Butyrophilin subfamily 2 member A1,42676,0.0201417376783971,0.00294481503549777,0.0143699002088215,0.0259135751479728,8.27633261166876e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASS1,Argininosuccinate synthase,40116,0.0557911084575172,0.0081789914943219,0.0397602851286463,0.0718219317863881,9.50103848307127e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CR2,Complement receptor type 2,42689,0.0342825506721763,0.00503571950503079,0.024412540442316,0.0441525609020367,1.03237517164089e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F3,Tissue factor,42636,-0.0195278914353076,0.00286856922867847,-0.0251502871235174,-0.0139054957470978,1.03496476721998e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNASE6,Ribonuclease K6,40468,0.0243036668002844,0.00357964345810711,0.0172875656223945,0.0313197679781744,1.18248945593079e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HMBS,Porphobilinogen deaminase,42721,0.0307892439149993,0.00453586199061176,0.0218989544134003,0.0396795334165984,1.18471239051697e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRRC37A2,Leucine-rich repeat-containing protein 37A2,40449,0.0309555022537587,0.00456545721279244,0.0220072061166855,0.0399037983908319,1.25865553882159e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SFTPD,Pulmonary surfactant-associated protein D,42636,0.0483091896088885,0.0071326828551253,0.0343291312128429,0.0622892480049341,1.31443417186497e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COPB2,Coatomer subunit beta',40116,0.0308719869542165,0.00456548405178557,0.0219236382127168,0.0398203356957162,1.4300840978585e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RGMB,RGM domain family member B,42711,0.0202234535993746,0.00299193940593052,0.0143592523637508,0.0260876548349985,1.4433404677102e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,42357,-0.0151840693661122,0.00224771397132454,-0.0195895887499083,-0.0107785499823161,1.48491957706584e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRP1,Prolow-density lipoprotein receptor-related protein 1,42587,-0.018816111908333,0.00279331891130609,-0.0242910169744929,-0.013341206842173,1.69322446790383e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,40080,0.0462884167670647,0.00687718688412085,0.0328091304741879,0.0597677030599416,1.77314926540436e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FASLG,Tumor necrosis factor ligand superfamily member 6,42754,0.0258316231867781,0.00384138330363021,0.0183025119116628,0.0333607344618933,1.83173394145697e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIRPB1,Signal-regulatory protein beta-1,42600,0.0339468911409255,0.00506025468280717,0.0240287919626235,0.0438649903192276,2.04478396483417e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",40449,0.0718346846679839,0.0107091989547698,0.0508446547166351,0.0928247146193326,2.07115698792894e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC4M,C-type lectin domain family 4 member M,40504,-0.0348943970660664,0.00520463605357079,-0.0450954837310651,-0.0246933104010676,2.11742183269878e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRAF3,"TNF receptor-associated factor 3, Isoform 2",40199,0.0257025697324723,0.00383524468604968,0.0181854901478149,0.0332196493171296,2.16111371855235e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOTCH1,Neurogenic locus notch homolog protein 1,42794,0.0112311786244111,0.00167625134347065,0.00794572599120866,0.0145166312576136,2.16360819606287e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSF3R,Granulocyte colony-stimulating factor receptor,40199,0.0212092130933336,0.00317276640166666,0.0149905909460669,0.0274278352406002,2.42477774032086e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42706,0.0206997816453004,0.00310005413830468,0.0146236755342232,0.0267758877563775,2.53011303804412e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LACRT,Extracellular glycoprotein lacritin,40419,0.0362443808445731,0.00542888456397964,0.025603767099173,0.0468849945899732,2.56764394306604e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGFBR2,TGF-beta receptor type-2,42679,0.0251653929030477,0.00377008985783405,0.017776016781693,0.0325547690244024,2.5687942477288e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,40199,0.0410995396753945,0.00615990621812322,0.0290261234878729,0.053172955862916,2.64267890079004e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAGA,Alpha-N-acetylgalactosaminidase,40166,0.0393132961532864,0.00590383196802706,0.0277417854959533,0.0508848068106194,2.88977485870036e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD101,Immunoglobulin superfamily member 2,40449,0.0305016915994214,0.00458453799020222,0.0215159971386251,0.0394873860602178,3.0016355132936e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNC,Tenascin,42689,-0.033761450141886,0.00507573834947498,-0.0437098973068569,-0.023813002976915,3.01227351987775e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLRK1,NKG2-D type II integral membrane protein,40483,0.0341419523099047,0.00513954195323161,0.0240684500815707,0.0442154545382386,3.21502264906147e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIMAP7,GTPase IMAP family member 7,40283,-0.0222377885641288,0.00334947431407569,-0.0288027582197171,-0.0156728189085404,3.30149774910228e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",40482,0.0334508132517746,0.00504187468865224,0.0235687388620162,0.0433328876415329,3.40271858892507e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,XPNPEP2,Xaa-Pro aminopeptidase 2,42679,0.0677629195320952,0.0102362844290039,0.0476998020512477,0.0878260370129428,3.73103955555075e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PON1,Serum paraoxonase/arylesterase 1,40532,-0.019013608913362,0.00287439329164514,-0.0246474197649865,-0.0133797980617375,3.88730134567603e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDCD1,Programmed cell death protein 1,42689,0.0313113674725411,0.00473557138298755,0.0220296475618855,0.0405930873831967,3.93556413388131e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RHOC,Rho-related GTP-binding protein RhoC,42443,0.0797024592392658,0.0120607550697644,0.0560633793025275,0.103341539176004,4.03318815789269e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALPP,"Alkaline phosphatase, placental type",42587,0.0699494763740177,0.0105932579800855,0.0491866907330501,0.0907122620149853,4.17531450201211e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WASF3,Wiskott-Aldrich syndrome protein family member 3,42311,0.0584120459898165,0.00885843018563714,0.0410495228259677,0.0757745691536653,4.44681707350741e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNG,Interferon gamma,42370,0.0782556583291426,0.0118781367002997,0.0549745103965552,0.10153680626173,4.62077089147014e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",40223,0.0336843435118389,0.00511321451986247,0.0236624430529085,0.0437062439707693,4.67017623921743e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42689,0.0298574908732272,0.0045441369861321,0.0209509823804083,0.0387639993660462,5.19682849530568e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ECE1,Endothelin-converting enzyme 1,42311,0.0245464519106102,0.00373757893035941,0.0172207972071058,0.0318721066141147,5.31052138042921e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",42292,0.0321832475973738,0.00492970184837796,0.022521031974553,0.0418454632201946,6.89098230476625e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPM3,Tropomyosin alpha-3 chain,40116,-0.0301781460788297,0.0046223504788558,-0.0392379530173871,-0.0211183391402724,6.92655051875076e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FLT3LG,Fms-related tyrosine kinase 3 ligand,42754,0.0237345281049807,0.00363974282499743,0.0166006321679857,0.0308684240419756,7.2345753623063e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENSA,Alpha-endosulfine,40451,0.0364236086732414,0.0055868437277363,0.0254733949668782,0.0473738223796045,7.35438121190332e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42587,0.0271128545731807,0.00416068463207135,0.0189579126943208,0.0352677964520405,7.45712975845682e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CAPG,Macrophage-capping protein,42461,0.0400104454825554,0.00614695035084452,0.0279624227949001,0.0520584681702107,7.83779427053601e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C2CD2L,Phospholipid transfer protein C2CD2L,42292,0.0294110827290183,0.00452040402693291,0.0205510908362298,0.0382710746218068,7.9828533948481e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BOC,Brother of CDO,42357,-0.0160066808333746,0.0024623164488838,-0.0208328210731869,-0.0111805405935624,8.28528134499301e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,40449,0.0279491078667619,0.00430110948381114,0.019518933278492,0.0363792824550317,8.47665260820192e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFYA,Nuclear transcription factor Y subunit alpha,40116,0.026690425911916,0.00411937378734335,0.018616453288723,0.0347643985351089,9.61508457544279e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42721,0.0233022134576506,0.00359768074143634,0.0162507592044353,0.0303536677108658,9.67930200144259e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXADR,Coxsackievirus and adenovirus receptor,42594,0.0352532673145706,0.00544863523241809,0.0245739422590311,0.04593259237011,1.0133610128693e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKD2,Serine/threonine-protein kinase D2,40116,0.0310758401567345,0.00481325942912447,0.0216418516756506,0.0405098286378185,1.1184749061554e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CELA3A,Chymotrypsin-like elastase family member 3A,42781,0.0402489374304367,0.00624323135405271,0.0280122039764934,0.05248567088438,1.18087068436583e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACTN2,Alpha-actinin-2,40116,-0.0404049619034568,0.00627297485471674,-0.0526999926187016,-0.028109931188212,1.23583072459317e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFIC,Nuclear factor 1 C-type,40482,0.0321671288724487,0.00499875119684549,0.0223695765266316,0.0419646812182659,1.28445560486038e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,42370,0.0291196503815423,0.0045297007374851,0.0202414369360715,0.0379978638270131,1.33220441529093e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42681,0.0202259978745105,0.00315745400705409,0.0140373880206845,0.0264146077283365,1.54554464740075e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPARCL1,SPARC-like protein 1,42644,-0.0186320146963734,0.00290957221448965,-0.0243347762367731,-0.0129292531559736,1.56701593509714e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PALM,Paralemmin-1,40384,0.0212425228467985,0.00331756291104101,0.0147400995411581,0.0277449461524389,1.58403117822059e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,USP47,Ubiquitin carboxyl-terminal hydrolase 47,40116,0.056307602295017,0.00881494115960922,0.0390303176221829,0.0735848869678511,1.75194893485717e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYL3,Myosin light chain 3,40223,-0.049348923986221,0.00772813302134093,-0.0644960647080492,-0.0342017832643928,1.77567987462407e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42587,0.0236455896794244,0.00370612476049472,0.0163815851488548,0.030909594209994,1.82748526046204e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL21,C-C motif chemokine 21,42676,0.0282581258877852,0.00443409383488904,0.0195673019714027,0.0369489498041677,1.91496009850413e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKR1C4,Aldo-keto reductase family 1 member C4,42357,0.0361154322155733,0.00567257849280989,0.0249971783696659,0.0472336860614807,1.99590837983138e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MANSC1,MANSC domain-containing protein 1,42679,-0.0187194388766276,0.00295230286342358,-0.0245059524889378,-0.0129329252643174,2.3613267863038e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GZMH,Granzyme H,42357,0.0516691690202833,0.00815464380205638,0.0356860671682528,0.0676522708723138,2.43227895334959e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AHSP,Alpha-hemoglobin-stabilizing protein,42590,0.0552917483269077,0.00873943934696698,0.0381624472068524,0.072421049446963,2.58439320346781e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42638,-0.0225321736735349,0.00359123023796829,-0.0295709849399527,-0.015493362407117,3.62164669680365e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGR2,Anterior gradient protein 2 homolog,42215,0.0666686504802009,0.0106488977592508,0.0457968108720694,0.0875404900883324,3.95505215550748e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSPB6,Heat shock protein beta-6,42721,0.0258522117988108,0.00414519603911303,0.0177276275621493,0.0339767960354723,4.60292274707041e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AOC3,Membrane primary amine oxidase,42689,-0.0197625884381119,0.00317629604686602,-0.0259881286899693,-0.0135370481862545,5.05694542258377e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,B2M,Beta-2-microglobulin,40539,0.020516487280346,0.00330288744050589,0.0140428278969545,0.0269901466637376,5.42556682799188e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,40182,0.0357024741799206,0.00574829792916916,0.0244358102387491,0.0469691381210922,5.45640671039132e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL18BP,Interleukin-18-binding protein,42689,0.0210943487752002,0.00339732089380842,0.0144355998233357,0.0277530977270647,5.48466021328142e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYAR,Cell growth-regulating nucleolar protein,42346,0.0354405339210716,0.0057157033010867,0.0242377554509417,0.0466433123912015,5.79480744467405e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CBS,Cystathionine beta-synthase,40223,0.0334830409257232,0.00540393542639852,0.0228913274899821,0.0440747543614643,5.99639875107618e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSF1,Macrophage colony-stimulating factor 1,42676,0.0180678564812197,0.00292463779176326,0.0123355664093637,0.0238001465530757,6.68663944865186e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VGF,Neurosecretory protein VGF,40482,0.0204468544561995,0.00332009471347658,0.0139394688177854,0.0269542400946135,7.59275405789589e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB44,Ras-related protein Rab-44,40451,0.02718323058602,0.0044161894172777,0.0185274993281557,0.0358389618438843,7.74573802171634e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARID4B,AT-rich interactive domain-containing protein 4B,42311,0.027080711095564,0.00440247739161766,0.0184518554079934,0.0357095667831347,7.91128422580705e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42587,0.0360732294688139,0.00586493649740166,0.0245779539339066,0.0475685050037211,7.93570005332555e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DKK3,Dickkopf-related protein 3,42794,-0.0195013525019034,0.00317250084765549,-0.0257194541633082,-0.0132832508404987,8.11709656512086e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SHISA5,Protein shisa-5,40527,0.017995731486992,0.00293029054511698,0.0122523620185628,0.0237391009554213,8.46020827078461e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,QPCT,Glutaminyl-peptide cyclotransferase,42681,0.0176121872956021,0.00286852598617011,0.0119898763627087,0.0232344982284955,8.49417309595219e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42594,0.0227681131868931,0.00370993343926236,0.0154966436459388,0.0300395827278473,8.64284515464453e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C4BPB,C4b-binding protein beta chain,42679,0.0259572903516646,0.00423203959289792,0.0176624927495846,0.0342520879537445,8.83592881035156e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BAX,Apoptosis regulator BAX,42292,0.0570638415247637,0.0093228164786734,0.0387911212265638,0.0753365618229635,9.57170340376308e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCAM,Basal cell adhesion molecule,42611,-0.015839473891277,0.00259147124652239,-0.0209187575344609,-0.0107601902480931,1.01018302064181e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYZL2,Lysozyme-like protein 2,40080,0.0231755390677306,0.00379310024697396,0.0157410625836616,0.0306100155517996,1.03089811476411e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CX3CL1,Fractalkine,42495,-0.0221092416551463,0.00362105707512279,-0.0292065135223869,-0.0150119697879056,1.05172423020224e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSIG2,V-set and immunoglobulin domain-containing protein 2,40451,0.0424647521970477,0.00696357792653767,0.0288161394610338,0.0561133649330615,1.10841684396023e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1RAP,Interleukin-1 receptor accessory protein,42611,-0.0287219416107342,0.00471484757324311,-0.0379630428542907,-0.0194808403671777,1.14696260746028e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPP7,Dipeptidyl peptidase 2,42551,0.0384924034339129,0.00632170182650505,0.026101867853963,0.0508829390138628,1.16784118013977e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MDM1,Nuclear protein MDM1,40182,0.0200553625362571,0.00329838112669077,0.0135905355279432,0.026520189544571,1.23893532249855e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPP1,Osteopontin,42771,-0.0302007150177111,0.00496862200427178,-0.0399392141460837,-0.0204622158893384,1.24726101046226e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNASE1,Ribonuclease pancreatic,40532,0.0168998461446189,0.00278063801187515,0.0114497956413436,0.0223498966478942,1.2584688289054e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,40449,-0.0225937139783914,0.00373892313189064,-0.029922003316897,-0.0152654246398857,1.5621688157726e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ULBP2,UL16-binding protein 2,42495,0.0253121151650986,0.0042041276848775,0.0170720249027387,0.0335522054274585,1.78153908912924e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEBPA,CCAAT/enhancer-binding protein alpha,40199,0.0234588906294036,0.00389834411200264,0.0158181361698785,0.0310996450889288,1.82596909928156e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SORBS1,Sorbin and SH3 domain-containing protein 1,40482,0.0260257545492401,0.00432833680718078,0.0175422144071658,0.0345092946913144,1.87898736105544e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGB6,Integrin beta-6,42370,0.0197227823121961,0.00328457442575138,0.0132850164377234,0.0261605481866688,1.96767390326955e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL1A1,Collagen alpha-1(I) chain,42794,-0.0158221226278577,0.00263658083818238,-0.0209898210706951,-0.0106544241850202,2.01090997678822e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,B4GALT1,"Beta-1,4-galactosyltransferase 1",42676,0.0177974009278443,0.00297007782665214,0.0119760483876061,0.0236187534680825,2.12255913598633e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRDX1,Peroxiredoxin-1,42261,-0.056424306717755,0.00941925835539745,-0.074886053094334,-0.037962560341176,2.14942634397672e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42778,0.0180103710106559,0.00300735183357138,0.012115961416856,0.0239047806044558,2.16757967000205e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDCD6,Programmed cell death protein 6,42636,-0.0443252462651107,0.00740205866144299,-0.0588332812415389,-0.0298172112886824,2.17545432882856e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMPD3,AMP deaminase 3,40483,0.044625335488201,0.00745165410718407,0.0300200934381203,0.0592305775382818,2.18034297673902e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTN4,Contactin-4,42611,-0.0151212180339362,0.00252880905816292,-0.0200776837879355,-0.0101647522799369,2.29397633247826e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCN4B,Sodium channel subunit beta-4,40223,0.027630548810556,0.00463509007987918,0.0185457722539928,0.0367153253671192,2.58108391203964e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD59,CD59 glycoprotein,42130,0.0156667700026861,0.00262987041274396,0.010512223993708,0.0208213160116643,2.63198001342714e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRS,Receptor-type tyrosine-protein phosphatase S,42794,-0.0155064734006745,0.00260966356214489,-0.0206214139824785,-0.0103915328188705,2.88549380388369e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",40199,0.0271254974154199,0.00456470392422419,0.0181786777239405,0.0360723171068993,2.89312102132591e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INSR,Insulin receptor,40199,0.010832887044739,0.00182977256616362,0.00724653281505835,0.0144192412744197,3.30856966246905e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDIA5,Protein disulfide-isomerase A5,40080,0.0382338314704008,0.00646218680027305,0.0255679453418656,0.0508997175989359,3.3867071337288e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,40539,0.0159005478143261,0.00269123506590389,0.0106257270851545,0.0211753685434977,3.55644569558127e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL9,C-X-C motif chemokine 9,42676,0.0419576767636459,0.00711923104692707,0.0280039839116688,0.0559113696156229,3.86970426620413e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VEGFD,Vascular endothelial growth factor D,42734,-0.0223273161847096,0.00379194093077255,-0.0297595204090238,-0.0148951119603954,3.99924775885895e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBC1D17,TBC1 domain family member 17,42311,0.0280518797009025,0.0047648044528071,0.0187128629734006,0.0373908964284045,4.02131885506102e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGALS3,Galectin-3,42669,0.0184380139925599,0.00314224296188342,0.0122792177872684,0.0245968101978514,4.52022816958646e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYOM2,Myomesin-2,40116,-0.0311084259713527,0.00531745563572502,-0.0415306390173737,-0.0206862129253317,5.04935661698277e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRR,Receptor-type tyrosine-protein phosphatase R,40483,0.0232434090771893,0.00397634069576706,0.0154497813134858,0.0310370368408927,5.19252666445696e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PIGR,Polymeric immunoglobulin receptor,42464,0.0219970797808683,0.00376384648743267,0.0146199406655003,0.0293742188962363,5.20622072462602e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFHR2,Complement factor H-related protein 2,40451,0.0354529151231152,0.00608642297590381,0.0235235260903438,0.0473823041558867,5.87045818869782e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDI2,Protein DDI1 homolog 2,40283,0.047996639504017,0.00824627911773104,0.0318339324332641,0.0641593465747698,6.03335846656237e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ROBO2,Roundabout homolog 2,42711,0.0142973136464371,0.00246049055871035,0.00947475215136483,0.0191198751415094,6.3592214126534e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRH,Corticoliberin,42322,0.0524743160325763,0.0090395116749896,0.0347568731495966,0.0701917589155559,6.58561123624279e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPL,Periplakin,40199,0.0203629428695071,0.0035085575356253,0.0134861700996815,0.0272397156393327,6.66209295798611e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIL1,Nucleotide exchange factor SIL1,40223,0.0189176761802982,0.00326171137367057,0.0125247218879039,0.0253106304726926,6.81679361017845e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VIPR1,Vasoactive intestinal polypeptide receptor 1,40223,-0.0143699369284053,0.00248605066692916,-0.0192425962355864,-0.0094972776212241,7.66221815899162e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD300E,CMRF35-like molecule 2,42677,0.0262606773313264,0.00454686367658776,0.0173488245252144,0.0351725301374384,7.83900201456696e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,42357,-0.0188481795231383,0.00326441242932476,-0.0252464278846148,-0.0124499311616617,7.92362992650907e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSF1R,Macrophage colony-stimulating factor 1 receptor,40532,0.0246659839100859,0.00427636933519743,0.0162843000130989,0.0330476678070728,8.23278843398866e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPM1A,Protein phosphatase 1A,42346,0.0192731081810707,0.00335016706766962,0.0127067807284383,0.0258394356337032,8.96899012856594e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PODXL,Podocalyxin,42587,0.00922984890939972,0.00160607436256333,0.00608194315877558,0.0123777546600239,9.29079740894028e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSIG10,V-set and immunoglobulin domain-containing protein 10,40451,0.0202499633380048,0.00352614243252977,0.0133387241702465,0.0271612025057632,9.55287553548187e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PECR,Peroxisomal trans-2-enoyl-CoA reductase,40223,0.0170925255175847,0.00297719657761756,0.0112572202254542,0.0229278308097151,9.65189434146551e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCL2L15,Bcl-2-like protein 15,40199,0.0339587109856577,0.0059265755253083,0.0223426229560534,0.045574799015262,1.03124903401661e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPO,Erythropoietin,42594,0.0444957189087866,0.00777212249203402,0.0292623588243999,0.0597290789931732,1.05626235977237e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BLVRB,Flavin reductase,42611,0.0394262574882012,0.00690870502034355,0.0258851956483278,0.0529673193280745,1.17588515203597e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,40511,0.0199726157045723,0.0035044652415512,0.013103863831132,0.0268413675780127,1.23384957761334e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPING1,Plasma protease C1 inhibitor,40516,0.0109688181498058,0.00192526934679609,0.00719529023008544,0.0147423460695261,1.24762456163378e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH1,Cadherin-1,42188,0.0238382439361964,0.00418622794359751,0.0156332371667452,0.0320432507056475,1.26454812780048e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",42346,0.0463040773630916,0.00813317090174168,0.0303630623956779,0.0622450923305053,1.27317333628677e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42676,0.0164754690741085,0.00290586015443524,0.0107799831714154,0.0221709549768015,1.45949052500565e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42611,0.0192453317682357,0.00339654090234043,0.0125881115996485,0.025902551936823,1.49039410714842e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPRR3,Small proline-rich protein 3,40483,0.0417588707492789,0.00737920721556523,0.027295624606771,0.0562221168917867,1.55974142770164e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCSK7,Proprotein convertase subtilisin/kexin type 7,40451,0.0272237372503754,0.00481248855556387,0.0177912596814702,0.0366562148192806,1.57896889841349e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANXA1,Annexin A1,40235,0.024732516557557,0.00437410451134041,0.0161592717153298,0.0333057613997842,1.6036457483285e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSH,Pro-cathepsin H,42332,0.0441714297035134,0.00782776609123578,0.0288290081646913,0.0595138512423356,1.70649245831245e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGER,Advanced glycosylation end product-specific receptor,42587,0.0248198385511319,0.00441360246845641,0.0161691777129574,0.0334704993893065,1.9088302647204e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,40199,0.0205169646114946,0.00366674465516138,0.0133301450873783,0.0277037841356109,2.25354695209299e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PBK,Lymphokine-activated killer T-cell-originated protein kinase,40080,-0.0181492145087834,0.00324393621050498,-0.0245073294813731,-0.0117910995361936,2.2619717757812e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VCAM1,Vascular cell adhesion protein 1,42663,-0.016437321974243,0.00293842003067164,-0.0221966252343594,-0.0106780187141266,2.26308044425013e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTPN,Myotrophin,42357,0.0194820031835615,0.00348996109763101,0.0126416794322047,0.0263223269349182,2.42054758631179e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AFAP1,Actin filament-associated protein 1,40283,0.0487035273536467,0.00874089453979791,0.0315713740556428,0.0658356806516506,2.57833457438125e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",40223,0.0217143978250398,0.00389774841348107,0.0140748109346169,0.0293539847154627,2.59205289040384e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GBP4,Guanylate-binding protein 4,42311,0.0289047029790871,0.00519132863048391,0.0187296988633386,0.0390797070948355,2.62920371093298e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LY9,T-lymphocyte surface antigen Ly-9,42443,0.0179573846415214,0.00322573896908548,0.0116349362621138,0.0242798330209289,2.64341838869013e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PVALB,Parvalbumin alpha,42654,0.0640163883417565,0.011541568750355,0.0413949135910606,0.0866378630924523,2.96781377306046e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PZP,Pregnancy zone protein,40539,0.0297474069536677,0.00536355562591812,0.0192348379268682,0.0402599759804673,2.9846603208449e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GZMB,Granzyme B,42594,0.0387050688220282,0.00698033907773038,0.0250236042296767,0.0523865334143798,2.99738453486107e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEZ6L2,Seizure 6-like protein 2,42587,-0.0138176274738948,0.00249760377473898,-0.0187129308723832,-0.00892232407540644,3.21889484675683e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTN1,Contactin-1,42794,-0.0161822646440377,0.00292704421600191,-0.0219192713074014,-0.0104452579806739,3.28866102112564e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42654,0.0512753064338111,0.00927660674024992,0.0330931572229213,0.069457455644701,3.31099389654258e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WFDC2,WAP four-disulfide core domain protein 2,41948,0.0254254703055909,0.00460808201747185,0.016393629551346,0.0344573110598357,3.50398763516702e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KEL,Kell blood group glycoprotein,42311,0.0209946983138559,0.00381300938681831,0.013521199915692,0.0284681967120198,3.73831684350991e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACVRL1,Serine/threonine-protein kinase receptor R3,42475,0.0154338364946161,0.00280718029391391,0.00993176311854481,0.0209359098706873,3.91247589646793e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42594,-0.0227188828925577,0.00414221255957795,-0.0308376195093305,-0.014600146275785,4.21627637222889e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42746,0.0232630495775654,0.00424554032793328,0.0149417905348162,0.0315843086203147,4.34369439341098e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LIF,Leukemia inhibitory factor,42311,0.029631857331362,0.00540796607805394,0.0190322438183763,0.0402314708443477,4.34894995516303e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LUZP2,Leucine zipper protein 2,40451,0.0265216868829717,0.00484112532708577,0.0170330812418836,0.0360102925240598,4.38387749196892e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42754,0.0205276547256086,0.00375329242316791,0.0131712015761995,0.0278841078750177,4.59977398950194e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REG4,Regenerating islet-derived protein 4,42638,0.0300744046542758,0.00553335155651934,0.0192290356034979,0.0409197737050537,5.57158085723108e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CKAP4,Cytoskeleton-associated protein 4,42713,0.0165205472235282,0.0030425288185418,0.0105571907391863,0.0224839037078701,5.73680982803462e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,40199,0.0191500618203667,0.00352779454176527,0.0122355845185068,0.0260645391222267,5.80888454901938e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SFTPA1,Pulmonary surfactant-associated protein A1,42346,0.0328794217334239,0.00607142701808936,0.0209794247779688,0.044779418688879,6.2214272584667e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LMNB2,Lamin-B2,40483,0.0163389775770452,0.00301893216607581,0.0104218705315366,0.0222560846225538,6.35386167332689e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCT,Secretin,40182,0.0284796437756498,0.005266118629151,0.0181580512625138,0.0388012362887857,6.50352890528085e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLYR1,Putative oxidoreductase GLYR1,40451,0.0334412463401815,0.00619697025632432,0.0212951846377858,0.0455873080425771,6.9375260672355e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCRL6,Fc receptor-like protein 6,42594,0.0396844447630958,0.00737137391817156,0.0252365518834796,0.0541323376427121,7.42459855100041e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIF1C,Kinesin-like protein KIF1C,40116,0.0203865026963889,0.00378932022072977,0.0129594350637586,0.0278135703290193,7.60290598389803e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GC,Vitamin D-binding protein,40539,0.0146465108824254,0.00272287573174971,0.009309674448196,0.0199833473166549,7.63635749498347e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNU13,NHP2-like protein 1,40116,0.0358043829939575,0.00668344117269735,0.0227048382954707,0.0489039276924443,8.62494257068801e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCGB3A1,Secretoglobin family 3A member 1,40283,-0.0150525790318674,0.00281411240164315,-0.0205682393390879,-0.00953691872464681,9.02197961752325e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCDH1,Protocadherin-1,42721,0.0122043952482378,0.00228369755729985,0.0077283480359301,0.0166804424605455,9.23221720289314e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PADI4,Protein-arginine deiminase type-4,42292,0.040353660479215,0.00755564117678526,0.0255446037727159,0.0551627171857141,9.40506290414963e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPTLC1,Serine palmitoyltransferase 1,40483,0.0217670487153792,0.00407741124197985,0.0137753226810987,0.0297587747496597,9.55627473849932e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLGN,Calmegin,40182,0.0260758534154022,0.00489778290585396,0.0164761989199284,0.0356755079108759,1.03504104054663e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,40527,-0.022195142912467,0.0041721078878689,-0.0303724743726901,-0.014017811452244,1.05809496594982e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ICOSLG,ICOS ligand,42587,0.0108162829868139,0.00203588868600837,0.00682594116223745,0.0148066248113903,1.09678445947518e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42495,0.0599274993076051,0.0112831703667119,0.0378124853888498,0.0820425132263604,1.10642571508289e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANGPTL1,Angiopoietin-related protein 1,42439,0.0162077209366324,0.00305478450868704,0.0102203432996058,0.022195098573659,1.14059876560371e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRRN1,Leucine-rich repeat neuronal protein 1,42370,0.0221073284647354,0.00417237952090761,0.0139294646037565,0.0302851923257143,1.18642765939099e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SAA4,Serum amyloid A-4 protein,40539,0.0180612954261845,0.00340978927451504,0.011378108448135,0.024744482404234,1.19992157755162e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF16,Fibroblast growth factor 16,40199,0.0264099258263936,0.00499142652869045,0.0166267298301603,0.0361931218226268,1.239469848987e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",40482,0.0238841163829704,0.00451812072513923,0.0150285997616975,0.0327396330042433,1.2714779833589e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX3,Syntaxin-3,40483,0.021589049866431,0.00408858920001,0.0135754150344114,0.0296026846984506,1.31355396437112e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DSG3,Desmoglein-3,42651,0.0195106315893821,0.0036974345193328,0.0122636599314899,0.0267576032472744,1.33497971687115e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA7,Carbonic anhydrase 7,40302,-0.0195743523279314,0.00371375049657215,-0.0268533033012128,-0.01229540135465,1.38393742478628e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PROK1,Prokineticin-1,42594,0.0305557094744026,0.00581295786409386,0.0191623120607787,0.0419491068880266,1.49091841157876e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SRPX,Sushi repeat-containing protein SRPX,40511,-0.0204703126760733,0.00389600739950819,-0.0281064871791093,-0.0128341381730372,1.51389823459683e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CILP,Cartilage intermediate layer protein 1,40527,0.0305287494197615,0.00581266138870296,0.0191359330979037,0.0419215657416193,1.53089307235781e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RPA2,Replication protein A 32 kDa subunit,40199,0.0174524230698836,0.00333986023713001,0.0109062970051087,0.0239985491346584,1.76867766546613e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK6,Kallikrein-6,42656,0.0174030639343588,0.00333518034562564,0.0108661104569326,0.0239400174117851,1.83524482892196e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NECTIN1,Nectin-1,40199,0.0179799763459332,0.00344813702820417,0.011221627770653,0.0247383249212134,1.87756380836359e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ECM1,Extracellular matrix protein 1,40269,0.0204686514544777,0.00393304092116183,0.0127598912490005,0.0281774116599549,1.98233694848248e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRTAP,Cartilage-associated protein,40182,0.0262201704497593,0.00505291103909125,0.0163164648131405,0.0361238760863782,2.15056205623492e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRPL46,"39S ribosomal protein L46, mitochondrial",42311,0.0152953350249859,0.00295164962333347,0.00951010176325227,0.0210805682867195,2.22823028061846e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGAP5,Rho GTPase-activating protein 5,40080,0.0435939046091331,0.0084161477086791,0.0270982551001221,0.0600895541181442,2.2610281554664e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL9A2,Collagen alpha-2(IX) chain,40302,0.0244233054764917,0.00471638993674776,0.0151791812004661,0.0336674297525173,2.27725341145236e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",40223,0.0377272715188314,0.00728606081632915,0.0234465923188263,0.0520079507188366,2.28220541070082e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOB,Apolipoprotein B-100,40532,0.0121441200841273,0.00234861146930562,0.00754084160428826,0.0167473985639663,2.37109611621806e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SATB1,DNA-binding protein SATB1,40482,0.0159498100101888,0.00308597115498686,0.00990130654641455,0.0219983134739631,2.40026169869063e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAMTOR5,Ragulator complex protein LAMTOR5,40451,0.0218595037602096,0.00422995484323208,0.0135687922674747,0.0301502152529445,2.40939715143227e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MUC16,Mucin-16,42587,0.104164835750161,0.0201944410831091,0.0645837312272669,0.143745940273055,2.53036951853865e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSTT2B,Glutathione S-transferase theta-2B,40483,0.130193630215071,0.0252533561285344,0.0806970522031438,0.179690208226999,2.57237766813833e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PROCR,Endothelial protein C receptor,40116,-0.0190052499154281,0.00368737395395352,-0.026232502865177,-0.0117779969656792,2.5924707805041e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRUNE2,Protein prune homolog 2,40302,0.0163283516929998,0.00316992723425806,0.0101152943138541,0.0225414090721456,2.63517165080123e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA1,Alpha-1-antitrypsin,40327,-0.00443759386032997,0.000862366415518117,-0.00612783203474548,-0.00274735568591446,2.70872677962206e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD48,CD48 antigen,42654,0.0167732407879829,0.00326093536840487,0.0103818074659094,0.0231646741100565,2.73178834996171e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATXN2,Ataxin-2,40136,0.0598784402585964,0.0116461417507423,0.0370520024271416,0.0827048780900513,2.77287581543716e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42495,0.0244933437254466,0.00476765415791502,0.0151487415759332,0.0338379458749601,2.82508566403679e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL25,C-C motif chemokine 25,42754,0.0258700046171947,0.00503626803557709,0.0159989192674636,0.0357410899669258,2.83421776245728e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42618,0.0216003518201588,0.00421313854610348,0.013342600269796,0.0298581033705216,2.98644627186034e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DEFA1_DEFA1B,Neutrophil defensin 1,42351,0.0296316208941483,0.00578255929434547,0.0182978046772311,0.0409654371110654,3.0286122296004e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1B,Interleukin-1 beta,42293,0.0306243476314515,0.00598206431005732,0.0188995015837392,0.0423491936791639,3.10918274890099e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OSM,Oncostatin-M,42534,0.0376511106141229,0.00735540605386259,0.0232345147485522,0.0520677064796936,3.11705770693107e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARG1,Arginase-1,42488,0.0278230139146621,0.00544372920277171,0.0171533046772295,0.0384927231520946,3.24869433448897e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MOG,Myelin-oligodendrocyte glycoprotein,42721,0.0182281342911376,0.00357214908957339,0.0112267220755738,0.0252295465067015,3.39114237978686e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP6V1G2,V-type proton ATPase subunit G 2,40116,0.0540157819675169,0.0105953709625833,0.0332488548808536,0.0747827090541802,3.48908314861292e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSB,Cathepsin B,42659,-0.0287312913886305,0.00564901921153042,-0.0398033690432301,-0.0176592137340309,3.7047890784774e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42495,0.0162399113558123,0.0031957053077102,0.00997632895270034,0.0225034937589243,3.78961662445011e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LCP1,Plastin-2,40527,0.0256547511822521,0.00505224640294247,0.0157523482324849,0.0355571541320194,3.87713610480521e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL28A1,Collagen alpha-1(XXVIII) chain,40182,0.0407362534674221,0.00802228810218853,0.0250125687871325,0.0564599381477116,3.87916071567815e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100A14,Protein S100-A14,40482,0.0293034960658422,0.00577646831247428,0.0179816181733926,0.0406253739582918,3.98006703332707e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB37,Ras-related protein Rab-37,42370,0.0430133157482807,0.00850601548271981,0.0263415254021499,0.0596851060944116,4.32052386826241e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EGFLAM,Pikachurin,40449,0.0165058943475946,0.00326426516635968,0.0101079346215297,0.0229038540736596,4.33646314821132e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DUSP3,Dual specificity protein phosphatase 3,42311,0.0454452461377109,0.00899871942918783,0.0278077560565028,0.0630827362189191,4.47296569685119e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOLR2,Folate receptor beta,42711,-0.0157091123473161,0.00311207942954045,-0.0218087880292153,-0.00960943666541677,4.52770679524201e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TDO2,"Tryptophan 2,3-dioxygenase",40182,0.020515702581348,0.00407975726141158,0.0125193783489813,0.0285120268137147,5.0172044466342e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BST2,Bone marrow stromal antigen 2,42711,0.0269436903837549,0.00537497720425416,0.0164087350634168,0.0374786457040931,5.43224234583825e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL5RA,Interleukin-5 receptor subunit alpha,42594,-0.0304167028892521,0.00607375333028289,-0.0423212594166065,-0.0185121463618976,5.5729303321095e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD14,Monocyte differentiation antigen CD14,42416,0.0219731888877531,0.0043898827432143,0.013369018711053,0.0305773590644531,5.64588334604098e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GBA,Lysosomal acid glucosylceramidase,40182,0.0292597303415466,0.00584651998587682,0.017800551169228,0.0407189095138651,5.68333886411253e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,40449,0.0269129444420579,0.00537933688491349,0.0163694441476274,0.0374564447364883,5.72906623264005e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRE1,Adhesion G protein-coupled receptor E1,40449,0.0294732600514372,0.00591603587135698,0.0178778297435775,0.0410686903592969,6.38894250176748e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100A13,Protein S100-A13,40199,0.0186515943573616,0.00375026662229365,0.0113010717776661,0.0260021169370572,6.67801704442108e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLU,Clusterin,40539,0.0164833595545131,0.00332061751745612,0.00997494922029909,0.0229917698887271,7.00797365224937e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AREG,Amphiregulin,42587,0.0222075604661356,0.00447905577937657,0.0134286111385575,0.0309865097937137,7.20613101130916e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAEA,E3 ubiquitin-protein transferase MAEA,42346,0.0206330518914694,0.00416526315248464,0.0124691361125995,0.0287969676703393,7.3757729769826e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPHB6,Ephrin type-B receptor 6,42476,0.0174674619350381,0.00353598960178651,0.0105369223155365,0.0243980015545396,7.91109600650782e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEPTIN8,Septin-8,40470,0.016877479359802,0.00341834977164105,0.0101775138073856,0.0235774449122185,8.033858578768e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLASP1,CLIP-associating protein 1,40080,0.0375252695127516,0.0076642285079163,0.0225033816372356,0.0525471573882675,9.91324598061437e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STC2,Stanniocalcin-2,42591,0.0127941689074842,0.00261652621037681,0.00766577753514561,0.0179225602798227,1.02133314044357e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TK1,"Thymidine kinase, cytosolic",40302,0.0233107087664028,0.00478669939971646,0.0139287779429586,0.0326926395898471,1.13198441616804e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,XG,Glycoprotein Xg,42734,0.0176164773242737,0.00362629494632044,0.0105089392294856,0.0247240154190618,1.19914995171592e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,42346,0.0223375323182188,0.00460304692952151,0.0133155603363566,0.031359504300081,1.23145321981822e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDGFRA,Platelet-derived growth factor receptor alpha,42636,-0.0147235883494685,0.00304038012928569,-0.0206827334028685,-0.00876444329606855,1.29525964558704e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSPA2,Heat shock-related 70 kDa protein 2,40451,0.0175128218988962,0.00361635196490656,0.0104247720476793,0.024600871750113,1.29806799619348e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPC1,Glypican-1,42721,0.0152256070195082,0.00314450081225305,0.00906238542749219,0.0213888286115242,1.29974068695766e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIM26,Tripartite motif-containing protein 26,40080,0.0287239350446101,0.00593195840783239,0.0170972965652586,0.0403505735239616,1.30153591123056e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BAMBI,BMP and activin membrane-bound inhibitor homolog,42346,0.0152581202962329,0.00315363505074413,0.00907699559677446,0.0214392449956914,1.32463450233648e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OLFM4,Olfactomedin-4,39870,0.0627390991571945,0.0129965676150867,0.0372658266316246,0.0882123716827643,1.40273964540483e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MNAT1,CDK-activating kinase assembly factor MAT1,40302,0.0223921941445637,0.00464227450213085,0.0132933361203872,0.0314910521687401,1.42906255472295e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX5,Syntaxin-5,40199,0.0208517931477214,0.00432806198307481,0.0123687916608947,0.029334794634548,1.47077491608927e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA12,Carbonic anhydrase 12,42587,-0.0167455302150716,0.00348330339129577,-0.0235728048620114,-0.00991825556813193,1.54589981126822e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NEDD9,Enhancer of filamentation 1,40199,0.0167906853935896,0.00351030002440787,0.00991049734575015,0.023670873441429,1.74711702562435e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD7,T-cell antigen CD7,40166,0.0224657631869657,0.00471086433095446,0.013232469098295,0.0316990572756365,1.8759429882291e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLAMF8,SLAM family member 8,42346,0.0277834357167869,0.00582661100049728,0.0163632781558122,0.0392035932777616,1.87714103694087e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK8,Kallikrein-8,42154,0.0187513381782584,0.00393608774024165,0.0110366062073847,0.026466070149132,1.91894904831289e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGB1BP1,Integrin beta-1-binding protein 1,42346,0.0206169742331283,0.00433158467909015,0.0121270682621116,0.029106880204145,1.95960794027617e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RPS10,40S ribosomal protein S10,40116,-0.0204587946148329,0.00429819451645443,-0.0288832558670836,-0.0120343333625823,1.962157558245e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPR1,Atrial natriuretic peptide receptor 1,40116,-0.0206025633970502,0.00433277561120618,-0.0290948035950144,-0.0121103231990861,2.0093392168288e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NXPH1,Neurexophilin-1,42311,0.0193804538462811,0.00409284461892992,0.0113584783931785,0.0274024292993838,2.21125199723088e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATXN10,Ataxin-10,42311,0.0359161404041478,0.00759323477936514,0.0210334002365921,0.0507988805717034,2.26839064732754e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOSB,Protein fosB,42311,0.0190812711575708,0.00403412337569858,0.0111743893412016,0.02698815297394,2.26896234253198e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRL,Prolactin,42711,-0.0371210865504815,0.00787055956413784,-0.0525473832961917,-0.0216947898047714,2.42397487537847e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD99,CD99 antigen,42611,-0.0100231725380081,0.00212558855934392,-0.0141893261143221,-0.00585701896169397,2.43567972182193e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL24A1,Collagen alpha-1(XXIV) chain,40449,0.0276472868347246,0.00586795569494605,0.0161460936726304,0.0391484799968189,2.4875788465437e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ICAM5,Intercellular adhesion molecule 5,42636,0.0227138940573929,0.00482160612930748,0.0132635460439502,0.0321642420708355,2.49147383921806e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCC,Netrin receptor DCC,40182,0.0115035830037511,0.00244516853418722,0.0067110526767441,0.016296113330758,2.57443715679466e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PFDN2,Prefoldin subunit 2,42311,0.0273319294463973,0.00582367260968834,0.0159175311314081,0.0387463277613864,2.71622786648479e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC10A,C-type lectin domain family 10 member A,42495,-0.0179533605829489,0.00383317540092547,-0.0254663843687628,-0.010440336797135,2.84559887348386e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHRDL1,Chordin-like protein 1,42654,0.0159130108553478,0.00339848473561717,0.0092519807735382,0.0225740409371575,2.86326789746693e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPEP1,Dipeptidase 1,42476,-0.0245721562475102,0.00525828398165078,-0.0348783928515457,-0.0142659196434747,2.99692931408837e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,40182,0.0528455535703946,0.0113359107418064,0.0306271685164541,0.0750639386243351,3.17172125059689e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VIT,Vitrin,40511,0.0188963352730131,0.00405900749324785,0.0109406805862473,0.0268519899597789,3.2701566316371e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB39B,Ras-related protein Rab-39B,40116,0.0453601823101096,0.0097448828391989,0.0262602119452797,0.0644601526749394,3.28162500241313e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOM,Apolipoprotein M,42663,0.0137882828173855,0.00296439166467195,0.00797807515462849,0.0195984904801425,3.329824237239e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,JAM2,Junctional adhesion molecule B,42711,0.0138912653025518,0.00298976058202445,0.00803133456178383,0.0197511960433197,3.41164087481397e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALCAM,CD166 antigen,42794,0.0096039858070096,0.0020672670772902,0.00555214233552081,0.0136558292784984,3.42036709418419e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACP1,Low molecular weight phosphotyrosine protein phosphatase,40199,0.0218570274757864,0.00470474229483195,0.0126357325779158,0.031078322373657,3.42783358579959e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UROS,Uroporphyrinogen-III synthase,40182,0.0332222743004939,0.00715722233184932,0.0191941185300692,0.0472504300709185,3.49414440348777e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRD1,Bromodomain-containing protein 1,40302,-0.01491499775492,0.00322662746594449,-0.0212391875881712,-0.00859080792166882,3.83465987348884e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRRC38,Leucine-rich repeat-containing protein 38,40182,0.0235107487639602,0.00510131491561306,0.0135121715293587,0.0335093259985618,4.09635479727764e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LEO1,RNA polymerase-associated protein LEO1,40482,0.0157318048943574,0.00342769065121751,0.0090135312179711,0.0224500785707437,4.48839970749089e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP1,Caspase-1,42311,0.0333012220436359,0.00726958243359371,0.0190528404737922,0.0475496036134796,4.67246474890629e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKR1B10,Aldo-keto reductase family 1 member B10,40182,0.0309806079599526,0.00678368858177673,0.0176845783396702,0.044276637580235,5.00309680230284e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLIC5,Chloride intracellular channel protein 5,40182,-0.0152312826414332,0.00333819072881061,-0.021774136469902,-0.00868842881296439,5.1038489160731e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRRC25,Leucine-rich repeat-containing protein 25,42587,0.0188124126994475,0.00412752323103247,0.0107224671666239,0.0269023582322712,5.2150331629767e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRF,Receptor-type tyrosine-protein phosphatase F,42794,-0.0138734751324346,0.00304603069939906,-0.0198436953032568,-0.00790325496161247,5.29394335877822e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42611,0.0170241022281245,0.00374051919021354,0.00969268461530593,0.024355519840943,5.37921259511346e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42611,0.0113459499064554,0.00249714480535204,0.00645154608796536,0.0162403537249454,5.57923062656325e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC6A,C-type lectin domain family 6 member A,42346,0.0227477801276016,0.0050083992937996,0.0129313175117544,0.0325642427434489,5.62381064019766e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPOCK1,Testican-1,42495,0.0123058629826369,0.0027100836188238,0.0069940990897422,0.0176176268755315,5.65416884652551e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTRL,Chymotrypsin-like protease CTRL-1,40483,-0.0337927242910324,0.00745141949310644,-0.0483975064975211,-0.0191879420845438,5.81771134450263e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HGFAC,Hepatocyte growth factor activator,40428,0.0132354111968391,0.00292001505169665,0.00751218169551367,0.0189586406981645,5.88496590827543e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VIM,Vimentin,42357,0.0550837359295585,0.0121871057076411,0.0311970087425819,0.0789704631165351,6.24266725795232e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LMOD1,Leiomodin-1,40482,-0.0170116153239307,0.00376742075328073,-0.0243957600003609,-0.00962747064750042,6.38215023617368e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,40482,-0.018554093425799,0.00411722623637864,-0.0266238568491011,-0.0104843300024969,6.65826657028276e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FUCA1,Tissue alpha-L-fucosidase,42721,0.0397853307396969,0.00884782739736697,0.0224435890408576,0.0571270724385361,6.96159180845455e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DLL4,Delta-like protein 4,40223,0.04063118874506,0.00904066465687842,0.0229114860175783,0.0583508914725418,7.05201129584012e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,40451,0.0311977956255788,0.00694815072882415,0.0175794201970835,0.0448161710540741,7.19023231859094e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THBS4,Thrombospondin-4,42652,0.0215432146529747,0.00481162987130991,0.0121124201052073,0.0309740092007422,7.6206806817564e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MST1,Hepatocyte growth factor-like protein,40370,0.0308374701826019,0.00689350832148571,0.01732619387249,0.0443487464927139,7.77431063331994e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRDX2,Peroxiredoxin-2,40333,0.0294438173461858,0.00658392107870223,0.0165393320319294,0.0423483026604421,7.82292446897366e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EFNA1,Ephrin-A1,42590,0.0142445726688071,0.00318815510340639,0.00799578866613059,0.0204933566714836,7.96134683549243e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YAP1,Transcriptional coactivator YAP1,40483,0.0135263318943773,0.00303041229550113,0.00758672379519505,0.0194659399935595,8.1402253402239e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,QSOX1,Sulfhydryl oxidase 1,40342,0.020333551529766,0.00456864320635415,0.0113790108453119,0.0292880922142201,8.64312940867773e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1QA,Complement C1q subcomponent subunit A,42701,-0.0102823352158526,0.0023168699256914,-0.0148234002702077,-0.00574127016149746,9.15055485497915e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THBS2,Thrombospondin-2,42611,0.0181026112350842,0.00408379465972422,0.0100983737020248,0.0261068487681437,9.37590407586745e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSD17B3,Testosterone 17-beta-dehydrogenase 3,40116,0.0229653085867654,0.00518252871211431,0.0128075523110214,0.0331230648625094,9.45820172049619e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FMR1,Synaptic functional regulator FMR1,42346,0.0165349729077339,0.00373215128013344,0.00921995639867238,0.0238499894167955,9.48126732380927e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDX25,ATP-dependent RNA helicase DDX25,40182,-0.017716148066021,0.00399962934610363,-0.0255554215843841,-0.00987687454765792,9.53884222266872e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PMS1,PMS1 protein homolog 1,40182,0.0242925088334236,0.00548533281458171,0.0135412565168435,0.0350437611500038,9.57500211320694e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KRT8,"Keratin, type II cytoskeletal 8",40136,0.037805378973227,0.00855578238907182,0.0210360454906463,0.0545747124558078,1.00254765267431e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFHR5,Complement factor H-related protein 5,40382,0.0196291807734188,0.00445036310354725,0.0109064690904662,0.0283518924563714,1.04003575049076e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SOD3,Extracellular superoxide dismutase,40532,-0.0271218531458582,0.00615165710274691,-0.0391791010672421,-0.0150646052244742,1.04868123418268e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SAFB2,Scaffold attachment factor B2,40482,0.0127511075488178,0.00289526659542794,0.007076385021779,0.0184258300758565,1.07191095988726e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VAMP5,Vesicle-associated membrane protein 5,42357,0.0256759743834777,0.00583335061614872,0.0142426071758262,0.0371093415911292,1.08310412894316e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DGCR6,Protein DGCR6,40136,0.020567344461166,0.00467594600736364,0.0114024902867332,0.0297321986355987,1.10010866814249e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHGA,Chromogranin-A,40527,-0.0453496697092884,0.0103175249515662,-0.0655720186143581,-0.0251273208042187,1.11574285987649e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCGB2A2,Mammaglobin-A,40116,-0.0146905294308718,0.00335642694536028,-0.021269126243778,-0.00811193261796565,1.21533695454344e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSMG4,Proteasome assembly chaperone 4,40199,0.0262613764127718,0.00600423711296694,0.0144930716713566,0.038029681154187,1.2322126174122e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERC2,ERC protein 2,40182,0.0349904444080539,0.00800687968156149,0.0192969602321933,0.0506839285839144,1.25360167635221e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPE,Carboxypeptidase E,42588,-0.0177216922281257,0.00406209341296992,-0.0256833953175468,-0.00975998913870466,1.29428383301912e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GGT5,Glutathione hydrolase 5 proenzyme,42495,0.010829144959097,0.00248296860633527,0.00596252649067987,0.0156957634275141,1.30222984039799e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42611,0.0197349644601917,0.00452877024276547,0.0108585747843713,0.028611354136012,1.32421219590132e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSF2,Granulocyte-macrophage colony-stimulating factor,40116,0.0168439504518742,0.00387361501267002,0.009251665027041,0.0244362358767075,1.38389854296321e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,40527,-0.0124272359764685,0.00286122153557536,-0.0180352301861962,-0.00681924176674075,1.4155789499968e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK11,Kallikrein-11,42543,0.0149617600554757,0.00344522222868712,0.00820912448724897,0.0217143956237025,1.41743965839046e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNPEP,Aspartyl aminopeptidase,40483,0.0261308450685238,0.00601721835647813,0.0143370970898267,0.0379245930472209,1.41984022667209e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FBP1,"Fructose-1,6-bisphosphatase 1",42636,0.0333088591986276,0.00767541238322587,0.0182650509275049,0.0483526674697503,1.43730362227373e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCAM1,Neural cell adhesion molecule 1,42689,-0.0137623992506961,0.00318026185873394,-0.0199957124938146,-0.00752908600757752,1.51936606793173e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSN,Gelsolin,40488,-0.00884089656864925,0.00204290832808407,-0.012844996891694,-0.00483679624560447,1.52037896384472e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42545,0.0128353288906871,0.00297553340591692,0.00700328341508994,0.0186673743662843,1.61754963238921e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCDH17,Protocadherin-17,42636,0.0168638851110642,0.00391596496618481,0.009188593777342,0.0245391764447865,1.67076262436445e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",40223,0.0346125340211841,0.00804261547012533,0.0188490076997384,0.0503760603426297,1.69462950010741e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPP6,Dipeptidyl aminopeptidase-like protein 6,42587,-0.0153454881225586,0.00356840505777556,-0.0223395620357987,-0.00835141420931855,1.7171475229978e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSBP1,Heat shock factor-binding protein 1,40223,0.0427980781193319,0.00996071021428999,0.0232750860993235,0.0623210701393403,1.74854333449969e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",40223,0.0151737484629045,0.00353258915331175,0.00824987372241345,0.0220976232033955,1.75902326637197e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RSPO3,R-spondin-3,42721,0.0134151937840973,0.00312828574284183,0.00728375372812734,0.0195466338400673,1.81251141581023e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD109,CD109 antigen,42611,-0.0151090876407304,0.00353959388219748,-0.0220466916498375,-0.00817148363162334,1.98060678870018e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,40449,0.00968236186696911,0.00226855361732065,0.00523599677702064,0.0141287269569176,1.9877985662716e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CREBZF,CREB/ATF bZIP transcription factor,40080,-0.0117776522721997,0.00276004617154081,-0.0171873427684197,-0.00636796177597974,1.99621992270969e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPHS1,Nephrin,40199,0.0151172872296061,0.00354381440876073,0.00817141098843502,0.0220631634707771,2.0083098830672e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL22RA1,Interleukin-22 receptor subunit alpha-1,42370,0.0193541894241683,0.00454338591407384,0.0104491530325836,0.0282592258157531,2.05974559319128e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD160,CD160 antigen,42754,0.021957033410929,0.00516011889649102,0.0118432003738066,0.0320708664480514,2.10320369110452e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLPS,Colipase,42590,0.0326105482249991,0.00766673640212705,0.0175837448768301,0.0476373515731681,2.11873069397389e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,40116,-0.0145390016094691,0.00342907751905049,-0.021259993546808,-0.00781800967213012,2.25443273108214e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSF,Cathepsin F,42679,0.017633662144986,0.00416383128701753,0.00947255282243162,0.0257947714675403,2.30107575846112e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SAT2,Thialysine N-epsilon-acetyltransferase,40302,0.0300811551763052,0.007121313185521,0.0161233813326841,0.0440389290199264,2.41808633080675e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OGN,Mimecan,42611,0.0196371092136802,0.00466335670827859,0.0104969300654541,0.0287772883619062,2.5597046947403e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSF3,Granulocyte colony-stimulating factor,42370,0.0216428588852222,0.00514321358282025,0.0115621602628945,0.0317235575075499,2.59299405039726e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RSPO1,R-spondin-1,42495,0.0149049176258186,0.00357074877804288,0.00790625002085458,0.0219035852307827,3.00975476524703e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,40223,0.0284947997431788,0.00682603492925012,0.0151157712818486,0.0418738282045091,3.01028134404522e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GOT1,"Aspartate aminotransferase, cytoplasmic",40527,0.0180468259051407,0.00432575754893064,0.00956834110923666,0.0265253107010448,3.04261257379668e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDRG1,p53 and DNA damage-regulated protein 1,40182,0.0225108606143945,0.00540651257460452,0.0119140959681696,0.0331076252606194,3.1558176669218e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD5L,CD5 antigen-like,40479,0.0208988549316366,0.00502853330207292,0.0110429296595737,0.0307547802036996,3.26181029937597e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGT,Angiotensinogen,40532,0.0104511186414787,0.00251526585796713,0.00552119755986311,0.0153810397230943,3.27566936929423e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMPRSS11D,Transmembrane protease serine 11D,40470,0.0179353914717989,0.00431884112358004,0.00947046286958197,0.0264003200740157,3.30814010790629e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PREB,Prolactin regulatory element-binding protein,42370,0.0128808539371779,0.00310373758132358,0.00679752827778371,0.0189641795965721,3.34402945132226e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINI1,Neuroserpin,40267,0.0131802756143743,0.00318376494577343,0.00694009632065838,0.0194204549080902,3.50124355609842e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GBP2,Guanylate-binding protein 2,42370,0.0263131008078547,0.00639324952402428,0.0137823317407671,0.0388438698749422,3.88249768876532e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CST7,Cystatin-F,42642,0.04053395417285,0.00985379523539575,0.0212205155114743,0.0598473928342257,3.91961319305924e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C9orf40,Uncharacterized protein C9orf40,40449,0.0351520443263479,0.00856415350261032,0.0183663034612317,0.0519377851914641,4.07951190085246e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF5,Fibroblast growth factor 5,42370,-0.0142793267442394,0.00348043406629356,-0.0211009775141748,-0.00745767597430401,4.10736366912924e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SDC1,Syndecan-1,42636,0.0175403953045722,0.00427541984576518,0.00916057240687247,0.025920218202272,4.10917457858239e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VCAN,Versican core protein,42711,-0.0131782952292632,0.00321509785136506,-0.0194798870179388,-0.0068767034405877,4.17582343903525e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCL7B,B-cell CLL/lymphoma 7 protein family member B,40451,0.0190956153863125,0.00467974421613464,0.00992331672268865,0.0282679140499364,4.52523151551447e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FABP3,"Fatty acid-binding protein, heart",40511,0.0225498671757036,0.00552747234674217,0.011716021376089,0.0333837129753183,4.54228929470227e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1RL1,Interleukin-1 receptor-like 1,42760,-0.0196280241032593,0.00481564540241347,-0.0290666890919897,-0.0101893591145289,4.61005505596302e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL34,Interleukin-34,42292,0.0156686592158701,0.0038478687551779,0.00812683645572139,0.0232104819760188,4.68780742365737e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NRTN,Neurturin,42370,0.0210843923296629,0.00518260352161813,0.0109264894272914,0.0312422952320345,4.76330000027766e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GUCA2A,Guanylin,42563,-0.0155766373041169,0.00383298162037546,-0.0230892812800528,-0.00806399332818097,4.85471772253739e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL14,C-X-C motif chemokine 14,42370,0.0241543182987128,0.00594530812274389,0.0125015143781348,0.0358071222192908,4.87783907991528e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",40483,0.0232565388183526,0.0057319937938518,0.012021830982403,0.0344912466543021,4.99729942614646e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP13,Collagenase 3,42311,-0.014159497817297,0.00350993469632844,-0.0210389698221008,-0.00728002581249328,5.5117891158326e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CALB1,Calbindin,42587,0.019342700018148,0.00480074907167266,0.00993323183766957,0.0287521681986264,5.6299981439437e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",40482,0.0307010038244935,0.00763778645557598,0.0157309423715645,0.0456710652774224,5.86707073874464e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CYTL1,Cytokine-like protein 1,40527,0.0108301208216165,0.00269535591548534,0.0055472232272652,0.0161130184159677,5.90567024655413e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRTG,Protogenin,42721,0.0105033002291577,0.00261894107991642,0.00537017571252151,0.0156364247457939,6.09122522556198e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCN3,CCN family member 3,42779,0.0149677482307439,0.00373422668596257,0.00764866392625726,0.0222868325352305,6.14945815623889e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,42370,0.015638485524808,0.00390528686889038,0.00798412326178287,0.0232928477878332,6.25056716028222e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NDRG1,Protein NDRG1,42311,0.0274354968946175,0.00685284398305155,0.0140039226878365,0.0408670711013985,6.27505451033792e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EBI3_IL27,Interleukin-27,42689,-0.0129745604891685,0.00324626758223469,-0.0193372449503485,-0.00661187602798848,6.45560903410687e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLSTN2,Calsyntenin-2,42754,-0.0166207584639359,0.0041724592858667,-0.0247987786642346,-0.00844273826363717,6.82785279044011e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIPC2,PDZ domain-containing protein GIPC2,40483,0.0129891056471314,0.00326352699324892,0.00659259274036351,0.0193856185538993,6.93225732378368e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UBE2B,Ubiquitin-conjugating enzyme E2 B,40451,0.0120909723332495,0.00303954657180852,0.00613346105250481,0.0180484836139942,6.99658959787551e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGA4,Pepsin A-4,40532,0.0337668779139829,0.00849849143105867,0.0171098347091079,0.0504239211188579,7.13287730080519e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRG2,Adhesion G-protein coupled receptor G2,42636,-0.0112878594877424,0.00284486620643825,-0.0168637972523614,-0.00571192172312344,7.29159088962647e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,42357,0.0204155127712112,0.005152684397228,0.0103162513526443,0.0305147741897781,7.46814848154762e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RCC1,Regulator of chromosome condensation,40451,0.0218043417210282,0.00553328278396059,0.0109591074644654,0.0326495759775909,8.17761494802058e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL6,Interleukin-6,42587,0.0318188981931213,0.00809195575903083,0.0159586649054209,0.0476791314808218,8.46085555584883e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNPY2,Protein canopy homolog 2,42357,0.0254943005568407,0.00649045804188304,0.0127730027947499,0.0382155983189314,8.61044565909242e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLIN3,Perilipin-3,42636,0.0173235778221133,0.00442049153247487,0.00865941441846251,0.025987741225764,8.9385208308228e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NTRK2,BDNF/NT-3 growth factors receptor,42636,0.0104989663874931,0.00268991449164628,0.00522673398386643,0.0157711987911198,9.54375090621016e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF5,Eukaryotic translation initiation factor 5,40116,0.0179779844411691,0.00465123729633698,0.0088615593403486,0.0270944095419895,0.000111638686484173
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAPRT,Nicotinate phosphoribosyltransferase,40483,0.013793248257242,0.00357085219325984,0.00679437795845277,0.0207921185560313,0.000112752093811541
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TINAGL1,Tubulointerstitial nephritis antigen-like,42607,0.00904284236898983,0.00234222383115595,0.00445208365992417,0.0136336010780555,0.000113549761828919
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AHNAK2,Protein AHNAK2,40223,0.0122564137023683,0.0031868516235552,0.0060101845202001,0.0185026428845365,0.000120770883515496
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YY1,Transcriptional repressor protein YY1,40199,0.0114143715465738,0.0029742545160044,0.0055848326952052,0.0172439103979425,0.000124873876124461
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFSF8,Tumor necrosis factor ligand superfamily member 8,40527,0.01493231939033,0.00389753586019657,0.00729314910434469,0.0225714896763153,0.000128197224170508
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGFBR3,Transforming growth factor beta receptor type 3,42794,-0.0127375367086643,0.00333511108002141,-0.0192743544255063,-0.00620071899182237,0.000134466805402712
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPTX2,Neuronal pentraxin-2,40527,-0.0132258536498275,0.00346292875184264,-0.020013194003439,-0.00643851329621587,0.000134561979281827
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MKI67,Proliferation marker protein Ki-67,40199,0.0155835123543697,0.0040850497392172,0.00757681486550403,0.0235902098432355,0.000137056889563522
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLAMF7,SLAM family member 7,42594,-0.0238519182695151,0.00626084567378492,-0.0361231757901335,-0.0115806607488966,0.00013975927563269
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REG3G,Regenerating islet-derived protein 3-gamma,40451,0.0164589828611249,0.00432170321289209,0.00798844456385639,0.0249295211583934,0.000140584443797815
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCR1,Natural cytotoxicity triggering receptor 1,42566,0.0154721467834551,0.0040743000333141,0.00748651871815943,0.0234577748487507,0.000146810228534284
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OSMR,Oncostatin-M-specific receptor subunit beta,42705,-0.0080516061465036,0.00212579066924744,-0.0122181558582286,-0.00388505643477862,0.000152779814837411
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ART3,Ecto-ADP-ribosyltransferase 3,42689,-0.0143234428676632,0.00378690534759258,-0.0217457773489447,-0.00690110838638174,0.000156018404272579
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42618,0.0116537554703004,0.00308514070801521,0.00560687968259059,0.0177006312580102,0.000159169732598253
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGSF21,Immunoglobulin superfamily member 21,40223,0.0156721926699202,0.00417526059094248,0.00748868191167293,0.0238557034281674,0.000175218690610318
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ROBO4,Roundabout homolog 4,40223,-0.00714952994982703,0.00191985615701485,-0.0109124480175761,-0.00338661188207794,0.000197073782356154
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBPMS,RNA-binding protein with multiple splicing,40199,0.0250073538759546,0.00673384805743291,0.0118090116833861,0.0382056960685231,0.000205276794176884
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42711,0.0276884922767164,0.00750555790345323,0.0129775987859481,0.0423993857674848,0.000225962455618155
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL31RA,Interleukin-31 receptor subunit alpha,40145,0.0148749309077865,0.00404224156079049,0.00695213744863719,0.0227977243669359,0.000234470812693942
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GFRA2,GDNF family receptor alpha-2,42587,0.00824247198804935,0.00224185732370323,0.00384843163359101,0.0126365123425077,0.000237262562277235
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACSL1,Long-chain-fatty-acid--CoA ligase 1,40116,-0.0151215822541492,0.00411973133888771,-0.0231962556783691,-0.00704690882992929,0.000243204930371108
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDK1,Cyclin-dependent kinase 1,40080,0.0142200029861244,0.00389101381073564,0.00659361591708255,0.0218463900551662,0.000258819628129432
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SSH3,Protein phosphatase Slingshot homolog 3,40080,0.011156934436404,0.00305406174166027,0.00517097342274987,0.0171428954500581,0.000260263068004218
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RANBP2,E3 SUMO-protein ligase RanBP2,40136,-0.0125172616099038,0.0034283662302858,-0.0192368594212639,-0.0057976637985436,0.000262350773094856
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL10RA,Interleukin-10 receptor subunit alpha,42370,0.022287048968174,0.006110118741223,0.010311216235377,0.0342628817009711,0.000265759463859081
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RETN,Resistin,42598,0.0166518885361072,0.00456684565996747,0.00770087104257098,0.0256029060296434,0.000267096289353449
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FDX2,"Ferredoxin-2, mitochondrial",40116,0.02170958908449,0.00596106877387942,0.0100258942876863,0.0333932838812937,0.00027189023520995
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PILRB,Paired immunoglobulin-like type 2 receptor beta,42636,0.0222270344594511,0.00612424002602879,0.0102235240084347,0.0342305449104676,0.000285185632380723
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLURP1,Secreted Ly-6/uPAR-related protein 1,40457,0.0145049669983124,0.00399754007012197,0.00666978846087329,0.0223401455357514,0.000286363883840361
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",42311,0.0114808599485386,0.00316605304778014,0.00527539597488948,0.0176863239221876,0.000288670894799379
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CENPJ,Centromere protein J,40302,0.0270800869128554,0.00747624461753662,0.0124266474624836,0.0417335263632272,0.00029346579072728
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPP4,Dipeptidyl peptidase 4,42441,0.0106966418474386,0.00296584325894755,0.00488358905990142,0.0165096946349758,0.000311363330521973
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGALS4,Galectin-4,42618,0.0213911515564189,0.00594394256076679,0.00974102413731604,0.0330412789755219,0.000320820654824563
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCDH12,Protocadherin-12,40482,0.00976170687308495,0.00271976046175845,0.0044309763680384,0.0150924373781315,0.000333127122663762
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRE5,Adhesion G protein-coupled receptor E5,42737,0.011702110169017,0.00327928554500849,0.00527471050080037,0.0181295098372336,0.000360280279077401
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL28,C-C motif chemokine 28,42538,0.0220400894598296,0.00617994267477887,0.009927401817263,0.0341527771023962,0.000363198619863081
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42570,0.0687026065886032,0.0192641522365121,0.0309448682050395,0.106460344972167,0.0003632591580272
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NRCAM,Neuronal cell adhesion molecule,42636,0.0108964617645411,0.00305660443524792,0.00490551707145513,0.016887406457627,0.00036527017285169
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAG3,Lymphocyte activation gene 3 protein,42587,-0.0153523104986664,0.0043216954843524,-0.0238228336479971,-0.00688178734933567,0.000383072992434319
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSPAN8,Tetraspanin-8,40449,0.0381770473765307,0.0107972178470792,0.0170145003962554,0.059339594356806,0.000408141309763863
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCL2,Apoptosis regulator Bcl-2,40449,0.021302044568428,0.00602929122552309,0.00948463376640279,0.0331194553704533,0.000412374499727653
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD200,OX-2 membrane glycoprotein,42594,-0.0101924846386006,0.00288935912032045,-0.0158556285144287,-0.00452934076277256,0.000420758603397238
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDR1,Epithelial discoidin domain-containing receptor 1,42711,0.00863706980890571,0.00245035983759303,0.00383436452722337,0.013439775090588,0.000425177021840986
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,40511,0.0105410968653467,0.00299302625642962,0.00467476540274461,0.0164074283279487,0.000430176181009592
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSAP,Gamma-secretase-activating protein,42346,0.0317141832847479,0.00902018681055325,0.0140346171360636,0.0493937494334323,0.000439721733149445
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,40116,0.0165766974373428,0.00472235950691828,0.00732087280378297,0.0258325220709026,0.000449477660733963
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCRLB,Fc receptor-like B,42346,0.0239891645298047,0.00684505863706281,0.0105728496011616,0.0374054794584478,0.000458822096239902
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LSM8,U6 snRNA-associated Sm-like protein LSm8,40302,0.031894534854746,0.00911207706035297,0.0140348638164541,0.0497542058930378,0.000466647214550418
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC1,Sialoadhesin,42676,0.0158895661525721,0.00454426720905921,0.00698280242281608,0.0247963298823282,0.000472712338003397
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THAP12,52 kDa repressor of the inhibitor of the protein kinase,40065,0.0323167623024056,0.00925770981744347,0.0141716510602164,0.0504618735445948,0.000483496867512894
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PNMA2,Paraneoplastic antigen Ma2,40136,0.0163415061383619,0.00469015304459492,0.0071488061709559,0.025534206105768,0.000495512545249034
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WIF1,Wnt inhibitory factor 1,42721,-0.0126043947903441,0.00362895042513624,-0.0197171376236111,-0.00549165195707705,0.000515728881868407
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LMNB1,Lamin-B1,40434,0.0218595405555984,0.00629680530192832,0.00951780216381891,0.0342012789473779,0.000519448659973894
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,40449,-0.0257405039829845,0.00743163808292607,-0.0403065146255196,-0.0111744933404494,0.000534906269955056
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GM2A,Ganglioside GM2 activator,40269,0.0149355705935573,0.00431557788970107,0.00647703792974319,0.0233941032573714,0.000540501667557512
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPESP1,Sperm equatorial segment protein 1,40511,0.0115661896945359,0.00334874696688704,0.00500264563943733,0.0181297337496345,0.000554594789105804
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHRM1,Muscarinic acetylcholine receptor M1,40182,-0.0135566525923036,0.00392606187862805,-0.0212517338744146,-0.00586157131019265,0.000556498565211233
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VWF,von Willebrand factor,42794,-0.0260859038940756,0.00756065191277855,-0.0409047816431216,-0.0112670261450297,0.000561832047538295
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRK1,Protein BRICK1,42311,0.0162974322841384,0.00472716790780899,0.0070321831848328,0.0255626813834441,0.000567344208682985
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EP300,Histone acetyltransferase p300,40199,0.0112581621355934,0.00326639802112681,0.0048560220141848,0.0176603022570019,0.000569683997796067
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CST6,Cystatin-M,42332,0.0183893792018333,0.0053388800351599,0.00792517433291993,0.0288535840707468,0.000574059038649689
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GFRAL,GDNF family receptor alpha-like,40109,-0.0227543265804565,0.00662648801339467,-0.03574224308671,-0.00976641007420292,0.000597297518740973
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,JUN,Transcription factor AP-1,42370,0.017317421986396,0.0050448067003945,0.00742960085362273,0.0272052431191692,0.00059938979828681
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSTP1,Glutathione S-transferase P,42237,-0.0252957135472304,0.00738313419882592,-0.0397666565769292,-0.0108247705175316,0.000614093153355356
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNXB,Tenascin-X,42611,-0.00930757941130643,0.00271675996684671,-0.014632428946326,-0.00398272987628688,0.000614409290753333
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCAR,Immunoglobulin alpha Fc receptor,42594,0.0175234102677799,0.00513458958987931,0.00745961467161644,0.0275872058639433,0.000644854548262854
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCAR2,Cell cycle and apoptosis regulator protein 2,40483,0.0194431625763532,0.00570180473598486,0.00826762529382282,0.0306186998588835,0.00065189919975851
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INSL3,Insulin-like 3,40483,0.0280571948946793,0.00824466076959897,0.0118976597862653,0.0442167300030933,0.00066863585562608
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42638,0.0124669298882076,0.00366523406488524,0.00528307112103257,0.0196507886553827,0.000672366450773316
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",40080,0.0208335874303887,0.00613070242543983,0.00881741067652665,0.0328497641842508,0.000680643825955717
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGFB2,Transforming growth factor beta-2 proprotein,40451,0.0186143586130511,0.00549786588600496,0.00783854147648141,0.0293901757496208,0.000712285920030719
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP6V1D,V-type proton ATPase subunit D,42587,0.00931722332791176,0.00275233870005228,0.00392263947580929,0.0147118071800142,0.000713300108409274
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,40199,0.0110751584051523,0.00327661456219962,0.00465299386324106,0.0174973229470636,0.000727214642264545
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PKD1,Polycystin-1,40511,0.00952763874578032,0.00282825922692186,0.00398425066101346,0.0150710268305472,0.000757676533110501
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSMD1,26S proteasome non-ATPase regulatory subunit 1,40482,0.0175541742345516,0.0052127567744802,0.00733717095657044,0.0277711775125328,0.00076095049182596
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINK4,Serine protease inhibitor Kazal-type 4,42594,0.0245899729875598,0.00730284069770422,0.0102764052200595,0.0389035407550601,0.000761549659056467
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,40116,0.0186086326138169,0.00553613640313531,0.00775780526367169,0.0294594599639621,0.000778416970339787
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,40483,0.0226752920762592,0.00675990952826126,0.00942586940086714,0.0359247147516513,0.000798055266611426
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CELA2A,Chymotrypsin-like elastase family member 2A,40527,0.0223338798164417,0.00668656736122495,0.00922820778844076,0.0354395518444425,0.000840151601002057
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPHA2,Ephrin type-A receptor 2,42125,0.0118406061958253,0.00355059534678701,0.00488143931612272,0.0187997730755278,0.000855938448992227
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJA4,DnaJ homolog subfamily A member 4,40483,0.0248410562197298,0.00745353036119743,0.0102321367117829,0.0394499757276768,0.000862560211069057
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC12A2,Solute carrier family 12 member 2,40116,-0.00957556068797455,0.00287698975509841,-0.0152144606079674,-0.00393666076798166,0.000876583480128916
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MILR1,Allergin-1,42370,-0.018052680986507,0.00542457418148972,-0.0286848463822268,-0.00742051559078709,0.000877289903172004
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC14A,C-type lectin domain family 14 member A,42611,-0.011674169580558,0.00351108154962265,-0.0185558894178184,-0.00479244974329758,0.00088671574679449
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AOC1,Amiloride-sensitive amine oxidase [copper-containing],42370,0.0198883277352901,0.00598665365542317,0.0081544865706607,0.0316221688999195,0.000895822864287988
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COMMD9,COMM domain-containing protein 9,40451,0.0138801834095266,0.00418598470620789,0.00567565338535915,0.0220847134336941,0.000916471607924277
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CALCB,Calcitonin gene-related peptide 2,40483,0.0143322967007644,0.00432463711722141,0.00585600795101041,0.0228085854505184,0.000922267995809839
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA11,Serpin A11,42794,-0.0142184894902059,0.00430186068605564,-0.0226501364348749,-0.00578684254553684,0.000951557985087544
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,42173,-0.0298476638994084,0.00904537307691435,-0.0475765951301605,-0.0121187326686563,0.000970243258284999
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLA2G1B,Phospholipase A2,42782,-0.0158343741137107,0.00479939787856516,-0.0252411939556984,-0.00642755427172295,0.000971957234611731
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,40223,-0.00729575451167181,0.00221512439617705,-0.0116373983281788,-0.00295411069516481,0.000992213621391728
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GABARAP,Gamma-aminobutyric acid receptor-associated protein,40451,0.0173344946684411,0.00527115707162199,0.00700302680806198,0.0276659625288202,0.00101011757015425
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TDGF1,Teratocarcinoma-derived growth factor 1,42311,0.0516641184447639,0.0157116168839148,0.0208693493522909,0.0824588875372368,0.00101068595361801
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALPI,Intestinal-type alkaline phosphatase,40199,0.0434405229057679,0.0132282761937656,0.0175131015659875,0.0693679442455484,0.00102695744189722
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNF31,E3 ubiquitin-protein ligase RNF31,40199,0.0122734062304214,0.00374006348336951,0.00494288180301712,0.0196039306578256,0.00103539975982758
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MSLN,Mesothelin,42553,0.0205596799907308,0.00627406285755975,0.00826251678991372,0.0328568431915479,0.00105209226162853
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,40539,-0.00680527783608471,0.0020833931330752,-0.0108887283769121,-0.00272182729525733,0.0010923241379591
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPHA4,Ephrin type-A receptor 4,40283,0.0100345379710429,0.00307342595172739,0.00401062310565725,0.0160584528364286,0.00109820989969913
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM171B,Protein FAM171B,40451,0.00908967996841979,0.00278597485471365,0.00362916925318103,0.0145501906836585,0.00110701947417356
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAPK13,Mitogen-activated protein kinase 13,40080,0.0143922862242425,0.00441293123031663,0.00574294101282188,0.0230416314356631,0.00111208881261562
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TFF2,Trefoil factor 2,42654,0.0199655099728124,0.00612569099598154,0.00795915562068859,0.0319718643249362,0.00111961805948811
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLNS1A,Methylosome subunit pICln,40182,0.0114548540521663,0.00352141947201777,0.0045528718870115,0.0183568362173212,0.00114575290667268
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CST1,Cystatin-SN,39042,0.0376333681829916,0.0116251045823286,0.0148481632016275,0.0604185731643556,0.00121087090078206
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPA4,Carboxypeptidase A4,40060,0.0150679126482355,0.00466070054756594,0.00593293957500627,0.0242028857214648,0.00122875348568059
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1R1,Interleukin-1 receptor type 1,42590,-0.00800387753209687,0.00248003635334744,-0.0128647487846579,-0.00314300627953589,0.00125254957492905
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HEPACAM2,HEPACAM family member 2,40483,-0.0143178178969797,0.00444283753973022,-0.023025779474851,-0.00560985631910851,0.00127360451367899
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,40255,-0.0163803962144112,0.00509872032896351,-0.0263738880591797,-0.00638690436964272,0.00131893841408268
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42618,0.0252150273404261,0.00785076503083395,0.00982752787999154,0.0406025268008606,0.00132220632458388
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NLGN2,Neuroligin-2,40136,-0.0162772238666224,0.0050764144873455,-0.0262269962618196,-0.00632745147142521,0.00134774177589117
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42495,0.0232757904091607,0.0072600251161975,0.0090461411814136,0.0375054396369078,0.00134902422290814
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPHX2,Bifunctional epoxide hydrolase 2,42357,0.0209657010267978,0.00654860928252254,0.00813042683305358,0.0338009752205419,0.00137015060561139
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLC,Galectin-10,42611,-0.0221665213913942,0.00692709700507191,-0.0357436315213352,-0.00858941126145328,0.00137760395049019
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRISP3,Cysteine-rich secretory protein 3,40439,-0.00918328435716425,0.00287590504248148,-0.014820058240428,-0.00354651047390055,0.00141102537632324
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LXN,Latexin,42461,-0.0227673314930892,0.00713150161101563,-0.0367450746506799,-0.00878958833549861,0.00141375131364319
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC28A1,Sodium/nucleoside cotransporter 1,40080,0.0198915726070816,0.0062381995504986,0.00766470148810435,0.0321184437260589,0.00143332557618652
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC12A,C-type lectin domain family 12 member A,40199,0.00695180855216143,0.0021847750322331,0.00266964948898455,0.0112339676153383,0.00146701981366542
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK4,Kallikrein-4,42721,-0.0212871736069431,0.00669283463669752,-0.0344051294948702,-0.00816921771901597,0.00147306352302739
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIMP2,Metalloproteinase inhibitor 2,40511,-0.00933509655082817,0.00293614270568292,-0.0150899362539667,-0.00358025684768965,0.00147991001833541
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIF20B,Kinesin-like protein KIF20B,40136,0.026253628239519,0.00826391069187771,0.0100563632834387,0.0424508931955993,0.00149271298083839
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EXTL1,Exostosin-like 1,40116,0.0158550536954596,0.00499946044098691,0.00605611123112529,0.025653996159794,0.00152150289188208
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIRT1,NAD-dependent protein deacetylase sirtuin-1,40199,0.0277806664959716,0.0087852926201596,0.0105614929604588,0.0449998400314845,0.00157018605782933
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPSAB1,Tryptase alpha/beta-1,42741,0.0174297287820963,0.00551479708377803,0.00662072649789138,0.0282387310663013,0.00157824456303924
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEZ6,Seizure protein 6 homolog,40182,-0.0104140384390159,0.00331287736209086,-0.016907278068714,-0.00392079880931784,0.00167383214218441
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ELAVL4,ELAV-like protein 4,40136,0.0280272514880036,0.0089706033439633,0.0104448689338355,0.0456096340421717,0.00178667571151643
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNF43,E3 ubiquitin-protein ligase RNF43,40302,0.0188847157437328,0.00604742445687858,0.00703176380825074,0.0307376676792148,0.00179617964522791
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BATF,Basic leucine zipper transcriptional factor ATF-like,40182,0.0276973701498406,0.00887467432626791,0.0103030084703555,0.0450917318293257,0.00180738918886181
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDX39A,ATP-dependent RNA helicase DDX39A,40199,0.00801201442569196,0.00256729664347445,0.00298011300448205,0.0130439158469019,0.00180828287727586
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNX18,Sorting nexin-18,40449,0.0144087591711987,0.00462011006629187,0.00535334344126659,0.0234641749011307,0.00182106265961931
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NMRK2,Nicotinamide riboside kinase 2,40080,-0.0139578934477531,0.00448357115431977,-0.0227456929102198,-0.00517009398528634,0.00185600769850425
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIAA1549L,UPF0606 protein KIAA1549L,40302,-0.0094760906790731,0.00305743392463866,-0.0154686611713649,-0.00348352018678133,0.00194423394606734
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENO1,Alpha-enolase,42588,0.025601614059532,0.0082692495997407,0.00939388484404026,0.0418093432750238,0.00196553845954518
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD55,Complement decay-accelerating factor,42201,0.00884927480246398,0.00286810069441422,0.00322779744141211,0.0144707521635159,0.0020369642886601
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FLT1,Vascular endothelial growth factor receptor 1,42559,0.00701904698128353,0.00227709693488272,0.00255593698891339,0.0114821569736537,0.00205719230723739
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPON1,Spondin-1,42638,0.0109636124203087,0.0035667911399699,0.00397270178596768,0.0179545230546497,0.00211772418156052
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNW1,Interferon omega-1,40116,-0.01196614516422,0.00389377034469193,-0.0195979350398162,-0.00433435528862384,0.00212332951499697
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,42458,0.0111677284609615,0.00365779879215775,0.00399844282833226,0.0183370140935906,0.00226917713979582
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NTF4,Neurotrophin-4,42346,0.0125545660305867,0.00411306155767684,0.00449296537754012,0.0206161666836333,0.00227498740025269
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NEO1,Neogenin,40482,0.00711568540727863,0.00234340351748949,0.00252261451299924,0.011708756301558,0.00239908262022691
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYOC,Myocilin,42611,-0.0142718451946097,0.00470430781283561,-0.0234922885077675,-0.00505140188145196,0.00241970702225432
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYPD3,Ly6/PLAUR domain-containing protein 3,42572,0.0109050133756083,0.00360149422566679,0.0038460846933014,0.0179639420579152,0.00246717546163959
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCN2B,Sodium channel subunit beta-2,40182,-0.00927916852737185,0.00307646309105596,-0.0153090361858415,-0.00324930086890217,0.00256566047447204
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEMA6C,Semaphorin-6C,40199,0.00834093157600884,0.00276968849856604,0.00291234211881939,0.0137695210331983,0.00260546052594037
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TFPI2,Tissue factor pathway inhibitor 2,42635,0.0119094007077104,0.00396009115153732,0.00414762205069725,0.0196711793647235,0.00264018992736546
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TG,Thyroglobulin,40451,-0.0363723310098139,0.0121483951483192,-0.0601831855005195,-0.0125614765191084,0.00275941516102176
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,40302,0.0166075273373458,0.00554870408693284,0.00573206732695743,0.0274829873477342,0.00276815455204086
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DSG4,Desmoglein-4,42543,0.0157464244551117,0.00527149232632515,0.00541429949551442,0.026078549414709,0.00282158022297255
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",42311,0.0166318478795299,0.00557044645347315,0.00571377283072256,0.0275499229283373,0.00283424667445603
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DKKL1,Dickkopf-like protein 1,42587,-0.0276142360738243,0.00925669848049086,-0.0457573650955864,-0.00947110705206224,0.00285800541509098
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDN1,Endothelin-1,40223,0.00956426947279733,0.00320900441419304,0.00327462082097897,0.0158539181246157,0.00288455302657654
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REG3A,Regenerating islet-derived protein 3-alpha,42794,-0.0204822352250477,0.00688452225907641,-0.0339758988528375,-0.00698857159725792,0.0029339478598435
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,40451,0.0146386470666953,0.00492626312074117,0.00498317135004257,0.024294122783348,0.00296925016342747
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UNG,Uracil-DNA glycosylase,40451,0.0106881345929091,0.00359884752353395,0.00363439344678259,0.0177418757390357,0.00298547441758672
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,40223,-0.00801002266864875,0.00270460255436114,-0.0133110436751966,-0.00270900166210091,0.00306670983490951
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKAP12,A-kinase anchor protein 12,40283,-0.00686459778555573,0.00232353059896662,-0.0114187177595303,-0.00231047781158115,0.00313953833888189
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOLR1,Folate receptor alpha,42600,0.00942880966989391,0.00319611570438251,0.00316442288930419,0.0156931964504836,0.00318236727925955
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NMI,N-myc-interactor,40421,0.0222659677225657,0.007584355293457,0.00740063134738999,0.0371313040977414,0.00333389304898058
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RGMA,Repulsive guidance molecule A,42711,-0.00983637936358099,0.00337064288071132,-0.0164428394097752,-0.0032299193173868,0.00352581848226239
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXNL1,Thioredoxin-like protein 1,40124,0.0303638813562115,0.0104130350505728,0.00995433265708875,0.0507734300553343,0.00355328934688875
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIAA1549,UPF0606 protein KIAA1549,40302,0.0217826770396848,0.00747192142137737,0.00713771105378511,0.0364276430255844,0.00356089724412364
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLA2G2A,"Phospholipase A2, membrane associated",42602,-0.0174809929777873,0.00600118984842402,-0.0292433250806984,-0.00571866087487621,0.00358655926188282
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LSM1,U6 snRNA-associated Sm-like protein LSm1,42346,0.0173626423963087,0.0059676454814992,0.00566605725257029,0.0290592275400472,0.00362657037458135
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THY1,Thy-1 membrane glycoprotein,42711,0.0092163327952448,0.00316944229921844,0.00300422588877666,0.015428439701713,0.00364489136706889
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,40302,0.019938234581378,0.00687798217575772,0.00645738951689286,0.0334190796458631,0.00375267904555088
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBP7,Retinoid-binding protein 7,40449,0.0183375405871388,0.00632658294245712,0.0059374380199229,0.0307376431543548,0.00375687758356034
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP112,Centrosomal protein of 112 kDa,40116,0.0137180754996469,0.00473900323491096,0.00442962915922141,0.0230065218400724,0.00380251570610159
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDA1,DET1- and DDB1-associated protein 1,40116,0.0123100788808879,0.00425305565738805,0.00397408979240734,0.0206460679693685,0.00380626147375584
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK14,Kallikrein-14,42721,-0.0143657566579003,0.00496368434571835,-0.0240945779755083,-0.00463693534029236,0.0038076723501441
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,40116,-0.00634711603475815,0.0021946903297676,-0.0106487090811026,-0.00204552298841366,0.00383513750015685
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GUK1,Guanylate kinase,40116,-0.0117051337231773,0.00405860867437855,-0.0196600067249592,-0.00375026072139532,0.00393393366311411
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGAV,Integrin alpha-V,42721,-0.00494807991367738,0.00172443279021332,-0.00832796818249548,-0.00156819164485928,0.00411894022903356
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNL1,Interferon lambda-1,42311,0.0137085095737027,0.0048205865383136,0.00426015995860808,0.0231568591887974,0.0044655925766538
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSV,Cathepsin L2,42677,0.0124917382207205,0.00440755209323055,0.00385293611798863,0.0211305403234524,0.00460136031294866
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LEG1,Protein LEG1 homolog,39926,-0.0209517481979537,0.00739260330303085,-0.0354412506718941,-0.00646224572401322,0.00460335134335707
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",40136,0.00969390926117188,0.00342472706279847,0.00298144421808687,0.0164063743042569,0.00465507060668214
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL19,Interleukin-19,42261,0.0214912807243417,0.00760849985368585,0.00657862101111748,0.036403940437566,0.00474053130045724
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRR5,Proline-rich protein 5,40199,0.0141983164730429,0.00504424720305989,0.00431159195504548,0.0240850409910403,0.004890123576357
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42611,0.00887670908864,0.00316324814066963,0.00267674273292753,0.0150766754443525,0.00502016828840217
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYOM1,Myomesin-1,40136,0.0142650099754121,0.00508411420726564,0.0043001461291714,0.0242298738216527,0.00502803923580451
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DSC2,Desmocollin-2,42488,-0.0104147501248201,0.00372947020842924,-0.0177245117333414,-0.00310498851629879,0.00523683114214117
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGLYRP1,Peptidoglycan recognition protein 1,42737,0.0124937417567774,0.00448217886233041,0.00370867118660978,0.021278812326945,0.0053202607034444
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACHE,Acetylcholinesterase,40283,0.00976700511423037,0.00350598235860467,0.00289527969136521,0.0166387305370955,0.00534846146311073
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYPD8,Ly6/PLAUR domain-containing protein 8,42346,0.0148517970305049,0.00533949601192604,0.00438638484712984,0.0253172092138799,0.00541857067189417
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRG3,Proteoglycan 3,40527,-0.0146037933775567,0.00525357544342631,-0.0249008012466723,-0.00430678550844118,0.00544851066446568
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AIF1L,Allograft inflammatory factor 1-like,40223,0.0163123477517533,0.00587262425950959,0.00480200420311449,0.0278226913003921,0.00548387905791014
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42594,0.0252574885782255,0.00913450809796156,0.00735385270622089,0.0431611244502302,0.00569896764141215
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CGA,Glycoprotein hormones alpha chain,42611,-0.0183029564818076,0.0066324020777247,-0.0313024645541481,-0.00530344840946721,0.00579458607665363
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TTN,Titin,40116,-0.0191051481465342,0.00693333804589667,-0.0326944907164917,-0.00551580557657671,0.00586909616007299
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACE,Angiotensin-converting enzyme,40532,-0.00777893752035701,0.00282841534970464,-0.0133226316057781,-0.00223524343493591,0.00596385613811041
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TLR1,Toll-like receptor 1,40199,0.00776651493408756,0.00282533009683416,0.0022288679442926,0.0133041619238825,0.00598953947864718
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH6,Cadherin-6,42636,-0.0111480086738404,0.00407172572421103,-0.019128591093294,-0.00316742625438677,0.00619128137932322
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEMA4C,Semaphorin-4C,42587,-0.00799852019751566,0.00292859099046616,-0.0137385585388293,-0.00225848185620198,0.0063189882110499
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSAPL1,Proactivator polypeptide-like 1,40449,-0.0146692228510595,0.00538623285070714,-0.0252262392384455,-0.00411220646367356,0.00647004538372781
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RRP15,RRP15-like protein,40136,-0.0264042270683996,0.00970123674809785,-0.0454186510946714,-0.00738980304212779,0.0065042329187773
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFD,Complement factor D,40539,0.00601350522052485,0.00220968062047218,0.00168253120439937,0.0103444792366503,0.00650980670512106
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PKLR,Pyruvate kinase PKLR,42636,0.0186009691134603,0.00686011606406663,0.0051551416278897,0.0320467965990309,0.00670716055736388
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP8,Neutrophil collagenase,42681,0.0207595619833284,0.00768045979115873,0.00570586079265728,0.0358132631739995,0.00688222274412816
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NRXN3,Neurexin-3,40182,0.0101467735690022,0.00375409592363325,0.00278874555868099,0.0175048015793233,0.00688525826656716
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NELL2,Protein kinase C-binding protein NELL2,42676,0.00818998460835101,0.00304781810594576,0.00221626112069732,0.0141637080960047,0.00721501408862506
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",40199,0.0100061645729071,0.00372471973097576,0.00270571390019463,0.0173066152456196,0.0072330508354041
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP164,Centrosomal protein of 164 kDa,42370,0.0186494374027836,0.00695473205110403,0.00501816258261974,0.0322807122229475,0.0073374031197469
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NME1,Nucleoside diphosphate kinase A,40199,-0.00621621962882176,0.00232306449029821,-0.0107694260298062,-0.00166301322783727,0.00746457979865044
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",40116,-0.0115196952759498,0.00430932708984171,-0.0199659763720395,-0.00307341417986002,0.00752430101188396
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,40116,-0.0109670941018854,0.00410489789092004,-0.0190126939680887,-0.00292149423568213,0.00755779309048708
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLP1R,Glucagon-like peptide 1 receptor,40136,-0.0107062211255823,0.0040074513984505,-0.0185608258665453,-0.00285161638461929,0.00756071740435456
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP1B4,Protein ATP1B4,40080,-0.0119192534167061,0.00446555105457374,-0.0206717334836707,-0.00316677334974159,0.00761548619907914
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAD51,DNA repair protein RAD51 homolog 1,40302,0.0152829748073039,0.0057319019450571,0.00404844699499196,0.0265175026196158,0.00768020911976464
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYBPC1,"Myosin-binding protein C, slow-type",40511,-0.0201489805243651,0.00755869146432035,-0.034964015794433,-0.00533394525429721,0.00769440833971888
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMPRSS5,Transmembrane protease serine 5,42438,-0.0106753164667868,0.00400969490614461,-0.0185343184828302,-0.00281631445074333,0.00776848313638433
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMOD4,Tropomodulin-4,40080,-0.0115860139729876,0.00435730911328822,-0.0201263398350325,-0.00304568811094268,0.00784914283985793
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDKL5,Cyclin-dependent kinase-like 5,40136,-0.0151618982500862,0.0057063987342857,-0.0263464397692861,-0.00397735673088619,0.00789540313916597
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNGR1,Interferon gamma receptor 1,42676,0.00612006093105574,0.00230469399176645,0.0016028607071935,0.010637261154918,0.00792895492357311
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCDC28A,Coiled-coil domain-containing protein 28A,40182,0.00839687107216918,0.00317637193806726,0.00217118207355735,0.014622560070781,0.00821601824967312
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIE1,Tyrosine-protein kinase receptor Tie-1,42794,0.0114399446228015,0.00433089360599051,0.00295139315506012,0.0199284960905429,0.00826404568988888
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SOX9,Transcription factor SOX-9,40182,0.00771027357532072,0.00292445127254008,0.00197834908114217,0.0134421980694993,0.008388756193612
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,JCHAIN,Immunoglobulin J chain,42370,-0.0173683171122076,0.00659936813186656,-0.0303030786506661,-0.00443355557374915,0.00850290190530699
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFHR4,Complement factor H-related protein 4,40509,0.020676683334515,0.00785802701814556,0.00527495037894972,0.0360784162900803,0.00851788186492234
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSC1,Hamartin,40199,0.0203535793439704,0.0077464315682057,0.00517057347028725,0.0355365852176536,0.00861396875058783
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKCQ,Protein kinase C theta type,42370,0.0120998395626796,0.00461610891240893,0.00305226609435815,0.0211474130310011,0.00877161940226163
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DRAXIN,Draxin,42495,0.0121009508040844,0.00461781272532975,0.00305003786243809,0.0211518637457307,0.00879022635582461
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C8B,Complement component C8 beta chain,40539,0.00838547623463522,0.00320018992616917,0.00211310397934365,0.0146578484899268,0.00879679992489139
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRE2,Adhesion G protein-coupled receptor E2,42676,0.00779306023998891,0.00298191402526153,0.00194850875047631,0.0136376117295015,0.00897347756476829
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRC1,Macrophage mannose receptor 1,40532,0.00803915066654427,0.0030769955431202,0.00200823940202867,0.0140700619310599,0.00899585219523386
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",42311,0.0139700180106821,0.00534744607310492,0.00348902370739646,0.0244510123139677,0.0089994267265404
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFKB2,Nuclear factor NF-kappa-B p100 subunit,40302,0.0144284232104341,0.00552501056207517,0.00359940250876673,0.0252574439121014,0.00902739705177366
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEPTIN7,Septin-7,40302,0.0149499134141415,0.00574380437836734,0.00369205683254154,0.0262077699957415,0.00925915834951349
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LTO1,Protein LTO1 homolog,42370,0.0115164368912979,0.00443616810387188,0.00282154740770897,0.0202113263748867,0.00944117832031762
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP152,Centrosomal protein of 152 kDa,40080,0.0114260182630184,0.00440183860585152,0.00279841459554939,0.0200536219304874,0.00945148383040583
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BABAM1,BRISC and BRCA1-A complex member 1,40199,0.00795358842745805,0.00307008561037146,0.00193622063112998,0.0139709562237861,0.00959147603862277
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXNDC15,Thioredoxin domain-containing protein 15,42679,0.00750744917074407,0.00289877341355939,0.00182585328016766,0.0131890450613205,0.00961151377503376
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL25,Interleukin-25,40036,0.00954631067236523,0.00369296112641598,0.00230810686458991,0.0167845144801406,0.00975078889441778
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AIDA,"Axin interactor, dorsalization-associated protein",40182,0.0229060679135678,0.00887807919867163,0.00550503268417143,0.0403071031429642,0.00989088261926483
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TEF,Thyrotroph embryonic factor,40116,0.0118326966493043,0.00458911017798239,0.00283804070045885,0.0208273525981498,0.00993802800984964
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TLR4,Toll-like receptor 4,40199,0.00796182678725403,0.00309269173868991,0.00190015097942181,0.0140235025950862,0.0100543511580925
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REXO2,"Oligoribonuclease, mitochondrial",40116,-0.0130320944368552,0.00506306778513783,-0.0229557072957253,-0.00310848157798502,0.0100674750200136
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REN,Renin,42636,-0.0231509142680729,0.00899742650286412,-0.0407858702136866,-0.00551595832245923,0.010091010137318
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMEM25,Transmembrane protein 25,40482,-0.0123629479146788,0.00481080375613733,-0.0217921232767079,-0.00293377255264959,0.0101875563880611
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TERF1,Telomeric repeat-binding factor 1,40199,-0.00801431223995086,0.00312094319852654,-0.0141313609090629,-0.00189726357083885,0.0102443461047013
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTR,Methionine synthase,40116,0.0179822257415534,0.00701062399658595,0.00424140270824495,0.0317230487748619,0.0103309213583423
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,40136,-0.0166421705343321,0.00650859434395029,-0.0293990154484747,-0.00388532562018958,0.0105727160399039
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STOML2,"Stomatin-like protein 2, mitochondrial",40080,0.0249210050643299,0.00975907667696879,0.00579321477747105,0.0440487953511887,0.0106743605341633
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FABP9,Fatty acid-binding protein 9,42594,0.015241220167579,0.00597830573887914,0.00352374091937586,0.0269586994157821,0.0108012255720273
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,USP28,Ubiquitin carboxyl-terminal hydrolase 28,40483,0.0102020352879354,0.00400737257784227,0.00234758503536456,0.0180564855405063,0.010915422867286
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIAA2013,Uncharacterized protein KIAA2013,40451,0.0143889097958172,0.00566350715100318,0.00328843577985095,0.0254893838117834,0.0110784205456406
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM3D,Protein FAM3D,40449,0.0229341459117688,0.00904220669053766,0.00521142079831499,0.0406568710252226,0.0112150662545822
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,40302,0.0121278503328037,0.0047997201038999,0.00272039892915992,0.0215353017364475,0.0115250329792562
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD2,T-cell surface antigen CD2,40116,0.010273669211764,0.0040697349615522,0.00229698868712167,0.0182503497364063,0.0116034015937435
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MBL2,Mannose-binding protein C,40379,-0.0289507458211538,0.0114731781182363,-0.051438174932897,-0.00646331670941055,0.0116382872429287
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPHB4,Ephrin type-B receptor 4,42794,-0.00700838425362786,0.00277800354833696,-0.0124532712083683,-0.00156349729888742,0.0116533282908777
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCG3,Secretogranin-3,42638,-0.00906998093749445,0.00359605024258299,-0.0161182394129571,-0.0020217224620318,0.0116735755225158
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TOP1,DNA topoisomerase 1,40449,0.0298491891902988,0.0118346533908673,0.00665326854419887,0.0530451098363987,0.0116765018661399
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPPP3,Tubulin polymerization-promoting protein family member 3,42311,0.0104823673838781,0.00416521502611299,0.00231854593269666,0.0186461888350596,0.0118596446183158
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OPTC,Opticin,42587,-0.0122747407442433,0.00487820908756993,-0.0218360305558803,-0.00271345093260622,0.0118730585457761
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NGF,Beta-nerve growth factor,42495,0.00316470896867398,0.00126421401104181,0.000686849507032033,0.00564256843031592,0.0123159533705686
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REG1A,Lithostathine-1-alpha,42575,-0.0137112327946001,0.00549577330762247,-0.0244829484775402,-0.00293951711166009,0.0126123341254925
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBFOX3,RNA binding protein fox-1 homolog 3,40482,0.0104943799284422,0.00423584365829982,0.00219212635817455,0.0187966334987099,0.0132444884184579
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,40283,0.00984976935517512,0.00397747979424037,0.00205390895846399,0.0176456297518863,0.0132868631977769
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC15,Sialic acid-binding Ig-like lectin 15,42311,0.0200658985319938,0.00813427573138663,0.004122718098476,0.0360090789655116,0.0136440803644275
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRD3,Bromodomain-containing protein 3,40116,0.012940310993052,0.00525375922633473,0.00264294290943592,0.0232376790766681,0.013791093488723
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WASL,Neural Wiskott-Aldrich syndrome protein,40199,-0.0159189528977057,0.00649228254406918,-0.0286438266840813,-0.00319407911133013,0.0142226442364559
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TFF1,Trefoil factor 1,42556,0.0213954531419956,0.00873049818998459,0.00428367668962579,0.0385072295943654,0.0142723173206218
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP290,Centrosomal protein of 290 kDa,40302,0.0140600593316529,0.00575684944401443,0.00277663442138465,0.0253434842419212,0.0146087498331501
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FDX1,"Adrenodoxin, mitochondrial",40116,0.0158808822257519,0.00654328184277209,0.00305604981391858,0.0287057146375852,0.0152381581301334
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCDC50,Coiled-coil domain-containing protein 50,40482,0.0192256676002155,0.0079605136379037,0.0036230608699242,0.0348282743305067,0.0157454231091701
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,METAP1,Methionine aminopeptidase 1,42311,0.00742033390032418,0.00307418318366386,0.00139493486034301,0.0134457329403053,0.0158025594946803
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,42346,0.0311296169486475,0.012941337476886,0.00576459549395094,0.056494638403344,0.0161667023469424
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDHR1,Cadherin-related family member 1,42311,0.0108201430084422,0.00450554691066566,0.00198927106353752,0.0196510149533469,0.0163411197253215
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",40302,0.0179130868223541,0.00746378535006972,0.00328406753621744,0.0325421061084907,0.0164114171327113
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDCD1LG2,Programmed cell death 1 ligand 2,42587,0.00804646335601187,0.00335534706309922,0.0014699831123374,0.0146229435996863,0.0164938895738318
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LTBR,Tumor necrosis factor receptor superfamily member 3,42566,0.00762367966317816,0.00317968562346294,0.0013914958411908,0.0138558634851655,0.016515577505503
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42594,0.0380732362716035,0.015882660565455,0.00694322156331174,0.0692032509798953,0.0165364353326038
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK1,Kallikrein-1,42505,-0.0326616443270152,0.0136556010962818,-0.0594266224757276,-0.00589666617830276,0.0167791735882333
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,40451,0.0243413348801815,0.0101938070072538,0.00436147314596412,0.0443211966143989,0.0169634086834082
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEMA3G,Semaphorin-3G,40283,0.011267557978132,0.00471917545596431,0.00201797408444195,0.020517141871822,0.0169748978367732
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGA,Fibrinogen alpha chain,40284,0.00777666491210533,0.00326116434802251,0.0013847827899812,0.0141685470342295,0.0171130884626793
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,M6PR,Cation-dependent mannose-6-phosphate receptor,40223,0.0100602723150297,0.00421955503461375,0.00178994444718674,0.0183306001828726,0.017133001953628
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PADI2,Protein-arginine deiminase type-2,42370,0.0139860699227944,0.00586921283628939,0.0024824127636672,0.0254897270819216,0.0171883839292204
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRR4,Proline-rich protein 4,40198,-0.0174196002436733,0.00733887136977489,-0.0318037881284321,-0.00303541235891453,0.0176323314204601
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,40136,0.0154940328398033,0.00653109655505213,0.00269308359190112,0.0282949820877055,0.0176926326585416
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPM1B,Protein phosphatase 1B,40199,0.0152573471711373,0.00643890321124093,0.00263709687710506,0.0278775974651695,0.0178265688254829
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DBH,Dopamine beta-hydroxylase,40515,0.0273047710192966,0.0115515985427318,0.00466363787554219,0.049945904163051,0.0181091613833947
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VCPKMT,Protein-lysine methyltransferase METTL21D,40080,0.0215544466194833,0.00914397860524785,0.00363224855319753,0.0394766446857691,0.0184295177586002
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL3A1,Collagen alpha-1(III) chain,40527,0.00580054384908288,0.00246274003882833,0.00097357337297935,0.0106275143251864,0.0185236475976175
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1QL2,Complement C1q-like protein 2,40199,0.0109409689848965,0.00465126391610992,0.00182449170932106,0.0200574462604719,0.0186773850368327
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SH3GL3,Endophilin-A3,40250,0.0211812685853224,0.00901054727945425,0.00352059591759206,0.0388419412530527,0.0187546247095462
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL36G,Interleukin-36 gamma,40154,0.0170702506879157,0.0072630966043682,0.00283458134335405,0.0313059200324774,0.0187773410088158
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NXPH3,Neurexophilin-3,40199,0.00761918739947995,0.00324341208526389,0.00126209971236272,0.0139762750865972,0.0188350627236743
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CYB5A,Cytochrome b5,40080,0.0181051924463616,0.00772052502488941,0.00297296339757832,0.0332374214951448,0.0190412321222369
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGAP30,Rho GTPase-activating protein 30,40302,0.00940008140588201,0.00402464953642525,0.00151176831448851,0.0172883944972755,0.0195283764322283
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TCN2,Transcobalamin-2,42771,-0.00758282871193345,0.0032478985828959,-0.0139487099344094,-0.00121694748945749,0.0195742432213271
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC13A1,Solute carrier family 13 member 1,40451,0.0153782479953293,0.00660110214040953,0.00244008780012663,0.028316408190532,0.0198423263566601
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOLH1,Glutamate carboxypeptidase 2,40199,0.0249624726373724,0.0107227460601074,0.00394589035956178,0.045979054915183,0.0199305308704101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTTG1,Securin,40302,0.0100340455738276,0.00432440020946476,0.00155822116327669,0.0185098699843785,0.0203409303141892
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PALM3,Paralemmin-3,40116,0.0175295334534508,0.00755882282614881,0.00271424071419908,0.0323448261927024,0.0204089224234596
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PI16,Peptidase inhibitor 16,40532,-0.00611846060222813,0.00264568945119313,-0.0113040119265667,-0.000932909277889605,0.0207616426395412
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TYMP,Thymidine phosphorylase,42563,0.0157578572946293,0.00682770988039973,0.00237554592904586,0.0291401686602128,0.0210183769837691
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,40223,-0.00962910470414164,0.00417992937633387,-0.017821766281756,-0.00143644312652727,0.0212606630794309
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPRING1,SREBP regulating gene protein,40080,0.0143800659238817,0.0062496785487817,0.00213069596826956,0.0266294358794938,0.0214144561993867
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTK7,Inactive tyrosine-protein kinase 7,42311,0.00920134215020886,0.00402179850606725,0.00131861707831705,0.0170840672221007,0.0221610753085828
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP350,Centrosome-associated protein 350,40080,0.00917855558475216,0.00401555643559736,0.00130806497098133,0.017049046198523,0.022288054312033
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",40482,0.0173819760588298,0.00760629056278952,0.0024736465557623,0.0322903055618972,0.0223189388672913
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUSD5,Sushi domain-containing protein 5,40235,-0.00835957336796722,0.00366912238399959,-0.0155510532406064,-0.00116809349532803,0.0227242878895149
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL17RA,Interleukin-17 receptor A,42611,0.0105119007967899,0.00463085774322564,0.00143541962006764,0.0195883819735122,0.0232252921669951
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA3,Carbonic anhydrase 3,42770,0.0142209735344088,0.00627055306090186,0.00193068953504113,0.0265112575337764,0.0233510788184374
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DEFB118,Beta-defensin 118,40136,0.0136568472549816,0.00602353610247727,0.00185071649412616,0.0254629780158371,0.0233945322829961
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL9A1,Collagen alpha-1(IX) chain,42594,0.0114957028483334,0.0051173866842754,0.0014656249471536,0.0215257807495132,0.0246945488836915
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BMP10,Bone morphogenetic protein 10,40283,-0.00680022373138191,0.00303123484039758,-0.0127414440185612,-0.000859003444202655,0.0248917238733223
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTN5,Contactin-5,42640,-0.00897364896744576,0.00400944537770649,-0.0168321619077505,-0.00111513602714105,0.0252290618198705
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,40302,0.00875467033824141,0.00392419729193892,0.00106324364604113,0.0164460970304417,0.0257046224766921
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLAMF1,Signaling lymphocytic activation molecule,42370,0.0141942918725559,0.00638303634560998,0.0016835406351603,0.0267050431099514,0.0261820006940689
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EFHD1,EF-hand domain-containing protein D1,40482,0.00845816964646165,0.00380682878826611,0.00099678522146008,0.0159195540714632,0.0263137797104152
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACRV1,Acrosomal protein SP-10,40199,0.0187940077172073,0.00846086311524708,0.00221071601132299,0.0353772994230915,0.0263517796023346
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INHBB,Inhibin beta B chain,40283,0.0126933053689207,0.00575069013059989,0.00142195271294495,0.0239646580248965,0.0273158545186733
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOA4,Apolipoprotein A-IV,40539,0.0083826836340202,0.00380245838475586,0.000929865199898714,0.0158355020681417,0.0275061663611458
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42586,0.0140190036130654,0.00636961064470511,0.00153456674944343,0.0265034404766874,0.0277586887011993
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PXDNL,Peroxidasin-like protein,40451,-0.0129333371223918,0.00588058231374176,-0.0244592784573257,-0.00140739578745799,0.0278747736499977
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA9,Carbonic anhydrase 9,42721,-0.0111815807283893,0.00510321136076049,-0.0211838749954799,-0.00117928646129872,0.0284624848730557
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH23,Cadherin-23,40483,-0.00603466707833413,0.00275499937635334,-0.0114344658559867,-0.000634868300681588,0.0285125571625086
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CALY,Neuron-specific vesicular protein calcyon,40116,-0.00905376027625952,0.00413788814818344,-0.0171640210466991,-0.00094349950581997,0.0286896428474996
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINT1,Kunitz-type protease inhibitor 1,42565,0.00598528655994476,0.00275235848627675,0.000590663926842328,0.0113799091930472,0.0296773634681199
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LHB,Lutropin subunit beta,42346,0.019307768452473,0.00887911005511759,0.00190471274444253,0.0367108241605035,0.0296841558258129
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNR,Tenascin-R,42495,-0.0096811306504808,0.00446411946447037,-0.0184308048008427,-0.000931456500118872,0.0301266233432917
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENDOU,Poly(U)-specific endoribonuclease,39633,0.0125211566705335,0.00577862325558993,0.00119505508957725,0.0238472582514898,0.0302721804328722
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,42357,0.00632183015690001,0.00291804700291075,0.00060245803119493,0.0120412022826051,0.0302939898207786
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCDHB15,Protocadherin beta-15,40451,-0.00920013848494536,0.00425023434771041,-0.0175305978064578,-0.000869679163432962,0.0304378166972431
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL20RB,Interleukin-20 receptor subunit beta,40199,0.00937563035347142,0.00433665651300239,0.000875783587986737,0.0178754771189561,0.0306435888087896
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42794,0.00623480971452623,0.0028857136384708,0.000578810983123461,0.011890808445929,0.0307453505640983
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPN1,Epsin-1,40302,0.0101493414959789,0.00469938587600879,0.000938545179001691,0.0193601378129561,0.0308159475829723
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,40511,0.00730717147437334,0.00339041004648802,0.00066196778325682,0.0139523751654899,0.031163524166202
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RALB,Ras-related protein Ral-B,40199,0.00681847691177073,0.00316377935118254,0.000617469383452954,0.0130194844400885,0.0311702879811873
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,40511,0.0169254751804212,0.00785487523043553,0.00152991972876759,0.0323210306320749,0.0312006126628844
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",40483,-0.005937877164664,0.00275636560765758,-0.0113403537556729,-0.000535400573655139,0.0312423326078936
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSTM1,V-set and transmembrane domain-containing protein 1,42311,0.0114363337274097,0.00531537463430514,0.00101819944417163,0.0218544680106478,0.0314504283047909
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LY6D,Lymphocyte antigen 6D,42548,0.00921311168937057,0.00429644697111378,0.000792075625987567,0.0176341477527536,0.0320223705805825
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PNLIPRP2,Pancreatic lipase-related protein 2,42618,0.0667884334667394,0.0312109268664995,0.0056150168084003,0.127961850125079,0.0323803795789302
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD86,T-lymphocyte activation antigen CD86,40449,0.00685033930125554,0.00320167929557675,0.000575047881925108,0.013125630720586,0.0324078859839182
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ID4,DNA-binding protein inhibitor ID-4,40302,-0.00980720298467016,0.00458504856251394,-0.0187938981671975,-0.000820507802142826,0.0324612219083181
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GART,Trifunctional purine biosynthetic protein adenosine-3,40482,0.00610339285022887,0.00286707304348655,0.000483929684995223,0.0117228560154625,0.0332933309108026
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRB3,Adhesion G protein-coupled receptor B3,42475,-0.00764917821268091,0.0036142326473447,-0.0147330742014765,-0.000565282223885288,0.0343289705338828
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VNN2,Vascular non-inflammatory molecule 2,42587,0.0101430736021606,0.00479281688434264,0.000749152508849035,0.0195369946954722,0.0343370726493941
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SAT1,Diamine acetyltransferase 1,40116,-0.011463794707606,0.00542911012484913,-0.0221048505523103,-0.000822738862901719,0.0347483939429805
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GBP6,Guanylate-binding protein 6,40116,-0.0102592884970587,0.00487457791322955,-0.0198134612069886,-0.000705115787128762,0.0353444281769587
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,40482,0.0255692361741442,0.0121590643184922,0.00173747010989948,0.0494010022383889,0.0354970257052024
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCN2A,Sodium channel protein type 2 subunit alpha,40136,0.0110856429139212,0.00527596303935416,0.000744755356787072,0.0214265304710554,0.0356497295192145
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LIFR,Leukemia inhibitory factor receptor,42594,-0.00533997579839959,0.00254215233404244,-0.0103225943731228,-0.000357357223676407,0.0356971297971937
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGLON5,IgLON family member 5,40080,-0.0209939433177493,0.0100107481119846,-0.0406150096172391,-0.00137287701825942,0.0360041657495366
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MEGF10,Multiple epidermal growth factor-like domains protein 10,42618,0.00835895469216636,0.00399316052317493,0.000532360066743511,0.0161855493175892,0.0363394974800894
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTNNA1,Catenin alpha-1,40136,-0.00773957869986976,0.0037158892737611,-0.0150227216764415,-0.00045643572329801,0.0372895669426935
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL15RA,Interleukin-15 receptor subunit alpha,42370,0.00793034501861693,0.00381094722833744,0.000460888451075541,0.0153998015861583,0.0374588457293217
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNN,Tenascin-N,40527,0.00966926955891504,0.00464798401409135,0.000559220891295993,0.0187793182265341,0.0375190876076167
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOP56,Nucleolar protein 56,40116,0.0245617181675312,0.0118229276607897,0.00138877995238343,0.0477346563826789,0.0377819738721634
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL22,Interleukin-22,40451,0.015328169929373,0.00738541683177777,0.000852752939088607,0.0298035869196575,0.0379661649456303
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MANSC4,MANSC domain-containing protein 4,40116,0.0156619120195486,0.00756420947531933,0.000836061447922707,0.0304877625911745,0.0384263118735544
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINK1,Serine protease inhibitor Kazal-type 1,42611,0.00987784151256794,0.00480528275771863,0.000459487307439421,0.0192961957176965,0.0398383431439164
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUMF1,Formylglycine-generating enzyme,40199,0.0139110516334758,0.00677314845444518,0.000635680662763287,0.0271864226041884,0.0400134895002598
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",40136,-0.0119034329463944,0.00579923890390195,-0.0232699411980422,-0.000536924694746541,0.0401365397425499
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBR1,T-box brain protein 1,40182,0.0105022190420552,0.00512481878147046,0.000457574230373093,0.0205468638537373,0.0404578568195086
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,42172,0.0144098335736899,0.00703333296159606,0.0006245009689616,0.0281951661784182,0.0405025643091966
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42794,0.0151398773762815,0.00739719014676745,0.000641384688617313,0.0296383700639457,0.0407060886119686
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SELL,L-selectin,40539,0.00514335324509028,0.00251495055272485,0.000214050161749567,0.010072656328431,0.0408669297837076
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GNPDA1,Glucosamine-6-phosphate isomerase 1,40223,0.00722854200996441,0.00353684866903719,0.00029631861865151,0.0141607654012773,0.040998951224736
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",40080,0.0111044645991345,0.00544050365810398,0.000441077429250739,0.0217678517690184,0.0412676478353784
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MFAP3,Microfibril-associated glycoprotein 3,42357,0.0104171994474293,0.00511149304596478,0.000398673077338306,0.0204357258175202,0.0415703401013156
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD79B,B-cell antigen receptor complex-associated protein beta chain,42754,0.0102412761878535,0.00504312080318563,0.000356759413609667,0.0201257929620973,0.0423006657398946
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KRT19,"Keratin, type I cytoskeletal 19",42562,0.0150699633619378,0.00742684772116462,0.000513341828455149,0.0296265848954205,0.0424658701238334
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,40116,0.0119422815543091,0.00589343362766968,0.000391151644076534,0.0234934114645417,0.0427510586360189
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX1B,Syntaxin-1B,40182,0.00866739235715157,0.00428512959216448,0.000268538356509182,0.017066246357794,0.0431316131776923
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSPG5,Chondroitin sulfate proteoglycan 5,40136,-0.0109528349923043,0.00542681711566255,-0.021589396539003,-0.000316273445605737,0.04358648922467
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL12,Stromal cell-derived factor 1,42370,0.00854061011070946,0.00423551349544202,0.000239003659643109,0.0168422165617758,0.043775438995149
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",40199,0.0136899106721593,0.00679739845214648,0.000367009705952154,0.0270128116383664,0.0440345915335904
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HAVCR2,Hepatitis A virus cellular receptor 2,42611,0.00777750679176021,0.00386728176884549,0.000197634524823057,0.0153573790586974,0.0443344101157521
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOH,Beta-2-glycoprotein 1,42611,-0.00769944163204069,0.00383420777215068,-0.015214488865456,-0.000184394398625346,0.0446535316147193
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRPL52,"39S ribosomal protein L52, mitochondrial",40059,0.00561693252087979,0.0027970978162169,0.00013462080109466,0.0110992442406649,0.0446543178623152
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",40182,-0.0105811656781985,0.0052696107458272,-0.0209096027400198,-0.000252728616377205,0.0446720126320135
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42611,0.00807824337900638,0.00403240441645523,0.000174730722754124,0.0159817560352586,0.0451617769004899
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANGPT2,Angiopoietin-2,42721,0.00796125226819036,0.00397767466585316,0.000165009923118169,0.0157574946132625,0.0453601912068007
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VASN,Vasorin,42449,-0.00576350671898645,0.0028978698395747,-0.0114433316045529,-8.36818334200304e-05,0.0467353035239302
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MELTF,Melanotransferrin,40511,0.00631373643908068,0.00318309449275637,7.48712332782038e-05,0.0125526016448832,0.0473333319843662
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHAD,Chondroadherin,40283,0.010849329441571,0.00547678857596558,0.000114823832678487,0.0215838350504636,0.0476198033526017
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL5A1,Collagen alpha-1(V) chain,40283,0.00854234189279491,0.00435406222295901,8.37993579524965e-06,0.0170763038497946,0.0497962361828652
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD58,Lymphocyte function-associated antigen 3,42600,-0.00366239105942182,0.00186727807806516,-0.00732225609242953,-2.52602641411274e-06,0.0498585502627772
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL3RA,Interleukin-3 receptor subunit alpha,42370,0.00676072160607504,0.00344978471240461,-8.56430237997606e-07,0.0135222996423881,0.050045862943793
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDCL2,Phosducin-like protein 2,40080,0.0109657361160953,0.00560421894485753,-1.85330158254202e-05,0.0219500052480161,0.0504090972312872
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CAPS,Calcyphosin,40483,0.0213359096922041,0.0109221185637119,-7.14426926712655e-05,0.0427432620770795,0.0507899088780942
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENOPH1,Enolase-phosphatase E1,40451,0.0113036631584926,0.00580137085805001,-6.70237232854604e-05,0.0226743500402706,0.0513863244031556
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GFAP,Glial fibrillary acidic protein,42326,0.0100111539679596,0.00515600665614087,-9.46190780764869e-05,0.0201169270139957,0.0522009950086741
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC39A14,Zinc transporter ZIP14,42311,-0.00699896582351224,0.00363452029006018,-0.0141226255920302,0.000124693945005714,0.0541644621007343
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOTCH2,Neurogenic locus notch homolog protein 2,40527,-0.00430856782479703,0.00223914550773163,-0.00869729301995102,8.01573703569673e-05,0.0543543042033125
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSRP3,Cysteine and glycine-rich protein 3,40116,-0.0203039520624164,0.0105601524521053,-0.0410018508685427,0.000393946743709919,0.0545443433555027
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGLYRP4,Peptidoglycan recognition protein 4,40116,0.0119947448230198,0.00625505616947575,-0.000265165269152684,0.0242546549151922,0.0551868056902923
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD3D,T-cell surface glycoprotein CD3 delta chain,40136,-0.00687736070624225,0.00359440529514315,-0.0139223950847228,0.000167673672238318,0.0557291386197623
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",40116,0.0177755066688915,0.0092962490115214,-0.000445141393690458,0.0359961547314734,0.0558874482012163
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBM19,Probable RNA-binding protein 19,40116,-0.00973697603105425,0.00510158196247287,-0.0197360766775011,0.000262124615392574,0.0563374504730922
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLITRK1,SLIT and NTRK-like protein 1,40199,-0.00660512995836594,0.00346297605146135,-0.0133925630192302,0.000182303102498305,0.0565004418883655
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DOC2B,Double C2-like domain-containing protein beta,40182,0.00727676956519701,0.00382383213504546,-0.000217941419492103,0.0147714805498861,0.0570660746015259
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GID8,Glucose-induced degradation protein 8 homolog,40482,0.00685739351290567,0.00361377584456731,-0.000225607142446266,0.0139403941682576,0.0577782092292957
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEPTIN3,Neuronal-specific septin-3,40482,-0.0149873104250027,0.00790270842095026,-0.0304766189300652,0.000501998080059761,0.0579224109310513
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLAUR,Urokinase plasminogen activator surface receptor,42547,0.00559918725749442,0.00295634533600328,-0.000195249601072011,0.0113936241160609,0.0582524751419636
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OBP2B,Odorant-binding protein 2b,42462,-0.0122317568915875,0.00646782457443712,-0.0249086930574843,0.000445179274309229,0.0586233950237456
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,40136,0.01159593000653,0.00613155165222125,-0.000421911231823687,0.0236137712448836,0.0586253565058537
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADA2,Adenosine deaminase 2,42572,0.0088270952479064,0.00467069573965657,-0.000327468401820486,0.0179816588976333,0.0587944416404686
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,42346,0.00717421529590339,0.00380478528687364,-0.000283163866368951,0.0146315944581757,0.0593740111387077
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SULT1A1,Sulfotransferase 1A1,42711,-0.0252144674095281,0.0134090327422355,-0.0514961715843097,0.0010672367652534,0.0600738256774156
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BTLA,B- and T-lymphocyte attenuator,40080,0.0174938514672003,0.00930308217665543,-0.000740189599044382,0.0357278925334449,0.0600753445522101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ODAM,Odontogenic ameloblast-associated protein,42292,0.0111191352641568,0.0059240603007315,-0.000492022925276895,0.0227302934535906,0.0605478452409954
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPVL,Probable serine carboxypeptidase CPVL,42698,0.00816326179556479,0.0043510517542533,-0.000364799642771666,0.0166913232339013,0.0606550998230295
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ICAM3,Intercellular adhesion molecule 3,42794,-0.00531005842478397,0.00283200390839373,-0.0108607860852357,0.000240669235667739,0.0608116532980439
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBM25,RNA-binding protein 25,40080,-0.00936806657939344,0.00501441460614716,-0.0191963192074419,0.000460186048654984,0.061757228468101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,40116,-0.00958367809861446,0.0051387320060148,-0.0196555928304035,0.000488236633174545,0.0622097585245499
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IDS,Iduronate 2-sulfatase,42754,0.00171460632908043,0.000919453129087074,-8.75218039302307e-05,0.0035167344620911,0.0622294834921998
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATF2,Cyclic AMP-dependent transcription factor ATF-2,42311,0.0131207989050411,0.0070403631539763,-0.000678312876752418,0.0269199106868347,0.0623926774503988
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100G,Protein S100-G,40482,-0.00947288126689038,0.00508915669311891,-0.0194476283854034,0.000501865851622697,0.0627157644827574
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,40482,0.00635342224413256,0.00342725572548647,-0.000363998977820924,0.013070843466086,0.0637948681494505
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42674,0.0139658819308983,0.00754800020328166,-0.000828198467533788,0.0287599623293303,0.0642956794011101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TJP3,Tight junction protein ZO-3,40136,-0.00817118693369772,0.00444537735704227,-0.0168841265535006,0.000541752686105127,0.0660701622785568
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARTN,Artemin,42370,0.00863547577811776,0.00471183205833214,-0.000599715056213222,0.0178706666124487,0.066866555586207
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",40116,-0.00838430257590244,0.00457595477384686,-0.0173531739326423,0.000584568780837414,0.0669410883483798
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42636,-0.00634412354460562,0.00347943153125044,-0.0131638093458565,0.000475562256645237,0.0682768564851383
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HCG22,Protein PBMUCL2,40116,-0.0109663392193445,0.00602290245487605,-0.0227712280309015,0.000838549592212601,0.0686686933325748
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",40268,-0.0121841589915315,0.00670891671185109,-0.0253336357467596,0.000965317763696655,0.0693798815090512
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMBN,Ameloblastin,42370,-0.00546939559946323,0.00301939215434336,-0.0113874042219762,0.000448613023049761,0.0700981992535584
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OSBPL2,Oxysterol-binding protein-related protein 2,40483,0.0076268585034713,0.00421216584832337,-0.000628986559242507,0.0158827035661851,0.070217927779726
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,40182,-0.00604184242600604,0.0033487954203343,-0.0126054814498613,0.000521796597849191,0.0712298720575255
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EGFR,Epidermal growth factor receptor,42794,0.00309132461278336,0.00171493751513525,-0.00026995291688173,0.00645260214244846,0.0714751803558118
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OTOA,Otoancorin,40136,-0.0104028359866009,0.00577327792767448,-0.0217184607248428,0.000912788751641131,0.0715895669052751
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYH7B,Myosin-7B,40080,-0.00847530272800247,0.00473841909139265,-0.0177626041471321,0.000811998691127117,0.0737013978199689
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAPPA,Pappalysin-1,42370,0.00879875543678006,0.00492425404844088,-0.000852782498164057,0.0184502933717242,0.0739895735714275
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DOCK9,Dedicator of cytokinesis protein 9,40136,0.022565874969411,0.0127522350333903,-0.0024285056960339,0.0475602556348559,0.0768279228481705
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MB,Myoglobin,42794,-0.0098491714046638,0.0055883087629872,-0.0208022565801187,0.00110391377079112,0.0780140455772148
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBP1,Retinol-binding protein 1,40182,0.0127012538878089,0.00721836513605865,-0.00144674177886605,0.0268492495544839,0.0785077404258137
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,40182,-0.00855611129410971,0.00486801246229042,-0.0180974157201989,0.000985193131979501,0.0788401975795
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SOX2,Transcription factor SOX-2,40461,0.00441894473300743,0.00252479475759061,-0.000529652991870172,0.00936754245788504,0.0801076830090174
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DUOX2,Dual oxidase 2,42357,0.0131107623609216,0.00752869197040565,-0.00164547390107352,0.0278669986229166,0.0816299125988188
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTRC,Chymotrypsin-C,42626,0.0121146392213364,0.00696616558999241,-0.00153904533504873,0.0257683237777215,0.0820456224971478
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFBP7,Insulin-like growth factor-binding protein 7,42794,0.00572375207346858,0.00330984984732748,-0.000763553627293279,0.0122110577742304,0.0837765551969784
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGOLN2,Trans-Golgi network integral membrane protein 2,40532,0.00496012970531338,0.00287038519560725,-0.000665825278076842,0.0105860846887036,0.0840089515648639
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,40539,0.00340365220783157,0.00197459561142407,-0.000466555190559609,0.00727385960622275,0.0847854401628783
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TEX101,Testis-expressed protein 101,40182,0.00957859776192074,0.00558926600206572,-0.00137636360212807,0.0205335591259696,0.0866030794387302
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC1A,C-type lectin domain family 1 member A,42357,-0.00632921036745534,0.00369545233463679,-0.0135722969433435,0.00091387620843278,0.0867908397012284
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TP73,Tumor protein p73,40182,0.00625311783704687,0.00365179160364353,-0.000904393706094445,0.0134106293801882,0.0868617899895922
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL13RA2,Interleukin-13 receptor subunit alpha-2,40136,-0.00525002515204442,0.0030662384741178,-0.0112598525613153,0.000759802257226472,0.0868874527067472
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NINJ1,Ninjurin-1,42346,0.00973539197915686,0.0056890187125583,-0.0014150846974574,0.0208858686557711,0.0870566469084698
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NTF3,Neurotrophin-3,42594,0.00644140067623638,0.00377812749271695,-0.000963729209488855,0.0138465305619616,0.0882327447111133
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGB5,Integrin beta-5,42679,-0.00665429223861428,0.00391550051761822,-0.014328673253146,0.00102008877591744,0.0892529290355947
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VWA5A,von Willebrand factor A domain-containing protein 5A,40080,0.0139333753630809,0.00820960432571356,-0.00215744911531764,0.0300241998414795,0.0896866367224219
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MERTK,Tyrosine-protein kinase Mer,42754,-0.00453922547606479,0.00268829472413101,-0.00980828313536156,0.000729832183231987,0.0913354403064634
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL33,Interleukin-33,42370,0.00688432007110809,0.00408464843029052,-0.00112159085226132,0.0148902309944775,0.0919325726809658
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MUC2,Mucin-2,40527,0.0165135598245641,0.00980627728757277,-0.00270674365907854,0.0357338633082067,0.0922133682242694
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42662,-0.00873776659555497,0.00519268245698258,-0.0189154242112408,0.00143989102013087,0.0924548755715814
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,40065,-0.0092430778316408,0.00549733114696769,-0.0200178468796975,0.00153169121641587,0.092718728474691
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPNMB,Transmembrane glycoprotein NMB,42315,0.00513557397189807,0.00306448438127055,-0.000870815415392217,0.0111419633591883,0.0937940999126339
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,POF1B,Protein POF1B,40199,0.00824155003499897,0.0049237718573343,-0.00140904280537626,0.0178921428753742,0.0941927126432063
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSTM4,Glutathione S-transferase Mu 4,40116,-0.0131542694767272,0.0078707253637708,-0.028580891189718,0.00227235223626353,0.0946929362973234
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TUBB3,Tubulin beta-3 chain,40136,-0.00493528524939336,0.00297202735302228,-0.010760458861317,0.000889888362530302,0.0968267463034749
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL20RA,Interleukin-20 receptor subunit alpha,42370,0.0078579106922598,0.00473853604186933,-0.00142961994980408,0.0171454413343237,0.0972808867199267
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRSS53,Serine protease 53,40483,0.00652668387795051,0.00393583785149466,-0.00118755831097903,0.0142409260668801,0.0972906588762233
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FABP1,"Fatty acid-binding protein, liver",42618,0.0164258996811025,0.00991830776014589,-0.00301398352878347,0.0358657828909884,0.0977210587649203
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGBL2,Cytosolic carboxypeptidase 2,40136,0.0158821691550935,0.00959821963960133,-0.0029303413385251,0.0346946796487121,0.0980141507864704
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TCL1B,T-cell leukemia/lymphoma protein 1B,42357,0.0134871608036198,0.00818537427275705,-0.00255617277098402,0.0295304943782236,0.0994351156738325
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DENND2B,DENN domain-containing protein 2B,40116,-0.00868154745897536,0.00527795809480391,-0.019026345324791,0.0016632504068403,0.10002569215048
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTAG1A_CTAG1B,Cancer/testis antigen 1,40287,-0.00870358213157251,0.00529855051551343,-0.0190887411419788,0.00168157687883382,0.100486911341686
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMPD1,Sphingomyelin phosphodiesterase,42644,-0.0084394710036574,0.00519240947678011,-0.0186165935781464,0.00173765157083161,0.104111914126518
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFL4,Insulin growth factor-like family member 4,40199,0.0125959249025152,0.00777085743371895,-0.0026349556675739,0.0278268054726044,0.105063814012218
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC7A,C-type lectin domain family 7 member A,42754,0.0103769022456918,0.00640200184372236,-0.00217102136800402,0.0229248258593876,0.105065773767298
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPR101,Probable G-protein coupled receptor 101,40136,-0.0103395855654392,0.00638152370578505,-0.0228473720287779,0.00216820089789952,0.105210032922106
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYO6,Unconventional myosin-VI,40482,0.00619837557441473,0.00383493243057454,-0.00131809198951137,0.0137148431383408,0.106058860454315
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HDDC2,5'-deoxynucleotidase HDDC2,40449,0.0074157184485081,0.00463414348131739,-0.00166720277487398,0.0164986396718902,0.109574534277923
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SHPK,Sedoheptulokinase,40302,-0.0069098141086983,0.00433666682377139,-0.0154096810832902,0.00159005286589363,0.111110870497938
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NELL1,Protein kinase C-binding protein NELL1,42679,-0.0073146422579981,0.00460407639105944,-0.0163386319844746,0.0017093474684784,0.112144415362629
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCP2,Non-specific lipid-transfer protein,42346,0.0123659767553311,0.00779467024515166,-0.00291157692516615,0.0276435304358283,0.112657753931885
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCARE,Photoreceptor cilium actin regulator,40136,0.0140743182117186,0.00888135630799538,-0.00333314015195239,0.0314817765753895,0.11306256894569
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAMA1,Laminin subunit alpha-1,40116,-0.00901212160065258,0.0056971417729028,-0.0201785194755421,0.0021542762742369,0.113708849553222
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYPD1,Ly6/PLAUR domain-containing protein 1,42311,-0.010214981706866,0.00645891773254413,-0.0228744604626525,0.00244449704892047,0.113780677782287
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RPGR,X-linked retinitis pigmentosa GTPase regulator,40182,0.00711839704480604,0.00452231417175212,-0.00174533873182812,0.0159821328214402,0.115502205641134
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42495,-0.00478008192476866,0.00305635424122439,-0.0107705362375685,0.00121037238803114,0.117845669576388
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANPEP,Aminopeptidase N,42666,-0.00456410257168234,0.00292064989412112,-0.0102885763641597,0.00116037122079504,0.118146422512002
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGB7,Integrin beta-7,42721,0.00756743012903052,0.0048520813554763,-0.00194264932770302,0.0170775095857641,0.118871785060002
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THSD1,Thrombospondin type-1 domain-containing protein 1,40110,0.00565665022616724,0.00362792396778778,-0.00145408075069681,0.0127673812030313,0.118978615709932
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINB5,Serpin B5,42357,0.00794450455970796,0.00512482142279504,-0.00210014542897033,0.0179891545483862,0.121117261727288
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNNI3,"Troponin I, cardiac muscle",42357,0.0137401562677448,0.00887914235225687,-0.00366296274267865,0.0311432752781683,0.121775354551321
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,40116,-0.00785343781625526,0.00511425923389902,-0.0178773859146973,0.00217051028218682,0.124666375895995
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,40451,0.0103108549266408,0.00672351767534644,-0.00286723971703818,0.0234889495703198,0.125168338365969
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HLA_DRA,,42549,-0.00595231033114348,0.00388984992101219,-0.0135764161763274,0.00167179551404041,0.125986973250148
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RYR1,Ryanodine receptor 1,40116,-0.00556719046312711,0.00364454455854412,-0.0127104977978736,0.00157611687161936,0.126655550563572
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1GALT1C1,C1GALT1-specific chaperone 1,40116,0.00525101119177947,0.00344163006099535,-0.00149458372777142,0.0119966061113304,0.127105137014414
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD27,CD27 antigen,42679,0.0071086466818647,0.0046617520099058,-0.00202838725755067,0.0162456806212801,0.12731064787739
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRC1,Protein regulator of cytokinesis 1,40451,0.00714316525287882,0.00469814555027653,-0.00206520002566318,0.0163515305314208,0.128432959746755
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MSLNL,Mesothelin-like protein,40182,-0.00629152037072199,0.0041578850501564,-0.0144409750690285,0.00185793432758456,0.130269307662275
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRPV3,Transient receptor potential cation channel subfamily V member 3,40116,-0.00776580599018548,0.00513805805656206,-0.0178363997810471,0.00230478780067616,0.13070831245301
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYPLA2,Acyl-protein thioesterase 2,40136,0.0178814254151477,0.0118346287550774,-0.00531444694480395,0.0410772977750993,0.130832369000866
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPIE,Peptidyl-prolyl cis-trans isomerase E,40302,0.0101354778502785,0.00672007930178345,-0.00303587758121702,0.0233068332817741,0.131522107160384
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KRT14,"Keratin, type I cytoskeletal 14",41948,0.00464576873166439,0.00308388632307024,-0.00139864846155328,0.0106901859248821,0.13197245163332
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OLR1,Oxidized low-density lipoprotein receptor 1,42521,0.00916506815841691,0.00608530328498123,-0.0027621262801463,0.0210922625969801,0.132065505472822
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TLR2,Toll-like receptor 2,40302,0.00371899699946198,0.00247255812789877,-0.00112721693121961,0.00856521093014356,0.132581726884976
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSTM2B,V-set and transmembrane domain-containing protein 2B,40302,0.00643477596867378,0.00427855559581294,-0.00195119299911958,0.0148207449364671,0.13262012689953
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMY2B,Alpha-amylase 2B,41779,-0.00795694367122769,0.0052921697301028,-0.0183295963422292,0.0024157089997738,0.132727143719786
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL5,Interleukin-5,42370,0.0220887811600061,0.0146928733000974,-0.00670925050818489,0.0508868128281971,0.132768392899642
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VWC2L,von Willebrand factor C domain-containing protein 2-like,40482,-0.00711958604283,0.00478170302235229,-0.0164917239666405,0.0022525518809805,0.136535668978157
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCL7A,B-cell CLL/lymphoma 7 protein family member A,40080,0.0100576596997749,0.00676238944900071,-0.00319662362026649,0.0233119430198163,0.136966202094181
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42582,-0.0106533684035334,0.00717068678254423,-0.0247079144973201,0.0034011776902533,0.137386500221546
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,40482,-0.00371494329333713,0.00250434229955494,-0.00862345420046482,0.00119356761379056,0.137995882262388
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDNRB,Endothelin receptor type B,40199,0.00697347063033225,0.0047066542622329,-0.00225157172364424,0.0161985129843087,0.138470204266224
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA11,Carbonic anhydrase-related protein 11,42346,0.00506232313884896,0.00342366560852468,-0.0016480614538594,0.0117727077315573,0.139264079833202
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,40136,0.00942766022437552,0.00639794015862211,-0.00311230248652382,0.0219676229352749,0.140632589793946
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZCCHC8,Zinc finger CCHC domain-containing protein 8,40116,0.00937696135755464,0.00637405703879299,-0.00311619043847962,0.0218701131535889,0.14128923400645
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUP50,Nuclear pore complex protein Nup50,40116,-0.0053946485461353,0.0036681189014543,-0.0125841615929857,0.00179486450071514,0.141405051028859
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD164L2,CD164 sialomucin-like 2 protein,40182,-0.00564909710659012,0.00385008119969602,-0.0131952562579943,0.00189706204481408,0.142332056553261
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCARB1,Scavenger receptor class B member 1,42311,0.00894461566164282,0.00612340028342397,-0.00305724889386815,0.0209464802171538,0.144114348787665
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL21R,Interleukin-21 receptor,40199,0.00861860088075287,0.0059071871761854,-0.00295948598457051,0.0201966877460763,0.144592959003986
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",42370,0.0174695241570847,0.012010194553467,-0.00607045716771059,0.04100950548188,0.145815495765469
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC2L,C-type lectin domain family 2 member L,40182,0.00756395448602591,0.00520396331673273,-0.00263581361477024,0.0177637225868221,0.146113868825814
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FBN2,Fibrillin-2,40182,0.00932430279953583,0.00643203306631157,-0.00328248201043485,0.0219310876095065,0.147180084723557
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42679,-0.00683555867746683,0.00472097262815497,-0.0160886650286506,0.0024175476737169,0.147664570277356
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FRMD7,FERM domain-containing protein 7,40182,0.00510824519683763,0.0035355548611955,-0.00182144233110554,0.0120379327247808,0.148536583920709
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CUZD1,CUB and zona pellucida-like domain-containing protein 1,40182,0.00608660751792381,0.0042181100426893,-0.00218088816574722,0.0143541032015948,0.14905734314943
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PMCH,Pro-MCH,40116,-0.0129198665457586,0.00895413004625139,-0.0304699614364113,0.00463022834489413,0.149078821387191
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42495,0.00938055525928645,0.00650531148360767,-0.0033698552485846,0.0221309657671575,0.149330423606911
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",40199,0.00715578713082482,0.00498200216449475,-0.0026089371115849,0.0169205113732345,0.150937573832548
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CORO6,Coronin-6,40136,-0.00564690066721783,0.00393156868445984,-0.0133527752887591,0.00205897395432346,0.150946409987687
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100A3,Protein S100-A3,40451,0.00655452055025799,0.00459195343496481,-0.00244570818227305,0.015554749282789,0.153494488181974
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARNT,Aryl hydrocarbon receptor nuclear translocator,42370,0.00549437559393001,0.00385994563179146,-0.00207111784438125,0.0130598690322413,0.15463422933326
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,40223,0.0055516808081599,0.00391227046462422,-0.00211636930250358,0.0132197309188234,0.155914680537389
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLMP,CXADR-like membrane protein,42721,0.00327276975524556,0.00231232670426978,-0.00125939058512321,0.00780493009561434,0.1569866222968
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FBLN2,Fibulin-2,40527,-0.00486671608578333,0.00344502974226862,-0.0116189743806298,0.00188554220906316,0.157778023735101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLI2,Zinc finger protein GLI2,40199,-0.00477215284308353,0.00338796060935805,-0.0114125556374253,0.00186824995125824,0.158992949041837
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIRREL2,Kin of IRRE-like protein 2,42311,0.00598923535231438,0.00425499027022847,-0.00235054557733343,0.0143290162819622,0.15927943780497
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZPR1,Zinc finger protein ZPR1,40136,0.0144886134313367,0.0103016638249563,-0.00570264766557761,0.034679874528251,0.159623597313689
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,40080,0.00399245644403085,0.00284155689685822,-0.00157699507381126,0.00956190796187296,0.160042591886921
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPHS2,Podocin,40199,-0.0154170269499818,0.0110889820744865,-0.0371514318159754,0.00631737791601181,0.164465498999578
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL15,Interleukin-15,42594,0.0048507014672829,0.00349405860758514,-0.00199765340358398,0.0116990563381498,0.165077510416728
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42676,0.00613442530693372,0.00445005789887569,-0.00258768817486263,0.0148565387887301,0.168070420140483
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHP1,Calcineurin B homologous protein 1,40136,0.0107282781113992,0.00783150715481162,-0.00462147591203156,0.02607803213483,0.170750356004936
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOS2,"Nitric oxide synthase, inducible",40116,-0.00576261589900926,0.00420922905727145,-0.0140127048512613,0.00248747305324278,0.171013962753686
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",40116,-0.0086535473010008,0.00633616130888253,-0.0210724234664106,0.00376532886440897,0.172048789380574
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCGN,Secretagogin,42370,-0.0065020952867397,0.00476580667781238,-0.015843076375252,0.00283888580177256,0.172489520833888
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF9,Fibroblast growth factor 9,40065,0.00592105368587713,0.0043528577731677,-0.00261054754953157,0.0144526549212858,0.173773296005704
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LCN2,Neutrophil gelatinase-associated lipocalin,42240,0.00576247957735997,0.00424889496059905,-0.00256535454541417,0.0140903137001341,0.175049413607314
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRHR1,Corticotropin-releasing factor receptor 1,42357,0.00849500462483851,0.00630507877584761,-0.00386294977582281,0.0208529590254998,0.177898041920902
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GDF15,Growth/differentiation factor 15,42794,0.00654697114092738,0.00487012105117921,-0.00299846611938387,0.0160924084012386,0.178869343652744
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJA1,DnaJ homolog subfamily A member 1,40080,-0.00670539041448864,0.00503597054313638,-0.016575892679036,0.00316511185005866,0.183052710182161
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZP4,Zona pellucida sperm-binding protein 4,40080,-0.00443177773683882,0.00333237651141486,-0.0109632356992119,0.0020996802255343,0.183574119449047
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDX4,Probable ATP-dependent RNA helicase DDX4,40199,0.00752374687024199,0.00566374983916643,-0.00357720281452422,0.0186246965550082,0.184072287335021
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KRT6C,"Keratin, type II cytoskeletal 6C",40116,-0.00549485116693922,0.00413969525040756,-0.013608653857738,0.0026189515238596,0.18441854482323
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SHH,Sonic hedgehog protein,40199,-0.00591034626925894,0.00445948285592349,-0.014650932666869,0.00283024012835111,0.185084786607306
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HRAS,GTPase Hras,40286,0.0137720418558026,0.0105237937609011,-0.00685459391556351,0.0343986776271688,0.190677500488365
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,40177,0.0052309750826657,0.00401189008885078,-0.00263232949148183,0.0130942796568132,0.192305921552734
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FLT3,Receptor-type tyrosine-protein kinase FLT3,42346,0.00420869438357976,0.00323721357555186,-0.00213624422450189,0.0105536329916614,0.193590220431095
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MFAP3L,Microfibrillar-associated protein 3-like,40182,0.00921531407088199,0.00712929674945452,-0.00475810755804888,0.0231887356998129,0.196177342961408
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTF,Ciliary neurotrophic factor,40136,-0.00469300343037887,0.00363152290097766,-0.0118107883162951,0.00242478145553735,0.196281860111259
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDX53,Probable ATP-dependent RNA helicase DDX53,40182,0.00494732998293472,0.00383211700160858,-0.00256361934021811,0.0124582793060875,0.196724781363109
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLK,STE20-like serine/threonine-protein kinase,40302,0.0108840810898336,0.00843678660361002,-0.00565202065324205,0.0274201828329092,0.197051737426311
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSPAN7,Tetraspanin-7,40136,-0.0127222984291765,0.00995919514600215,-0.0322423209153407,0.00679772405698774,0.201473197104311
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GGA1,ADP-ribosylation factor-binding protein GGA1,42311,0.00882993001710747,0.00691244457281521,-0.00471846134561035,0.0223783213798253,0.201485035545831
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATRAID,All-trans retinoic acid-induced differentiation factor,40449,0.0039948497306674,0.00313342746362222,-0.00214666809803216,0.010136367559367,0.202366092593618
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DIPK2B,Divergent protein kinase domain 2B,40283,0.00374837184547949,0.00294150093191402,-0.00201696998107199,0.00951371367203098,0.202581747987937
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,40532,0.00503290052486488,0.00397569427944923,-0.00275946026285561,0.0128252613125854,0.205568670320191
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGEF5,Rho guanine nucleotide exchange factor 5,40136,-0.00994272203683032,0.00785823984745061,-0.0253448721378335,0.00545942806417287,0.205804833169909
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,40080,0.00783644686743093,0.00620248415185947,-0.00432042207021362,0.0199933158050755,0.206459294890258
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DEFB104A_DEFB104B,Beta-defensin 104,40136,0.00714615211582324,0.00566234034040973,-0.00395203495137983,0.0182443391830263,0.206957981603099
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMPRSS11B,Transmembrane protease serine 11B,40136,0.0103591800253061,0.00823334268622047,-0.005778171639686,0.0264965316902982,0.208346797855787
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FSTL1,Follistatin-related protein 1,40223,-0.00299883794989774,0.00238947072309649,-0.00768220056716686,0.00168452466737139,0.209497422810457
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC51B,Organic solute transporter subunit beta,40116,-0.0102062577077554,0.00814169048300535,-0.0261639710544459,0.00575145563893511,0.210021655183037
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSLP,Thymic stromal lymphopoietin,42357,0.00802028240942671,0.00642645169216338,-0.00457556290721351,0.0206161277260669,0.212049227957357
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,H2AP,Huntingtin-interacting protein M,40080,-0.00694328344524923,0.00556443458329914,-0.0178495752285156,0.00396300833801709,0.212132335153715
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLAU,Urokinase-type plasminogen activator,42611,-0.00386159799616956,0.00310275322463676,-0.00994299431645761,0.00221979832411848,0.213311069575204
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MATN3,Matrilin-3,42475,-0.00429178005355629,0.00344922167511963,-0.0110522545367908,0.00246869442967818,0.213420353543332
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITM2A,Integral membrane protein 2A,42594,-0.00808798339309002,0.00650033060433545,-0.0208286313775875,0.00465266459140746,0.213432327621669
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD82,CD82 antigen,40302,-0.00537876012875519,0.00432544659571572,-0.013856635456358,0.00309911519884762,0.213704155455987
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL9,Interleukin-9,40302,0.0073614634395573,0.00593929571161959,-0.00427955615521711,0.0190024830343317,0.215204870168522
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLINT1,Clathrin interactor 1,40080,0.00603803324038269,0.0048800836644553,-0.00352693074194969,0.0156029972227151,0.216009585403138
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACTA2,"Actin, aortic smooth muscle",42357,-0.0057025358945146,0.0046277496263732,-0.0147729251622061,0.00336785337317688,0.21787841362735
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,40482,-0.00346276159848088,0.00282633901003597,-0.00900238605815139,0.00207686286118963,0.22053462864785
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTNAP2,Contactin-associated protein-like 2,42594,-0.00536853244303523,0.00440683997763855,-0.0140059387992068,0.00326887391313632,0.223159084509718
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HIP1,Huntingtin-interacting protein 1,40116,0.00425239420569955,0.00353067551110947,-0.00266772979607502,0.0111725182074741,0.228455790960096
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCNE1,G1/S-specific cyclin-E1,40199,0.0112229135943706,0.00935566189801854,-0.00711418372574575,0.0295600109144869,0.230326300819931
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRPS16,"28S ribosomal protein S16, mitochondrial",40199,0.00357210032753674,0.00300180368879455,-0.00231143490250058,0.00945563555757405,0.234078093773311
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMED10,Transmembrane emp24 domain-containing protein 10,40116,-0.00605500171975526,0.00509553544401291,-0.0160422511900206,0.00393224775051005,0.234742856941749
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYH4,Myosin-4,40116,-0.0056899346532116,0.00479174797340845,-0.0150817606810922,0.00370189137466895,0.235078169877425
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MUCL3,Mucin-like protein 3,40080,-0.00533433135785805,0.00449743700323661,-0.0141493078842018,0.0034806451684857,0.235615604351306
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTNAP4,Contactin-associated protein-like 4,40182,0.0128528520794087,0.0108678416602757,-0.00844811757473174,0.0341538217335491,0.236973508583683
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NEFL,Neurofilament light polypeptide,42262,0.00575916516974658,0.00487113017547205,-0.00378824997417863,0.0153065803136718,0.237105920292159
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGFR4,Fibroblast growth factor receptor 4,40283,0.00659199800173601,0.00560190094669413,-0.00438772785378449,0.0175717238572565,0.239323338282875
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNER,Delta and Notch-like epidermal growth factor-related receptor,42587,0.00307885431343658,0.00262862690631824,-0.00207325442294717,0.00823096304982034,0.241507667673249
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB6A,Ras-related protein Rab-6A,42594,0.00565539874599184,0.00483072535885693,-0.00381282295736775,0.0151236204493514,0.241734496567644
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGFBR1,TGF-beta receptor type-1,40199,0.0026687477155946,0.0022815440063162,-0.00180307853678516,0.00714057396797436,0.24214251736101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRD2,Bromodomain-containing protein 2,40136,0.00441212219896238,0.00377857635385134,-0.00299388745458625,0.011818131852511,0.242966205291347
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RTKN2,Rhotekin-2,40116,-0.0063667692835796,0.00545295885070444,-0.0170545686309603,0.0043210300638011,0.243001443988632
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANXA10,Annexin A10,42311,0.0105640420504731,0.00908472160001801,-0.00724201228556217,0.0283700963865084,0.244917170110061
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CAPN3,Calpain-3,40451,-0.00467029859427719,0.00403429660011334,-0.0125775199304993,0.00323692274194496,0.247031949989137
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDGFRB,Platelet-derived growth factor receptor beta,42794,0.00420629765929434,0.00363980299744289,-0.00292771621569372,0.0113403115342824,0.247849222118537
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC44A4,Choline transporter-like protein 4,40182,-0.00870107058917161,0.00753324530644422,-0.0234662313898023,0.00606409021145905,0.248106179418311
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCN3A,Sodium channel protein type 3 subunit alpha,40182,-0.00449920355798654,0.00391979166120606,-0.0121819952139504,0.00318358809797734,0.251069101480005
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL31,Interleukin-31,40199,0.00681979884043964,0.00594947255685395,-0.0048411673709941,0.0184807650518734,0.251701635978559
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH4,Cadherin-4,40136,0.00598975303214983,0.00525630652506736,-0.00431260775698221,0.0162921138212819,0.254504406775415
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRTAC1,Cartilage acidic protein 1,42794,-0.00357731818901291,0.00314515111714825,-0.00974181437862348,0.00258717800059766,0.255388049021565
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RELB,Transcription factor RelB,40199,0.00593911261734217,0.00524542380494655,-0.00434191804035307,0.0162201432750374,0.257555494873723
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSIG4,V-set and immunoglobulin domain-containing protein 4,42591,0.00521067347187413,0.0046094856313139,-0.00382391836550111,0.0142452653092494,0.258317816859193
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASPN,Asporin,40511,0.00335053755925387,0.00296410941356034,-0.0024591168913244,0.00916019200983214,0.2583447029407
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH22,Cadherin-22,40302,-0.00335149809662555,0.00296761949513524,-0.00916803230709062,0.00246503611383951,0.258772185627519
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIRREL1,Kin of IRRE-like protein 1,40136,-0.00686379391703938,0.00608030686419808,-0.0187811953708676,0.00505360753678886,0.258983122723512
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGAX,Integrin alpha-X,40302,0.00647813975177838,0.00574718896953621,-0.0047863506285126,0.0177426301320694,0.259689019754795
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNPO1,Transportin-1,40302,0.00421566005720863,0.00374173833967534,-0.00311814708855504,0.0115494672029723,0.259911374427679
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAG,Myelin-associated glycoprotein,40182,0.00578496072904343,0.00518239607587931,-0.00437253557968001,0.0159424570377669,0.264330372651721
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMY2A,Pancreatic alpha-amylase,42114,-0.00574489137954884,0.0051565422355903,-0.0158517141613058,0.00436193140220815,0.265258038681305
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UPK3BL1,Uroplakin-3b-like protein 1,40281,-0.0064062469711122,0.00575180470096157,-0.0176797841849969,0.00486729024277247,0.265397580076999
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC4C,C-type lectin domain family 4 member C,42594,0.00560375708259608,0.0050507315406728,-0.0042956767371226,0.0155031909023148,0.26723697855036
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRPL24,"39S ribosomal protein L24, mitochondrial",40116,0.00457643722621859,0.0041253865067616,-0.00350932032703415,0.0126621947794713,0.267309950589118
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL2RG,Cytokine receptor common subunit gamma,40451,0.00428238658365811,0.00386335186327558,-0.00328978306836204,0.0118545562356783,0.267685146062737
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CBX2,Chromobox protein homolog 2,40116,-0.00468922610522389,0.00424153905299565,-0.0130026426490954,0.00362419043864758,0.26894644824693
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHGB,Secretogranin-1,42664,-0.00499913738273258,0.0045259952015212,-0.0138700879777141,0.00387181321224898,0.269379204731206
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,40116,-0.0059377641353965,0.00537885853476359,-0.0164803268635331,0.00460479859274015,0.269657435303441
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TCN1,Transcobalamin-1,40337,0.00397173411770525,0.00360089090087296,-0.00308601204800575,0.0110294802834163,0.270056839970829
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD3E,T-cell surface glycoprotein CD3 epsilon chain,40302,0.00424930177623171,0.00389020409215265,-0.00337549824438748,0.0118741017968509,0.274721352973768
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SKIV2L,Helicase SKI2W,40116,-0.00455991425969528,0.00420720559941457,-0.0128060372345478,0.00368620871515727,0.278462143650085
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1A,Interleukin-1 alpha,42370,0.00665496630988572,0.00614479827780647,-0.00538883831461495,0.0186987709343864,0.278817422911712
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACTN4,Alpha-actinin-4,42370,0.00373190363540971,0.00345085833060355,-0.00303177869257324,0.0104955859633927,0.279520275287114
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LTA4H,Leukotriene A-4 hydrolase,42721,-0.00665471824161839,0.00615840544189952,-0.0187251929077414,0.00541575642450466,0.279898298736002
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP9,Matrix metalloproteinase-9,42594,0.00681323576453116,0.00632382751852559,-0.00558146617177901,0.0192079377008413,0.281324953918371
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSMD5,26S proteasome non-ATPase regulatory subunit 5,40182,-0.00636131929706413,0.005910390591395,-0.0179456848561983,0.00522304626207007,0.281819318242232
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SELENOP,Selenoprotein P,40539,-0.0026073732949594,0.00242642267567046,-0.0073631617392735,0.00214841514935471,0.282587875577045
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPR158,Probable G-protein coupled receptor 158,40482,0.00408226586517169,0.0037999805348414,-0.00336569598311746,0.0115302277134608,0.282717483614023
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPTP,Ceramide-1-phosphate transfer protein,40116,-0.00452790345663346,0.00422469156667525,-0.012808298927317,0.00375249201405003,0.283846418128607
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL4,Interleukin-4,42370,0.0105789501406573,0.00987268722979603,-0.00877151682974289,0.0299294171110576,0.283947647706666
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,40527,-0.0159965317397419,0.014982439836763,-0.0453621138197974,0.0133690503403135,0.285685204739903
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42679,-0.00393635171693774,0.00368943114179804,-0.0111676367548619,0.00329493332098642,0.286024144685448
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LMOD2,Leiomodin-2,40136,0.00698917235614937,0.00659129357075011,-0.00592976304252085,0.0199081077548196,0.289002304286619
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGB1,Integrin beta-1,42638,-0.00238050278659465,0.00224959953453174,-0.00678971787427686,0.00202871230108755,0.28998803338042
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GKN1,Gastrokine-1,42017,0.00310172886429121,0.00295878007388563,-0.00269748008052461,0.00890093780910704,0.294513985607079
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,40116,-0.00375757571565143,0.00358644361809134,-0.0107870052071105,0.0032718537758076,0.294792483865025
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,40080,-0.00934884047389929,0.00893556808400144,-0.0268625539185421,0.00816487297074352,0.295468731305389
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KCNC4,Potassium voltage-gated channel subfamily C member 4,40136,0.00620830340733641,0.00593752619611256,-0.00542924793704421,0.017845854751717,0.295766822922105
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,42346,0.0139614054957873,0.0133755075147195,-0.0122545892330628,0.0401774002246375,0.29659536060246
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCTPP1,dCTP pyrophosphatase 1,42636,0.0034611353262253,0.00333181196581323,-0.00306921612676862,0.00999148677921923,0.29890959759776
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD33,Myeloid cell surface antigen CD33,42679,0.00876052686094896,0.00843995522614967,-0.00778178538230439,0.0253028391042023,0.299296756646306
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDC123,Cell division cycle protein 123 homolog,40080,0.00692292429727326,0.00667032512424745,-0.00615091294625174,0.0199967615407983,0.299354055771473
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PEPD,Xaa-Pro dipeptidase,40532,0.00288713548788502,0.00278532910678002,-0.00257210956140382,0.00834638053717386,0.299967296325283
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,40116,-0.00654681423071648,0.00633000068739591,-0.0189536155780125,0.00585998711657951,0.301041390408022
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,40449,0.00336793574693204,0.00326039647328772,-0.00302244134071189,0.00975831283457597,0.301633817629258
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FSHB,Follitropin subunit beta,40223,-0.00589441338928339,0.00571385042823646,-0.0170935602286269,0.00530473345006008,0.302281727589672
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,40182,-0.0044460631404765,0.00432979070777727,-0.01293245292772,0.00404032664676696,0.304511796082324
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EFNB2,Ephrin-B2,40182,0.00591381439014035,0.00576371196783074,-0.0053830610668079,0.0172106898470886,0.304894060269228
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYL4,Myosin light chain 4,40223,0.00564204395113531,0.00550584636600771,-0.00514941492623981,0.0164335028285104,0.305509820483898
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,40136,0.00544184715607168,0.005314962241115,-0.00497547883651371,0.0158591731486571,0.305917826439696
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL17F,Interleukin-17F,42370,0.00811609610216295,0.00796613801498194,-0.00749753440720165,0.0237297266115276,0.308305027189445
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB6B,Ras-related protein Rab-6B,42311,0.00523623209429812,0.00518943615607504,-0.00493506277160895,0.0154075269602052,0.31298483557494
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FH,"Fumarate hydratase, mitochondrial",40136,0.00910683324567178,0.00904478116797891,-0.00862093784356689,0.0268346043349105,0.314024061841627
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA6,Corticosteroid-binding globulin,40539,0.00166356311983264,0.00165491798399687,-0.00158007612880123,0.00490720236846651,0.314810485476164
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SAG,S-arrestin,40136,-0.00555381309007509,0.0055367413578807,-0.0164058261515213,0.00529819997137108,0.315842827124337
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNL2,Interferon lambda-2,40136,0.00656136839634685,0.00654158972740666,-0.0062601474693702,0.0193828842620639,0.315871690353149
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,42357,0.00351597751339896,0.0035265383378551,-0.00339603762879704,0.010427992655595,0.318780250778118
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPP10,Inactive dipeptidyl peptidase 10,42594,0.00376323842667405,0.00378416882428632,-0.00365373246892714,0.0111802093222752,0.320012567925626
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPLX2,Complexin-2,40080,-0.00332752747381859,0.00335476420324435,-0.00990286531217752,0.00324781036454033,0.321277537163285
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HBZ,Hemoglobin subunit zeta,40511,0.0111183026162427,0.0112185683120213,-0.010870091275319,0.0331066965078044,0.321676240180908
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPT1,Palmitoyl-protein thioesterase 1,40182,0.00803775650786422,0.0081392501985777,-0.00791517388134806,0.0239906868970765,0.323404461903894
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAP1A,Ras-related protein Rap-1A,40199,0.00739386237360895,0.00749563912984838,-0.00729759032089388,0.0220853150681118,0.323947823384061
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTSL5,ADAMTS-like protein 5,40511,-0.00408285238169204,0.00416355219863401,-0.0122434146910147,0.00407770992763063,0.326802335874634
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FZD10,Frizzled-10,40182,0.00627986727958645,0.00640996966090963,-0.00628367325579643,0.0188434078149693,0.327254254792582
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SAP18,Histone deacetylase complex subunit SAP18,40302,-0.00758842089934016,0.00781976749345452,-0.022915165186511,0.00773832338783069,0.331860726001371
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,42311,0.00465025514173436,0.00480248255515697,-0.00476261066637329,0.014063120949842,0.332911244887227
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDX1,ATP-dependent RNA helicase DDX1,40449,0.0050881963002505,0.00527749967532408,-0.0052557030633847,0.0154320956638857,0.335001416752419
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAC3,Ras-related C3 botulinum toxin substrate 3,40182,0.00724540647647211,0.00752923887182087,-0.00751190171229679,0.022002714665241,0.335918776939686
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,40302,0.0048088738519634,0.00499935615598601,-0.00498986421376917,0.014607611917696,0.336121463378968
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42676,0.00581228355799327,0.00605407818859956,-0.00605370969166187,0.0176782768076484,0.337041798890427
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL13,Interleukin-13,42370,-0.00480402524127086,0.00500479717075778,-0.0146134276959561,0.00500537721341439,0.337131161484881
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DTX2,Probable E3 ubiquitin-protein ligase DTX2,40182,-0.00642265414729428,0.00669783930375721,-0.0195504191826584,0.00670511088806985,0.337622999232998
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HTR1A,5-hydroxytryptamine receptor 1A,40136,-0.00791742419447211,0.00828964854494861,-0.0241651353425714,0.00833028695362717,0.339549395484275
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NME3,Nucleoside diphosphate kinase 3,42638,0.0024074068341638,0.0025216070661418,-0.00253494301547414,0.00734975668380173,0.339740864627899
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC1A4,Neutral amino acid transporter A,40182,0.00524707521543469,0.00550493405684812,-0.00554259553598763,0.016036745966857,0.34053068784123
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL10,Interleukin-10,42370,0.00850920462088364,0.00895241760127962,-0.00903753387762441,0.0260559431193917,0.341879563128941
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD70,CD70 antigen,42594,-0.00428846468710617,0.0045594040192228,-0.0132248965647829,0.0046479671905705,0.346939287587681
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNF168,E3 ubiquitin-protein ligase RNF168,40199,0.00396558685980956,0.00423628310245238,-0.00433752802099711,0.0122687017406162,0.349241970781175
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TFRC,Transferrin receptor protein 1,42673,0.00372604614149284,0.00398338795385935,-0.00408139424807147,0.0115334865310572,0.349600887853949
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MED21,Mediator of RNA polymerase II transcription subunit 21,40116,0.00474539187907143,0.00507525101527131,-0.00520210011086034,0.0146928838690032,0.349805703199461
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LY96,Lymphocyte antigen 96,42495,0.00350573912980227,0.00376139741852557,-0.00386659981050785,0.0108780780701124,0.351337403678065
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAPRE3,Microtubule-associated protein RP/EB family member 3,40080,0.0138965860736745,0.0151396691308951,-0.0157771654228798,0.0435703375702288,0.358695576549644
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RASA1,Ras GTPase-activating protein 1,42311,0.0031209163634922,0.00341116847664293,-0.00356497385072794,0.00980680657771233,0.360255049523143
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UGDH,UDP-glucose 6-dehydrogenase,40116,0.00921341312217314,0.0101076463405308,-0.0105975737052672,0.0290243999496135,0.362036811555585
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VTCN1,V-set domain-containing T-cell activation inhibitor 1,42346,-0.00302740126085767,0.00335864182337487,-0.00961033923467242,0.00355553671295707,0.367404606322075
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRME1,Break repair meiotic recombinase recruitment factor 1,40136,-0.00398010177552752,0.00442951330075417,-0.0126619478450057,0.00470174429395065,0.368916672242499
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INSL4,Early placenta insulin-like peptide,40451,-0.00461563882947467,0.00513846425504549,-0.0146870287693638,0.00545575111041448,0.369070113115208
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HIF1A,Hypoxia-inducible factor 1-alpha,40199,0.00585135818928352,0.00655681504950203,-0.00699999930774045,0.0187027156863075,0.372193471507482
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAAA,N-acylethanolamine-hydrolyzing acid amidase,42439,0.00562578430815592,0.00630741277200219,-0.00673674472496837,0.0179883133412802,0.372445497873752
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERCC1,DNA excision repair protein ERCC-1,40080,0.00320636103438521,0.00360991298680609,-0.00386906841975473,0.0102817904885252,0.374447392280303
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINK8,Serine protease inhibitor Kazal-type 8,40116,0.00353645919379563,0.00399483346503815,-0.00429341439767914,0.0113663327852704,0.376036862591595
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP4,Caspase-4,40302,0.0161083682493633,0.0182401935533138,-0.0196424111151318,0.0518591476138584,0.377187929267098
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYL6B,Myosin light chain 6B,40182,0.00844321343738099,0.00960870984144176,-0.0103898578518449,0.0272762847266068,0.379580909607268
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OFD1,Oral-facial-digital syndrome 1 protein,40302,0.00609658313370765,0.0069487364872867,-0.00752294038137429,0.0197161066487896,0.380307005744307
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CGN,Cingulin,40182,0.00381380451578261,0.00435344996523096,-0.00471895741607008,0.0123465664476353,0.381026414109765
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MFAP4,Microfibril-associated glycoprotein 4,40283,-0.00300517473716735,0.00343167613464231,-0.00973125996106629,0.00372091048673158,0.381203248399395
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RGS8,Regulator of G-protein signaling 8,42370,0.0059159462578043,0.00679646363805513,-0.00740512247278376,0.0192370149883924,0.384073244766742
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMED1,Transmembrane emp24 domain-containing protein 1,40302,0.00494663714796435,0.00570756929191867,-0.00624019866419625,0.016133472960125,0.386135991284335
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NENF,Neudesin,40451,0.0100282680005971,0.0116136060903671,-0.0127343999365225,0.0327909359377166,0.387884842848613
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,40136,0.00684879525639125,0.00798974726283552,-0.00881110937876636,0.0225086998915489,0.391354249249146
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TFF3,Trefoil factor 3,42613,0.00388316184633322,0.00453474750644891,-0.00500494326630666,0.0127712669589731,0.391840133157588
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BHLHE40,Class E basic helix-loop-helix protein 40,40136,0.00628001874689333,0.00741449562241242,-0.00825239267303501,0.0208124301668217,0.397018084595341
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERVV_1,,40116,-0.00387180749508169,0.00461175765182496,-0.0129108524926586,0.00516723750249523,0.401178346092411
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,42357,0.00279417310465971,0.00333091468346384,-0.00373441967492942,0.00932276588424885,0.401562770488429
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HYAL1,Hyaluronidase-1,42544,0.00204419492548013,0.00244162278280017,-0.0027413857288082,0.00682977557976845,0.402479416374442
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42737,0.00305633173882844,0.00365283824500889,-0.00410323122138898,0.0102158946990459,0.402775677581237
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42658,-0.00569275536548568,0.00684765596124464,-0.0191141610495252,0.00772865031855382,0.405794259908755
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAGE2A,G antigen 2A,40080,0.00582850021134848,0.00704295821760411,-0.00797569789515558,0.0196326983178525,0.407935480138844
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HNF1A,Hepatocyte nuclear factor 1-alpha,40182,0.00625699560709113,0.00757506698077735,-0.00859013567523248,0.0211041268894147,0.40882275353838
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK12,Kallikrein-12,42346,0.0121439113195755,0.0147189946796863,-0.0167053182526097,0.0409931408917608,0.409357984801161
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GJA8,Gap junction alpha-8 protein,40080,0.00566845878609283,0.00689428442678915,-0.00784433869041391,0.0191812562625996,0.410982891709695
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MN1,Transcriptional activator MN1,40182,-0.00514030517131363,0.00626350734610983,-0.0174167795696889,0.00713616922706164,0.411849101497256
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GUCY2C,Heat-stable enterotoxin receptor,40302,-0.006933848722161,0.00850846285850267,-0.0236104359248262,0.00974273848050424,0.415126683517584
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLB1,"Phospholipase B1, membrane-associated",40483,-0.0051657421919855,0.00634054130321772,-0.0175932031462922,0.00726171876232123,0.415251921429063
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDSN,Corneodesmosin,42710,-0.00381560509870901,0.00469059084720811,-0.0130091631592369,0.00537795296181889,0.415969058579101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK15,Kallikrein-15,40429,0.00457931672543391,0.00563247425054362,-0.00646033280563159,0.0156189662564994,0.416223563964191
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF3,Fibroblast growth factor 3,40199,0.00247892927257682,0.00307179881593758,-0.00354179640666083,0.00849965495181448,0.41968624364921
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42611,0.0100589025585525,0.0124948217382324,-0.0144309480483829,0.0345487531654879,0.420807571929045
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPSG1,Tryptase gamma,40199,0.00224215209641642,0.00280697083985681,-0.00325951074970293,0.00774381494253578,0.424435242046963
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL17C,Interleukin-17C,42370,-0.00628461813845461,0.00787205229028799,-0.0217138406274191,0.00914460435050985,0.42468436406345
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IMPG1,Interphotoreceptor matrix proteoglycan 1,40136,-0.00254084816952286,0.00318906237327928,-0.00879141042115025,0.00370971408210453,0.425620315501377
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA3,Alpha-1-antichymotrypsin,40502,-0.001273085137383,0.0016020147723303,-0.00441303409115039,0.00186686381638439,0.426817785844897
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD177,CD177 antigen,42595,-0.0110001122235844,0.0138766060537056,-0.0381982600888473,0.0161980356416786,0.427961346594248
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL20,Interleukin-20,42370,-0.00403585019805307,0.00518287953249018,-0.0141942940817338,0.00612259368562768,0.436177044305174
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SYT1,Synaptotagmin-1,40483,0.00347442204076938,0.00447054432229298,-0.00528784483092487,0.0122366889124636,0.437068284005128
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KRT17,"Keratin, type I cytoskeletal 17",40116,0.00323290285843764,0.00416580194249318,-0.004932068948849,0.0113978746657243,0.437731696056949
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCND2,G1/S-specific cyclin-D2,40302,0.00301924627574788,0.00389713051259883,-0.00461912952894584,0.0106576220804416,0.4385123204026
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MZB1,Marginal zone B- and B1-cell-specific protein,42660,0.00430738014655834,0.0055645534501937,-0.00659914461582132,0.015213904908938,0.438900196412836
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLSPN,Claspin,42292,0.00284130979705401,0.0036932268787953,-0.00439741488538477,0.0100800344794928,0.441711375330798
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZP3,Zona pellucida sperm-binding protein 3,40223,0.0219713460634415,0.0285973285383971,-0.0340794178718167,0.0780221099986998,0.44232503934174
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPHA10,Ephrin type-A receptor 10,42311,-0.00539953543055043,0.00705359832782162,-0.0192245881530808,0.00842551729197994,0.443987140989817
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OSTN,Osteocrin,40182,-0.0033746578085621,0.00441934405397974,-0.0120365721543624,0.0052872565372382,0.44511574676468
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC4A1,Band 3 anion transport protein,40527,0.00377256898753746,0.00494750267704525,-0.00592453625947124,0.0134696742345462,0.44576567182059
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PALLD,Palladin,40199,-0.00310681850066083,0.00411462815669382,-0.0111714896877807,0.00495785268645905,0.450225150489671
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ICAM2,Intercellular adhesion molecule 2,42794,0.00256196147489279,0.00341409604804827,-0.00412966677928182,0.00925358972906739,0.453022615678114
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PYDC1,Pyrin domain-containing protein 1,40223,-0.00338777641924998,0.00451699099892494,-0.0122410787771429,0.00546552593864291,0.453266280437532
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXK,Tyrosine-protein kinase TXK,40302,0.00592395789653785,0.00792321219436731,-0.00960553800442208,0.0214534537974978,0.454674309214411
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GH2,Growth hormone variant,42346,0.0131481854324701,0.0175878376846245,-0.0213239764293939,0.0476203472943341,0.45473136639354
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSF2RB,Cytokine receptor common subunit beta,40199,-0.00342170043819635,0.00459396101101085,-0.0124258640197776,0.00558246314338492,0.456392973447613
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDA2R,Tumor necrosis factor receptor superfamily member 27,42721,-0.00321602584247487,0.00432969447339768,-0.0117022270103343,0.00527017532538459,0.457625633438138
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRTN3,Myeloblastin,42276,0.00380683742186882,0.00513995567555581,-0.00626747570222057,0.0138811505459582,0.458927323884095
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAD2,Glutamate decarboxylase 2,40199,-0.00360209722602667,0.00486816316646249,-0.0131436970322932,0.00593950258023981,0.459358596098438
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TFAP2A,Transcription factor AP-2-alpha,40136,0.00474107852670698,0.00644576616069083,-0.00789262314824704,0.017374780201661,0.462030261501609
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL4R,Interleukin-4 receptor subunit alpha,42594,-0.00293383747942957,0.00399392750420921,-0.0107619353876796,0.00489426042882048,0.462611499328286
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL11,Interleukin-11,42370,0.0048058005358455,0.0066052719690036,-0.00814053252340156,0.0177521335950926,0.466889517951654
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMIGO1,Amphoterin-induced protein 1,40182,0.00388473555653615,0.00534155903847413,-0.00658472015887314,0.0143541912719454,0.467078369636548
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP15,Matrix metalloproteinase-15,40511,0.00371655012104927,0.00515258575807308,-0.00638251796477396,0.0138156182068725,0.470741049690744
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HDAC8,Histone deacetylase 8,40199,0.00447770052132236,0.00623999030971005,-0.00775268048570933,0.0167080815283541,0.473030706192873
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC11A,C-type lectin domain family 11 member A,42592,0.00369772741124761,0.00516609855666523,-0.00642782575981624,0.0138232805823115,0.474147162671039
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSH1,Chorionic somatomammotropin hormone 1,40532,-0.00214326380792203,0.00300472746226374,-0.00803252963395897,0.0037460020181149,0.475676525497654
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALMS1,Alstrom syndrome protein 1,40302,-0.00335088215695114,0.00470935053828454,-0.0125812092119888,0.00587944489808655,0.47676581486818
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRTAM,Cytotoxic and regulatory T-cell molecule,42495,0.00388919662745117,0.0054792092548726,-0.00685005351209912,0.0146284467670015,0.477834511197348
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPBGL,Trophoblast glycoprotein-like,40182,-0.00314236827690953,0.00443758860710665,-0.0118400419468386,0.00555530539301951,0.478882538223464
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BSND,Barttin,40080,0.00252866722367444,0.00360693279781756,-0.00454092106004797,0.00959825550739685,0.483282128165699
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCN,Decorin,42357,-0.00177313343967895,0.00253085753524333,-0.00673361420875587,0.00318734732939797,0.483561448231252
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UHRF2,E3 ubiquitin-protein ligase UHRF2,40116,-0.00266628659760578,0.00383126439264967,-0.0101755648071991,0.00484299161198757,0.486488331619617
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TAGLN3,Transgelin-3,40080,0.00447606049315362,0.00647615088871964,-0.00821719524873688,0.0171693162350441,0.489479343462871
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRAME,Melanoma antigen preferentially expressed in tumors,40080,-0.00183822277666216,0.00266412758934366,-0.00705991285177572,0.00338346729845141,0.490214858787175
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRP2,Low-density lipoprotein receptor-related protein 2,40182,0.00268538575929793,0.00389403662044369,-0.00494692601677169,0.0103176975353676,0.490450944129152
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPB41L5,Band 4.1-like protein 5,40182,0.00446404571245215,0.0064734952795474,-0.00822400503546074,0.0171520964603651,0.490467776230689
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IKZF2,Zinc finger protein Helios,42346,0.00638321318415555,0.00927432333153916,-0.0117944605456612,0.0245608869139723,0.491296628988034
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTLA4,Cytotoxic T-lymphocyte protein 4,40527,0.00217343287963555,0.00317071869787211,-0.00404117576819379,0.00838804152746489,0.493061339326526
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAL,Galanin peptides,42676,-0.0046230832141384,0.00676128859456165,-0.0178752088594792,0.00862904243120244,0.494139925659279
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCAN,Brevican core protein,42495,-0.00249134092839236,0.00364824565788927,-0.00964190241785533,0.00465922056107061,0.494689900847492
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCLRE1C,Protein artemis,40080,0.00222102259112233,0.00330161581832613,-0.00425014441279688,0.00869218959504153,0.501147506691736
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,40116,-0.00479524864423101,0.0071428420971341,-0.0187952191546139,0.00920472186615183,0.502020560758361
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",40482,-0.00288608223837098,0.00430901196556345,-0.0113317456908753,0.00555958121413338,0.503012898456532
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UBQLN3,Ubiquilin-3,40116,0.00383849501522448,0.00573284807010926,-0.00739788720218967,0.0150748772326386,0.503151443889067
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLXDC2,Plexin domain-containing protein 2,40483,-0.00192205061274593,0.00287992907816602,-0.00756671160595134,0.00372261038045947,0.504533424018643
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSCA,Prostate stem cell antigen,40449,0.0186800120144925,0.0280819102264259,-0.0363605320293022,0.0737205560582872,0.505937911241486
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENPEP,Glutamyl aminopeptidase,40116,-0.00335085849139603,0.00504079533958686,-0.0132308173569863,0.00652910037419421,0.506225738259064
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPTX1,Neuronal pentraxin-1,42611,-0.00275313574588531,0.00421936688794872,-0.0110230948462648,0.00551682335449418,0.514090027130506
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BMP4,Bone morphogenetic protein 4,42475,-0.00319681834174078,0.00490717590403956,-0.0128148831136583,0.00642124643017675,0.514762239331108
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOS1,"Nitric oxide synthase, brain",42311,-0.00364842683158578,0.00571258672990465,-0.0148450968221989,0.00754824315902734,0.523052307343577
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DAND5,DAN domain family member 5,40199,0.00371506970011567,0.00585187789565754,-0.0077546109753731,0.0151847503756045,0.525538888266838
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,40451,-0.00298609989198543,0.00473774094238706,-0.0122720721390641,0.00629987235509322,0.52852467862225
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADRA2A,Alpha-2A adrenergic receptor,40116,-0.00462692398309133,0.00735027168217542,-0.0190334564801551,0.00977960851397248,0.52904135006577
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,40136,-0.00387008861806785,0.00617874429458552,-0.0159804274354555,0.00824025019931977,0.531095053559866
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TET2,Methylcytosine dioxygenase TET2,40286,0.00670450506044033,0.0108079548193283,-0.014479086385443,0.0278880965063237,0.535052899401301
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EVPL,Envoplakin,40302,-0.00228533565042987,0.00371682444063934,-0.00957031155408298,0.00499964025322323,0.538658180865644
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARG2,"Arginase-2, mitochondrial",40451,0.00277028615529794,0.00450858260140774,-0.00606653574346123,0.0116071080540571,0.538932242577535
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDIA2,Protein disulfide-isomerase A2,40080,-0.00273445558859444,0.00445241924390013,-0.0114611973066387,0.00599228612944981,0.539128701652682
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SHD,SH2 domain-containing adapter protein D,40083,-0.00567276558709763,0.00928734688163105,-0.0238759654750945,0.0125304343008992,0.541340884590148
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRPL28,"39S ribosomal protein L28, mitochondrial",40482,-0.00238011621562398,0.00391648909455329,-0.0100564348409484,0.00529620240970047,0.543387544875265
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCDC2C,Doublecortin domain-containing protein 2C,40080,0.00405853844728696,0.00669062421680498,-0.0090550850176508,0.0171721619122247,0.544128474777629
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MORN4,MORN repeat-containing protein 4,40080,-0.00490330006106971,0.00812343741675439,-0.0208252373979083,0.0110186372757689,0.546122743020414
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCUN1D2,DCN1-like protein 2,40080,0.00508645317508753,0.00846698414210495,-0.0115088357434382,0.0216817420936132,0.548025905912686
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,40116,0.00451015294786162,0.0075736446631826,-0.0103341905919763,0.0193544964876995,0.551517442308067
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KHDC3L,KH domain-containing protein 3,40080,-0.00434178979405431,0.00729225489937886,-0.0186346093968369,0.00995102980872826,0.551590222850113
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL4A4,Collagen alpha-4(IV) chain,40284,-0.00334925807784547,0.00565112603051852,-0.0144254650976618,0.00772694894197082,0.553413489051919
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PITHD1,PITH domain-containing protein 1,40065,-0.00503343164655421,0.00852913063406042,-0.0217505276893126,0.0116836643962042,0.555105091288382
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRV1,Adhesion G-protein coupled receptor V1,40136,-0.00442282994500391,0.00752381162018293,-0.0191695007205625,0.0103238408305546,0.556648922115014
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH17,Cadherin-17,42636,-0.0042893531757939,0.00731577561290682,-0.0186282733770913,0.0100495670255035,0.557673312346042
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EVI2B,Protein EVI2B,40080,-0.00252390192254182,0.00432570525110754,-0.0110022842147126,0.00595448036962896,0.55959172923557
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HTR1B,5-hydroxytryptamine receptor 1B,40136,-0.00265043668955359,0.00456929168288589,-0.0116062483880099,0.00630537500890275,0.561890032777092
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL2RB,Interleukin-2 receptor subunit beta,42370,0.00240021989656244,0.0041380281789333,-0.00571031533414682,0.0105107551272717,0.561897882882073
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRNN,Cornulin,42209,0.00418544773811142,0.00728237633197317,-0.010088009872556,0.0184589053487788,0.565479428695246
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UPK3A,Uroplakin-3a,40136,0.00309603682887763,0.00540120801270305,-0.00749033087602034,0.0136824045337756,0.566512992305615
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,40527,0.00152618659689538,0.0026668517453225,-0.00370084282393672,0.00675321601772748,0.567143475841399
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100A16,Protein S100-A16,42292,-0.00365955988148844,0.00639575972170982,-0.0161952489360397,0.00887612917306281,0.56720624558771
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGR,Progesterone receptor,40199,0.0059022113545329,0.0103263793738454,-0.014337492218204,0.0261419149272698,0.567627445423071
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THRAP3,Thyroid hormone receptor-associated protein 3,40116,0.00665468621129619,0.0116488929395897,-0.0161771439502995,0.0294865163728919,0.567827042401143
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GFRA3,GDNF family receptor alpha-3,42474,-0.00172478446870578,0.00303170640567942,-0.00766692902383743,0.00421736008642588,0.569423173431703
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAD1,Glutamate decarboxylase 1,40080,-0.00156986130658441,0.00276512968458072,-0.00698951548836263,0.00384979287519381,0.570226530908673
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCIN,Adseverin,40136,0.00434586297716734,0.00770544229658328,-0.0107568039241359,0.0194485298784706,0.572766263522305
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,40302,0.00419111203206158,0.00744526961176532,-0.0104016164069985,0.0187838404711216,0.573498813692318
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRISP2,Cysteine-rich secretory protein 2,42721,0.0035182203768965,0.00625357953514126,-0.00873879551198038,0.0157752362657734,0.573721349595761
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COMP,Cartilage oligomeric matrix protein,42511,-0.00199096720446755,0.00354175611622735,-0.00893280919227315,0.00495087478333805,0.574029247982709
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSP90B1,Endoplasmin,42247,-0.00394483592098936,0.00702800292754985,-0.0177197216589871,0.00983004981700834,0.574600943658001
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IZUMO1,Izumo sperm-egg fusion protein 1,40080,-0.00282564638642126,0.00503924400170004,-0.0127025646297533,0.00705127185691082,0.574994357456232
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REST,RE1-silencing transcription factor,40080,-0.00202781653047577,0.00362427061583382,-0.00913138693751005,0.00507575387655851,0.575825054190224
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARMCX2,Armadillo repeat-containing X-linked protein 2,40136,-0.00368142948884183,0.00661495711389473,-0.0166467454320755,0.00928388645439185,0.57785920794923
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STEAP4,Metalloreductase STEAP4,40136,0.00426543123877993,0.00769514322219067,-0.0108170494767138,0.0193479119542737,0.579383691418355
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAEP,Glycodelin,42495,0.00525022319609524,0.00949015205577734,-0.0133504748332284,0.0238509212254188,0.580116208015577
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPEP2,Dipeptidase 2,42587,-0.00171640071544334,0.00310826848084181,-0.00780860693789328,0.0043758055070066,0.580817273650034
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL17A,Interleukin-17A,42347,-0.00250300784964004,0.00454948742247556,-0.0114200031976921,0.00641398749841206,0.582209655221136
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KDM3A,Lysine-specific demethylase 3A,40199,-0.00505438713638472,0.00925177322532029,-0.0231878626580125,0.013079088385243,0.584860156960744
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ISM2,Isthmin-2,40527,0.00248046354590644,0.00457228398577246,-0.00648121306620759,0.0114421401580205,0.587484852618367
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BTN1A1,Butyrophilin subfamily 1 member A1,40429,0.00222707818065551,0.00416387171003205,-0.0059341103710073,0.0103882667323183,0.592758955661376
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COPE,Coatomer subunit epsilon,42311,0.00267140463282763,0.00499627263431428,-0.00712128973042835,0.0124640989960836,0.5928805511955
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF6,Fibroblast growth factor 6,40199,-0.00233878533884475,0.00437859577041366,-0.0109208330488555,0.00624326237116602,0.593255119690601
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,42113,-0.00211497145806373,0.00396131510336233,-0.0098791490606539,0.00564920614452644,0.593415484986441
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL24,Interleukin-24,42370,0.00284302454570052,0.00532740594137169,-0.007598691099388,0.013284740190789,0.593585648816173
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF20,Fibroblast growth factor 20,40199,-0.00251601334003597,0.0047645116020668,-0.0118544560800869,0.00682242940001495,0.597458821388021
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LELP1,Late cornified envelope-like proline-rich protein 1,40136,-0.00408836280271762,0.00775030379129712,-0.01927895823366,0.0111022326282247,0.597850165049345
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLHL41,Kelch-like protein 41,40482,-0.00264907683260847,0.00505625507230142,-0.0125593367743193,0.00726118310910231,0.600343964153715
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGB2,Integrin beta-2,42569,0.00157453059201292,0.003014490188802,-0.004333870178039,0.00748293136206484,0.60145571725435
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSMA1,Proteasome subunit alpha type-1,42346,0.00253000786189367,0.00487389521961001,-0.00702282676854195,0.0120828424923293,0.603704198950136
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPPP2,Tubulin polymerization-promoting protein family member 2,40302,-0.00437045750963809,0.00856679509238134,-0.0211613758907055,0.0124204608714293,0.609947765759699
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RUVBL1,RuvB-like 1,42346,0.00556207553835475,0.0111422447445948,-0.0162767241610511,0.0274008752377606,0.617655254863058
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SSB,Lupus La protein,42311,0.00305303268338794,0.00613394315563652,-0.00896949590165964,0.0150755612684355,0.618684409644614
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DHODH,Dihydroorotate dehydrogenase,40116,0.00255160587340379,0.00513951517601437,-0.00752184387158437,0.012625055618392,0.619574105924837
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPTXR,Neuronal pentraxin receptor,42636,0.0017686769327315,0.00357557514209154,-0.00523945034576793,0.00877680421123092,0.620851595568346
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LCN15,Lipocalin-15,40482,-0.00326622976815652,0.00660492103212633,-0.0162118749911241,0.00967941545481109,0.620952433878897
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ABO,Histo-blood group ABO system transferase,40532,-0.00751156283235973,0.0153129276706186,-0.0375249010667721,0.0225017754020527,0.623763205577197
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGM2,Phosphoglucomutase-2,40182,0.00309339635863274,0.00631635955009507,-0.0092866683595536,0.0154734610768191,0.624325156641809
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIPR,Gastric inhibitory polypeptide receptor,40199,0.00253011304100607,0.00516974370149956,-0.00760258461393307,0.0126628106959452,0.624562748847365
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NEB,Nebulin,40116,-0.00198075887583575,0.00405792510780772,-0.00993429208713888,0.00597277433546737,0.625473863743894
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARID3A,AT-rich interactive domain-containing protein 3A,40136,0.00203143498459348,0.00429301408622699,-0.00638287262441142,0.0104457425935984,0.636083141163698
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MORC3,MORC family CW-type zinc finger protein 3,40483,0.00140447306564908,0.00298495478328353,-0.00444603830958663,0.0072549844408848,0.637994519446184
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASQ2,Calsequestrin-2,40116,-0.0024345480628551,0.0051894195309059,-0.0126058103434307,0.00773671421772046,0.638981166870783
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTHRC1,Collagen triple helix repeat-containing protein 1,40527,-0.00145229678041246,0.00310143495370132,-0.00753110928966705,0.00462651572884213,0.639603329426211
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL6ST,Interleukin-6 receptor subunit beta,42636,0.0008618737570339,0.00184106559513204,-0.00274661480942489,0.00447036232349269,0.639693111334428
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AXL,Tyrosine-protein kinase receptor UFO,42689,0.00136216276292032,0.00291545525328279,-0.00435212953351395,0.00707645505935459,0.640349107002351
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DIPK1C,Divergent protein kinase domain 1C,40182,0.00206770023561101,0.00443960607915174,-0.0066339276795264,0.0107693281507484,0.641411154537173
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL2,Interleukin-2,42370,-0.00156798005811311,0.0033817774206092,-0.00819626380250714,0.00506030368628092,0.642902167542225
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACAN,Aggrecan core protein,42488,0.00134040540333596,0.00292237922623993,-0.00438745788009431,0.00706826868676624,0.64647921813153
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PODXL2,Podocalyxin-like protein 2,42679,-0.00136475160044432,0.00297891433922642,-0.0072034237053281,0.00447392050443946,0.646861226279443
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL3,Interleukin-3,40080,0.00298852516637496,0.00652864529585804,-0.00980761961350681,0.0157846699462567,0.647137039376209
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REG1B,Lithostathine-1-beta,42794,0.00282106142358676,0.00616631919605116,-0.00926492420067352,0.014907047047847,0.647322460956805
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCRL5,Fc receptor-like protein 5,42611,-0.00283203578703952,0.00620790329074489,-0.0149995262368995,0.00933545466282045,0.648254672235563
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TYRO3,Tyrosine-protein kinase receptor TYRO3,42636,0.00134915365944354,0.00298723540252675,-0.00450582772950889,0.00720413504839598,0.651535958243615
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BTNL10,Butyrophilin-like protein 10,40080,-0.00202615133250056,0.00450586012924704,-0.0108576371858248,0.00680533452082364,0.652957165696241
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,POLR2A,DNA-directed RNA polymerase II subunit RPB1,40199,0.00138283677978798,0.00309441214774572,-0.00468221102979363,0.00744788458936958,0.65496912729708
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PFDN6,Prefoldin subunit 6,40182,0.00304408687449578,0.00684381224155534,-0.0103697851189527,0.0164579588679442,0.656477365123863
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDC25A,M-phase inducer phosphatase 1,40080,-0.00182574010138966,0.00411873567500813,-0.0098984620244056,0.00624698182162628,0.657574320343359
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANXA5,Annexin A5,42261,0.00141525144412835,0.00323064242134885,-0.00491680770171539,0.00774731058997209,0.661341902803939
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TCP11,T-complex protein 11 homolog,40302,0.00273384657017188,0.00625128079466675,-0.00951866378737494,0.0149863569277187,0.661883566395487
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPA33,Cell surface A33 antigen,42587,-0.00636478021264582,0.0146270562571901,-0.0350338104767384,0.0223042500514467,0.663469660618443
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PEAR1,Platelet endothelial aggregation receptor 1,42794,0.00102883976176083,0.00239555687409626,-0.00366645171146784,0.0057241312349895,0.667581965534469
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALDH2,"Aldehyde dehydrogenase, mitochondrial",40451,0.00239352539060513,0.00559008863411382,-0.00856304833225795,0.0133500991134682,0.668533315537917
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDAN1,Codanin-1,40483,0.00101621705155588,0.00238677453937501,-0.00366186104561913,0.0056942951487309,0.670283548832593
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42711,-0.00211261298645323,0.00501202568026419,-0.011936183319771,0.00771095734686458,0.673390281042951
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF7,Fibroblast growth factor 7,40080,-0.00352289974882672,0.00837676177185269,-0.019941352821658,0.0128955533240046,0.67408742772564
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNASE10,Inactive ribonuclease-like protein 10,40223,0.0021931826859459,0.00522037763042952,-0.00803875746969597,0.0124251228415878,0.674406307887972
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TP53INP1,Tumor protein p53-inducible nuclear protein 1,42357,0.00135817327916153,0.0032334061663352,-0.00497930280685546,0.00769564936517853,0.674460072124536
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HMCN2,Hemicentin-2,40269,-0.00255605317734364,0.00616825660806926,-0.0146458361291594,0.00953372977447211,0.678597804454309
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPRR1B,Cornifin-B,40302,-0.00363367724166793,0.00877097167255923,-0.020824781719884,0.0135574272365482,0.678673794495827
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL12RB2,Interleukin-12 receptor subunit beta-2,40199,-0.00180774755149198,0.00440198294791644,-0.0104356341294082,0.00682013902642424,0.681324986249485
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OMP,Olfactory marker protein,40136,-0.00217887810131193,0.00531771173007297,-0.0126015930922549,0.00824383688963108,0.682004857375125
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,40116,-0.00163039512587876,0.00398765093489878,-0.00944619095828036,0.00618540070652284,0.682649654972255
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MSMB,Beta-microseminoprotein,42559,0.00306486364518354,0.0076259823828024,-0.0118820618251092,0.0180117891154762,0.687765851507927
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZNF75D,Zinc finger protein 75D,40302,0.00259257093736834,0.0064787658585001,-0.0101058101452919,0.0152909520200285,0.689043187160342
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MLLT1,Protein ENL,40080,0.00280299467565539,0.0070138001805151,-0.0109440536781542,0.016550043029465,0.689429575875595
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL18RAP,Interleukin-18 receptor accessory protein,42425,-0.00712716889536427,0.0181460644043361,-0.0426934551278631,0.0284391173371346,0.69449816732547
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPGN,Epigen,40451,0.00188063496499094,0.00480219691438034,-0.00753167098719451,0.0112929409171764,0.695346634865139
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINK5,Serine protease inhibitor Kazal-type 5,42611,-0.00138421576243346,0.00362759622852645,-0.0084943043703453,0.00572587284547839,0.702779456100142
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ECSCR,Endothelial cell-specific chemotaxis regulator,40136,-0.00207533945268753,0.00545093854110633,-0.0127591789932559,0.00860850008788088,0.703410503666415
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF5A,Eukaryotic translation initiation factor 5A-1,42370,0.00118305767873193,0.00313645373671047,-0.00496439164522058,0.00733050700268445,0.70603405712117
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42674,-0.00138460877159096,0.00367243406187491,-0.00858257953286577,0.00581336198968386,0.706159075284729
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,40136,-0.00123027971229824,0.00334465403742572,-0.00778580162565266,0.00532524220105618,0.713003630898828
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TP53BP1,TP53-binding protein 1,40199,0.00336729871075052,0.00916475813083775,-0.0145956272256915,0.0213302246471925,0.713314181409201
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDDM3B,Epididymal secretory protein E3-beta,40451,-0.00204233175652478,0.00556037410088566,-0.0129406649942607,0.00885600148121111,0.71340130706001
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CINP,Cyclin-dependent kinase 2-interacting protein,40302,-0.00170078053733928,0.00463495516442209,-0.0107852926596066,0.00738373158492802,0.713665921054498
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CADPS,Calcium-dependent secretion activator 1,40182,0.00164415992563959,0.00452481381966489,-0.0072244751609036,0.0105127950121828,0.7163390765314
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCNA,Proliferating cell nuclear antigen,40080,0.00240030060701495,0.0066079975608324,-0.0105513746122166,0.0153519758262465,0.716431354442105
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,40136,-0.00244737906624403,0.0067399409158972,-0.0156576632614025,0.0107629051289145,0.71652539339811
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,40116,-0.000988420373206742,0.00273336179355329,-0.00634580948857119,0.0043689687421577,0.717647911518227
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NRN1,Neuritin,40482,0.00138593713367273,0.00383862582171002,-0.00613776947687891,0.00890964374422436,0.718068577107805
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DLGAP5,Disks large-associated protein 5,40482,0.00191229748151101,0.00536144562191519,-0.00859613593744276,0.0124207309004648,0.721341250378442
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRP2BP,LRP2-binding protein,40182,0.00324261444310546,0.00911635064592247,-0.0146254328229026,0.0211106617091135,0.72207794579074
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KCNH2,Potassium voltage-gated channel subfamily H member 2,40182,0.00293463062781609,0.00830070667950035,-0.0133347544640046,0.0192040157196368,0.723690538782734
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,40182,0.00189039123120516,0.0053815659339044,-0.00865747799924747,0.0124382604616578,0.725391340221961
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,40116,0.00197280574364035,0.0056408307057007,-0.00908322243953302,0.0130288339268137,0.726543021299097
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DUSP29,Dual specificity phosphatase 29,40182,-0.00245690256032986,0.00711431039601596,-0.0164009509365211,0.0114871458158614,0.729840464624503
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZNF830,Zinc finger protein 830,40451,-0.00282003793442727,0.00818267856320434,-0.0188580879183078,0.0132180120494532,0.730375181324736
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPT1,Translationally-controlled tumor protein,42370,-0.00236992814671778,0.00688917929533262,-0.0158727195655697,0.0111328632721342,0.730846266274615
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CYTH3,Cytohesin-3,40080,-0.00271319529203776,0.0078915402694887,-0.0181806142202356,0.0127542236361601,0.730995358940387
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCAN,Neurocan core protein,42711,-0.00136761557292633,0.00399908731843736,-0.00920582671706355,0.0064705955712109,0.732369812696361
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NGFR,Tumor necrosis factor receptor superfamily member 16,40511,0.001051766067425,0.00312032367782538,-0.00506406834111275,0.00716760047596274,0.736070729231838
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP5PO,"ATP synthase subunit O, mitochondrial",42311,0.00144276334551743,0.00430924907996189,-0.00700336485120788,0.00988889154224274,0.737776630389648
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IDI2,Isopentenyl-diphosphate delta-isomerase 2,42311,-0.00169067102204805,0.00509444238045345,-0.0116757780877368,0.00829443604364072,0.739995923958821
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRND,Prion-like protein doppel,40483,0.00182597219257457,0.00552320539894392,-0.0089995103893555,0.0126514547745046,0.740952714819611
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,40283,-0.00149941316522524,0.00456437375803232,-0.0104455857309686,0.00744675940051812,0.742537133312706
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,40449,0.00599739222738325,0.0184811204276038,-0.0302256038107201,0.0422203882654866,0.745554549653901
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUSD4,Sushi domain-containing protein 4,40451,-0.00140673857567886,0.00442927646106071,-0.0100881204393579,0.00727464328800014,0.75079420116046
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCUN1D1,DCN1-like protein 1,40136,-0.00250940943511575,0.00791879829698812,-0.0180302540972125,0.013011435226981,0.751331061052513
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA8,Carbonic anhydrase-related protein,40199,0.000952232486613699,0.00302356243899618,-0.0049739498938188,0.0068784148670462,0.75281525739946
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,40482,-0.000962225024563046,0.00310864909047394,-0.00705517724189196,0.00513072719276587,0.756922916651279
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK3,Prostate-specific antigen,40527,0.00315354327045321,0.0103602494723093,-0.0171525456952729,0.0234596322361793,0.760837335003024
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HMMR,Hyaluronan mediated motility receptor,40059,0.0015909741648209,0.00524960154281292,-0.00869824485909243,0.0118801931887342,0.76184559555057
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",40136,0.00178588357970215,0.0060185815218507,-0.0100105362031252,0.0135823033625295,0.766679566597899
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HEBP1,Heme-binding protein 1,42357,0.00164753715096384,0.00555321615707788,-0.0092367665169088,0.0125318408188365,0.766714273687482
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NECTIN4,Nectin-4,42679,-0.0010724389208642,0.00363575990533077,-0.00819852833531251,0.00605365049358411,0.768021585632759
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMPD3,Sphingomyelin phosphodiesterase 3,40199,-0.00170116053915521,0.00578769225126876,-0.013045037351642,0.00964271627333156,0.768819028461974
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MORF4L2,Mortality factor 4-like protein 2,40080,0.00113740367343046,0.00388355434292322,-0.00647436283869904,0.00874917018555997,0.769621766069931
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SOD2,"Superoxide dismutase [Mn], mitochondrial",42611,-0.00115637118192821,0.00397156126386587,-0.00894063125910532,0.00662788889524889,0.770931257983358
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DEFB116,Beta-defensin 116,40136,-0.00236009023421414,0.00813687026327318,-0.0183083559502296,0.0135881754818013,0.771784327431856
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNLZ,DNL-type zinc finger protein,40136,0.00276379574074766,0.00961982587678249,-0.016091062977746,0.0216186544592413,0.773886489976538
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WFDC12,WAP four-disulfide core domain protein 12,42698,0.00197199058003638,0.00689314463597405,-0.0115385729064728,0.0154825540665455,0.774821264023063
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,40182,-0.00155126050117442,0.00547242921473405,-0.0122772217620532,0.00917470075970432,0.776823177603131
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OMG,Oligodendrocyte-myelin glycoprotein,42587,0.00190892541736434,0.00697017699410827,-0.0117526214910879,0.0155704723258166,0.784188414792043
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENG,Endoglin,42794,-0.000501287077268612,0.00183080282073519,-0.00408966060590958,0.00308708645137236,0.784236913425124
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCN3B,Sodium channel subunit beta-3,40136,0.00139247998773853,0.005087865431326,-0.00857973625766044,0.0113646962331375,0.784330733300919
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WNT9A,Protein Wnt-9a,42370,0.000850898298255391,0.00312869185657513,-0.00528133774063186,0.00698313433714264,0.7856523034666
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNF4,E3 ubiquitin-protein ligase RNF4,40302,0.00192332160944223,0.00707863340798806,-0.0119507998702144,0.0157974430890988,0.785851568191052
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPHA2,Glycoprotein hormone alpha-2,40449,-0.00132652764112855,0.00491355176264423,-0.0109570890959112,0.00830403381365413,0.787185766722452
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGLC2,Immunoglobulin lambda constant 2,40519,0.000713830395630069,0.00267073932390471,-0.00452081867922317,0.00594847947048331,0.78925983822014
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BEX3,Protein BEX3,40080,0.00134462681339523,0.00505107324872173,-0.00855547675409936,0.0112447303808898,0.790085480791638
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMC3,Structural maintenance of chromosomes protein 3,40080,0.00156088885472717,0.00586980083942312,-0.00994392079054215,0.0130656984999965,0.790306983926093
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LPO,Lactoperoxidase,42134,0.00167250202685213,0.00640805444966551,-0.0108872846944923,0.0142322887481965,0.794096682919917
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FZD8,Frizzled-8,40136,0.00123674638677709,0.0048349990411157,-0.00823985173380968,0.0107133445073639,0.79811748755091
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",40136,-0.00120335843133278,0.00471297870913392,-0.0104407967012353,0.00803407983856971,0.798474082398699
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MORF4L1,Mortality factor 4-like protein 1,40302,0.00106273099078859,0.00421694297175993,-0.00720247723386088,0.00932793921543805,0.801034478903994
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PFDN4,Prefoldin subunit 4,40080,0.00138639507710392,0.00554798526395581,-0.00948765604024947,0.0122604461944573,0.802675871989592
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ART5,Ecto-ADP-ribosyltransferase 5,40136,-0.00169545360085231,0.0068003472179931,-0.0150241341481188,0.0116332269464142,0.803118961671999
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42613,-0.000839539939659922,0.00342001414518212,-0.00754276766421687,0.00586368778489702,0.8060897081148
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39845,-0.00132167001737078,0.00543502405840213,-0.011974317171839,0.0093309771370974,0.807873369488527
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM171A2,Protein FAM171A2,40482,0.00408758992291034,0.0168754464732481,-0.028988285164656,0.0371634650104767,0.808613213894795
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATF4,Cyclic AMP-dependent transcription factor ATF-4,40080,-0.000879291968409334,0.0036545284024823,-0.00804216763727463,0.00628358370045596,0.809867043616257
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNGB3,Cyclic nucleotide-gated cation channel beta-3,40136,0.00133049050091313,0.00569041524918125,-0.00982272338748212,0.0124837043893084,0.81513488010415
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TOP1MT,"DNA topoisomerase I, mitochondrial",40080,-0.0011924233385605,0.00517259414627034,-0.0113307078652504,0.00894586118812937,0.8176865079782
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NLGN1,Neuroligin-1,40182,-0.0016946651580513,0.00738210299246683,-0.0161635870232863,0.0127742567071837,0.818434849481744
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NXPE4,NXPE family member 4,40116,-0.000812654703071669,0.00356244411958204,-0.00779504517745247,0.00616973577130913,0.819559415544526
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ESR1,Estrogen receptor,40199,-0.00131096082328453,0.00583932601181913,-0.01275603980645,0.010134118159881,0.822368153401857
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC34A3,Sodium-dependent phosphate transport protein 2C,40080,0.00119437352883983,0.00534111535159058,-0.0092742125602777,0.0116629596179574,0.823058170242523
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,40451,0.00174352998899839,0.00808609102599856,-0.0141052084219588,0.0175922683999556,0.829287192319997
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHIT1,Chitotriosidase-1,42699,0.00350184930107737,0.0162518618009487,-0.0283517998287821,0.0353554984309368,0.829401244416208
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPTN,Neuroplastin,42346,-0.00164600169856367,0.0082919719691589,-0.0178982667581151,0.0146062633609878,0.842652682579102
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ESPL1,Separin,40080,0.00119968076151222,0.00607734169578166,-0.0107119089622198,0.0131112704852443,0.843516475560243
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP2B4,Plasma membrane calcium-transporting ATPase 4,40116,-0.00126373249063314,0.00647695705057324,-0.0139585683097567,0.0114311033284904,0.845308843744663
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42653,-0.000991287148541128,0.00517868020405602,-0.0111415003484909,0.00915892605140868,0.848201832063857
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRRT3,Proline-rich transmembrane protein 3,40223,0.000783748814832806,0.00422155584656382,-0.00749050064443228,0.00905799827409789,0.852719501927445
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HBQ1,Hemoglobin subunit theta-1,42721,0.00114394997740351,0.00634556713620432,-0.011293361609557,0.013581261564364,0.856939027670416
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",40116,0.000937905394500351,0.00523571895107499,-0.00932410374960663,0.0111999145386073,0.857834291384052
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",40080,0.00103714044403079,0.00586661616277766,-0.0104614272350134,0.012535708123075,0.859679127078924
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD3G,T-cell surface glycoprotein CD3 gamma chain,40199,-0.00166340090782372,0.00956210101797329,-0.0204051189030514,0.0170783170874039,0.861901921285162
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RANGAP1,Ran GTPase-activating protein 1,42346,0.000872254201689451,0.00509206928597953,-0.00910820159883042,0.0108527100022093,0.8639931818973
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UNC5D,Netrin receptor UNC5D,40199,0.000468442783559379,0.00276209128004968,-0.00494525612533799,0.00588214169245675,0.865330088593506
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,40302,0.00122391738105608,0.00737586305636488,-0.0132327742094191,0.0156806089715312,0.868210744990352
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,40080,0.000962257011428717,0.00611797693990611,-0.0110289777907873,0.0129534918136447,0.875024316581794
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSMC3,26S proteasome regulatory subunit 6A,40080,-0.000495375628644628,0.00323572346777741,-0.00683739362548834,0.00584664236819909,0.878325576269151
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAYN,Layilin,42476,-0.000608356864634971,0.00398784017127024,-0.00842452360032463,0.00720780987105469,0.878753131985251
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CBLN1,Cerebellin-1,40136,0.00152193391202304,0.0100279645071851,-0.0181328765220598,0.0211767443461058,0.879371949628132
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,42346,-0.00123405661900248,0.00848543181440651,-0.0178655029752392,0.0153973897372343,0.884371722562221
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RICTOR,Rapamycin-insensitive companion of mTOR,40199,0.000737844669407381,0.00516843981007889,-0.00939229735834725,0.010867986697162,0.88648261706413
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DLL1,Delta-like protein 1,42679,-0.0004718986628489,0.00331334730449813,-0.00696605937966524,0.00602226205396744,0.886747594945502
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAMT,Guanidinoacetate N-methyltransferase,40116,0.000561006211981292,0.00400423214846293,-0.00728728879900605,0.00840930122296863,0.888580942140499
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRYBB2,Beta-crystallin B2,40483,0.00118915671119024,0.00861619895938139,-0.0156985932491973,0.0180769066715778,0.890231756938967
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOLR3,Folate receptor gamma,42629,-0.00267237830048106,0.0195346675556407,-0.0409603267095369,0.0356155701085748,0.891189485718138
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCLN,Nicalin,42370,0.000746463780446682,0.00546488394615624,-0.00996470875401956,0.0114576363149129,0.891354757613176
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,40302,0.000892125055750903,0.00664547457141819,-0.0121330051042287,0.0139172552157306,0.893210879921594
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTN2,Contactin-2,42721,0.000617524741668461,0.00469583633286873,-0.00858631447075424,0.00982136395409116,0.895377991933924
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TEX33,Testis-expressed protein 33,40302,-0.000525344382426808,0.00402892088311075,-0.00842202931332387,0.00737134054847025,0.896257610047521
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHEK2,Serine/threonine-protein kinase Chk2,42357,0.000453746595107541,0.00350193671731757,-0.00641004937083489,0.00731754256104997,0.896908471496687
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CREB3,Cyclic AMP-responsive element-binding protein 3,40080,0.000784048935028511,0.00609306912282211,-0.0111583665457028,0.0127264644157598,0.897614173648432
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MEGF11,Multiple epidermal growth factor-like domains protein 11,40116,0.000457056154530158,0.00355663508362694,-0.00651394860937865,0.00742806091843897,0.897749312983129
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL36A,Interleukin-36 alpha,40199,-0.000776306728084206,0.00607792614968656,-0.0126890419814699,0.0111364285253014,0.898368468572903
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL2RA,Interleukin-2 receptor subunit alpha,42517,-0.000556733044726246,0.00438899697922566,-0.00915916712400853,0.00804570103455604,0.899063059032711
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KCNIP4,Kv channel-interacting protein 4,42311,-0.00065292370519054,0.00519444932907021,-0.0108340443901682,0.00952819697978708,0.899974159047637
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,40302,-0.000829150051727293,0.00669260364931901,-0.0139466532043925,0.012288353100938,0.901404211855602
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HLA_A,,40482,-0.000430801460562938,0.00350053799634463,-0.00729185593339841,0.00643025301227253,0.902056063890002
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",40182,0.00100554151225659,0.00832657998081682,-0.0153145552501444,0.0173256382746576,0.903881085771942
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,40080,-0.000521307790291357,0.00477806142962495,-0.00988630819235626,0.00884369261177355,0.913121652026728
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPRKB,EKC/KEOPS complex subunit TPRKB,40080,-0.000748373744417684,0.00697268115917112,-0.0144148288163931,0.0129180813275577,0.91452963256023
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,L1CAM,Neural cell adhesion molecule L1,42679,-0.000326378391876947,0.00308250561451865,-0.00636808939633349,0.0057153326125796,0.91567844313181
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLXDC1,Plexin domain-containing protein 1,42346,0.000326446746780449,0.00332417603071832,-0.00618893827342745,0.00684183176698835,0.921771954767904
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLSTN1,Calsyntenin-1,42311,-0.000548937443471172,0.00559676171717824,-0.0115185904091405,0.0104207155221982,0.921869266429113
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEND1,Cell cycle exit and neuronal differentiation protein 1,40136,-0.000600370427975979,0.00625714925715616,-0.0128643829720021,0.0116636421160501,0.923562426879161
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF12,Fibroblast growth factor 12,40199,-0.000473196910045226,0.00494357063945449,-0.010162595363376,0.00921620154328557,0.923744967527436
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSPAN15,Tetraspanin-15,40116,0.000513431111689157,0.00550714076981716,-0.0102805647971525,0.0113074270205308,0.925722497148856
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FHIP2A,FHF complex subunit HOOK interacting protein 2A,40116,0.000468752695054832,0.00502821557791796,-0.00938654983766436,0.010324055227774,0.925726950585377
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HK2,Hexokinase-2,42357,-0.000269209328667435,0.00290580761714167,-0.00596459225826511,0.00542617360093023,0.926186788741376
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAMDC2,MAM domain-containing protein 2,40511,-0.000346119622231867,0.0038512779296386,-0.00789462436432353,0.00720238511985979,0.928391023209728
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAPT,Microtubule-associated protein tau,42311,-0.000494672698173599,0.00560648176379268,-0.0114833769552073,0.0104940315588601,0.929693404396339
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SHC1,SHC-transforming protein 1,40080,-0.0010867550629151,0.0124815767999825,-0.0255506455908809,0.0233771354650507,0.93061848078561
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,40451,-0.000821816046518091,0.00955978208514154,-0.0195589889333955,0.0179153568403593,0.931494989068611
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZNF174,Zinc finger protein 174,40199,0.000329153831971555,0.00395248638919089,-0.00741771949084259,0.0080760271547857,0.933632275081552
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP5F1D,"ATP synthase subunit delta, mitochondrial",40116,0.000448556570899625,0.00549232675068633,-0.0103164038604456,0.0112135170022448,0.934910885738662
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42794,-0.00022387175121479,0.00289815307628074,-0.00590425178072503,0.00545650827829545,0.938428704941918
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANK2,Ankyrin-2,40116,0.000535633453689669,0.00778076790446949,-0.0147146716390705,0.0157859385464499,0.945117686873977
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HDAC9,Histone deacetylase 9,40136,-0.00041061186120776,0.00693465394087434,-0.0140025335853215,0.0131813098629059,0.952784662490073
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PHLDB2,Pleckstrin homology-like domain family B member 2,40080,0.000555059624233775,0.0101719073438083,-0.0193818787696305,0.020491998018098,0.956483713968504
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",40116,0.000383328587933646,0.00738769076250143,-0.0140965453065692,0.0148632024824364,0.958619306661556
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMEM132A,Transmembrane protein 132A,40223,0.000334920232226364,0.00661413615826414,-0.0126287866379714,0.0132986271024241,0.959615669425822
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIAA0319,Dyslexia-associated protein KIAA0319,40483,-0.000148064113858261,0.0033089421744248,-0.00663359077573086,0.00633746254801434,0.964310032229617
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAGEA3,Melanoma-associated antigen 3,40302,0.000379734553767383,0.00916823367859447,-0.0175900034562778,0.0183494725638126,0.966963003144088
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GHRHR,Growth hormone-releasing hormone receptor,42311,-0.000234353110281121,0.00592217232619284,-0.0118418108696191,0.0113731046490568,0.968434830850281
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,40136,-0.00012099038891648,0.00351495158021421,-0.00701029548613634,0.00676831470830338,0.972541557377236
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRIK2,"Glutamate receptor ionotropic, kainate 2",40482,0.000148707861339648,0.00472482840419808,-0.00911195581088859,0.00940937153356788,0.974892317558811
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANKRA2,Ankyrin repeat family A protein 2,40080,0.00019028621708666,0.00606528177672545,-0.0116976660652952,0.0120782384994685,0.974972631227644
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYBPC2,"Myosin-binding protein C, fast-type",40223,0.000255789835135615,0.00894998354654039,-0.0172861779160836,0.0177977575863548,0.977200142259526
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINT3,Kunitz-type protease inhibitor 3,40449,-0.000442349677646477,0.0156786312106608,-0.0311724668505416,0.0302877674952486,0.977492338951783
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRX,Cone-rod homeobox protein,42357,-0.000289816445497081,0.0111923471609236,-0.0222268168809074,0.0216471839899132,0.979342149421769
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMED4,Transmembrane emp24 domain-containing protein 4,40116,0.000155528543481121,0.00605588190828231,-0.0117139999967522,0.0120250570837145,0.979511267903183
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",40199,7.66931971056129e-05,0.00299952787807759,-0.00580238144392647,0.00595576783813769,0.979602036342176
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EXOSC10,Exosome component 10,40116,0.00015658000122351,0.00638261927784476,-0.0123533537833522,0.0126665137857992,0.98042850915778
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEZ6L,Seizure 6-like protein,42679,6.36225507340968e-05,0.00295581337887325,-0.00572977167185747,0.00585701677332566,0.982827538968147
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42711,-6.18700153006904e-05,0.0029966470172681,-0.00593529816914617,0.00581155813854479,0.983528019971177
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RLN1,Prorelaxin H1,40482,-8.82940577478129e-05,0.00510914816907205,-0.010102224469129,0.0099256363536334,0.98621230071109
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD34,Hematopoietic progenitor cell antigen CD34,42674,-3.54547037216729e-05,0.00255428221617561,-0.00504184784742588,0.00497093843998253,0.988925527698146
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TAP1,Antigen peptide transporter 1,40302,8.96091806267056e-05,0.00650626186676543,-0.0126626640782335,0.0128418824394869,0.989011522502149
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPSD1,Tryptase delta,40482,4.86033607739459e-05,0.00405226245567978,-0.00789383105235842,0.00799103777390631,0.990430510640351
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42711,2.54206721605613e-05,0.00489907766210652,-0.00957677154556821,0.00962761288988933,0.995859976695866
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOS,Proto-oncogene c-Fos,40065,1.74684585923123e-05,0.00377502972216078,-0.00738158979684281,0.00741652671402743,0.996307991149755
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",40199,1.88994924525744e-05,0.00448260125910845,-0.0087669989754,0.00880479796030515,0.996636054575235
